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Characterisation	of	the	avian	TopBP1	protein	and	its	functions	
One of the proteins that lie at the heart of the DNA Damage Response (DDR) is 
Topoisomerase II-binding protein I (TopBP1). TopBP1 was initially identified and has 
been extensively studied in the yeast model organisms. However, the lack of readily 
available tools, including genetically defined mutant cell lines, has rendered the 
characterisation of TopBP1 in higher eukaryotes more challenging.  
 Sequence information obtained from the characterisation of the gallus gallus 
TopBP1 mRNA revealed a different splicing pattern at the 5’end to the one reported in 
the Genome Browser. Our assembled TopBP1 mRNA sequence containing a novel 
open reading frame (ORF) enabled the creation of a conditional knockout cell line of 
TopBP1 in DT40, which has been impossible with the use of the annotated cDNA 
sequence. Thus the avian TopBP1 ORF identified herein contained the necessary 
function(s) to sustain viability of DT40 cells in the absence of the endogenous protein. 
Additionally, the establishment of an isogenic set of stable cell lines from the chicken B 
cell line DT40 by targeted deletion of the TopBP1 alleles revealed a gene dosage-
dependent reduction of the TopBP1 protein levels and functions. This work establishes 
a novel gene-dosage system that can be used for the knock in of point mutations within 
the endogenous TopBP1 locus. Using this system, a novel characterisation of knock-in 
point mutants of the ATR Activation Domain (AAD) of TopBP1 was carried out, 
providing in vivo evidence of its DDR function(s). Finally, a stably integrated 
overexpression system (SIOS) capable of producing increased amounts of a protein of 
interest has been established in DT40 cells. SIOS represents an easy to use versatile 
system for various experimental purposes in the field of DT40.   
The work presented in this thesis represents a novel characterisation of the avian 
TopBP1 mRNA and the TopBP1 protein and its functions. This is crucial to gain insight 
into the mechanistics of the DDR network and the genetic instability characterising 
cancer development. 
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1.1 The cell division cycle; from its discovery to its understanding 
 
1.1.1 Cell division cycle; definition and a historical perspective  
The cell division cycle is a complex series of events that involve the duplication 
of the genetic material and other cellular compartments of a single parental cell and the 
subsequent division and formation of two daughter cells. It is the process by which a 
multicellular organism arises from a single fertilized oocyte as well as the process by 
which stem cells in our bodies acquire differentiation fates to replace mature tissue like 
hair, skin and blood cells when these become lost, damaged or scarce (Alberts 2002, 
Dalton 2015).  It is thus central to the understanding of multicellular life. 
The concepts of the “cell” and the “cell theory” have been proposed as early as 
the 18th and 19th centuries respectively but it was not until the improvement of 
microscopy at the turn of the 20th century that enabled scientists to study the cytology of 
cell division (Nurse, Masui et al. 1998, Alberts 2002). In particular, the pioneer 
developmental biologist Theodor Boveri (1862-1915) introduced the concepts of cell 
division and for the first time identified the chromosomes as the carriers of the heritable 
material (Boveri, 1902). Not surprisingly, with his elegant experiments and 
groundbreaking concepts Boveri has set the ground for the cell cycle research of the 
new century (Balmain 2001).  
Half a century later, technological advances have made it possible for scientists 
to go beyond the mere observations of the cellular division and the cell cycle. Early in 
the 1950’s the structure of the DNA had been proposed by James Watson and Francis 
Crick in one of the most famous papers of all time (Watson and Crick 1953). A few 
years later and in accordance with the Watson-Crick model, Meselson and Stahl shed 
light on the molecular mechanism of DNA synthesis; within a single cell cycle the 
genetic material doubles and each daughter cell receives one copy composed of a 
parental strand (subunit) and a newly synthesized strand (Meselson and Stahl 1958). 
The unprecedented breakthrough in unravelling the molecular basis of the cell 
cycle, however, came in the late 1960’s when three scientist, two geneticists and a 
biochemist, although working from different angles and using different model systems, 
made monumental contribution into understanding the regulation of the cell cycle in 
eukaryotic cells. Working with S. pombe and S. cerevisiae, respectively, Paul Nurse and 
Lee Hartwell created mutants that deregulated or halted the progression through the cell 
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cycle and by cloning the genes they identified a network of proteins responsible for cell 
cycle control. Most importantly, the first members of the cyclin dependent kinase 
(CDKs) family of enzymes, namely spCdc2 and scCdc28, were identified by Nurse and 
Hartwell respectively, in genetic studies looking for cdc (cell division cycle) mutants, 
defective in cell cycle progression (Nurse 1997). Future studies by numerous 
researchers have discovered human homologues of these genes by complementation 
analysis of yeast mutants (Malumbres and Barbacid 2005). Tim Hunt on the other hand 
used sea urchin embryos and biochemistry to identify yet another key player, the cyclin. 
(Evans, Rosenthal et al. 1983, Hartwell and Weinert 1989, Nurse 1997, Nurse, Masui et 
al. 1998). Soon after, the biochemical connection between the two families of enzymes 
was established and the regulatory circuit of the cell cycle has just started to be 
delineated. For their pioneering research, Paul Nurse, Lee Hartwell and Tim Hunt were 
awarded the 2001 Nobel Prize in Physiology and Medicine. 
 
1.1.2 The eukaryotic cell cycle and its regulation 
 The cell cycle of eukaryotic cells (Figure 1.1) is comprised of two main phases, 
synthesis (S) and mitosis (M). The S phase is when the genetic material gets duplicated 
through the process of DNA replication. Mitosis is the nuclear division, which involves 
the segregation of sister chromatids into separate nuclei and is followed by cytokinesis, 
the cellular division and the formation of two daughter cells.  Cells spend only 5% of 
their life in the M phase, with the rest of their cell cycle spent in interphase, the period 
between two sequential mitoses. The main event of the interphase is the duplication of 
the DNA during S phase and the two key phases of the eukaryotic cell cycle, S and M, 
are separated by two gap phases, G1 and G2. During G1 the cell grows in size and 
prepares for DNA replication and during G2 the cell continues to grow and prepares for 
the onset of mitosis in human cells (Cooper, 2000). At the onset of the G1 phase there is 
a specific point known as the “restriction point” and once the cell is past this point for 
example in response to mitogen stimulation, it becomes committed to the next cell 
cycle. If however it is favourable for the cell to remain non dividing, it enters the G0 
phase which is a state of quiescence and can be reversible or irreversible (Pardee 1974). 
Passage from one stage to the next is a highly regulated process and the 
mechanisms of regulation are highly conserved across species, from yeast to higher 
eukaryotes. Yeast has only one CDK responsible for both S and M phase entry, Cdc2 in  
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Figure 1.1: Diagrammatic representation of the standard eukaryotic cell cycle. It consists of four 
phases: G1, S, G2, and M phases. G1, S and G2 are collectively referred to as Interphase. There are three 
main phase transitions in the cell cycle: G1/S to initiate DNA replication, G2/M to enter mitosis, and 
metaphase/anaphase to exit mitosis (not shown). R in green is the restriction point at which the cell 
becomes committed to the cell cycle. Red coloured segments in the arrows represent the checkpoints, 
namely the G1/S, intra-S, G2/M and S/M, which are discussed in later sections. 
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S. pombe and Cdc28 in S. cerevisiae (Bueno, Richardson et al. 1991, Forsburg and 
Nurse 1991, Hayles, Fisher et al. 1994, Mondesert, McGowan et al. 1996).  At the heart 
of the human cell cycle regulation machinery are also the CDKs, which encompass a 
family of 20 members in human cells. Of these, CDK1, 2, 3, 4, 6 and 7 are 
serine/threonine kinases functioning in cell cycle regulation. For full enzymatic activity 
they all (except CDK7) require the provision of additional peptide sequences through 
association with cyclins. CDK-cyclin complexes phosphorylate specific protein targets 
on K/R-S/T-P-X-K/R consensus sites in a temporally specific manner and this is what 
allows the proper progression through the cell cycle (Masumoto, Muramatsu et al. 2002, 
Malumbres and Barbacid 2005, Malumbres 2014). The protein levels of CDKs remain 
fairly constant throughout the division cycle but their respective activities oscillate 
cyclically (Hochegger, Takeda et al. 2008). CDK activity is largely dependent on its 
association with cyclins and biochemical experiments have shown that binding of 
cyclins to CDK results to a 40,000 fold increase to its kinase activity (Lees 1995). 
Additionally, regulation of CDK activity occurs via 
phosphorylation/dephosphorylation and binding to CDK inhibitors (CKIs) (Nurse 
1997). Phosphorylation of the tyrosine 15 (Y15) and additionally, only in mammals, of 
the adjacent threonine 14 (T14) residues within the active site inhibits CDK activity. 
For example, Wee1 and Myt1, whose activity remains high throughout interphase, 
phosphorylate CDK1Cdc2 thus preventing premature entry into mitosis. At the G2/M 
transition however, this inhibitory phosphorylation is removed by the Cdc25 (A/B/C) 
phosphatase, favouring an active CDK1Cdc2 and entry into mitosis (Russell and Nurse 
1986, Russell and Nurse 1987, Lees 1995, Malumbres and Barbacid 2005, Calonge and 
O'Connell 2008). Cdc25 is activated by phosphorylation by the Polo kinase as well as 
by the CDK1-cyclin B complex (also called the mitosis promoting factor; MPF) itself, 
which also phosphorylates and inhibits Wee1. This creates a positive feedback loop that 
quickly leads to the activation of all M-CDK complexes in the cell (Alberts 2002, 
Toyoshima-Morimoto, Taniguchi et al. 2002). Finally, full activation of the CDK 
catalytic subunit requires CAK-mediated phosphorylation of the conserved T160 
residue within the CDK activation loop (Lees 1995). 
Inactivation of CDKs is also promoted through their binding to CKIs. CKIs bind 
CDK-cyclin complexes and inhibit their activity. One of the most potent inhibitors is 
p21Cip1 which inhibits the complexes of both CDK1 and CDK2 by either direct binding 
or by preventing CAK-mediated phosphorylation of T160 (Lees 1995). 
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The cell cycle regulation machinery described above not only controls the 
ordered sequence of events within the cell cycle but also cross talks to a network of 
checkpoint factors which monitor the cell for the presence of incomplete DNA synthesis 
or unrepaired DNA damage. One of the end receivers of this signalling mechanism is of 
course the cell cycle machinery again; in the event of damage to the genetic material, 
cell cycle progression is halted to allow cells time to overcome the damage. These 
mechanisms contribute to the successful completion of the two central events of the cell 
cycle, DNA replication (S) and chromosome segregation (M), and ensure fidelity of 
genetic transmission to future generations.  
 
1.1.3 DNA Replication 
Replication initiation 
A fundamental aspect of genome stability is the faithful replication of DNA 
prior to each cell division. Chromosome duplication in eukaryotes occurs during the S 
phase of the cell cycle and is initiated by multiple origins. Chromosome duplication 
initiated at origins is mediated by a number of essential and non-essential proteins that 
collaborate in a spatially and temporally regulated manner to perform the basic steps of 
DNA replication: pre-replicative complex (pre-RC) formation, maturation and 
activation of the pre-RC to form the pre-initiation complex (pre-IC) and progression of 
the fully functional replisome, known as the replisome progression complex (RPC) 
(Bryant and Aves 2011, Wu, Liu et al. 2014) (Figure 1.2). 
 
Pre-RC formation 
The first step of replication initiation is the binding of the 6-subunit origin 
recognition complex (ORC, Orc1-6) to those origins that will fire during the S phase, 
thus marking them as active origins.  
During the G1 phase cell division control protein 6 (Cdc6) and chromatin 
licensing and DNA replication factor 1 (Cdt1), associate with the origin bound ORC 
independently of each other (Maiorano, Moreau et al. 2000). They are both essential for 
origin licensing (Coleman, Carpenter et al. 1996, Rialland, Sola et al. 2002). Cdc6 is an 
ATPase and is thought to bind ORC (Speck, Chen et al. 2005), whereas Cdt1 on the 
other hand is a coiled-coil domain protein that associates with the C terminus of Cdc6 
and together they cooperatively promote the recruitment and subsequent loading of the  
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Figure 1.4: Initiation of DNA replication in eukaryotes. Origin licensing: (A) During late M-early G1 
ORC binds the origin of replication and (B) together with Cdc6 and Cdt1 help recruit the MCM complex, 
forming the pre-RC. Soon after Cdc6 and Cdt1 dissociate and get destroyed. (C) At the start of S, CDK 
and DDK-mediated recruitment of Cdc45 and GINS form the CMG replicative helicase. Cdc45 is found 
associated with Treslin and binds the origins whereas RecQL4 is found in complex with GINS, pol2 and 
TopBP1 in a complex known as the pre-LC. Mcm10 is also recruited via an unknown mechanism. (D) All 
factors recruited in C define the pre-IC, a macromolecular complex at the origin that still has not fired 
replication. (E) Recruitment of additional factors such as the polymerases (α, ε and δ), RFC, PCNA, Ctf4 
and Tipin-Tim-Claspin (and others not shown) results to the formation of the RPC and causes the 
necessary biochemical changes that will fire replication, thus defining the S phase. Treslin, RecQL4 and 
TopBP1 do not travel with the fork. (For details see the text) 
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hexameric minichromosome maintenance (MCM, Mcm2-7) complex onto double-
stranded DNA as an inactive double hexamer (Nishitani, Lygerou et al. 2000). Given 
their importance in recruiting MCM, Cdc6 and Cdt1 proteins are both regulated by the 
cell cycle machinery. Cdc6 is subject to CDK-mediated phosphorylation, which takes it 
out of the nucleus in S phase as well as targeting to APC-mediated ubiquitylation and 
subsequent proteolysis during M phase. Geminin on the other hand, associates with and 
inhibits Cdt1 in human cells and this inhibition translates to an inability to promote pre-
RC formation (Wohlschlegel, Dwyer et al. 2000). In fact, Geminin is present in high 
levels after entry into S phase but it gets destroyed via an APC-dependent pathway in 
mitosis.  This is thought to provide yet another mechanism for the prevention of 
endoreduplication of the genetic material within a single cell cycle (Bell and Dutta 
2002). Overall, ORC, Cdc6, Cdt1 and the inactive double hexamer of MCM altogether 
form the pre-RC and soon after its formation, CDC6 and Cdt1 dissociate, defining the 
next step of replication, replication initiation (Blow and Laskey 1986, Blow 1993, Bell 
and Dutta 2002, Arias and Walter 2007, Araki 2011). 
 
Pre-IC formation 
MCM is loaded around double-stranded DNA as an inactive double hexamer 
and it is only at the start of S phase that it associates with Cdc45 and GINS to form the 
CMG replicative helicase holocomplex (Evrin, Clarke et al. 2009, Gambus, Khoudoli et 
al. 2011). Maturation of the pre-RC and CMG activation is mediated via the action of 
two essential kinases, CDK and DDK (Dbf4 and Drf1-dependent kinase). Studies have 
shown that phosphorylation of Sld2RecQL4 and Sld3Treslin/ticrr by Cdc28CDK in budding 
yeast is the minimal requirement for replication initiation (Zegerman and Diffley 2007). 
The substrate of DDK, on the other hand, appears to be the MCM complex (Jones and 
Petermann 2012). In particular, DDK phosphorylates MCM2, MCM4 and MCM6 
(Jiang, McDonald et al. 1999, Masai, Taniyama et al. 2006, Sheu and Stillman 2006, 
Chuang, Teixeira et al. 2009). Phosphorylation of Sld2RecQL4 and Sld3Treslin/ticrr by CDK 
create binding sites for the C-terminal and N-terminal BRCT domains of Dpb11TopBP1, 
respectively (Zegerman and Diffley 2007, Labib 2010).  
 
The role of TopBP1 in pre-IC formation 
 An essential function of TopBP1Dpb11/Rad4 that is conserved among all the 
homologs is contributing to the initiation of DNA replication. Its role during initiation 
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involves bringing Polε and GINS to the origin-loaded Cdc45-Mcm2-7 complex via 
scaffolding Sld2RecQL4 and Sld3Treslin/ticrr (Zegerman and Diffley 2007).   
Work in S. cerevisiae has shown that the interaction between Sld2RecQL4 and 
Dbp11 is CDK-dependent. Phosphorylation of a number of canonical motifs within 
Sld2RecQL4 is first required but this does not play a direct role in complex formation, but 
rather regulates phosphorylation of another residue, T84. This phosphorylated 
Sld2RecQL4 is then competent to interact with the BRCT3 and BRCT4 of Dpb11TopBP1 
(see Figure 1.2) (Masumoto, Muramatsu et al. 2002). CDK-phosphorylated Sld2RecQL4 
forms a fragile complex with GINS (Sld5, Psf1-3), the replicative polymerase ε (the 
Pol2 catalytic subunit) and Dpb11TopBP1 in vitro, in a complex known as the pre-loading 
complex or pre-LC (Araki 2011). 
Furthermore, CDK needs to phosphorylate Sld3Treslin/ticrr and this is required for 
its interaction with Dpb11TopBP1 (Zegerman and Diffley 2007, Tanaka and Araki 2010). 
In addition, Sld3Treslin/ticrr itself interacts with Cdc45 throughout the cell cycle and DDK 
phosphorylation of Sld3Treslin/ticrr promotes binding of Dpb11 to Cdc45-associated 
Sld3Treslin/ticrr (Tercero, Labib et al. 2000, Kamimura, Tak et al. 2001, Yabuuchi, 
Yamada et al. 2006).  A more recent finding from the Diffley laboratory suggests that 
Sld3 recognises DDK-phosphorylated peptides on Mcm4 and Mcm6, and this provides 
another explanation of how Cdc45 associates with the inactive origin-loaded MCM 
(Deegan and Diffley 2016, Deegan, Yeeles et al. 2016). Overall, Sld2RecQL4 and 
Sld3Treslin/ticrr are the minimal set of CDK targets required for promoting replication by 
bringing GINS-Polε and Cdc45 together (Zegerman and Diffley 2007). GINS and 
Cdc45 can then interact with Mcm2-7, forming the active helicase complex CMG. Once 
CMG forms and departs from the origin, the Dpb11TopBP1-Sld2RecQL4-Sld3Treslin/ticrr 
complex dissociates and does not travel with the fork (Bruck et al. 2011). 
Similarly to Dpb11TopBP1, in fission yeast, CDK-mediated phosphorylation of 
Sld2RecQL4 and Sld3Treslin/ticrr allows their interaction with Rad4TopBP1 BRCTs3-4 and 1-2, 
respectively. Both of these interactions are required for replication initiation and like 
Dpb11TopBP1, Rad4TopBP1 does not travel with the fork (Fukuura, Nagao et al. 2011). 
These interactions seem to be conserved in higher eukaryotes though the exact 
mechanisms are less understood. Studies in Xenopus suggest that RecQL4Sld2 does not 
get phosphorylated by CDK, nevertheless it co-immunoprecipitates with TopBP1 and it 
is the C-terminus of TopBP1 that mediates the interaction (Doi, Nagasaki et al. 2006). 
Treslin/Ticcr on the other hand, the Sld3Treslin/ticrr homolog, gets phosphorylated on two 
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serine residues by CDK2-Cyclin E in Xenopus (Kumagai, Shevchenko et al. 2011) and 
evidence from human cells suggests that it contacts BRCTs 1-2 of TopBP1 (Boos, 
Sanchez-Pulido et al. 2011). 
Two additional interactions of TopBP1 at origins of replication described in 
Xenopus extracts are with GEMC1 (GEMinin Coiled-coil containing protein 1) and 
DUE-B (DNA unwinding element binding protein), both suggested to promote 
replication initiation by mediating recruitment of Cdc45 on replication origins 
(Balestrini, Cosentino et al. 2010, Chowdhury, Liu et al. 2010). Whether these 
interactions are relevant to H. Sapiens remains to be identified. 
 
RPC and DNA synthesis 
The exact molecular mechanisms of the transition from a stationary MCM 
double hexamer to a processive CMG translocase are still the subject of intense 
research. Several recent studies, however, suggest that DDK mediated phosphorylation 
of the MCM ring results to a conformational change that promotes ATP hydrolysis thus 
allowing duplex unwinding. All current models favour the idea that the active CMG 
translocates along single stranded DNA in a process that excludes the lagging strand 
from the central channel of the MCM holoenzyme ring (strand exclusion model) 
(Simon, Sannino et al. 2016, Sun, Yuan et al. 2016, Yuan, Bai et al. 2016).  An 
additional factor required for initiation of replication is Mcm10, which is essential for 
the activation of the CMG helicase and the unwinding of the duplex, at least in budding 
yeast but the exact underlying mechanism has not yet been elucidated (van Deursen, 
Sengupta et al. 2012). All these interactions are key in bringing together all the players 
required for the replication progression complex (RPC) assembly and origin firing. And 
although the main aspects of the initiation reaction have been elucidated there is still a 
lot to learn about the precise molecular mechanisms and perhaps about the involvement 
of novel proteins in some of these steps (Labib 2010). 
Unwinding of the double helix by CMG is followed by DNA synthesis which is 
bidirectional and occurs in a 5’-3’ direction with respect to the newly synthesized 
strand. Due to the antiparallel nature of the duplex, replication is semi-discontinuous. 
One strand (the leading strand) is synthesized continuously and in the same direction as 
fork unwinding whereas the other strand (the lagging strand) is synthesized 
discontinuously (i.e. requires repeated priming and synthesis events) which leads to 
Okazaki fragments being formed (Sakabe and Okazaki 1966). In addition, because of 
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the fact that DNA strands are intertwined, DNA unwinding of the double helix results in 
topological stress building up ahead of the fork which is relieved by topoisomerases 
(Recolin, van der Laan et al. 2014). The actual reaction of the bulk of DNA synthesis in 
eukaryotes is catalysed by the replicative polymerases ε and δ. Experiments in yeast 
model systems assign Pol ε to the leading strand and Pol δ to the lagging (O'Donnell and 
Li 2016). There is however evidence of Pol δ synthesizing both strands under normal 
circumstances (Johnson, Klassen et al. 2015) or after replication restart following a 
pause site (Miyabe, Mizuno et al. 2015).  
Interestingly, although both replicative polymerases are capable of dNTP 
incorporation hence DNA synthesis, they are not able to initiate de novo DNA 
synthesis. A third polymerase, known as polymerase α-primase, is instead required to 
initiate replication once in the leading strand and for each Okazaki fragment on the 
lagging strand (Kunkel and Burgers 2014, O'Donnell and Li 2016). The current 
favoured model of the architecture of the eukaryotic replisome suggests that the single 
stranded DNA exiting from the N terminus of the MCM U-turns to reach Pol ε sitting at 
the C-terminus side of the CMG helicase. This positions Pol ε ahead of the replicative 
helicase, suggesting that it might be involved in nucleosome disruption (Foltman, Evrin 
et al. 2013, O'Donnell and Li 2016). Another interesting feature of polymerases is that 
their “semi-closed hand” structure (see figure 1.2) does not allow them to continuously 
and stably associate with the DNA. To increase their processivity, polymerases 
associate with sliding clamps. The eukaryotic sliding clamp is a homotrimeric ring 
shaped molecule known as PCNA, which in addition to strengthening the interaction 
between the polymerases and the DNA it also has regulatory roles at the fork. PCNA 
itself is loaded onto DNA by the Replication Factor C (RFC, RFC1-5), which 
recognises primer-template junctions and uses energy from ATP to open the PCNA ring 
and load it on the DNA so as to encircle the duplex and also contact the polymerase 
(Leman and Noguchi 2013). 
Other factors travelling with the replication fork include Ctf4 (also called And1) 
and Tipin-Tim-Claspin. Ctf4 is a homotrimeric protein that functions as a scaffold, 
bridging the CMG helicase to polymerase α (Gambus, van Deursen et al. 2009), 
although recent work suggests that it might associate with more partners, e.g. GINS 
(Villa, Simon et al. 2016). The Tipin-Tim-ClaspinCsm3-Tof1-Mrc1 component of the RPC on 
the other hand, has more specialized roles in checkpoint signalling following replication 
fork pausing (Hodgson, Calzada et al. 2007, Yao and O'Donnell 2016) but has also been 
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suggested to maintain normal replication fork rates in human cells (Petermann, 
Helleday et al. 2008). 
It has emerged that the duplication of the genetic material as part of the S phase 
of the cell cycle is a highly orchestrated event. The recruitment of specialized factors, 
the biochemical changes triggered and, in parallel, the regulatory effects of the cell 
cycle machinery on the complexes recruited at the origins, all set the scene for the 
eventual assembly of the eukaryotic RPC and the firing of replication. Completion of S 
phase thus results in the generation of two copies of the genetic material that will be 
segregated to the daughter cells in mitosis. 
 
1.1.4 Nuclear and cellular division 
Following duplication of the hereditary material, cells go through the other 
important phase of their cell cycle, chromosome segregation and cellular division. In 
fact progression to the M phase generally occurs only if cells have successfully 
completed DNA replication. If errors have been incorporated during synthesis or if the 
DNA has been damaged in any way checkpoint pathways will be activated that will halt 
the progression of the cell cycle and allow time for repair. 
Chromosome segregation happens in M phase and involves the partitioning of 
each genetic copy made in S phase into independent nuclei. The most striking 
characteristic of a mitotic cell compared to an interphase cell is the condensation of 
chromatin. So although an interphase cell has its chromatin diffused and cohesin keeps 
the sister strands held together, during mitosis a remarkable condensation takes place 
such that individual chromosomes become visible (Figure 1.1). And this is what 
allowed researchers, like Walther Flemming (1843-1905) to correctly deduce the events 
of chromosome movements during mitosis even before the improvement in microscopy 
(Paweletz 2001). And this condensation is also what gave mitosis its actual name; 
mitosis in Greek means “threads” which refers to the threadlike appearance of 
chromatin.  
An increase in the levels of CDK1-Cyclin B (MPF) signals entry into mitosis. 
Mitosis is divided into five phases based on the physical state of the DNA and the 
spindle, the organelle organising and separating the chromosomes during mitosis. These 
are prophase, prometaphase, metaphase, anaphase and telophase. During prophase, there 
is transition from an amorphous DNA mass, where sister strands are attached to each 
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other via cohesin, to two distinguishable rod-shaped arms joined at the centromere, in a 
process known as resolution (Hagstrom and Meyer 2003).  
Chromosome condensation continues until metaphase when chromosomes are 
fully compacted (Hagstrom and Meyer 2003). During the next stage of mitosis, 
prometaphase, MPF phosphorylates microtubule-associated proteins leading to the 
formation of the spindle apparatus. The spindle apparatus consists of two pairs of 
centrioles that move to opposite poles of the cells and catalyse the nucleation of 
microtubules. Microtubules polymerise to a length sufficient to mediate binding to the 
kinetochore of the sister chromatids. The kinetochore is a structure that forms at the 
centromere of each sister chromatid during prophase and provides an attachment site for 
microtubules. Necessary for the assembly of the spindle in metazoan cells is the nuclear 
memabrane breakdown, which is mediated through phosphorylation and subsequent 
depolymerisation of the nuclear lamins. In addition to nuclear membrane breakdown, no 
vesicular transport happens inside a mitotic cell as MPF promotes the breakdown of the 
endoplasmic reticulum and the Golgi apparatus (Lodish et al 2000).  
At the end of prometaphase sister chromatids are arranged in such a way so that 
their kinetochores are attached to microtubules of opposite poles, in a process known as 
bi-orientation (Hagstrom and Meyer 2003). Next, during metaphase, chromosomes 
become fully condensed and they align along the centre of the cell (at the metaphase 
plate). Tension builds up but chromosomes can withstand spindle forces due to their 
condensed physical state and cohesin acting like glue at the centromeres (Hagstrom and 
Meyer 2003). At this point the cell activates the spindle assembly checkpoint and it is 
only when all the kinetochores are biorientated on the spindle that the checkpoint is 
released and the cell progresses to anaphase. Anaphase is characterised by the 
separation of sister chromatids which involves the cleavage of cohesin by an enzyme 
called separase. Sister chromatids start moving towards opposite spindle poles in a 
process that involves shortening of the microtubules as well as the action of motor 
proteins that move along the microtubules (Peters 2002).  
When chromosomes reach the poles at telophase they start decondensing and 
also lamins get dephosphorylated and the nuclear lamina reforms using membrane 
vesicles from the parent cell’s old nuclear membrane. By the end of telophase two 
daughter nuclei, each with a full set of chromosomes in the interphase conformation 
have formed (Lodish et al. 2002).  The final step of the cell cycle is the division of the 
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two daughter cells, which is mediated by the contractile ring (Hauf, Waizenegger et al. 
2001). 
Mitosis is a crucial step within the living cycle of cells as it ensures that the 
progeny will receive an identical set of chromosomes. Together with DNA replication 
they comprise the key processes underpinning the cell cycle, hence life. DNA 
replication synthesizes (copies) the molecule of DNA, which is the carrier of the 
hereditary information and mitosis passes a complete copy of this information to the 
progeny. This cycle of life, no matter how simple it might seem from the above 
description, it is in reality a very complex system. And perhaps the only way of making 
sense of a composite biological system is to think of it in an organised, but still 
complex, way. 
 
1.2 The DNA Damage Response (DDR) 
1.2.1 DNA damage 
DNA is a macromolecule and it is perhaps not surprising that it is subject to 
physical and chemical damage. Every cell in the human body can experience tens of 
thousands of DNA lesions per day (Jackson and Bartek 2009). DNA lesions can be 
generated by intracellular DNA damage or result from exogenous insult. DNA lesions 
generated by intracellular DNA damage include depurination due to loss of bases, base 
transitions due to deamination, SAM-induced methylation as well as oxidation 
generated by physiological by-products of oxidative respiration (Ciccia and Elledge 
2010). Another threat to the integrity of the DNA double helix is impediments to the 
movement of a replication fork causing replication stress. In addition to sites of 
damaged DNA, replication stress can also be induced by nucleotide depletion, clashes 
between the replicative and transcriptional machineries, specific secondary DNA 
structures (e.g. G-quadruplex), tight DNA-protein complexes, triplet repeats, telomeric 
repeats and tRNA genes. Replication fork barriers (RFBs) can either block the 
polymerization step or interfere with duplex opening and, depending on the nature of 
the barrier, different cellular responses will be mounted (Lambert and Carr 2005). DNA 
damage can also result due to exogenous insult. Ultra violet (UV) light from sunlight 
causes chemical changes to the DNA helix and can induce approximately 100,000 
lesions (e.g. pyrimidine dimers) per hour in a single cell. In addition, cosmic ionising 
radiation (IR) as well as IR used in medical treatments can generate a variety of DNA 
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lesions, with the most toxic being single-strand and double-strand breaks (SSBs and 
DSBs, respectively). Other DNA damaging sources include chemotherapeutic agents, 
pollution, cigarette smoke as well as certain chemicals in foods such as heterocyclic 
amines in overcooked meat. Overall, the effects of these agents on the double helix 
include base lesions, base alterations, strand breaks, nicks and crosslinks (Jackson and 
Bartek 2009, Ciccia and Elledge 2010).  
 
 
1.2.2 The DDR; a genome maintenance network 
The cell cycle regulation machinery not only controls the ordered sequence of 
events within the cell cycle but also cross talks to a network of factors which monitor 
the cell for the presence of incomplete DNA synthesis or unrepaired DNA damage. 
Inherent to this network is the ability of some cell cycle proteins themselves to perform 
genome maintenance functions. The maintenance of genome integrity is key to cell and 
organismal survival as DNA encodes the information to direct the production of 
proteins required for correct development and proliferation. To counteract DNA damage 
thus diminishing the risk of mutations that would endanger both the survival of the 
organism as well as the accurate transmission of the genetic material to future 
generations, cells have evolved sophisticated response mechanisms, collectively known 
as the DNA Damage Response (DDR) (Polo and Jackson 2011). The DDR involves a 
complex interplay between DNA damage signal transduction pathways that act to 
promote the repair or bypass of the damage. At the same time DDR collaborates with 
the cell cycle and apoptotic machineries of the cell. The presence of damage temporarily 
arrests the progression of the cell cycle to allow time for repair (Gorgoulis, Vassiliou et 
al. 2005). During this window of arrest and repair, higher eukaryotes have evolved to 
consider several cell fate options such as apoptosis, senescence or even activation of the 
immune system (Ciccia and Elledge 2010). And this is because of the different priorities 
of multicellular systems; elimination rather than propagation of an “unhealthy” cell is 
more favourable for the organism (Wahl and Carr 2001). 
 
1.2.2.1 Checkpoint signaling  
The concept of the checkpoint was first described in studies using Ataxia 
Telangiectasia (AT) patient-derived cell lines. Two studies were published describing 
the defect of AT cells in inhibiting DNA synthesis (i.e. delaying S phase) after exposure 
to radiation compared to control cells. So despite the lack of advanced technological 
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means researchers realized that the phenotypes observed could not be explained by 
defects in the repair process per se but rather by a “process playing a broader role in 
development” that was actually compromised (Houldsworth and Lavin 1980, Painter 
and Young 1980). Almost a decade later, Hartwell and Weinert described it as a 
“control mechanism enforcing dependency in the cell cycle” (Hartwell and Weinert 
1989). In other words, an alarm system in place within the cells that ensures that a 
proceeding event within the cell cycle begins only when and if the previous event has 
been successfully completed. Their idea was born from the observation that although 
wild type yeast cells irradiated in S phase delayed the cell cycle to allow time for repair 
before mitosis, cells defective in particular genes (Sc RAD9, homologue of the human 
53BP1, in particular) failed to delay. Imposing an artificial delay by chemical means, 
however, would largely rescue the observed phenotypes (Weinert and Hartwell 1988). 
With the power of yeast genetics, a battery of genes have been cloned by 
complementation and many proteins have been identified as “stop buttons” or 
“checkpoints” within the reproductive cycle of a cell and have been shown to be 
conserved in Homo sapiens (Carr 1996, O'Connell, Walworth et al. 2000). These will be 
discussed in the following sections.  
DNA damage checkpoints are subdivided into categories and named after the 
cell cycle stage at which they operate (Figure 1.3). Thus there is a G1-S checkpoint 
responding to damage during G1, an intra-S checkpoint dealing with DNA damage 
during replication, a replication checkpoint responding to replication stress, a G2-M 
checkpoint dealing with damage during G2 (and lesions that have remained unrepaired 
from previous stages) and an S-M checkpoint that delays the onset of mitosis until DNA 
replication has been completed (Enoch and Nurse 1990, Kastan and Bartek 2004, Smith, 
Tho et al. 2010). These checkpoints are comprised of specialized macromolecular 
complexes, which upon DNA damage are capable of catalysing specific reactions to 
communicate the problem and help resolve it. They should not be viewed as solid 
machineries that have evolved to perform one function. In reality they are very 
complicated networks of dozens if not hundreds of proteins that are extremely dynamic 
in nature and pleiotropic in their functions and this explains why they are under 
stringent control. And it is the type of damage that dictates the specific mechanisms that 
will be activated and the cell-cycle checkpoint machineries will orchestrate the fine- 
tuning of the response. 
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Figure 1.3: DNA structure-dependent checkpoints. Cells possess points along the length of the cell 
cycle where they can activate the checkpoint pathways, which act to halt the progression to the next phase 
until damage is repaired. In the presence of DNA damage, cell cycle halts at the G1-S, S or G2-M, 
depending on which phase exactly the cell was traversing at the time damage occurred. Replication stress-
associated damage or other factors that cause replication fork stalling activate the replication checkpoint 
which has many functions including the inhibition of origin firing, stabilisation of stalled forks, 
restoration of the dNTP pools and inhibition of mitosis (S-M checkpoint). Adapted from Smith Gillespie 
et al 2010. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA damage checkpoints
G1	 G2	S	 M	
G1/S	 Intra-S	 G2/M	
Origin		
ﬁring	
Fork		
stabilisa8on	 S/M	
Replica6on stress checkpoints
dNTPs	pool	
restora8on	
 32 
PIKKs at the heart of signalling  
Life on earth would certainly not be as we know it if cells have not evolved 
defense mechanisms of keeping their precious code of life –the DNA– intact. 
Mechanisms which are themselves produced from what they evolved to protect; a series 
of nitrogen-based molecules which “carry” the code of life just like a computer 
software. A computer software however, more advanced than any other ever been 
created. And just like a defect in a computer will show as a pop up window to its user 
who will embark on strategies to try and repair it, defects on the DNA can somehow 
alert the cell and activate a series of processes that will attempt to restore the problem. 
Although it is not known exactly how DNA damage on the duplex is physically 
detected, it is well established that DNA damage leads to a quick and robust activation 
of a protein-signaling cascade that regulates several aspects of nuclear and cellular 
physiology to provide an environment conducive for successful maintenance of 
genomic integrity. The existence of such a cascade is beneficial as it allows a single 
input (damage) to be translated to many different outputs in a short period of time. At 
the heart of the signal transduction network of the DDR checkpoints lie two protein 
kinases, ataxia telangiectasia mutated (ATM) and ATM-and-Rad3-related (ATR).  
Both kinases are conserved down to the yeasts S. pombe and S. cerevisiae as 
Rad3ATR/Tel1ATM and Mec1ATR/Tel1ATM, respectively (Ciccia and Elledge 2010). The 
ATM gene was cloned in 1995 and took its name after being identified as the gene 
responsible for the AT phenotypes (A-T mutated) (Savitsky, Bar-Shira et al. 1995). 
Soon after, the full sequence of the yeast Rad3 was identified and the human ATR 
cDNA cloned by virtue of sequence similarities (Bentley, Holtzman et al. 1996). ATM 
and ATR are large kinases that belong to the phosphoinositide 3-kinase-like protein 
kinases (PIKKs) family of proteins together with mechanistic target of rapamycin 
(mTOR), suppressor of morphogenesis in genitalia (SMG1), DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs) and transformation/transcription domain-
associated protein (TRRAP) (Figure 1.4). All members of this family share sequence 
similarity to the 300 amino acid kinase domain of phosphatidylinositol-3 kinases 
(PI3Ks), a classical family of inositol lipid kinases (Hunter 1995, Bosotti, Isacchi et al. 
2000, Foster, Traer et al. 2003). They nonetheless lack lipid kinase activity; instead they 
are all highly conserved Ser/Thr-kinases and contain a kinase domain KD (although in 
TRRAP is not active) located at the C-terminus, flanked by the FRAP-ATM-TRRAP  
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Figure 1.4: Domain architecture of PIKKs. The kinase domain (except TRRAP which lacks kinase 
activity) is located at the C-terminus and is flanked by the FAT and FATC domains. Note that the KD of 
TRRAP is inactive as designated by the red cross. Between the FAT and FATC domain lies the PRD 
domain, which is specific to each PIKK.  The substrate-binding site SBS is shown for ATR and ATM and 
also regions important for the interaction of TopBP1 with ATR are depicted. Adapted from (Kastan and 
Bartek 2004, Derheimer and Kastan 2010). 
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(FAT) and FAT-C-terminal (FATC) domains. Sitting between the KD and FATC is the 
so-called PIK-kinase regulatory domain (PRD), which differs among the different 
PIKKs and is thought to be important for their regulation (Cimprich and Cortez 2008). 
The N-terminus on the other hand, does not seem to harbor specific domains but instead 
contains HEAT (Huntingtin Elongation Factor 3 Alpha subunit and TOR1) repeats, 
each of which is a pair of antiparallel α-helices linked by a flexible “intra-unit” loop 
(Perry and Kleckner 2003). Despite their sequence similarity, PIKKs have quite diverse 
biological functions (Lempiainen and Halazonetis 2009, Lovejoy and Cortez 2009). 
SMG1 regulates elimination of mRNA molecules containing premature termination 
codons, mTOR functions in nutrient signaling, metabolism and cell growth and TRRAP 
is involved in transcription (Lovejoy and Cortez 2009). DNA-PKcs on the other hand 
has a role in DNA repair and will be discussed later. So that leaves only ATM and ATR 
having the key role in DNA-damage-dependent checkpoint signaling.  
ATM and ATR kinases, once activated, can phosphorylate substrates on serine 
and threonine residues followed by a glutamine (SQ/TQ). In particular, they have a 
preference in phosphorylating SQ/TQs found in clusters, known as SQ/TQ cluster 
domains (SCDs). Protein phosphorylation events therefore play a key role in signal 
transmission and amplification (Nam and Cortez 2011). In the following paragraphs I 
will attempt to illustrate the present-day understanding of the molecular aspects of this 
signaling cascade. 
 
 
The ATM signaling cascade 
The ATM kinase can be activated in the G1, S and G2 phases of the cell cycle. 
This became evident long before the identification of the ATM gene. Researchers 
observed that contrary to wild-type cells, AT cells failed to delay the cell cycle 
following irradiation in G1 and G2 and they also exhibited IR-insensitive DNA 
synthesis (Houldsworth and Lavin 1980, Painter and Young 1980, Hong, Gatti et al. 
1994, Khanna, Beamish et al. 1995). But how do these cellular phenotypes translate to a 
human disorder? AT is a rare autosomal recessive disorder characterized by radio 
sensitivity, early onset debilitating cerebellar ataxia, dilation of blood vessels 
(telangiectasia), neurodegeneration, susceptibility to bronchopulmonary disease and 
predisposition to cancer, particularly lymphoid tumours. This broad spectrum of severe 
symptoms arises from the many roles of ATM in the DDR and other cellular processes 
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(Jeggo, Carr et al. 1998, Lavin 2008).  
 
ATM activation 
ATM is primarily activated in response to DSBs, a lesion generated when each 
strand of the duplex is broken close in time and space such that the DNA ends fail to be 
kept juxtaposed. DSBs represent one of the most toxic lesion on the DNA. Such 
dangerous breaks can be caused by ultraviolet light (UV), mutagenic chemicals, 
radiomimetic drugs and reactive oxygen species (ROS) (produced by IR or 
physiological processes of cellular metabolism) as well as be generated at broken or 
collapsed replication forks. The potential toxicity of DSBs lies in the susceptibility of 
the free damaged DNA ends towards pathogenic chromosomal rearrangements, which 
can result to genomic instability, a hallmark of cancer (Hoeijmakers 2001, Jackson 
2002, Tsai and Lieber 2010).  
Initial studies on its biochemical properties revealed that activation of the ATM 
kinase, which is present throughout the cell cycle, is one of the earliest events observed 
following DNA damage (Canman, Lim et al. 1998). In its inactive state ATM non-
covalently homodimerises, with each monomer inserting its KD into the FAT region of 
its partner (Figure 1.5). Intermolecular phosphorylation of S1981 (a hallmark of 
activated human ATM) within the FAT domain from the pairing molecule is thought to 
be a necessary but not sufficient step in the monomerisation and subsequent activation 
of the kinase (Guleria and Chandna 2016). An engineered S1981A non-
phosphorylatable form of ATM was unable to rescue the checkpoint defect of AT cells 
and also displayed a dominant inhibitory effect over activation of endogenous ATM 
when transfected in wild type human cells (Bakkenist and Kastan 2003). 
Phosphorylation of S1981 is also thought to stabilize ATM at the break site (So, Davis 
et al. 2009).  
Subsequent studies (Kozlov, Graham et al. 2006, Kozlov, Graham et al. 2011) 
have revealed that activation of ATM is more complex as it involves 
autophosphorylation of more residues (S367, S1893, S2996). The importance of all 
these sites for the activity of the kinase is however a subject of debate. 
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Figure 1.5: The ATM signalling cascade at DSBs. A) In an unstressed cell ATM exists in an inactive 
dimer as well as dephosphorylated through the action of phosphatases. B) In response to DSB formation, 
however, ATM undergoes autophosphorylation and TIP60-mediated acetylation and converts from 
inactive dimers to active monomers that bind the MRN sensor bridging the ends of the break. Full 
activation of ATM following recruitment allows the phosphorylation and activation of many factors. 
Phosphorylation of H2AX to form γ-H2AX at nearby nucleosomes allows recruitment of MDC1 that 
promotes a feed-forward loop spreading activated ATM and γ-H2AX to long distances flanking the site of 
break. Activated MDC1 recruits RNF8 ubiquitin ligase, which promotes the recruitment of yet another 
one RNF168. This sets the scene for a ubiquitination cascade that helps recruit RAP80-associated BRCA1 
and 53BP1. C) Checkpoint signalling through the ATM cascade results to activation of the CHK2 
effector kinase, which halts the cell cycle, promotes repair as well as activation of gene expression and 
apoptotic pathways. Adapted from (Marechal and Zou 2013). 
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            Dephosphorylation and acetylation might also contribute to the activation of 
ATM. In fact, PP2A and WIP1 phosphatases interact with ATM and negatively regulate 
its phosphorylation status perhaps in an effort from the cell to prevent unwanted 
activation of the kinase (Ali, Zhang et al. 2004). In addition, the histone acetyl-
transferase TIP60 modifies K3016 and this also promotes ATM activation (Derheimer 
and Kastan 2010).  In fact this modification precedes the autophosphorylation of ATM 
thus possibly having a predominant role in ATM monomerisation and activation (Sun, 
Xu et al. 2007). TIP60 itself is regulated by the c-Abl kinase which catalyses the 
phosphorylation-mediated association of TIP60 with H3K9m3 and subsequent 
acetylation of ATM (Kaidi and Jackson 2013), thus suggesting that activation of ATM 
happens in a chromatin-proximal manner. Such post-translational modifications of 
ATM provide very dynamic mechanisms of not only contributing to the activation of 
the kinase but also in allowing recovery from DNA damage and return of the cell to its 
physiological state. 
The exact biochemical mosaic of ATM activation as well as the initial trigger 
that will convert the quiescent dimers of ATM into an “avid phosphorylation machine” 
are still a matter of ongoing debate (Shiloh and Ziv 2013). Nevertheless, it is accepted 
that the other key step in the activation of this kinase is its (re)localization to the break 
site. Although ATM seems to possess a weak DNA binding activity (Smith, Cary et al. 
1999) its localization in vivo is most of the times dependent on the Mre11-Rad50-Nbs1 
(MRN) complex. Initial evidence for the role of MRN in ATM activation came from the 
observation that mutation of its components leads to human disease. The most 
favourable model suggests that MRN is the most proximal sensor of DSBs, possibly 
mediated through its intrinsic DNA binding ability. The recruitment of MRN makes the 
break lesion accessible to ATM and also promotes end-processing and repair to occur 
(Bhatti, Kozlov et al. 2011).  Via the Mre11-Rad50 subunits, MRN binds DNA as a 
heterotetramer bridging in this way the broken ends together (Paull and Lee 2005). Its 
subsequent interaction with ATM allows the kinase to stably associate with the DSB.  
Another key determinant for the activation of ATM is catalyzed by the C-
terminal 20 amino acids of Nbs1 by a mechanism, which seems to be important for the 
activation of most PIKKs by their co-factors (Falck, Coates et al. 2005). Finally, as well 
as being an upstream regulator of ATM, MRN is also one of its downstream factors. 
ATM subjects all MRN subunits to phosphorylation and although the functional roles of 
these phosphorylation events are not entirely understood, it is clear that they regulate 
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many aspects of the damage-induced cascade, not only of ATM, but of ATR as well. 
For instance, Nbs1 gets phosphorylated on S278 and S343 by ATM, with the latter 
residue also being a target of the ATR kinase. Phosphorylation of these residues is 
required for S-phase checkpoint control and for activation of the Chk2 effector kinase 
(Paull 2015). 
 
The mediators take over 
 The recruitment and interaction of ATM and MRN at the site of damage and the 
activation of ATM through the action of the mechanisms described above sets the scene 
for the propagation of the signal to more damage response protein factors on the 
chromatin flanking the break.  
Activated ATM phosphorylates histone H2AX on S139 forming γ-H2AX 
(Burma, Chen et al. 2001). Although phosphorylation of H2AX is not required for the 
activation of ATM substrates like CHK2 and p53, it is important for the recruitment of 
DNA repair proteins (Fernandez-Capetillo, Chen et al. 2002). In fact, γ-H2AX provides 
a high-affinity binding platform for MDC1, which orchestrates the recruitment of 
essentially all of the downstream factors. As well as binding γ-H2AX via its BRCT 
domain, MDC1 also binds ATM via its FHA domain and also makes contact with Nbs1, 
thus helping concentrate ATM at the break and sustain signal amplification (Lou, 
Minter-Dykhouse et al. 2006, Wu, Luo et al. 2008). The direct binding of MDC1 to γ-
H2AX per se is also thought to protect the histone variant from dephosphorylation, 
which again contributes to a sustained response (Stucki, Clapperton et al. 2005). As a 
result, γ-H2AX near the break gets continuously phosphorylated by ATM leading to the 
formation of a positive feedback loop that recruits more MDC1 molecules. This helps 
maintain the construction and the shape of the DSB focus and the processes that take 
place within it (Savic, Yin et al. 2009).  
ATM also phosphorylates MDC1 within its various TQXF clusters and this 
phosphorylation is critical for the recruitment of the ubiquitin ligase RNF8 (Kolas, 
Chapman et al. 2007). RNF8 forms a complex with an E3 ubiquitin conjugating enzyme 
called UBC-13 and together catalyze polyubiquitination of γ-H2AX (Plans, Scheper et 
al. 2006, Mailand, Bekker-Jensen et al. 2007). Important for the ability of UBC-13 to 
catalyze ubiquitination is its acetylation by TIP60 (Ikura, Tashiro et al. 2007). This 
creates a favorable chromatin environment for the recruitment of another ubiquitin 
ligase RNF168 (Kolas, Chapman et al. 2007, Doil, Mailand et al. 2009). In fact, 
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RNF168 is capable of binding to the RNF8-created ubiquitin chains on γ-H2AX, in a 
reaction that is dependent on RNF8. Upon binding it further boosts the formation of 
K63-linked ubiquitin conjugates to a level that is favorable for recruitment of BRCAI 
and 53BP1 (Doil, Mailand et al. 2009). Another factor to join the party is RAP80, which 
has an intrinsic binding affinity for ubiquitin chains and once localized to the site is able 
to recruit many factors including BRCA1 (Sobhian, Shao et al. 2007, Wang and Elledge 
2007). The recruitment of 53BP1 on the other hand is mediated by methylation marks 
on the chromatin, in particular H4-K20m2 and H3-K79m3. Evidence suggests that these 
histone residues are constitutively methylated in human cells so it is more likely that the 
processing of the DSB region results to a change of the conformational status of 
chromatin, allowing these methylation marks to become exposed and accessible 
(Huyen, Zgheib et al. 2004, Botuyan, Lee et al. 2006).  
53BP1 and BRCA1 are both substrates of ATM (Cortez, Wang et al. 1999, Xia, 
Morales et al. 2001) and are able to not only influence the outcomes of the response by 
help recruiting other factors but also dynamically interact with factors already bound on 
the lesion. In fact, 53BP1 interacts with both ATM and Rad50, which is thought to 
sustain the signal at low levels of MRN (Lee, Goodarzi et al. 2010).  
Interestingly, other molecular factors get recruited and activated by ATM. 
Factors involved in DSB repair like RAD9, DNA-PK, CtIP and the already bound Nbs1 
and Rad50, proteins involved in chromatin relaxation, remodeling of nucleosomes and 
regulation of transcription. All of these proteins have their own substrates and this 
allows the signal to diverge (Lavin and Khanna 1999, Khanna, Lavin et al. 2001, Lavin 
2008, Shiloh and Ziv 2013, Awasthi, Foiani et al. 2015). One of the best-characterized 
kinase substrates of ATM is the effector kinase CHK2. CHK2 is a protein expressed 
throughout the cell-cycle that remains stable but inactive unless damage occurs (Lukas, 
Bartkova et al. 2001). ATM phosphorylates CHK2 on T68 within the SQ-TQ-rich motif 
at the N-terminus. The phosphorylated SQ-TQ-rich motif of one CHK2 monomer is 
then recognized by the FHA domain of another, leading to homodimerisation and 
intermolecular activation (Ahn, Li et al. 2002). Activated CHK2 is then released from 
the site of the lesion to perform pan-nuclear functions by phosphorylating numerous 
substrates (Lukas, Falck et al. 2003). The tumor suppressor p53 and its regulator 
MDMX, the cell-cycle phosphatase CDC25, the tumor suppressor BRCA1 and the 
transcriptional regulator E2F1 are few of the substrates of CHK2 which are also ATM 
substrates. The concerted action of these and other proteins determine the choice of 
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repair machineries recruited and also contribute to the decision-making between the 
activation of cell survival and cell death programs (Smith, Tho et al. 2010).  
The initial discovery of ATM and its position in the DDR was a milestone step 
towards uncovering a very complex signaling network that for sure researchers did not 
expect. Over 700 ATM substrates have been identified and the list might grow even 
bigger (Matsuoka, Ballif et al. 2007). A single lesion on the DNA can activate the apical 
kinase ATM and within minutes an orchestrated network of hundreds of proteins that all 
collaborate in an astonishingly orderly way to pursue unique physiological functions 
that determine the fate of the entire cell. The key determinants within this network are 
phosphorylation-dephosphorylation events, which modulate the activity, localization, 
stability, interplay and turnover of all these factors as well as chromatin dynamics to 
fine-tune the outcomes of this massive signaling network (Shiloh and Ziv 2013). 
Interestingly, the fission and budding yeast homologs of ATM, Tel1, are 
involved in telomere maintenance and play a minor role in the checkpoint response 
(Greenwell, Kronmal et al. 1995).  
 
Cell cycle functions of the ATM cascade 
 Damage within the G1 phase of the cell cycle leads to activation of the G1-S 
checkpoint, which is executed in two phases. The first phase involves the ATM-
mediated activation of the effector kinase CHK2. Activated CHK2 phosphorylates and 
inhibits CDC25A phosphatase and in this way stabilizes the inhibitory phosphorylations 
of T14 and Y15 on CDK2. This blocks the formation of an active CDK2-CyclinE 
complex and prevents G1 to S transition (Mailand, Falck et al. 2000). The second phase 
of the G1 checkpoint is responsible for a more delayed and sustained response to the 
damage and relies on an ATM- and CHK2-dependent activation of the tumor suppressor 
p53 (Kastan, Onyekwere et al. 1991, Kastan, Zhan et al. 1992, Chehab, Malikzay et al. 
2000). p53 is a transcription factor capable of activating numerous genes required for 
blocking the G1 to S transition, repairing the damage as well as genes involved in 
apoptotic pathways (Hirao, Cheung et al. 2002, Takai, Naka et al. 2002).  
The molecular mechanisms underlying the operation of the S-phase checkpoint 
are much less understood. In general, activation of this checkpoint is thought to stabilize 
stalled replication forks and inhibit origin firing until damage has been repaired 
(Lambert and Carr 2005). S-phase checkpoint-mediated CHK2 activation is important 
for cell cycle arrest via the same mechanisms described for G1 arrest. In addition to 
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that, other factors that get phosphorylated by ATM include BRCA1, FANCD2, SMC1 
and Nbs1. Although all of these factors are required for a successful S phase 
checkpoint, their exact effect on inhibiting replication is not yet clear. Nonetheless, the 
function of all these S-phase checkpoint regulators is better understood in the context of 
damage repair (Derheimer and Kastan 2010, Guleria and Chandna 2016). 
Arrest at the G2 phase is achieved via CHK2- and NEK11-mediated 
phosphorylation of CDC25C. Phosphorylated CDC25C associates with 14-3-3-σ, which 
targets it for nuclear export (Peng, Graves et al. 1997, Melixetian, Klein et al. 2009). 
BRCA1 also has a role in inhibiting the CDK-Cyclin complex by regulating the 
expression of WEE1 and 14-3-3-σ (Yarden, Pardo-Reoyo et al. 2002). Interestingly, the 
G2-M-specific function of BRCA1 can be abrogated by mutation of S1423, which is a 
target of ATM (Xu, Kim et al. 2001). Finally, a p53-mediated expression of genes, such 
as p21 and 14-3-3-σ, also contributes to the delay of damaged cells in the G2 phase of 
their cell cycle (Flatt, Tang et al. 2000).  
 
Repair function of the ATM cascade  
 Several repair pathways can process and correct sites of DSBs on the DNA, such 
as non-homologous end joining (NHEJ), homologous recombination (HR) and single-
strand annealing (SSA). The key determinant in the choice of pathway is the extent of 
resection, with NHEJ not requiring any, MMEJ requiring 5-25 resected nucleotides and 
HR and SSA requiring more extensive tracts (Hartlerode and Scully 2009).  
 DSBs occurring before DNA replication are repaired by end joining pathways 
due to the lack of a homologous sequence (provided by the sister chromatid in S and 
G2) (Marechal and Zou 2013). NHEJ occurs throughout the cell cycle and is initiated 
with the binding of the Ku70/Ku80 heterodimer to the exposed ends of the break and 
the recruitment of the catalytic subunit of DNA-PK (DNA-PKcs). The DNA-
PKcs/Ku70/Ku80 complex recruits ligase IV, which joins the ends together, thus 
healing the lesion (Blier, Griffith et al. 1993, Nick McElhinny, Snowden et al. 2000, 
Sonoda, Hochegger et al. 2006). DNA ends that are not compatible for ligation can be 
processed by nucleases, such as Artemis and APLF (Mahaney, Meek et al. 2009). This 
classic NHEJ pathway is thought to proceed with fast kinetics and to be ATM-
independent, although several substrates of DNA-PKcs are phosphorylated by ATM 
(Ciccia and Elledge 2010). A more direct role of ATM and Artemis in DSB repair has 
been proposed by Jeggo and Lobrich laboratories, with both factors being responsible 
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for the slow repair of a subset of breaks in both the G1 and the G2 phases of the cell 
cycle. In particular, ATM and Artemis channeled the G1 subset of breaks to NHEJ 
repair whereas they promoted an HR-mediated repair of the G2 subset of breaks 
(Beucher, Birraux et al. 2009). In S and G2, CDK activation allows extensive 
generation of ssDNA through the MRN-mediated recruitment of CtIP, Exo1 and Dna2. 
This promotes a switch from ATM to ATR at DSBs and repair via homology search and 
will be discussed later (Ciccia and Elledge 2010, Marechal and Zou 2013). 
 
The role of the ATM cascade in cell fate decision – live or die?  
 ATM-mediated activation of the tumor suppressor p53 activates the expression 
of genes that impose cell-cycle arrest but at the same time drives the expression of 
genes that promote programmed cell death (Shiloh and Ziv 2013). p53 mechanism of 
action has been described to entail wave-like changes or pulses of its protein levels 
following damage in human cell lines (Geva-Zatorsky, Rosenfeld et al. 2006). This 
pulsatile nature of p53 protein works like a molecular timer that allows cell cycle arrest 
at low thresholds and induction of apoptosis at higher thresholds. A key determinant in 
this model proposed by Zhang and colleagues is the severity of DNA damage. Low 
levels of damage go down the repair route whereas at high levels of damage repair is 
suppressed and apoptosis begins. This mechanism makes the p53 network a flexible and 
dynamic network that can very elegantly decide cell fates based on the integrity status 
of the duplex (Zhang, Liu et al. 2009). Post-translational modifications also play a role 
in the regulation of this network. Just like phosphorylation of p53 on S15 drives cell 
cycle arrest, phosphorylation of S46 is thought to promote expression of pro-apoptotic 
genes (Oda, Arakawa et al. 2000). Loss of p53 is a driver to uncontrolled growth and 
genomic instability, both hallmarks of carcinogenesis (Carr 2000). 
 
The ATR signaling cascade 
Although ATM is predominantly activated by DSBs, a relatively rare type of 
damage, ATR is primarily activated by ssDNA. This structure is generated during the 
physiological process of DNA replication but also, in higher amounts, at compromised 
replication forks (Lonn and Lonn 1988). Different amounts of ssDNA are thought to 
allow cells to sense the severity of the problem thus mounting various degrees of 
checkpoint activation (Recolin, van der Laan et al. 2014). ssDNA is also formed at sites 
of DNA damage through DSB processing by nucleases, and also at sites of ongoing 
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repair through the processing of bulky lesions. Thus the ability of ATR to sense ssDNA 
gives it a broad function and renders it a key response mechanism to a plethora of DNA 
metabolic processes (Lambert and Carr 2005, Cimprich and Cortez 2008, Marechal and 
Zou 2013).  
Attempts from many labs to biochemically characterize ATR have all failed to 
purify an active form of the kinase. A key step in the activation of the kinase is its 
localization to sites of ssDNA where it is required. Early studies in S. pombe have 
identified Rad3ATR and Rad26ATRIP to exist as a soluble complex in cells, having a 
checkpoint function upstream of other Rad proteins (Edwards, Bentley et al. 1999). 
Subsequent studies in human cells have shown that the two partners are mutually 
dependent to each other as reduction of the protein levels of one leads to a decrease in 
the levels of the other and a subsequent checkpoint defect (Cortez, Guntuku et al. 2001). 
Perhaps the strongest evidence of the mutual dependence of ATRRad3 and ATRIPRad26 
comes from the fact that loss of either of the two produces the same phenotypes at an 
organismal and cellular level (Cimprich and Cortez 2008). Additionally, the stability of 
the ATR-ATRIP complex has been suggested to involve phosphorylation by the NEK1 
kinase (Liu, Ho et al. 2013). So unlike ATM, which exists as inactive homodimers that 
break apart after damage, ATR is always found in a stoichiometric heterocomplex with 
its obligate co-factor ATRIP (ATR-interacting protein), even in untreated cells (Recolin, 
van der Laan et al. 2014). ATR itself is unable to sense ssDNA regions and it is instead 
ATRIP that acts as the sensor. ATRIP can localize ATR to sites of damage by binding 
directly not to ssDNA itself but to the tripartite complex of RPA, which always coats 
exposed DNA strands (Zou and Elledge 2003, Dart, Adams et al. 2004, Fanning, 
Klimovich et al. 2006).  
RPA is composed of the subunits RPA70, RPA32 and RPA14 and binds ssDNA 
with a very high affinity (Kd ~10−9-10−10 M) through oligonucleotide/oligosaccharide-
binding (OB) fold domains (Kim, Paulus et al. 1994). RPA is a complex subjected to 
extensive post-translational modifications in a cell-cycle regulated manner. In response 
to replication stress ATR phosphorylates RPA32 on S33 whereas at DSBs S33 is 
followed by phosphorylation on S4/S8 by DNA-PK (Shiotani, Nguyen et al. 2013). 
Treatment of cells with chemical agents that cause replication stress in a checkpoint 
defective background causes exhaustion of RPA pools and leads to replication 
catastrophe, marked by phosphorylation of RPA32 on T21 and S4/S8 (Toledo, 
Altmeyer et al. 2013). The RPA70 subunit on the other hand is key for the DDR 
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through its ability to recruit important factors such as ATR-ATRIP, 9-1-1, MRN and 
PRP19 (Marechal and Zou 2015).  
Crucial for ATR activation is the ability of ATRIP to recognize RPA70 via an 
acidic alpha helix within its checkpoint recruitment domain (CRD) (Ball, Ehrhardt et al. 
2007). Mutating the ATRIP binding surface on RPA70 causes a significant defect in 
ATR-mediated Chk1 phosphorylation (Xu, Vaithiyalingam et al. 2008). The importance 
of ATRIP in ATR recruitment to RPA-ssDNA substrates in yeast model systems is 
evident from the fact that, in S. cerevisiae, ddc2ΔATRIPΔ has the same phenotype as a 
mec1ΔATRΔ and mutating RPA leads to a reduction of Ddc2ATRIP foci formed following 
DNA damage (Zou and Elledge 2003).  Another interesting observation coming from 
budding yeast is that the C-terminus of Mec1ATR is also contacting RPA in a Ddc2ATRIP-
dependent way (Nakada, Hirano et al. 2005). 
As with ATM, localization of ATR-ATRIP to RPA-ssDNA nucleofilaments is 
by itself not sufficient to activate the signaling response fully. In addition to RPA-
ssDNA, the junction of ssDNA and dsDNA is also an important structure for ATR 
activation. These junctions are recognized by the PCNA-like 9-1-1 complex (sp/h Rad9-
Rad1-Hus1, sc Ddc1-Rad17-Mec3), which is loaded onto chromatin independently of 
ATR and in an ATP-dependent manner (Parrilla-Castellar, Arlander et al. 2004, 
MacDougall, Byun et al. 2007). In particular, 9-1-1 recognizes the DNA end that is 
proximal to the RPA-coated ssDNA and its loading is mediated by the damage-specific 
clamp loader Rad17-RFC (RFC2-5; i.e. Rfc1 replaced by Rad17 for checkpoint control) 
in a manner analogous to PCNA loading by RFC during replication (Caspari, Dahlen et 
al. 2000, Bermudez, Lindsey-Boltz et al. 2003, Ellison and Stillman 2003). An 
important determinant during this process seems to be the RPA heterotrimer. Firstly, the 
defined polarity by which RPA wraps around the ssDNA (with the C-terminus of RPA1 
facing the 3’-end of the ssDNA), directs loading of the 9-1-1 complex to 5’junctions 
(Bochkarev, Pfuetzner et al. 1997, Majka, Binz et al. 2006). Secondly, pre-mRNA 
processing factor (PRP19)-mediated ubiquitination of RPA is thought to promote 
ATRIP tethering on chromatin (Marechal, Li et al. 2014). 
The independent recruitment of the two RPA-dependent complexes, ATR-
ATRIP and the 9-1-1 complex, at the site of the damage promotes the in trans 
phosphorylation of ATR on T1989 in the FAT domain. This autophosphorylation event, 
although it only enables the basal kinase activity of ATR, has been described as a 
molecular switch towards robust checkpoint activation, owing to its ability to promote 
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interaction of the ATR kinase with its main activator –at least in higher eukaryotes– 
TopBP1 (Topoisomerase II binding protein I; spRad4, scDpb11) (Furuya, Poitelea et al. 
2004, Liu, Shiotani et al. 2011). The importance of the 9-1-1 complex could be 
envisaged since its discovery as mutations within the rad9 gene caused sensitivity to IR 
and UV, thus suggesting a role in the checkpoint response (Murray, Carr et al. 1991). 
rad9 knockout mouse embryonic stem cells show spontaneous chromosomal 
aberrations, are sensitive to DNA damaging agents and have a partially defective G2 
checkpoint whereas homozygous mutant embryos die within the early days of gestation 
(Hopkins, Auerbach et al. 2004). An interesting function of 9-1-1 has been described in 
yeasts. In S. cerevisiae, it has been shown that Ddc1-Rad17-Mec39-1-1 can directly 
stimulate the Mec1ATR kinase activity in vitro (Majka, Binz et al. 2006). Using in vivo 
budding yeast LacO systems, Bonnila et al (2008) showed that artificial co-localization 
of Mec1ATR-Ddc2ATRIP and Ddc1-Rad17-Mec39-1-1 onto chromatin was sufficient to 
activate the checkpoint even in the absence of damage (Bonilla, Melo et al. 2008). 
Another in vivo study conducted by Navadgi-Patil and Burgers (2009) showed that 
residues W352 and W544 at the C-terminus of Ddc1Rad9 were sufficient to activate 
Mec1ATR in both the G1 and G2 phases of the cell cycle (Navadgi-Patil and Burgers 
2009). Whether the 9-1-1 complex can activate ATR-ATRIP activity in other organisms 
is still unclear. Instead, a conserved function of the 9-1-1 complex in checkpoint 
activation is its interaction with TopBP1 (Cimprich and Cortez 2008). Apart from its 
essential function in replication initiation, TopBP1 also functions in checkpoint 
activation. 
 
TopBP1; the cornerstone of the ATR signaling cascade 
 The recruitment of the ATR-ATRIP complex is considered an independent event 
from the recruitment of 9-1-1 and TopBP1 (Melo, Cohen et al. 2001). This requirement 
for ATR activation has reasonably led Cimprich and Cortez (2008) to suggest that it 
might serve a functional importance. By having two independent sensor complexes 
being required for mounting a response, like a molecular version of the “two-man rule”, 
cells ensure that the checkpoint will less likely be activated accidentally or by default. 
Alternatively, the functional importance of this independent recruitment might lie in an 
increased probability of ATR-ATRIP and 9-1-1 to co-localize to sites of perturbed 
replication as the length of the ssDNA tracts become longer (Cimprich and Cortez 
2008). Or it could be that this mechanism provides flexibility for the activation of 
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different cellular responses when each is recruited alone (or with different partners), 
compared to when they co-localise. Indeed, ATM-mediated phosphorylation of Rad9 on 
S272 acts to promote damage repair in S and G2 (Shin, Yuan et al. 2012). 
 
The TopBP1 protein and its homologs 
 TopBP1 was first identified in two independent screens in S. pombe. In the first 
screen it was identified as a radiation sensitive mutant rad4 (Schupbach 1971). 
Interestingly, unlike most rad mutants it also displayed a temperature sensitive lethal 
phenotype indicating a function in an additional cellular pathway (Garcia, Furuya et al. 
2005). More than a decade later, Hirano et al (1986) identified the same gene, cut5, in a 
cut mutant screen searching for mutations that block mitosis but allow cytokinesis such 
that the septum bisects the nucleus (hence the name “cells ultimately torn”, cut) 
(Hirano, Funahashi et al. 1986). Saka et al (1993) cloned and sequenced cut5 and 
showed that it was identical to rad4, which had in the meantime been cloned by Fenech 
et al (1991) and was already thought to play a role in DNA metabolism as judged by its 
sequence similarity to Xrcc1 (Fenech, Carr et al. 1991, Lehmann 1993). More 
importantly, Saka et al (1993) demonstrated that the function of the rad4/cut5 was 
required both for the S-  
M checkpoint and for the initiation of replication (Saka and Yanagida 1993). The 
essential role of this protein in replication initiation was strengthened by the  
identification of the S. cerevisiae homolog, Dpb11TopBP1, as a high-copy-number 
suppressor of temperature sensitive mutants in the catalytic subunit as well as the DPB2 
subunit of polymerase ε (Araki, Leem et al. 1995). Finally, the mammalian homolog of  
Rad4/Dpb11, namely TopBP1, was identified in a two-hybrid system that searched for 
interactors of the Topoisomerase IIβ protein and was shown to be required for cell 
survival (Yamane, Kawabata et al. 1997). Since then, homologs of this protein have 
been found in a plethora of species. 
 TopBP1 and its homologs are multiple BRCT domain proteins and a schematic 
representation of Rad4, Dpb11, Xenopus TopBP1 (XTopBP1) and human TopBP1 
(hTopBP1) is shown in Figure 1.6. The BRCT domain is a folding unit that is 
approximately 95 residues long and consists of a four-stranded parallel β-sheet 
surrounded by three α-helices: two α-helices (α1 and α3) on one side and one α-helix 
(α2) on the other side of the β-sheet. The BRCT domains are named after the breast  
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Figure 1.6: Diagrammatic representation of TopBP1 and its homologs in yeasts, Xenopus and 
human. BRCT domains are represented by boxes and known interactors are colour-coded according to 
their functionality. The position of the ATR activating domain within the C-terminus is also shown in red.  
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cancer associated protein 1 (BRCA1) C-terminus as the conserved globular domain they 
contain was first identified in BRCA1 (Lindsay A. Matthews and Alba Guarne, 2013, 
(Watts and Brissett 2010). The BRCT domain is very common among proteins involved 
in the DDR and mainly occurs as a singleton (single BRCT) or tandem pair (double 
BRCT) and often contains a phosphate-binding pocket (Manke, Lowery et al. 2003). 
Two types of single BRCT domains (sGroup I and sGroup II) and double BRCT 
domains (dGroup I and dGroup II) have been identified through phylogeny analysis and 
these four groups seem to differ in their phosphate-binding pockets.   Evolution studies 
in eukaryotic organisms suggest that the phosphate-binding pocket changed from a 
DNA-binding type to a protein-binding site between the two types of single BRCT 
domains. Later in evolution a tandem duplication event of the protein-binding type 
domain gave birth to double BRCT domain. In all members of the first type of double 
BRCT domains, the phosphate-binding pocket is observed in BRCT a, but not in BRCT 
b and, unlike singletons, the main function of this pocket is binding to the phosphate of 
phosphopeptides. It is believed that the evolution of eukaryotic BRCT domains is 
associated with the evolution of the DNA damage response system. So in the early 
stages of evolution where the DNA damage response network of cells was less 
complicated, the BRCT-containing damage/repair proteins were targeted to the exact 
site of the damage directly via their BRCT domain(s).   Thus, the BRCT domains had 
DNA-binding motifs. But as the DDR network became more sophisticated, more 
protein factors were targeted to the damaged sites, providing a more rapid and efficient 
way of mounting a response. And this may explain why the singletons changed their 
function from binding DNA to binding protein, such that they can transmit the signals 
generated by damage sensors to the repair machinery and other cellular processes (cell 
cycle checkpoint, apoptosis, transcription etc.) (Sheng, Zhao et al. 2011). 
 TopBP1 contains both Group I and Group II BRCT domains and its BRCT 
domains are essential for its ability to recruit client proteins and mediate protein-protein 
interactions. But the number of BRCT domains varies among the different species. The 
S. pombe Rad4TopBP1 and the S. cerevisiae Dpb11TopBP1 both contain four BRCT 
domains that come as two tandem repeats. The C. elegans and D. melanogaster 
homologs have 6 and 7 BRCT domains, respectively. The Xenopus and human 
TopBP1were originally shown to contain eight BRCT domains with BRCTs 1-2, 4-5 
and 7-8 occurring as double domains whereas BRCT3 as a singleton (Garcia, Furuya et 
al. 2005, Wardlaw, Carr et al. 2014). More recently, an extra BRCT domain, BRCT0, 
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has been identified at the extreme N-terminus (Rappas, Oliver et al. 2011). 
Interestingly, studies on the crystal structure of TopBP1 have shown that not all the 
domains have the same phospo-binding ability; only BRCTs 1, 2, 5 and 7 seem to bind 
phosphorylated peptides. Interestingly, although all homologs function within the same 
cellular pathways, it overall seems that the similarity between the homologs is weak. 
TopBP1 shares 73% similarity (60% identity) with Xenopus XTopBP1. The similarity 
shared with S. pombe Rad4TopBP1 and Dpb11TopBP1 is concentrated over the regions 
containing the tandem BRCTs 1-2 and 4-5, which are conserved in all orthologs. 
Rad4TopBP1 and Dpb11TopBP1 share 38% similarity (24% identity) with each other 
(Garcia, Furuya et al. 2005, Wardlaw, Carr et al. 2014).  
 Perhaps the most interesting feature of the architecture of TopBP1 is that it 
contains an ATR Activation domain (AAD). In fission and budding yeasts this domain 
is located at the extreme C-terminus of the sequence whereas in Xenopus and humans it 
is found between the sixth and seventh BRCT domain (Kumagai, Lee et al. 2006, 
Mordes, Glick et al. 2008, Mordes, Nam et al. 2008, Lin, Wardlaw et al. 2012). 
 
TopBP1 activates ATR  
One of the biggest challenges in the DDR field has been the elucidation of the 
molecular mechanisms underlying ATR activation (Figure 1.7). The mode of activation 
of the ATR kinase seems to slightly differ between yeasts and mammals, possibly due 
to alterations in the protein’s functions that have occurred in the course of evolution. 
The first evidence for the possible role of TopBP1 in the checkpoint response came 
from the observation that TopBP1 localised to sites of damage and replication stress 
(Makiniemi, Hillukkala et al. 2001). We now know that TopBP1Rad4/Dpb11 is a key 
regulator of the ATR kinase activity, though the precise role it plays in different 
organisms and the extent to which it regulates the ATR pathway may slightly vary. 
 Perhaps the most interesting role of TopBP1 within the ATR signaling pathway 
is its ability to directly activate the ATR kinase. The AAD contacts a region in the C-
terminus of ATR, located between the kinase and FATC domains, namely the PIKK 
Regulatory Domain (PRD). Mutating a conserved residue, K2598, within the PRD 
abolishes TopBP1-dependent activation of ATR. However, even in the absence of 
TopBP1-dependent ATR activation, ATR still possesses some basal kinase activity 
sufficient to promote the initial in trans phosphorylation of ATR on T1989. Thus PRD 
is not required for the basal activity of ATR but is required for its full activity both in 
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Figure 1.7: Model for the activation of the ATR checkpoint at perturbed replication forks. A) When 
a replication fork encounters a barrier, the polymerase and helicase activities may uncouple leading to the 
formation of long tracts of ssDNA in front of the stalled fork, which rapidly gets decorated with RPA. 
ssDNA formed at sites of replication stress recruits ATR-ATRIP and the 9-1-1 complex independently. 
B) The 9-1-1 complex in turn associates with and recruits the master ATR activator TopBP1. Rhino is 
also mediating the interaction between the 9-1-1 complex and TopBP1. ATR autophosphorylates and 
phosphorylates ATRIP which contacts the N-terminus of TopBP1. So TopBP1 acts like a bridge between 
the two binding partners, ATR and ATRIP. ATR itself is also interacting with TopBP1 via its 
autophosphorylation site and TopBP1 BRCTs 7-8. TopBP1 activates ATR through an interaction between 
its AAD and ATR’s PRD. ATR then phosphorylates TopBP1, leading to further stimulation of ATR’s 
kinase activity by TopBP1. Thus the interaction between ATR and TopBP1 provides a possible 
mechanism of signal auto-amplification. ATR is now competent to phosphorylate its downstream targets, 
thus fully activating the checkpoint. Whether TopBP1 can activate ATR at other stages of the cell cycle 
or after DNA damage awaits further characterization.  
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vitro and in vivo. Mutation of this domain in ATRflox/- cell lines causes defects in 
checkpoint activation and loss of viability (Mordes, Glick et al. 2008). Kumagai et al 
(2006) incubated recombinant TopBP1 with human and Xenopus ATR and showed that 
it can stimulate its kinase activity. The region of TopBP1 responsible for the activation 
was narrowed down to a region between the 6th and 7th BRCT domains (AAD) and the 
critical residue that mediates the interaction, W1138, was also identified. Mutation of 
this residue abolished this ectopic ATR activation and also caused a checkpoint defect 
in aphidicolin-treated egg extracts. What is more, it appears that the 
TopBP1/ATR/ATRIP interaction is transient and weak because TopBP1 separates from 
the kinase complex upon gel filtration and ATR returns to its basal kinase activity 
(Kumagai, Lee et al. 2006). The crucial function of the AAD in activating ATR is also 
evident from the fact that fusion of this domain to H2B histone or PCNA was sufficient 
to activate ATR in 9-1-1 knockout DT40 cells (Delacroix, Wagner et al. 2007) or Nbs1 
knockout DT40 cells (Kobayashi, Hayashi et al. 2013). In addition, directly tethering 
TopBP1 to DNA is sufficient to induce ATR-mediated phosphorylation of Chk1 both in 
vitro and in vivo. Of interest is the synergistic activation of Chk1 when the mediator 
protein Claspin is also tethered to the DNA with TopBP1 (Lindsey-Boltz and Sancar 
2011). A recent study in mice conducted by Zhou et al (2013) showed that the TopBP1 
AAD is essential for embryonic development; a knock-in point mutant (W1147R) that 
ablates mouse TopBP1-AAD function causes early embryonic lethality, similar to an 
ATR knock out. In addition, AAD inactivation impaired cell proliferation, promoted 
premature senescence and compromised Chk1 activation following UV irradiation, 
highlighting the crucial role of TopBP1 as an ATR activator (Zhou, Liu et al. 2013). 
Finally, it has been reported that the TopBP1 AAD is capable of activating ATR and 
initiating checkpoint signaling even in the absence of damage. Persistent cell cycle 
arrest caused senescence (Toledo et al 2008). 
  Necessary for TopBP1’s ability to activate ATR is yet another interaction, this 
time with ATR’s binding partner, ATRIP. Mutating the domain of ATRIP that is 
involved in the interaction leads to HU sensitivity, defect in the G2/M checkpoint and 
reduced cell viability (Mordes, Glick et al. 2008). In their attempt to reconstitute the 
ATR checkpoint pathway, Choi et al (2010) showed that it is the N-terminus of TopBP1 
that interacts with ATRIP but the details of this interaction are not yet known (Choi, 
Lindsey-Boltz et al. 2010). 
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A recently characterized protein called ETAA1 has also been suggested to have 
an ATR activating capability via a domain that harbors sequence similarity to the 
TopBP1 AAD (Bass, Luzwick et al. 2016, Haahr, Hoffmann et al. 2016). Authors 
suggest that ETAA1 represents a TopBP1-independent mechanism of activating ATR 
that is confined to stalled as opposed to collapsed replication forks. It is thus interpreted 
as a pathway parallel to TopBP1 that gives cells the flexibility to respond to replication 
stress in different ways according to the functional status of the perturbed chromatin 
region. However, the fact that depletion of ETAA1 has no discernable effect on CHK1 
phosphorylation raises the question of whether this protein is only responsible for a 
small subset of ATR targets, such as RPA. Alternatively, it might be a mechanism 
specific to some cell lines or not conserved among all organisms, at least not to the 
same extent (Bass, Luzwick et al. 2016, Feng, Zhao et al. 2016, Haahr, Hoffmann et al. 
2016, Lee, Zhou et al. 2016). 
In the yeast model systems, the mode of ATR activation seems to involve more 
players. A functionally conserved AAD has been found in scDpb11TopBP1. Despite the 
fact that the yeast TopBP1 has half the number of BRCT domains present in higher 
eukaryotes, studies in the budding yeast model have shown that Dpb11TopBP1 is able to 
bind and activate Mec1ATR. Mordes et al (2008) showed that Dpb11TopBP1 interacts with 
Mec1ATR-Ddc2ATRIP and activates Mec1ATR and similarly to higher eukaryotes this 
activation is dependent on Ddc2ATRIP. This interaction is mediated via an AAD located 
within the C-terminus of Dpb11 and in particular the key residues that act as contact 
points are W700 and Y735. This AAD, however, does not have any sequence similarity 
with the mammalian AAD (Mordes, Nam et al. 2008, Navadgi-Patil and Burgers 2009). 
Ddc1Rad9, as already mentioned, is also able to activate Mec1ATR and this acts 
synergistically with Dpb11TopBP1 (Navadgi-Patil and Burgers 2008).  
Interestingly, a third mode of activation of the Mec1ATR kinase has been recently 
reported by Kumar and Burgers (2013). In particular, it has been shown that the 
unstructured N-terminal domain on the Dna2 nuclease is capable of stimulating Mec1 
and that mutation of W128 and Y130 abrogates this function. Thus Dna2 shows partial 
redundancy for the replication checkpoint with checkpoint initiators Ddc1–Mec3–
Rad179-1-1 and Dpb11TopBP1. A triple mutant that eliminates the checkpoint functions of 
all three initiators abrogates the Mec1ATR-dependent checkpoint (Kumar and Burgers 
2013). Finally, in an attempt to unravel the mechanistics of the Rad3ATR/Rad4TopBP1 
interaction in fission yeast, Lin et al (2012) identified and characterized an AAD within 
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Rad4TopBP1 that is crucial for activation of Rad3ATR in vivo. AAD-defective strains were 
found to be DNA damage-sensitive during G1/S phases but not during G2, suggesting 
that this Rad4TopBP1 AAD is specific to G1/S but not evident in G2. Interestingly, it was 
suggested that S. pombe Rad4TopBP1 acts in a chromatin-dependent pathway to amplify 
the levels of activated Rad3ATR in order to gain a full checkpoint response. This is 
predominant during the G1/S phases of the cell cycle where resection hence ssDNA, 
which is required for Rad3ATR activation, is limited (Lin, Wardlaw et al. 2012). 
Nonetheless, in all organisms studied to date, ATR activation is not exclusively 
mediated by a single protein. It is tempting to speculate that the existence of more than 
one AAD-containing proteins may dictate different modes of signaling through the ATR 
pathway in accordance with the morphology of the chromatin at the lesion. 
 
Role of TopBP1 in ATM-mediated activation of ATR at DSBs 
The initial study that identified the human TopBP1 homologue as a protein 
required for cell survival, has also characterized TopBP1 as a substrate of both the ATR 
and the ATM kinases (Yamane, Wu et al. 2002). Few years later, TopBP1 was proposed 
to have a role in a pathway that connects ATM to ATR at sites of DSBs (Figure 1.8). 
Yoo et al (2007) found that Xenopus ATM-catalyzed phosphorylation of TopBP1 on 
S1131 in the AAD is necessary for activation of ATR-ATRIP in response to DSBs, but 
not to replication blockages. The TopBP1 mutant unable to be phosphorylated on this 
residue displayed a defect in Chk1 phosphorylation following DNA damage but not 
replication stress. This favors a model whereby phosphorylation of this residue by ATM 
may mediate a handover from ATM to ATR checkpoint at DSBs by increasing the 
ability of TopBP1 to stimulate the kinase activity of ATR via the AAD (Yoo, Kumagai 
et al. 2007). The ATM-dependent phosphorylation on S1131 shows that there is a role 
of TopBP1 at DSBs and a quite intriguing question is whether TopBP1 can directly 
activate the ATM kinase by an as yet unidentified ATM activation domain, discussed 
later.  
 
TopBP1 as a molecular scaffold of the ATR checkpoint 
 In addition to turning on the kinase activity of ATR, TopBP1 also acts as a 
molecular landing pad for checkpoint proteins. It brings a number of factors into close 
proximity at the site of damage thus promoting the propagation of the checkpoint 
signaling.  
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Figure 1.8: Handover from ATM to ATR of extensively resected DSBs. A) Activation of ATM at the 
site of DNA damage. B) Extensive resection of DSB leads to the formation of long tracts of RPA-coated 
ssDNA and the subsequent activation of the ATR kinase at the junction distal to the break. TopBP1 has a 
role to play in this handover from ATM to ATR as phosphorylation of its residue S1131 by ATM has 
been shown to activate ATR at regions of damage (see page 39 for details). 
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Efforts to unravel its mechanisms of recruitment revealed that TopBP1 is 
recruited to the lesion through interaction with phosphorylated Rad9. The Rad4TopBP1- 
Rad9 interaction was first described in fission yeast and it was shown to occur between 
the Rad4TopBP1 BRCTs3-4 and two damage induced phosphorylation events on Rad9, 
T412 and S423 (Furuya, Poitelea et al. 2004, Taricani and Wang 2006). This was 
similarly observed in S. cerevisiae where phosphorylation of a threonine residue on the 
tail of Ddc1Rad9 by Mec1ATR allows its interaction with Dpb11TopBP1 and recruitment of 
the mediator Rad953BP1 and the effector kinase Rad53Chk2 (Puddu, Granata et al. 2008, 
Pfander and Diffley 2011). More recently, Germann et al showed that the interaction of 
Dpb11TopBP1 with Ddc1Rad9 is important for Dpb11 foci formation in response to damage 
in all phases of the cell cycle (Germann, Oestergaard et al. 2011). 
In human cells, the interaction of TopBP1 with Rad9 seems to be constitutive. 
The important residue on Rad9 that contacts TopBP1 is S387 and it is constitutively 
phosphorylated by CK2. This suggests that the interaction between the two proteins 
may be independent of damage formation in human cells (St Onge, Besley et al. 2003). 
Consistent with this idea TopBP1 and Rad9 co-immunoprecipitate even in untreated 
cells (Greer, Besley et al. 2003). Rad9 S341 has also been found important for Rad9 
tethering with TopBP1, hence for amplification of the checkpoint signal (Ueda, 
Takeishi et al. 2012, Ohashi, Takeishi et al. 2014). Rappas et al (2011) showed that it is 
the BRCTs 1-2 pair of TopBP1 that contacts Rad9 and mutational analysis of the 
phospho-binding pocket of each of these domains revealed that both domains provide 
binding surfaces. More specifically, BRCT1 is the primary binding site for S387 and 
BRCT2 plays a minor role in S387 binding but might also be involved in contacting 
another phosphorylated residue on Rad9, such as S341 (Rappas, Oliver et al. 2011). 
Interestingly, the ability of TopBP1 to bind Rad9 has switched from the second BRCT 
pair in yeast to the first one in humans. 
Although the Rad9-TopBP1 interaction provides a mechanism of how TopBP1 
is tethered to the lesion, the fact that they are recruited independently of each other 
leaves us with the question of what is the initial sensing mechanism of TopBP1. Using 
Xenopus extracts, Acevedo et al (2016) demonstrated that TopBP1 associates with sites 
of replication stress through a direct interaction with ssDNA-RPA via BRCT2 
(BRCTs4-5 also interacted weakly) (Acevedo, Yan et al. 2016). TopBP1 has also been 
shown to bind damaged DNA in vitro through its C-terminus and this was sufficient to 
activate ATR (Yamane and Tsuruo 1999, Choi, Lindsey-Boltz et al. 2009). Another 
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protein able to associate with both 9-1-1 and TopBP1 is RHINO (Rad9, Rad1, Hus1 
interacting nuclear orphan, encoded by RHNO1). It is not yet known what the binding 
surfaces that mediate these protein-protein interactions are and their functional 
importance in the ATR checkpoint is also unknown. One possibility is that it acts like a 
bridge between the checkpoint clamp and TopBP1. Alternatively, it might promote 
prolonged retention of TopBP1 to the site of the lesion or even enhance the ability of 
TopBP1 to activate ATR, thus providing another possible mechanism for signal 
amplification (Cotta-Ramusino, McDonald et al. 2011). 
The C-terminal BRCT domains present in higher eukaryotes, BRCTs 7-8, were 
also identified as functional players in the activation of the checkpoint since their 
deletion led to a checkpoint defect in Xenopus extracts (Yan, Lindsay et al. 2006). 
Subsequent studies have made it clear that BRCT pairs 1-2 and 7-8 are important during 
replication stress (Cescutti, Negrini et al. 2010, Yan and Willis 2013). The 7th and 8th 
BRCT domains of TopBP1 bind to the Fanconi Anemia helicase FancJ and this is also a 
phospho-specific interaction that occurs after replication stress and is required for the 
extension of RPA-coated ssDNA and hence the activation of the checkpoint (Gong, 
Kim et al. 2010, Leung, Gong et al. 2011).  Finally, BRCTs7-8 have the ability to bind 
ATR on its T1989 residue that gets autophosphorylated when ATR is recruited to the 
RPA-rich site of the damage. This positive feedback interaction promotes the full 
activation of ATR via TopBP1 and the subsequent activation of the checkpoint 
apparatus (Liu, Shiotani et al. 2011). 
 
The mediators take over for propagation of the ATR signaling to transducers 
The 9-1-1-mediated recruitment of TopBP1 is a catalytic event for the activation 
of the ATR kinase and for the molecular assembly of the cascades’ mediators and 
transducers. Once activated by the localisation of 9-1-1 and TopBP1 (and/or ETAA1) to 
the lesion, ATR is fully active and ready to phosphorylate its substrates leading to the 
recruitment of the mediators and the propagation of the checkpoint signaling.  
The mediator of the ATR signaling cascade at sites of replication stress is 
ClaspinMrc1. It was initially identified in Xenopus extracts by the Dunphy lab as a 
protein essential for Chk1 phosphorylation and replication stress-dependent cell cycle 
arrest (Kumagai and Dunphy 2000).  Claspin is a key component of the replication fork 
and in response to replication stress is required to bring ATR into close proximity with 
its effector kinase Chk1. Binding of Claspin to Chk1 in Xenopus requires 
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phosphorylation of Claspin residues S864 and S895 but the kinase responsible for this 
has not been identified yet (Kumagai and Dunphy 2003). Crucial for the retention of 
Chk1 phosphorylation is the binding of Claspin to Rad17, which has been already 
phosphorylated by ATR (Bao, Tibbetts et al. 2001, Wang, Zou et al. 2006). Another 
fork-associated protein that is also promoting ATR-mediated phosphorylation of Chk1 
is Timeless/Tipin. Claspin together with Timeless/Tipin form the Fork Protection 
Complex (FPC) that apart from supporting Chk1 phosphorylation at sites of perturbed 
replication it also associates with the fork during unperturbed S phase (Unsal-Kacmaz, 
Chastain et al. 2007).  
The yeast homolog, Mrc1Claspin, was similarly identified as a protein required for 
the recruitment of the effector kinases, Cds1Chk2 (S. pombe) and Rad53Chk2 (S. 
cerevisiae). This recruitment required Mrc1Claspin phosphorylation and was confined to S 
phase (Alcasabas, Osborn et al. 2001, Tanaka and Russell 2001). The S. pombe and S. 
cerevisiae Mrc1Claspin also form the FPC with Tof1/Swi1Timeless and Swi3/Csm3Tipin 
(Unsal-Kacmaz, Chastain et al. 2007). It is interesting to note here that the functions of 
the Chk1 and Chk2 kinases have swapped over the course of evolution from fungi to 
higher eukaryotes. In particular, although Cds1Chk2 responds to replication stress in 
fission yeast, its mammalian homolog Chk2 responds mainly to DNA damage whereas 
Chk1 is the replication stress effector. In budding yeast, however, it seems that 
Rad53Chk2 is responsible for the response to both types of damage, with budding yeast 
Chk1 providing a relatively minor backup role (Rhind and Russell 2000). 
The Chk1 transducer can then be recruited and activated by ATR. In mammals, 
this activation involves the phosphorylation of two SQ sites, S317 and S345, both 
required for Chk1 activation and used as surrogate markers of ATR activation (Guo, 
Kumagai et al. 2000, Liu, Guntuku et al. 2000).  These two SQ sites are conserved in 
the fission yeast but only S345 is required to stimulate Chk1 (Lopez-Girona, Tanaka et 
al. 2001). The ATR-mediated phosphorylation is also important for inducing a 
conformational change that relieves the intra-molecular auto-inhibitory state at which 
Chk1 molecules exist in undamaged conditions. Activated Chk1 is then released from 
the chromatin such that the phosphorylated Chk1 pools can only be detected in soluble 
fractions of cellular lysates (Smits 2006, Smits, Reaper et al. 2006). 
Overall, ATR activated after replication stress at disturbed forks phosphorylates 
various substrates to coordinate cell cycle arrest, maintenance of replication fork 
stability, origin firing and restart of broken forks. 
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TopBP1 scaffolds the mediators at sites of damage 
In addition to activating ATR and providing docking sites for the replication 
stress proteins, TopBP1 also helps recruit mediator proteins to sites of damage.  
Initial evidence for the interaction of TopBP1 with damage mediators came from 
Saka et al (1997) who showed that Crb253BP1 is recruited to damage-associated 
Rad4TopBP1. Crb253BP1 interacts with Rad4TopBP1 via BRCTs1-2 (Saka, Esashi et al. 
1997). Recruitment of Crb253BP1 to sites of damage and activation of the Rad3ATR 
checkpoint was also found to depend on interaction of Rad4TopBP1 with Rad9 (Furuya, 
Poitelea et al. 2004, Taricani and Wang 2006). Three CDK phosphorylation sites on 
Crb253BP1 have recently been identified to be required for contacting Rad4TopBP1. These 
sites are phosphorylated sequentially with the phosphorylation of two canonical sites, 
T215 and T235, bringing Crb253BP1 into close proximity to the Rad4TopBP1-associated 
Cdc2CDK, which is then able to phosphorylate the non-canonical T187. This leads to a 
strong interaction between BRCTs1-2 and two molecules of Crb2, an interaction 
required for the recruitment of the effector kinase and the activation of the DNA 
damage checkpoint in G2 (Qu, Rappas et al. 2013). This interaction is also conserved in 
the budding yeast where the same BRCT domains of Dpb11TopBP1 bind to two 
phosphorylated residues on Rad953BP1. This is also required for bringing the effector 
kinase to the lesion but whether there are two molecules of Rad953BP1 binding to 
Dpb11TopBP1 is not yet known (Pfander and Diffley 2011). Conserved throughout 
evolution, 53BP1 is also interacting with BRCT4-5 of TopBP1 in human cells and this 
seems to be required for full activation of the checkpoint during the G1 phase of the cell 
cycle. Whether TopBP1 activates the G1 checkpoint through direct activation of ATM, 
ATR or ATM-mediated activation of ATR is not known (Cescutti, Negrini et al. 2010). 
BRCTs 4-5 are also important for the recruitment of TopBP1 to sites of damage 
and replication-associated stress and it was Yamane et al (2002) who first showed that 
TopBP1 focus formation relies on BRCT5 (Yamane, Wu et al. 2002). BRCT5 was later 
found to interact with the MDC1 mediator through the SDT repeat of MDC1 (Wang, 
Gong et al. 2011). 
TopBP1 can also be recruited to sites of damage in an MRN-dependent manner 
and this has been shown in Xenopus. The TopBP1-Rad9 interaction, however, was still 
required to activate the ATR cascade effector kinase Chk1. The fragment of XTopBP1 
required for the interaction was narrowed down to BRCTs 3-6 (Duursma, Driscoll et al. 
2013). XTopBP1 has also been reported to bind MRN at sites of DSBs through 
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interaction with the Nbs1 subunit of MRN (Yoo, Kumagai et al. 2009). A more recent 
study suggests that it is the first pair of the BRCT domains of TopBP1 that contacts 
Nbs1 and that MDC1 mediates this interaction (Choi and Yoo 2016). Interestingly, 
Shiotani et al (2013) showed that Nbs1 mediates ATR activation on RPA-ssDNA in a 
TopBP1-dependent but Rad17-independent manner. Authors suggested a quite 
interesting model of a bi-phasic nature of DSB processing resulting to distinct 
molecular requirements. This idea has been around for many years and supported by in 
vitro studies (Shiotani and Zou 2009). Initial processing of the break exposes limited 
amount of RPA-ssDNA, decorated by ATR-ATRIP and juxtaposed to the Rad17/9-1-1-
decorated ss-dsDNA junction. In this context, RPA is phosphorylated in a Rad17-
dependent manner. But as resection proceeds and long tracts of RPA-ssDNA form, the 
Rad17/9-1-1 complexes become out of reach. Now, Nbs1 recognizes the distal portion 
of RPA-ssDNA and ATR-ATRIP is activated by recruitment of TopBP1 in an Nbs1-
dependent but Rad17-independent manner (Yoo, Kumagai et al. 2009, Shiotani, Nguyen 
et al. 2013). In line with this model, depletion of both Nbs1 and Rad17 from Xenopus 
egg extracts abolishes phosphorylation of CHK1 in response to the polymerase inhibitor 
aphidicolin (Lee and Dunphy 2013). Finally, CtIP is another documented interactor of 
XTopBP1 and this is a damage-stimulated and MRN-dependent interaction, possibly 
involved in an ATM to ATR hand-over as well (Ramirez-Lugo, Yoo et al. 2011). Future 
studies will hopefully shed light on the details of this interaction and reveal whether it is 
occurring in organisms other than Xenopus too. 
Other mediators of the ATR pathway that do not interact with TopBP1 also 
exist. One of the best-characterized substrates of ATR is H2AX, which gets 
phosphorylated by the kinase at sites of defective replication to yield γ-H2AX. This 
favors the recruitment of MDC1 and interacting TopBP1, the propagation of γ-H2AX to 
flanking chromatin and subsequently the recruitment of other ATR substrates (Wang, 
Gong et al. 2011). Alternatively, it might promote recruitment of ATM to the chromatin 
surrounding the stressed fork (Ward and Chen 2001). 
 
ATR functions during unperturbed replication  
 Unlike ATM, ATR is essential for viability of proliferating cells. Germ-line 
inactivation of ATR or Chk1 results in early embryonic lethality in mice and genetic 
inactivation causes cell death in human cells, whereas ATM- and CHK2-knock out mice 
are viable (Brown and Baltimore 2000, de Klein, Muijtjens et al. 2000, Liu, Guntuku et 
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al. 2000, Takai, Tominaga et al. 2000, Brown and Baltimore 2003). Furthermore, 
ablation of ATR and CHK1 causes high levels of genomic instability in S phase 
(Casper, Nghiem et al. 2002, Syljuasen, Sorensen et al. 2005). Surprisingly, CHK1 can 
be genetically deleted in DT40 lymphoma cells although CHK1-deficient DT40 show 
severe defects in both the DNA damage and the replication checkpoints (Zachos, 
Rainey et al. 2003). This points to fundamental differences in the normal physiological 
functions of the ATM and ATR checkpoint pathways. ATR responds to ssDNA and this 
is a much more physiologically relevant DNA structure compared to DSBs, which 
activate ATM (Cimprich and Cortez 2008).  
 The essential function of ATR seems to be the stabilisation of replication forks 
even in undamaged cells. ATR phosphorylates various factors at the replication fork and 
at origins of replication and although the precise molecular significance of most of these 
phosphorylation events is not entirely understood, it is well accepted that they promote 
genomic stability during S phase (Cimprich and Cortez 2008, Flynn and Zou 2011). For 
example, ATR, Claspin, Rad9 and Hus1 were found to be required for proper regulation 
of CHK1 and CDC25 in a normal S phase (Sorensen, Syljuasen et al. 2004). Similarly, 
in fission yeast, histone H2A is phosphorylated in S phase at difficult-to-replicate 
regions such as ribosomal DNA repeats (Rozenzhak, Mejia-Ramirez et al. 2010). 
Interestingly, this basal level of the activated checkpoint in yeasts increases DNA 
damage tolerance (Tsaponina and Chabes 2013). ATR also acts to sustain fork integrity 
in situations where a moving replication fork runs into an actively transcribed region 
(Bermejo, Capra et al. 2011). Finally, ATR acts to maintain stability of common fragile 
sites (Casper, Nghiem et al. 2002) and to control activation of the mitotic CDK at the 
centromeric regions (Kramer, Mailand et al. 2004). 
 
Cell cycle functions of the ATR cascade 
The levels of ATR and Chk1 increase in late G1 as part of the E2F-dependent S-
phase promoting transcriptional programme that allows the expression of genes required 
for S phase (Kastan and Bartek 2004). Unlike CHK2, CHK1 is a quite labile protein that 
is restricted to S and G2 phases and it remains active even in unperturbed cell cycles 
(Lukas, Bartkova et al. 2001). 
Replication stress results to an enhancement of the action of the CHK1 kinase, 
rather than de novo activation as is the case of CHK2, simply because CHK1 is already 
operating in unperturbed S. More specifically, Chk1 remains largely inactive through an 
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intra-molecular auto-inhibitory mechanism. Phosphorylation of CHK1 by ATR on 
residues S317 and S345, however, relieves this inhibition via an induction of a 
conformational change as well as via release from chromatin as already mentioned. This 
allows CHK1 to interact with other protein, such as 14-3-3 (Jiang, Pereira et al. 2003, 
Kastan and Bartek 2004, Smits 2006). One of the targets of CHK1 includes the CDC25 
proteins, leading to S phase arrest via CDC25 phosphorylation and inhibition of 
CDK2/Cyclin E (Sanchez, Wong et al. 1997). A CHK1-mediated phosphorylation and 
activation of Wee1 kinase has also been described (Lee, Kumagai et al. 2001). 
Furthermore, CHK1 functions in the S-M checkpoint to prevent mitotic entry in cells 
with under-replicated or damaged DNA (Brown and Baltimore 2003). Finally, in 
response to persisting damage in G2, CHK1 promotes degradation of CDC25A and 14-
3-3-medited cytoplasmic sequestration of CDC25C, promoting in this way the 
inactivation of CDK1 and imposing a G2/M arrest (Peng, Graves et al. 1997, Sanchez, 
Wong et al. 1997, Nghiem, Park et al. 2001, Mailand, Podtelejnikov et al. 2002).  
 
ATR functions at stalled replication forks 
To avoid activating late-firing origins in the presence of DNA damage, cells 
have evolved mechanisms to regulate the complexes required for replication initiation. 
Phosphorylation of TreslinSld3 by Chk1 prevents its interaction with TopBP1 (Boos, 
Sanchez-Pulido et al. 2011) and a similar mechanism has been described in budding 
yeast (Zegerman and Diffley 2010). Similarly Rad53 phosphorylates Sld3 inhibiting its 
association with MCM in addition to Dpb11 and Cdc45 binding (Deegan, Yeeles et al. 
2016).  
ATR also physically functions on the chromatin to stabilize stalled forks. This 
function of ATR is in large part an enhancement of the already physiologically 
operating mechanism of the ATR-CHK1 arm. Perhaps the most vital function of ATR 
on stalled replication forks is promoting their stable association with the replisome. This 
is thought to prevent fork breakage and to assist in replication resumption (Dimitrova 
and Gilbert 2000). Interestingly, several observations have led to the suggestion that 
primase and polymerase activities at stalled replication forks are required for the actual 
activation of the ATR checkpoint. Synthesis and elongation of de novo DNA primers on 
the single-stranded templates of stalled forks promote the formation of such DNA 
structures required for the loading of the 9-1-1 and recruitment of TopBP1. This might 
explain why the checkpoint machinery functions to avoid the dissociation of 
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polymerases from stalled forks (Recolin, van der Laan et al. 2014). 
Although ATR signaling through Chk1 acts to reduce the overall rates of 
replication, interestingly, ATR can also promote dormant origin firing to rescue forks 
stalled at DNA lesions. It does so via a mechanism that acts independently of Chk1 and 
involves phosphorylation of the MCM2 subunit on S108 (Cortez, Glick et al. 2004, 
Yoo, Shevchenko et al. 2004) and subsequent recruitment of Polo-like kinase 1 (PLK1) 
(Trenz, Errico et al. 2008). This seems to create a biphasic situation characterized by 
inhibition of origin firing on a global scale and replication synthesis on a local scale, 
near the stalled fork (Cimprich and Cortez 2008, McIntosh and Blow 2012). 
The replicative machinery also has the ability to re-prime DNA synthesis 
downstream of the lesion, leaving behind single-stranded DNA gaps that can be filled 
by the so-called “DNA damage tolerance” (DDT) pathways (also known as “Post-
replication repair, PRR). This involves the use of specialized low fidelity translesion 
synthesis (TLS) polymerases to bypass the lesion, for repair after the completion of 
DNA replication. The functional link between DDT and the ATR signalling pathway 
remains elusive. However, studies in yeasts suggest that the ATR pathway and its 
components are important for the recruitment of TLS polymerases as well as for the 
ubiquitination of PCNA, a catalytic event for the regulation of DDT (Ghosal and Chen 
2013). 
As part of its role in promoting replication fork stability of stalled replication 
forks, ATR recruits factors like the RecQ family of helicases, which help clear DNA 
structures that could be deleterious for the cells. Timeless/Tipin are also ATR substrates 
that accumulate at stalled forks and promote the Claspin-mediated activation of CHK1 
as well as the prevention of continued unwinding of the DNA by the replicative 
helicase, hence the dissociation of the RFC from the site of synthesis. Finally, in fission 
yeast Rad3ATR phosphorylates Mus81 leading to its dissociation from chromatin and this 
helps avoid fork collapse or DSB formation induced by direct cleavage of the DNA by 
the Mus81/Eme1 endonuclease complex. Overall, the various interactions of ATR at 
stalled forks and their importance in fork stabilization are a matter of ongoing research 
(Paulsen and Cimprich 2007, Ciccia and Elledge 2010).  
Early work suggested that failure to resume DNA synthesis leads to fork 
collapse (Cobb et al, 2003, 2005; Katou et al, 2003; Lucca et al, 2004). A stalled fork 
largely retains the ability to resume replication as it is stabilized by the checkpoint 
machinery, whereas a collapsed fork is not stabilized and requires the assistance of 
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restart mechanisms to resume. Whether failure to activate the checkpoint always leads 
to fork collapse and whether this collapse event is always characterized by the 
dissociation of replisome components is not yet clear (Lambert and Carr, 2013). 
Recombination-mediated repair pathways are among the mechanisms that promote 
continuity of DNA replication and faithful inheritance of the genetic code.  
HR plays a pivotal role in the repair and restart of stalled replication forks 
(McGlynn and Lloyd 2002, Lambert and Carr 2013). HR is described as gene 
conversion in the sense that the sequence of a particular locus is replaced by copying the 
sequence of a homologous locus (Haber 2000). ATR signaling at collapsed replication 
forks regulates repair by HR as many recombination proteins are ATR substrates 
(Ciccia and Elledge 2010). A characteristic example of HR factors regulated by ATR 
are the BRCA1 and BRCA2 proteins, involved in end resection and loading of the 
Rad51 nucleoprotein concomitantly with RPA displacement (Prakash, Zhang et al. 
2015). Furthermore, ATR is involved in the pathway of Nucleotide Excision Repair 
(NER), which removes bulky helix-distorting DNA lesions as part of an oligonucleotide 
fragment, creating in this way short stretches of ssDNA (Marteijn, Lans et al. 2014). 
Finally, the Fanconi Anemia pathway of repair is also targeted by ATR and this is partly 
a TopBP1-mediated regulation, discussed in the next section. 
 
ATM and ATR; more than just independent DDR regulators  
 A particularly interesting aspect of the signaling network of the DDR is the 
cross-talk between the ATM and ATR kinases themselves. Although they sense 
different DNA structures and they respond to these in unique ways, ATM and ATR 
have interdependent activities as well, as it might have already emerged from previous 
sections (Cimprich and Cortez 2008). In particular, ATM and MRN are required for 
ATR activation in response to DSBs, suggesting the conversion of a DSB to a ssDNA 
checkpoint substrate (Myers and Cortez 2006). When cells are deficient for ATM, ATR 
is required for Chk2 phosphorylation signaling in response to IR-induced DSBs (Wang, 
Redpath et al. 2006). Similarly, ATM signaling is activated at collapsed replication 
forks where DSBs are formed (Cimprich and Cortez 2008). What is more, evidence of 
the interplay between ATM and ATR comes from the overlapping in substrate 
specificity. As well as having their unique substrates, they can also phosphorylate the 
same substrates (Cimprich and Cortez 2008). 
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 Of particular interest in the current research study is the function of TopBP1 
within the ATM and ATR signaling pathways. Its role in scaffolding the checkpoints 
and in acting as a catalyst for the activation of the ATR kinase on both broken 
chromatin and ssDNA renders TopBP1 an integral component of the checkpoint 
pathways. Unraveling its mechanisms of action and regulation will shed light into 
fundamental questions concerning the DDR.  
 
Other roles of TopBP1  
TopBP1 has also been reported to have a role in regulating DNA repair. 
Depletion of TopBP1 leads to an increase in inter-sister chromatid exchange and a 
reduced level of DSB-induced HR. Depletion of TopBP1 also causes sensitivity to 
DSB-forming agents (Morishima, Sakamoto et al. 2007). One explanation for the role of 
TopBP1 in suppressing sister-chromatid exchange is its recently identified interaction 
with the BLM helicase during S phase. BLM, which is part of the 
BLM/TOP3A/RMI1/RMI2 Dissolvasome complex, was shown to interact with the 
BRCT5 domain of TopBP1 and this interaction seems to be important for suppressing 
origin firing, sister chromatid exchanges (SCEs) and generally preventing the formation 
of aberrant DNA structures within recombinational repair (Wang, Chen et al. 2013, 
Blackford, Nieminuszczy et al. 2015). Phosphorylated S304 of BLM seems to be the 
point of contact for TopBP1 BRCT5 but the exact mechanism by which TopBP1 
regulates the activity of BLM remains elusive (Wang, Chen et al. 2013). Furthermore, 
TopBP1 is involved in the regulation of the Fanconi-Anemia (FA) pathway, a group of 
proteins catalyzing the repair of interstrand crosslinks that would otherwise block the 
replication fork bi-directionally (Ciccia and Elledge 2010). A key player within this 
pathways is yet another helicase, FANCJ (also known as BACH1 or BRIP1), which is 
known to be phosphorylated after damage and replication stress (Peng, Litman et al. 
2006). In particular, a phospho-specific interaction between FANCJ T1133 and TopBP1 
BRCTs 7-8 was required for the loading of RPA onto chromatin following HU 
treatment suggesting a role in the activation of the replication stress checkpoint (Gong, 
Kim et al. 2010, Leung, Gong et al. 2011).  
TopBP1 also emerges as a key regulator of other HR-mediated repair. Moudry et 
al (2016) found that depletion of TopBP1 sensitized cells to olaparib, a drug known to 
hyper sensitize cells already defective in bona fide HR factors. In an effort to 
understand the potential role of TopBP1 in HR, authors observed that TopBP1 promotes 
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the loading of Rad51. Although BRCTs 7-8 were found to be sufficient for this 
function, the exact mechanism remains unkown (Moudry, Watanabe et al. 2016). Other 
suggested interactions of TopBP1, which are of relevance to recombinational repair 
include the one with BRCA1 (Greenberg, Sobhian et al. 2006) and PARP1 (Wollmann, 
Schmidt et al. 2007). Such interactions, however, remain to be validated and their 
functional importance identified. Interestingly, TopBP1 has emerged as one of the 
minimal requirements for ATR-mediated repair of NER DNA substrates in an in vitro 
system developed by the Sancar laboratory (Lindsey-Boltz, Kemp et al. 2014). Finally, 
TopBP1 has been described as a key player in V(D)J recombination during B- and T-
cell development in the immune system (Kim, Lee et al. 2014). 
In yeast, the interaction of Dpb11TopBP1 with the repair scaffold Slx4 provides 
another example of the various possibilities by which TopBP1 functions in DNA repair 
pathways. CDK-mediated phosphorylation of Slx4 on S486 enables binding to 
Dpb11TopBP1 BRCTs 1-2 thus competing with the binding of the Rad953BP1 checkpoint 
adaptor. This was suggested to provide a mechanism of Dpb11TopBP1 sequestration and 
dampening of the DNA damage signaling to allow room for repair and avoid persistent 
cell cycle arrest (Ohouo, Bastos de Oliveira et al. 2010, Ohouo, Bastos de Oliveira et al. 
2013). The Slx4-Dpb11 interaction has more recently been described as being important 
in DNA end resection (Dibitetto, Ferrari et al. 2016) and resolution of repair 
intermediates (Gritenaite, Princz et al. 2014). 
 Furthermore, as an indirect way of exerting an effect on repair, TopBP1 seems 
to play a role in the recruitment of chromatin remodelers. A recent study from the 
Pfander laboratory has identified a novel interaction between the Fun30 nucleosome 
remodeler and BRCTs1-2 of Dpb11TopBP1, which seems to be essential for the function 
of Fun30 in end resection (Bantele, Ferreira et al. 2017). Additionally, the BRG1 
chromatin remodeler also involved in end resection has been suggested to be recruited 
in an Rb-dependent manner at DSBs, in what seems as a novel function of the Rb 
tumour suppressor at sites of damage. But localization of Rb depends on E2F1, which in 
turn interacts with TopBP1. Mutating the site of interaction of E2F1 with TopBP1 in 
mice impairs the recruitment of all these factors to the lesion and leads to checkpoint 
and repair defects (Velez-Cruz, Manickavinayaham et al. 2016). 
In recent years, increasing evidence identifies TopBP1 as a key regulator of yet 
another cellular process, that of mitosis. It is possible for cells to proceed into mitosis 
with regions of their genome being under-replicated simply because of an inefficiency 
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of the G2-M checkpoint to sense and allow the repair of some lesions. This poses a 
problem for chromosome segregation and if such structures are not repaired within M, 
then they persist to the daughter cells in G1 as nuclear bodies of the 53BP1 marker of 
DNA damage. Interestingly, work from the Lisby and Oestergaard laboratories has 
revealed that TopBP1 marks such aberrant chromatin structures and its depletion causes 
an increase in anaphase bridges, probably caused by persisting HJs between the sister 
chromatids (Germann, Schramke et al. 2014). In fact, it was shown that TopBP1 
promotes the resolution of HJs by Slx4 but also facilitates DNA synthesis at under-
replicated or unreplicated regions in mitosis (Pedersen, Kruse et al. 2015), 
independently of translesion polymerases (Gallina, Christiansen et al. 2016).  
TopBP1 has also been found to localize to mitotic centrosomes (Reini, Uitto et 
al. 2004, Bang, Kim et al. 2013) and centromeric UFBs (Broderick, Nieminuszczy et al. 
2015). Centrosomes are crucial for the initiation of mitosis as it is the structure where 
activation of CDK1/CyclinB happens (Jackman, Lindon et al. 2003). At these regions 
TopBP1 co-localises with Topoisomerase IIα, thus presumably promoting the resolution 
of centromeric DNA catenations. Whether TopBP1 localises to centrosomes via its in 
vitro identified DNA-binding activity or via some protein-protein interaction remains 
unknown. Nonetheless, mutation of the phosphor-binding pocket of BRCT5 results to 
an increase in centromeric UFBs (Broderick, Nieminuszczy et al. 2015).    
 In addition to mitosis, TopBP1 is also emerging as a key regulator of 
transcription. Human TopBP1 has been shown to contain a transcription activation 
domain between residues 460 and 500 as well as two transcription repressor regions that 
map to BRCT2 and BRCT5 (Wright, Dornan et al. 2006). A number of interactions 
have also been identified concerning the role of TopBP1 in transcription control. 
Perhaps one of the most interesting interactions is the one with E2F-1, a member of the 
E2F family of transcription factors involved in the regulation of the cell cycle and, 
contrary to other members of its family, of apoptosis (Field, Tsai et al. 1996). The 
interaction of TopBP1 with E2F-1 inhibits the known E2F-1 activities but recruits E2F-
1 to a BRCA1-containing repair complex, suggesting a direct role of E2F-1 in 
checkpoint/repair at stalled forks (Liu, Lin et al. 2003). The E2F-1-TopBP1 interaction 
has been found to occur at the G1-S boundary and after DNA damage. It presumably 
functions to prevent apoptosis during replication in the first case and to prevent 
replication of damaged genetic material in the second. For this interaction to occur, 
phosphorylated E2F-1 S31 interacts with BRCT6 of TopBP1 (Liu, Lin et al. 2003, Liu, 
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Luo et al. 2004). This interaction is also mediated by an AKT-dependent 
phosphorylation of S1159 on TopBP1, which leads to oligomerisation of TopBP1 via 
BRCTs7-8 and subsequent binding to E2F-1. Recent evidence suggests that 
oligomerisation of TopBP1 through BRCTs7-8 prevents its interaction with ATR and 
hence switches the role of TopBP1 from checkpoint activation to transcriptional 
regulation. AKT-mediated oligomerisation of TopBP1 seems to enable TopBP1 to 
interact with most of the transcription factors that are known to bind to it (Liu, Lin et al. 
2003, Liu, Paik et al. 2006, Liu, Graves et al. 2013). Interestingly, TopBP1 has been 
reported to bind to the DNA-binding domain of p53 and repress its activity thus 
promoting growth and survival (Liu, Bellam et al. 2009). Finally, TopBP1 exerts an 
effect on the cell cycle machinery through its ability to interact with Miz1, a 
transcriptional activator of the p21 CDK inhibitor. In unperturbed cells, TopBP1 binds 
to and inhibits Miz1 whereas after UV irradiation it dissociates leading to cell cycle 
arrest (Herold, Wanzel et al. 2002). Perhaps more intriguing is the observation that 
depletion of TopBP1 in G1 led to an accumulation of p21 and p27, inactivation of the 
CDK2/Cyclin E complex and subsequent G1/S arrest. Co-depletion of p21, p27 and 
TopBP1 restored the levels of CDK2/Cyclin E but did not relieve the cell cycle block 
due to the additional role of TopBP1 in pre-IC assembly at origins (Jeon, Lee et al. 
2007). 
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How to approach TopBP1 and what questions to ask 
 Conditional knock out of TopBP1 in mice results to early embryonic lethality 
and depletion in human cancer cell lines causes cellular apoptosis. TopBP1 depletion in 
mouse untransformed or human primary cells, however, leads to cellular senescence 
(Jeon, Ko et al. 2011). TopBP1 is also essential for neurogenesis as tissue specific 
deletion in the central nervous system (CNS) of mice leads to genomic instability and 
p53-mediated apoptosis in neuronal progenitors. Interestingly, authors observed that 
TopBP1 loss resulted to impaired neurogenesis more aggressively than ATR loss, 
pinpointing to a broader role in genome stability (Lee, Katyal et al. 2012).  
 TopBP1 has emerged as a central activator of the ATR kinase, a function that is 
of pivotal significance for the regulation of cellular proliferation under normal 
circumstances but also for the repair of potentially deleterious lesions on the genetic 
material. Like ATR and Chk1, TopBP1 is essential for progression of cells through the 
S phase, but to what extent this is attributed to its role in replication initiation or to its 
additional roles in cell cycle arrest, stabilization of stalled forks and restart/repair of 
broken forks, or indeed both remains enigmatic. The fact, nonetheless, that not that 
many mutations within TopBP1 have been identified in cancer patients suggests that 
mutations affecting the protein’s function, also impair the replicative potential of pre-
cancerous lesions. TopBP1 thus functions as a crucial regulator of genome integrity. Its 
ability to dialogue with so many proteins downstream of the ATM and ATR kinases as 
well as with the kinases themselves renders it a central modulator in the fine-tuning of 
the numerous signaling routes encompassing the DDR and a key catalyst towards the 
repair of damaged chromatin and the suppression of tumorigenesis. 
Interestingly signaling through the ATR-Chk1 arm can potentially lead to 
TopBP1-dependent repression of E2F-1- and p53-mediated apoptosis. So in addition to 
its checkpoint activation function, TopBP1 can also orchestrate a transcriptional 
regulatory programme (Akt-mediated) that suppresses checkpoint activation when 
growth-promoting signals are communicated to the cell. This function renders TopBP1 
a global regulator of cellular proliferation in addition to its local activities at perturbed 
replication forks or sites of damage. It also renders TopBP1 an attractive target for 
cancer treatment. The progression of solid tumors is usually driven by a de-regulation of 
DDR pathways such as Rb, p53 and PI3K/Akt. And TopBP1 sits at the crossroad of all 
these oncogenic pathways, like a common modulator at the point of convergence. Could 
we perhaps target TopBP1 in cancer cells to activate apoptosis? Probably yes, as is the 
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case with other DDR factors. Chowdhury et al (2014) have identified Calcein as a 
molecule capable of blocking oligomerisation of TopBP1 hence inhibiting its binding to 
p53 and re-activating apoptosis in a spectrum of cancer cell lines over-expressing 
TopBP1 (Chowdhury, Lin et al. 2014).  
Furthermore, though still contradictory, a number of studies have implicated 
aberrant expression of TopBP1 in breast cancer. Going et al (2007) analysed 12 samples 
of breast tissue from cosmetic breast reduction surgery; immunohistochemical analysis 
demonstrated that in a significant number of breast carcinomas TopBP1 was aberrantly 
expressed, as it was detected in the cytoplasm and nucleus of some tumors and 
exclusively in the cytoplasm of others. Liu et al on the other hand reported TopBP1 
overexpression in the nucleus of primary breast cancer tissue-derived cells (Liu, Bellam 
et al. 2009). In another study, Forma et al (2013) examined the association between five 
single nucleotide polymorphisms located in the 3′UTR region of the TopBP1 gene and 
endometrial cancer risk and their results raise the possibility of TopBP1 being a 
susceptibility gene for endometrial cancer, though more studies are required to confirm 
this. Overall, whether TopBP1 can be used as a prognostic marker for breast cancer 
requires further investigation.  
 The question for now, I think, is not whether we can target TopBP1 to regulate 
its function but whether we truly know enough about this protein to be able to design 
the appropriate inhibitor molecules and predict with accuracy their effect firstly at a 
molecular level and then at the level of the cell/organism. Research in recent years has 
greatly expanded the information about TopBP1 and its multi-faceted nature in various 
cellular processes has been revealed. But we still lack answers to fundamental 
questions. For example; where is this protein localized throughout the cell cycle? How 
is its localization altered after DNA damage or replication stress? How is it regulated? 
How do the levels of TopBP1 affect its functions? What is the mechanism of activation 
of ATR by TopBP1? Can TopPB1 directly activate ATM? What is the ATM- and 
TopBP1-mediated mechanism of ATR activation at DSBs? Which of the in vitro-
described interacting partners of TopBP1 happen in vivo as well? What are the in vivo 
physiological functions of TopBP1 protein-protein interactions? How are its pro- and 
anti-survival functions regulated? And many more. 
  Of course there are many unanswered questions. Experimental observations 
suggest levels of complexity beyond the skeletal framework of the ATM and ATR 
cascades. Especially critical will be the development of novel genetic systems that will 
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allow the analysis of separation of function point mutants of TopBP1 in genetically 
defined systems in vivo. Additionally, complete understanding of the underlying 
molecular mechanisms of action of TopBP1 or indeed any other protein will require 
high-resolution structural information. 
 TopBP1 is a multifunctional protein and unraveling in detail its plethora of 
effects on genome biology requires an understanding of every functional aspect of this 
protein in both stressed and unstressed cellular contexts. More importantly, a true 
mechanistic understanding of the antagonistic roles of TopBP1 in suppressing and 
supporting tumorigenesis will require new tools and persistent research to pull the 
puzzle apart. 
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Preface to Results 
To better understand the roles of TopBP1 in DNA replication and the DDR, I 
have used reverse genetics to create genetically defined systems of TopBP1 in DT40 
cells. The DT40 cells have rapidly gained a leading place in the field of cellular biology 
by providing an efficient and relatively easy model system to answer key biological 
questions by reverse genetics. DT40 is a transformed cell line derived from an avian 
leukosis virus (ALV)-induced bursal lymphoma. DT40 cells have a modal chromosome 
number of 80, with 11 autosomal chromosomes, the ZW sex chromosomes (thus 
making it a ‘female’) and 67 microchromosomes (Sonoda, Sasaki et al. 1998). This is 
two more chromosomes than generally found in the chicken (Gallus gallus) and is due 
to a trisomy of chromosome 2 and an additional microchromosome (Smith and Burt 
1998, Sonoda, Sasaki et al. 1998). These pre-B lymphocytes have very high gene 
targeting frequency (around 80% efficiency), which makes entire gene deletions 
relatively easy. They also have a higher growth rate than mammalian cells, with the cell 
cycle lasting for about 8 hours. Importantly, DT40 cells have a very stable karyotype 
and have been successfully used to create isogenic mutants and assays by various 
laboratories working in the field of the DDR (Yamazoe, Sonoda et al. 2004, Hochegger, 
Dejsuphong et al. 2006). Finally, the DT40 lymphocytes are generally considered a cell 
line that does not express p53. This widespread idea is mainly based on a study 
conducted by Takao et al (1999) where it was shown that RT-PCR analysis using p53-
specific primers produced a reaction product when RNA from chicken embryos, liver 
and testis were used but no product was generated from DT40 RNA (Takao, Kato et al. 
1999). A few years later, however, a different group reported that Yin Yang 1 (YY1) 
negatively regulates p53 in DT40. In fact they showed that depletion of YY1 resulted to 
accumulation of p53 protein and proposed that YY1 exerts its function via direct 
physical interactions with both p53 and its regulator Mdm2 that promote ubiquitination 
and subsequent degradation of p53 (Sui, Affar el et al. 2004). 
 The work presented here describes my initial (unsuccessful) attempts to create a 
TopBP1 knockout model system in DT40 cells. Part of this involved the development of 
a stably integrated overexpression system (SIOS) useful for the overexpression of the 
TopBP1 transgene that can be adapted to express any protein of interest. The next 
significant step towards achieving the experimental aim was the characterization of the 
gallus gallus TopBP1 RNA, which helped me identify previously unreported 
characteristics of its primary sequence and post-transcriptional control. This 
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characterization allowed the assembly of a novel TopBP1 cDNA that provided the 
essential function(s) missing from the annotated TopBP1 cDNA and which was 
necessary for the creation of a conditional TopBP1 knockout model system in DT40 
cells. 
Furthermore, the creation of an isogenic set of stable cell lines with varying 
copies of TopBP1, allowed the study of the kinetics of the events induced by 
progressive loss of function of TopBP1. This work characterises the TopBP1+/+/+, 
TopBP1-/+/+ and TopBP1-/-/+ cell systems for their replicative ability and cell cycle-
dependent checkpoint proficiency. This data is necessary for the use of these systems as 
gene knock in platforms for the study of TOPBP1 mutants of interest. Additionally, to 
create an equivalent system for the study of human TopBP1, I generated a TopBP1 
degron system in human RPE cells. This system allows the degradation of the 
endogenous protein and can be used to ectopically express mutants of interest.  
Finally, application of the TopBP1-/-/+ point mutation knock in system to the 
study of the TopBP1 AAD revealed various roles of this domain in checkpoint 
activation and signaling following replication stress and DNA damage. 
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Chapter 2 
 
 
 
Materials and Methods 
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2.1 General Molecular Techniques 
2.1.1 Gel Electrophoresis 
Gels were poured at 0.8% agarose in 0.5x TBE containing 0.5µg/mg ethidium bromide 
(Sigma #E7637). Samples were mixed with loading dye and were loaded on the gel. 
The gel was run in 0.5× TBE at 100V and then visualised under UV light. 
2.1.2 Nucleic Acid ethanol precipitation 
2 volumes of 100% ethanol and 1/10 volume of 3M NaOAc were added to the DNA 
sample and the mixture was vortexed and placed on ice for 10 minutes. Samples were 
then centrifuged at 13000rpm for 15 minutes. The supernatant was removed and the 
samples were washed with 0.5ml 70% ethanol. The pellet was then air dried and then 
resuspended in the appropriate volume of 1× TE. 
2.1.3 DNA Restriction Digests 
Restriction digests were carried out using New England Biolabs (NEB) restriction 
enzymes or the Fermentas FastDigest™ enzymes according to the manufacturers 
recommended conditions. Restriction digested plasmid DNA fragments were gel 
purified using agarose gel electrophoresis and a Nucleospin clean up kit (Macherey 
Nagel, #740609.10). 
 
2.1.4 Plasmid DNA Ligations 
To set up DNA ligation mixtures, DNA concentrations of the insert and vector was 
measured using NanoDropTM 1000. 
T4 Ligation 
Restricted insert DNA was incubated with appropriate amount of restricted vector DNA 
and ligated using the T4 DNA Ligase (NEB, #M0202) and according to manufacturers’ 
guidelines. 
Infusion cloning 
Restricted insert DNA was incubated with appropriate amount of restricted vector DNA 
using the In-Fusion® HD Cloning Plus kit (Clontech, #638910) according to the 
manufacturers’ guidelines. 
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2.1.5 Oligos annealing 
1µg of sense and anti-sense oligos were mixed to a final volume of 50µl with dH2O. 
The oligos were boiled for 5 minutes and then allowed to cool to room temperature 
slowly. The annealed oligos were stored at -20°C until use. 
2.1.6 Removal of the 5’ phosphate group from DNA ends 
Antarctic Phosphatase (NEB, #M0289S) was used to remove the 5’-P group from DNA 
ends. To do this the linearized vector was mixed with Antarctic Phosphatase Reaction 
Buffer and Antarctic Phosphatase enzyme following the NEB guidelines and were 
incubated at 37°C for 30-60 minutes. The reaction was then stopped by incubating the 
samples at 80°C for 2 minutes. 
2.1.7 TOPO cloning 
PCR amplified products were cloned into the TOPO vector pCR® 4Blunt-TOPO 
(Amp/Kan). 
First, PCR products were purified using the Gel Extraction method (See 2.1.13) and 
then cloned into the TOPO vector.   
Reagents Volume (µl) 
Purified PCR Product 4 
Salt 1 
TOPO Vector 1 
Total 6 
The reaction mixture was incubated for 30-40 minutes at room temperature and then 
transformed into E.coli DH5α competent cells for amplification.  
 
2.1.8 PCR for Molecular Cloning 
For the amplification of plasmid DNA by the Polymerase Chain reaction method, KOD 
Hot Start DNA Polymerase (EMD Millipore) was used due to its high fidelity. The 
standard reaction was set up according to the manufacturers instructions. The annealing 
temperature was often adjusted between 50˚C and 58˚C depending on the primers used. 
PCR products were then purified using a Nucleospin clean up kit (Macherey Nagel, 
#740609.10) 
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2.1.9 PCR of DT40 genomic DNA 
To PCR amplify genomic DNA LA Taq Polymerase (Clontech, #RR002A) was used, 
due to its high fidelity across long DNA templates. The standard reaction set up as well 
as the standard cycling conditions for the PCR reaction were as suggested by the 
manufacturer.  
 
2.1.10 Site Directed Mutagenesis (SDM) 
Site directed mutagenesis was used to insert DNA point mutations into a gene of 
interest, already subcloned in a plasmid. Overlapping forward and reverse primers of 
20bp containing a point mutation were designed and used in the SDM PCR reaction. 
The PCR reaction was as follows: 50ng of plasmid DNA, 5µl of 10x PFU Turbo Buffer, 
5µl of dNTPs at 2mM each, 1µl of PFU Turbo polymerase (Agilent, #600250), 0.25µM 
of primers and the volume made to 50µl with dH2O. The standard cycling conditions for 
the SDM PCR were: 1x 94˚C for 3 minutes, 20x 94 for 30 seconds, 58˚C for 1 minute, 
68˚C for 16.5 minutes. Followed by a final elongation step of 1 x 68˚C for 7 minutes. 
The annealing temperature may have been altered depending on the Tm of the primers 
and the elongation time was adjusted in accordance with the size of the plasmid. The 
template DNA was then digested using 1µl of Dpn1 (NEB) for 1 hour at 37˚C. The 
reaction was then cleaned up using a Nucleospin clean up kit (Macherey Nagel, 
#740609.10). All of the reaction was transformed into DH5α competent cells. 
2.1.11 E. coli media 
Luria-Bertani (LB) 
10 g/l Tryptone 
5 g/l Yeast Extract 
10 g/l Sodium Chloride 
Luria-Bertani Agar (LA/LB plates) 
As LB plus: 
12 g/l Agar 
 
 
 
 
 
 77 
Drugs used for selection: 
Antibiotic Concentration Stock 
Kanamycin (Melford, #K0126) 35 µg/ml 35mg/ml 
Ampicillin sodium salt (Sigma, 
#A95180) 
100 µg/ml 100mg/ml 
 
2.1.12 E. coli Transformation 
Competent DH5α E. coli cells were thawed on ice. Plasmid DNA was mixed with the 
thawed cells and incubated on ice for 30 minutes. The DNA-cell mixture was heat 
shocked at 42˚C for 30 seconds and placed back on ice for 5 minutes. 1 ml of LB was 
added and transformed cells incubated for 60 minutes at 37˚C before being plated on to 
LB plates with the appropriate selection drug. Plates were then incubated at 37˚C 
overnight. 
 
2.1.13 Extraction of Plasmid DNA from E. coli 
For minipreps and maxipreps E. coli cells were inoculated in 5 ml or 100ml respectively 
of LB media containing Amplicillin at 100µg/ml or Kanamycin at 35µg/ml, and 
incubated over night at 37˚C. Cells were then pelleted at 4,600 rpm for 10 minutes at 
room temperature. The plasmid DNA was then extracted using a Qiagen Miniprep Kit 
(#27104) or a Midiprep Kit (#12145) according to the manufacturer’s 
recommendations. The Plasmid DNA was resuspended in an appropriate volume of 
dH2O and the concentration measured on a Nanodrop ND-1000 spectrophotometer. 
 
2.1.14 Extraction of DNA from agarose gel 
DNA sample of interest was run on 1% agarose gel (in 0.5% TBE) for 30min at 100V. 
The gel was then visualized using a UV transilluminator (350nm wavelength to avoid 
damage on DNA). The DNA fragment of interest was excised with a clean scalpel, 
transferred to a falcon tube and weighted. DNA was then isolated using the Nucleospin 
clean up kit (Macherey Nagel, #740609.10) in accordance with the manufacturer’s 
instructions. The DNA was finally checked by gel electrophoresis. 
 
2.1.15 Gateway cloning 
Gateway technology is a quick and efficient cloning technique based on the 
bacteriophage λ recombination system in which the phage λ integrates into the bacterial 
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chromosome. Recombination takes place between specific sites called the att sites in the 
presence of specific enzymes, called the clonase enzymes, resulting in the formation of 
hybrid DNA sequences. These enzymes recognize the att sites and mediate their in 
between recombination reaction and then attach the ends together. The Gateway 
technology is based on the same principle with some modifications and consists of three 
major steps (see methods). 
 
BP recombination reaction  
The BP reaction was carried out for sub-cloning the 5’ arm and the 3’ arm into the 
donor vectors pDONOR P4-P1R and pDONOR P2-P3R, respectively (Invitrogen). The 
reaction was performed according to the manufacturers’ instructions.  
 
LR recombination reaction  
The LR reaction was carried out for sub-cloning the 5’ arm and the 3’ arm entry clones 
and the Puromycin-containing entry clone into the pDEST DTA-MLS vector 
(Invitrogen). The reaction was performed according to the manufacturers’ instructions. 
 
2.1.16 DNA Sequencing  
The Source Bioscience Sanger sequencing service in Nottingham, UK carried out DNA 
sequencing for all the work presented in the thesis.  
2.1.17 RNA analysis 
RNA purification 
The TRI Reagent (Sigma Aldrich) was used to isolate RNA from DT40 cells, according 
to the manufacturer’s instructions. The purity of the RNA was assessed on a denaturing 
MOPS/ buffer/formaldehyde gel by gel electrophoresis. To prepare 1% 
agarose/formaldehyde gel containing 0.5µg/ml ethidium bromide, 20 ml of 5xMOPS 
(0.2M MOPS pH7, 0.05M sodium acetate, 0.005M EDTA pH8) were mixed with 72 ml 
nuclease-free water and 1g of agarose (molecular biology grade). The mixture was 
heated to boiling in a microwave and let to cool down to 55°C before adding 17.6 ml of 
37% formaldehyde and 5 µl of 10mg/ml ethidium bromide. The gel was then poured 
and allowed to solidify. The RNA samples were mixed with RNA sample buffer* at a 
1:2 ratio, heated to 60°C for 5 minutes and cooled on ice for 2min. Then 2 µl of RNA 
loading buffer** was added and samples loaded on the gel. Gel electrophoresis was 
performed at 100V and gel visualized shortwave UV (254nm). 
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*RNA sample buffer: 3.5 ml 37% formaldehyde, 2ml 5x MOPS and 10 ml deionized 
formamide (Dowex XG8 mix-bed resin was added to formamide and stirred at room 
temperature for 45min and filtered through Whatman filter paper) 
**RNA loading buffer: 50% glycerol, 1mM EDTA, 0.4% bromophenol blue, 1mg/ml 
ethidium bromide. 
 
5’ RACE 
RACE was performed with the SMARTER RACE 5’/3’ Kit (Clontech) and according 
to the manufacturer’s instructions. 
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2.2 Cell Biology 
2.2.1 Tissue culture 
2.2.1.1 Culturing suspension cells (DT40) 
DT40 Basic Cell Culture Conditions 
DT40 cells were cultured in culture flasks, petri dishes or in 6/24- well plates, whereas 
microtiter plates were used for transfection or subcloning. Cells were passaged by 
diluting 1:10-1:20 into fresh media every 1-2 days to maintain the cells in exponential 
growth phase. 
 
The optimum culture condition for the cells is 39.5◦C with 5%CO2 and the growth 
media used is: 
RPMi complete Media: 
RPMi 1640 [-L]                                                     500ml 
FCS                                                                        50ml 
Chicken Serum                                                       5ml 
L-Glutamine (200mM)                                           5ml 
Penicillin (10000U/ml)/Streptomycin (10mg/ml)  5ml 
500mM β-Mercaptoethanol                                 0.6ml 
 
Drugs used for selection: 
The following drugs and chemicals were added to the appropriate media in order to 
select for the cells expressing the appropriate genetic marker (table 2-1). 
Antibiotic Concentration Stock 
G418 2mg/ml 50mg/ml 
Histidinol 1mg/ml 100mg/ml 
Hygromycin B 2.5mg/ml 100mg/ml 
Puromycin 0.5µg/ml 0.5mg/ml 
Blasticidin S 20µg/ml 10mg/ml 
 
 
2.2.1.2 Culturing adherent cells (RPE) 
RPE Basic Cell Culture Conditions 
RPE cells were cultured in culture flasks whereas microtiter plates were used for 
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subcloning. Once the cells had reached confluence an aliquot of the cells was 
transferred to a new flask to allow continued growth of the culture. The media was first 
aspirated and cells were washed with 10mls of pre-warmed PBS. 1ml of pre-warmed 
0.25% trypsin in PE was added to the flask (the volume of trypsin depends on the size 
of the flask/dish, 1ml is sufficient for a T75 flask) and the trypsin solution was 
distributed evenly over the surface of the flask/dish. The flask was then returned to the 
incubator for 2-3 minutes until the cells had detached form the plate. Once detached, 
10mls of fresh pre- warmed media was added to the cells to inactivate the trypsin. Cells 
were then centrifuged at 1500rpm for 5min and resuspended in fresh 10ml media. A 
1ml aliquot of that was added to a flask containing fresh media to continue growth. 
The optimum culture condition for RPE cells is 37◦C with 5%CO2 and the growth 
media used is: 
DMEM/F-12 (Dulbecco's Modified Eagle Medium/Ham's F-12 + L-glutamine)    500ml 
FCS                                                                                                                             50ml 
Penicillin (10000U/ml)/Streptomycin (10mg/ml)                                                        5ml 
Drugs used for selection: 
The following drugs and chemicals were added to the appropriate media in order to 
select for the cells expressing the appropriate genetic marker. 
 
Antibiotic Concentration Stock 
G418 1mg/ml 50mg/ml 
Zeocin 500µg /ml 100mg/ml 
 
2.2.1.3 Cryogenic preservation of cell lines 
For long-term storage of cells, log phase healthy cells were pelleted and resuspended in 
90% FCS/10% DMSO and divided into 500µl aliquots in 1.5ml cryovials. Initial 
freezing was carried out in a -70°C freezer to give a cooling rate of 1°C/minute. Once a 
temperature of -70°C was reached the cells were transferred to storage in liquid nitrogen 
vapour phase tanks at -180°C. To wake up the cells the vials were quickly warmed up to 
37°C by placing in a container of warm water. Once thawed the cells were added to pre-
warmed media. RPE cells were instead resuspended in 10ml prewarmed growth media, 
pelleted by centrifugation to remove the DMSO and added to a flask containing fresh 
media. The following day the cells were passaged or the media was changed depending 
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on the confluence of the cells. 
2.2.1.4 Stable targeted Transfection of DT40 cells 
Linearization of the plasmid for transfection 
20µg of the targeting vector were linearized with the appropriate restriction enzyme 
prior to transfection to increase the chances of both the resistance gene and the gene of 
interest being expressed from the preferred locus. The linear DNA was ethanol 
precipitated and resuspended in 50µl dH2O under the tissue culture hood to avoid 
contamination. 
Transfection of DT40 cells by electroporation 
Stable transfection was performed to insert a construct into a targeted locus in DT40. 20 
µg of the targeting construct plasmid was linearized with the appropriate restriction 
enzyme and purified by ethanol precipitation. 5-10×106 DT40 cells were centrifuged at 
1500 rpm for 5 minutes at room temperature and the cell pellet was resuspended in 
0.5ml chilled PBS carefully. 30µg of linearized and purified plasmid was mixed with 
the cell suspension. All the mixture was transferred to an electroporation cuvette 
(Biorad, #1652088) and incubated on ice for 10 minutes. Cell electroporation was 
performed in the Gene Pulser Xcell total system at 550V and 25µF. The cuvette was 
incubated on ice for 10 minutes. The transfected cell suspension was transferred to a 
flask containing 20ml fresh pre-warmed RPMi media and incubated at 37oC overnight. 
Selection was then made with the appropriate antibiotic and cells were plated on four 
96-well plates.  
 
2.2.1.5 Stable non-targeted Transfection of DT40 cells 
Stable non-targeted transfection of DT40 cells was performed in the same way as the 
targeted transfection except that cell electroporation was performed at 250V and 950µF. 
 
2.2.1.6 Expansion of drug resistant DT40 clones 
Following the selection process clones were visible by eye in the 96 well plates. Clones 
were inspected under the microscope to ensure only single colonies were isolated. So 
single colonies were resuspended and then transferred to 800µl of fresh media (plus 
selection) in a 24 well plate. When the cells had reached confluence 500µl of the cells 
was added to 4.5mls of fresh media (plus selection) in a 6 well plate. The cells were 
transferred to T25 flasks while still being kept under selection. An aliquot of the newly 
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created clones was frozen down as soon as possibly to prevent in vitro evolution.  
 
2.2.1.7 Excision of floxed-DNA sequences by induction of Mer-Cre-Mer 
105 cells transfected with floxed vectors were cultured in 1ml of chickem medium 
containing 2µM 4-hydroxytamoxifen (4-HT) for 24 or 48h, depending on the 
experiment. Cell were then subcloned with limiting dilution for final concentration of 
30, 100, 300 and 1000 cells per 96-well plate. 6-8 days ater subcloning, single clones 
can be observed as single colonies on the bottom of the plate. To expand single clones, 
10µl of stable transfectants were transferred into 1ml of chicken medium. To assess for 
successful excision of the drug resistance gene cassettes, duplicates were made if the 
transfectants in selection drug-containing medium. 
 
2.2.1.8 Stable Transfection of RPE cells using the Neon®Transfection System 
Logarithmically growing cells were trypsinized and 1x106 cells were transfected with the 
Neon®Transfection System according to the manufacturers’ instructions. 
 
2.2.2 DT40 Cell Biology techniques 
2.2.2.1 Extraction of Genomic DNA from DT40 cells  
DT40 cells were centrifuged at 1500 rpm for 5 minutes at room temperature and the cell 
pellet was resuspended in 0.5ml Tail Buffer (50mM Tris-HCl pH 8.0, 100mM  EDTA, 
100mM NaCl, 1% SDS) containing 0.5mg/ml Proteinase K.. The mixture was incubated 
at 55oC overnight. 300µl of 5M NaCl was added for protein denaturation and the 
mixture was vortexed for 1 minute. The mixture was centrifuged at 13,000 rpm for 5 
minutes and 700µl of supernatant containing genomic DNA (gDNA) was transferred to 
1.5ml fresh microfuge tube. DNA was precipitated with 400µl isopropanol, vortexed for 
1 minute and centrifuged at 13,000 rpm for 5 minutes. The supernatant was discarded 
and 1 ml chilled 70% ethanol was added to the pellet. The tube was vortexed to wash 
the pellet and then centrifuged at 13,000 rpm for 5 minutes. The supernatant was 
discarded and the pellet was dried at room temperature for 10-15 minutes and 
resuspended in 50µl of TE buffer pH 8.0. The pellet was dissolved by 20 minutes 
incubation in a 65oC water bath. 
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2.2.2.2 Southern blot 
Genomic DNA was extracted using a standard ethanol extraction process as described 
above. Concentration of DNA was measured using a Nanodrop and appropriate amount 
of DNA was digested in a final volume of 200µl at 37°C. Digested DNA was 
isopropanol precipitated and resuspended in 20µl of dH2O and loading buffer (30% 
glycerol, 0.25% (w/v) bromophenol blue, 0.25% (w/v) Xylene cyanol FF). The samples 
were then run on a long agarose gel of appropriate concentration (depending on the size 
of the fragment) in 1× TBE at 50V. The gel was then incubated for 20 minutes in 
depurinating solution (0.25M HCl) in a shaker. Then the gel was washed in denaturing 
solution (1.5M NaCl and 0.5M NaOH) for 30 minutes on a shaker. Then gel was 
washed in neutralizing solution (1M Tris and 1.5M NaCl). The gel was then transferred 
to a membrane employing 10× SSC buffer (1.5M NaCl, 0.15M sodium citrate pH 7) and 
capillary force over night. The membrane was then washed in 2× SSC buffer for 5 
minutes on a shaker. The membrane was air dried on a piece of filter paper and then the 
DNA was cross-linked to the membrane using UV light at 1200J/m2. The membrane 
was stored at 4°C. 
A specific probe for Southern blot analysis was generated by PCR amplification of a 
≈500bp fragment of the locus of interest and gel extraction. For Hybridising probe to 
the membrane, first the membrane was washed in dH2O for 5 minutes. Then 80ml of 
preheated 65°C hybridising solution I (6× SSC, 1x Denhardt [100x: 2% Ficoll 400, 
300mM NaCl, 2% polyvinylpyrrolidone, 2% BSA], 1% sarcosyl, 0.1% BSA) was added 
to the hydrated membrane in a tube. The tube then was placed in hybridising oven for 
one hour at 65°C. Meanwhile, 1µl of 50ng/µl probe was added to 44µl dH2O. The 
solution was boiled in a water bath for 5 minutes and then placed on ice. In the 
radioactivity room, the labelling mix and 5µl of 32P-αdCTP were added to the DNA 
and the mixture was incubated at 37°C for 15 minutes. The labelled probe was then 
spun in a pre-spun G50 column at 3000rpm for 1 minute and incubated at 100°C for 5 
minutes. Then the mixture was kept on ice. Then the probe was added to 20ml 
preheated 65°C hybridising solution II (6× SSC, 1x Denhardt, 1% sarcosyl, 200µl 
10mg/ml salmon sperm DNA). Then hybridising solution I was replaced with 
hybridising solution II and the tube was put back in the oven at 65°C over night. The 
next day the membrane was washed with 50ml preheated 65°C wash buffer I (2× SCC, 
1% SDS) in the oven for 10 minutes and then with 450ml of wash buffer I on a shaker 
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for 15 minutes. In the following step the membrane was washed twice, each time with 
500ml of 42°C buffer II (0.1× SSC, 0.1% SDS) on a shaker for 15 minutes. The 
membrane was then air dried on tissue and wrapped in cling film and placed in a 
phosphoimager cassette over night. The membrane was scanned to obtain the Southern 
blotting results. 
2.2.2.3 Growth curves and doubling time 
1 x 105 cells were seeded in pre warmed growth media and counted after 24h. The 
culture was split 1/10 to the same volume, left to grow for another 24h and counted 
again. The procedure was repeated for the specified number of days. The doubling time 
d was calculated using the growth rate:  𝑵 𝒕 = 𝑵 𝟎 ×𝒆𝒈𝒓×𝒕      ≫      𝒈𝒓 = 𝒍𝒏𝑵 𝒕𝑵 𝟎𝒕        ,where 
N(t) = the number of cells at time t 
N(0) = the number of cells at time 0 
gr = growth rate (amount of doubling in a unit of time) 
t = time (usually in hours) 
Then the doubling time d can be derived as:  𝑑 = 𝑙𝑛2𝑔𝑟  
 
Viable and dead cells were distinguished by trypan blue exclusion (Fisher, #15250061) 
in a Countess™ automated cell counter (Life Technologies) and values represent the 
mean of three independent experiments. 
 
2.2.2.4 DNA damaging treatments of DT40 cells 
To monitor the response of DT40 cells to replication stress, the ribonucleotide reductase 
inhibitor hydroxyurea (HU, Sigma) was added to the desired number of cells in culture, 
for the desired length of time and at the specified concentration depending on the 
experiment. For washing the drug off the culture, cells were spun down at 1500rpm for 
5min, HU-containing media aspirated and cell pellet resuspended in fresh pre-warmed 
growth media. 
To investigate the response to replication stall at damaged bases, MMS (Sigma) was 
added to cells in culture as in the case of HU. 
As a method of inducing DNA damage cells were treated with either γ-irradiation or 
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UV-C light. Cells were irradiated with γ rays using an Alcyon II Cobalt-60 Teletherapy 
Unit. Dose rates varied from 1-10Gy. Cells were irradiated directly in the media in the 
culture flask. Control cells were handled in parallel but were not exposed to the 
radiation.  
Cells were treated with UV-C light using a Stratalinker 1800 (Agilent Technologies, 
Stockport, UK) containing 254nm bulbs set to deliver 5000µJcm-2 (50Jm-2). Prior to the 
UV-C exposure the DT40 cells were first washed with PBS and resuspended in a small 
volume of 1%FCS/PBS. The cells were returned to complete growth media following 
irradiation. 
2.2.2.5 Colony Formation Assay  
In general, serially diluted cells were plated in triplicate onto 6‐well plates or single plates with 
5 ml/well of DT40 growth medium with 1.5% (w/v) methylcellulose (Sigma). To determine 
sensitivity to MMS (Sigma) or HU (Sigma), serially‐diluted cells were plated in MMS or HU‐
containing methylcellulose plates. To test sensitivity to UV or γ-irradiation, the appropriate 
number of cells was first resuspended in 1% FCS/PBS (for UV) or normal growth media (for γ-
irradiation) and irradiated before being plate on methyl cellulose-containing media. A 60Co γ-
ray source and UVC (254 nm wavelength) were used for the respective treatments. Colonies at 
the bottom of the plated were counted by eye 7-10 days after plating. Percentage survival was 
determined relative to the number of colonies formed in the untreated control. The experiment 
was repeated at least three independent times. 
 
2.2.2.6 Cell Titer Blue Viability assay 
To test the sensitivity of specified cell lines to the ribonucleotide reductase inhibitor HU, cells 
were treated with HU in 1 ml of medium using 24-well plates and incubated at 39.5°C for 48 h. 
To analyse sensitivity to MMS, 1 × 106 cells in PBS containing 1% FCS were exposed to MMS 
for 1h at 39.5°C and 10µl of exposed cells were transferred to 1 ml of medium using 24-well 
plates and incubated at 39.5°C for 48 h. To investigate sensitivity to γ-irradiation, cells were 
irradiated using a 60Co γ-ray source and diluted to 104 cells /ml in 24-well plates and incubated 
at 39.5°C for 48 h. For sensitivity to UV light, 1 × 106 cells were suspended in 0.5 ml of 1% 
FCS/PBS in 6-well plates and irradiated with UVC (254 nm wavelength) and 10 µl of irradiated 
cells were transfer to 1 ml of medium using 24-well plates and incubated at 39.5° C for 48 h. 
Then, we transferred 100µl of medium containing the cells to 96-well plates and measured the 
amount of ATP using Alamar Blue (Thermofisher) according to the manufacturer's instructions. 
Luminescence was measured by Fluoroskan Ascent FL (Thermo Fisher Scientific Inc., 
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Pittsburgh, PA). Percentage viability was determined relative to an untreated sample prepared in 
parallel. The experiment was repeated at least three independent times. 
 
2.2.2.7 Mitotic index 
Cells were collected, cytospun onto microscopy slides and fixed with 3 % 
paraformaldehyde/PBS for 10min. Slides were then washed with PBS and a drop of 
DAPI mounting media (Vector laboratories) was added on top of the fixed cells. By 
microscopy a minimum of 200 nuclei was scored for each mitotic index measurement 
and the experiment was repeated at least three times. In some cases, indicated cells were 
incubated with nocodazole with or without prior γ-irradiation. A decrease in the number 
of mitotic cells was taken as indicative of activation of the G2/M checkpoint. Cells were 
imaged/counted on a wide-field DeltaVision Olympus IX70 microscope or on a Nikon 
E400 microscope. 
2.2.2.8 Flow Cytometry 
Fixing cells 
500µl of mid logarithmically growing cells were washed with PBS and fixed in 1ml ice-
cold 70% ethanol/PBS while vortexing. This minimises the formation of clumps and 
ensures uniform fixing of the cells. Fixed cells were stored at 4°C overnight or at -20°C 
for a couple of hours to several weeks before further analysis. 
DNA content analysis 
Fixed cells were centrifuged at 1500rpm for 5min, fixing solution aspirated and cell 
pellet washed twice with 3% BSA/PBS. Then cells were resuspended in 500µl of 3% 
BSA/PBS containing 250 µg/ml Ribonuclease A (RNase) and 10µg/ml propidium 
iodide (PI) (Sigma #81845). Samples were left for one hour at room temperature in the 
dark or at 4°C overnight before analysis on a BD FACSCanto machine (BD) using the 
FL-A setting. 
S phase analysisTo monitor actively replicating cells, cells were tested for their ability to 
incorporate the EdU analogue into their DNA. Cells in culture were treated as required and 
30min before harvest 10µM EdU was added. Cells were washed and fixed as above and then the 
Click-iT® EdU Alexa Fluor® 488 Imaging Kit was used as a detection reagent to gain access to 
the DNA. The cells were then washed twice with 3% BSA/PBS and stained for DNA content 
analysis as explained above. Analysis was performed on FacsCanto machine using the FL-A 
setting. 
 
 88 
2.3 Biochemical Techniques 
 
2.3.1 Purification of antibody from rabbit serum 
5ml of GST-fusion strain was grown at 37°C to confluence before added to 1 litre LB-
Amp and grown to OD595 ~0.6. IPTG was added to final concentration of 0.5mM and 
cells were grown overnight at 20°C. Cells were pelleted by centrifugation and 
resuspended in 35ml PBS plus 1 protease inhibitor tablet (Roche) and AEBSF. Cell 
mixture was sonicated on ice and then cleared by centrifugation at 20k rpm for 1h. In 
the meantime, 1ml of Glutathione Sepharose was washed with water to remove the 
ethanol and then with PBS to equilibrate it. Cell lysate was then added and resin/lysate 
incubated for 1h at 4°C with rolling/gentle agitation. Resin was subsequently washed 
three times with 30ml of PBS and twice with 10ml of 0.2M sodium borate pH9. 
Dimethylpimelimidate (DMP) was then added to 20mM taking into account the volume 
of beads only. Resin/GST-fusion was gently mixed for 1h at room temperature to cross-
link. Cross-linking was terminated with the addition of 0.2M Tris-HCl pH8. Resin was 
then washed with 5ml of 0.1M glycine-HCl pH2.5 and twice with 10ml PBS. 
For antibody purification, 9ml of serum were mixed with 1ml of 10x PBS and incubated 
with 1ml GST-linked resin and incubated at 4°C rolling for 4h. Serum was then allowed 
to elute and column was washed with 10ml PBS. A second wash was performed with 
10ml TrisHCl pH7.5 250mM NaCl and a third was with 10ml TrisHCl pH7.5 750mM 
NaCl. Antibody was eluted with triethylamine pH11.5 and equilibrated with TrisHCl 
pH5 to adjust the pH. The eluted serum was re-applied to the column (after column was 
washed with PBS) and this process was repeated three times. 
 
2.3.2 Whole Cell Protein Extracts  
Cells were collected, washed in PBS and resuspended in 100µl of 1x sample buffer (see 
below) and boiled for 5 minutes and spun for 5 minutes at 13000 rpm before loading on 
SDS gel. 
1x TCA Sample Buffer: 
1 volume 4x SDS sample buffer 
1 volume 1 M Tris, pH 8 
2 volumes dH2O 
2.5% β-mercaptoethanol 
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4x SDS Sample Buffer: 
250 mM Tris-base, pH6.8 
20% Glycerol 
0.004 g/ml (w/v) Bromophenol blue 
0.08 g/ml (w/v) SDS 
 
2.3.3 SDS PAGE and Immunostaining of Proteins (Western Blot) 
Whole cell protein extracts were separated by sodium dodecyl sulphatepolyacrylamide 
gel electrophoresis (SDS-PAGE).  
Gels were run in a BIORAD Mini-POTEAN TetraCell or a C.B.S Double or Triple-
wide electrophoresis system in 1x SDS running buffer (0.025M Tris Base, 0.25M 
Glycine, 0.1% SDS) at 80 volts constant through the stacking gel (Table 2-3) and 100-
120 volts through the separating gel. A prestained Protein Marker (NEB, #P7708 or 
#14208S) was run alongside the samples. 
Resolving gel: 
Component volumes (ml) per gel mold volume of 5ml 
Component 6% 8% 10% 12% 
H2O 2.6 2.3 1.9 1.6 
30% acrylamide mix 1 1.3 1.7 2 
1M Tris (pH6.8) 1.3 1.3 1.3 1.3 
10% SDS 0.05 0.05 0.05 0.05 
10% APS 0.05 0.05 0.05 0.05 
Temed  0.004 0.003 0.002 0.002 
Stacking gel: 
Component volumes (ml) per gel 
mold volume of 5ml 
Component 5% 
H2O 3.4 
30% acrylamide mix 0.83 
1M Tris (pH6.8) 0.63 
10% SDS 0.05 
10% APS 0.05 
Temed  0.005 
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Proteins were then transferred from the gel to a Nitrocellulose membrane (GE 
Healthcare, Nitrocellulose, Hybond, #RPN3032D) via wet transfer at 300mA constant, 
in 1x transfer buffer (20mM Tris base, 750mM Glycine, 20% (v/v) Methanol, 0.025 % 
(v /v) SDS). 
The membrane was stained with Ponceau-S solution (0.2% (w/v) Ponceau S, 3% (w/v) 
TCA) to confirm protein transfer and allow accurate cutting of the membrane for 
immunostaining with different antibodies.  
The membrane was blocked with 3% milk PBST (Marvel dried skimmed milk in 
phosphate buffered saline (PBS), 0.1% Tween (Sigma #P7949)) or 5% TBST/BSA (for 
phosphor-specific antibodies) for 1 hr at room temperature. The primary antibody was 
added to the blocking solution and incubated with the membrane for 1 hr at room 
temperature or 4˚C overnight whilst being gently shaken. The primary antibody was 
then washed off by 3x 5 minute washes in PBST or TBST. It was then incubated with 
the appropriate secondary antibody in for 1 hr at room temperature whilst being gently 
shaken. The secondary antibody was washed off via 3x 5minute washes. The bound 
antibody was then detected by chemilluminescence (ECL Plus Western Lightning, 
Perkin Elmer, #NEL104001EA) and exposed to GE Healthcare Hyperfilm ECL 
(#GZ28906837). The film was developed with a Xograph Imaging Systems Compact 
X4. Quantification of western blots, was carried out using the ‘Analyse -> Gels’ 
function in ImageJ (NIH). 
 
Specifications of antibodies used in this thesis and dilution factors 
Anti-TopBP1 rabbit polyclonal (raised by Eurogentec) 1:250 
Mouse anti-Chk1 (Santa Cruz Biotechnology) 1:1000 
Rabbit anti pS345 Chk1 (Cell Signalling Technology) 1:1000 
Mouse anti-pS139 (γH2A.X) clone JBW301 (Millipore) 1:1000 
Mouse anti-Tubulin (Sigma, T5168) 1:10,000 
Mouse anti-GADPH (abcam) 1:10,000 
Rabbit anti-Mouse HRP Rabbit polyclonal (DakoCytomation P0260) 1:2500 
Swine anti-Rabbit HRP Rabbit polyclonal (DakoCytomation P0217) 1:2500 
Anti-TopBP1 rabbit polyclonal (Bethyl laboratories) 1 :1000 
Anti-myc (Merck) 1 :5000 
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2.3.4 Oligonucleotides list 
 
P	 SEQUENCE	(5’-3’)	
1	 GGGGACAACTTTGTATAGAAAAGTTGATCACTAGTTGTGAAATCAGTGG	
2	 GGGGACTGCTTTTTTGTACAAACTTGCCTTTAACTGAGAAGCAAACC	
3	 GGGGACAGCTTTCTTGTACAAAGTGGTGAGAAAGTTCCGTGCTTTTAATTTG	
4	 GGGACAACTTTGTATAATAAAGTTGAAAACAGATGAGCTATGAGAAGG	
5	 GCGTCGAGATGCTAGCGAGGCTCACCTGGACTTCATATCCTTTTGG	
6	 ACGAAGTTATGTCGACGGATGGGAGAGAAGACTGGGAAATATTG	
7	 TAAGCAGGCGCGCCTAGTTCTGGGACAGTTTGCTACCC	
8	 TGCTTACTCGAGGGTACCTCTTTCTATGCATTTTATCCCTACCA	
9	 CAAGCTGGCGCGGCCGCATGAAAGGCAGCAAGGAGGTGTTCTT	
10	 TTTAAACTGACCCGGGTCAGTGCATTCTGGATCGCTTGA	
11	 GGGGACAGCTTTCTTGTACAAAGTGGACAGAAGATGAGAAGGTAGATG	
12	 GGGACAACTTTGTATAATAAAGTTGTTTCTGGGATAATCCAGTCC	
13	 GATTGCCAGATGTAGACTCAGATGC	
14	 CAGTGTCCTCTTCAGAGTCTGGATC	
15	 AGGCTAGAGCCACCGGATCCATGACTGAGTATAAACCAACCGTGAGAC	
16	 CCCCAGAGTCCCGCGAATTCTCAGGCTCCAGGTTTTCTTGTCATAC	
17	 TTGGGTACCGGGCCCCCCCTCGAGGTCGACATGAAAGGCAGCAAGGAGGTG	
18	 TCTGATATCAAGCTTATCGATACCGTCGACTGACCCCCAGCTCACTACAAC	
19	 GAATCGATAGCGATAATCTAGAGCGGCCGCCGTTCTGAGCACCCTCTTCC	
20	 AAGCTGGAGCTCCACCGCGGTGGCGGCCGCGTGCATTCTGGATCGCTTGAC	
21	 GGTACCCGCATGAAAGGCAGCAAGGAGGTGTT	
22	 GGTACCTCAATGCATCCGGCTCCTTTTTACTCTGCTCATTTCTCCCGGTGCTTTTC	
23	 GGGCTATCGAAACTTAATTAAAGAACCAGCTGTGGAATGTGTGTC	
24	 CTGACTTGACTGGTTAATTAAGGTACCTCTTTCTATGCATTTTATCCCTACCA	
25	 ACCTTTTTGGCAGCGATCGGAGCTCACCTGGACTTCATATCCTTTTGG	
26	
ATGTCGGGAGCCGCGATCGATAACTTCGTATATAATACCATATACGAAGTTATG
TCGAC	
27	 TAA	GCA	GCT	AGC	CTTCCTATGTTTTGCTTTACCATTCAC	
28	 TGCTTAGTCGACGATTTCTGCAGTACAGAATATTAGG	
29	 TAAGCAGGCGCGCCCAGTACTCCCACACAAGCAAG	
30	 GACCACCTGAAATCTATAGTGATACACCTCGAGTGCTTA	
31	 GGGCTATCGAAACTTAATTAAAGAACCAGCTGTGGAATGTGTGTC	
32	 CTGACTTGACTGGTTAATTAAGACCACCTGAAATCTATAGTGATACAC	
33	 ACCTTTTTGGCAGCGATCGCTTCCTATGTTTTGCTTTACCATTCAC	
34	 GGATCCATGGCCAAGCCTTTGTCTCAAGAA	
35	 TCTGGTTATGTGTGGGAGGGCTAAGAATTC	
36	 CCCCCTCGAGGTCGACATCACTAGTTGTGAAATCAGTGG	
37	 TATCGATACCGTCGACCCTTTAACTGAGAAGCAAACC	
38	 TAATCTAGAGCGGCCGCTGAGAAAGTTCCGTGCTTTTAATTTG	
39	 ACCGCGGTGGCGGCCGCAAAACAGATGAGCTATGAGAAGG	
40	 GCAAGACTTGTCAGCAACTTCG	
41	 GGGCAGAACTGAACAAATCTGGC	
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42	 GGTACCCACCCGCATGAAAGGCAGCAAGGAGGTGTT	
43	 GGTACCTCAGTGCATTCTGGATCGCTTGA	
44	 GGGCTATCGAAACTTAATTAAAGAACCAGCTGTGGAATGTGTGTC	
45	 CTGACTTGACTGGTTAATTAACACAGGAAACAGCTATGACCATG	
46	 CGATAACTTCGTATATGGTATTATATACGAAGTTATCGAT	
47	 CGATAACTTCGTATATAATACCATATACGAAGTTATCGAT	
48	 CACCAACCGTAAGACCTCCTAGAA	
49	 AAACTTCTAGGAGGTCTTACGGTTC	
50	 CACCGGCTTGCCCACCTTCCATGC	
51	 AAACGCATGGAAGGTGGGCAAGCCC	
52	 CACCGGACTGGATTATCACAAAAG	
53	 AAACCTTTTGTGATAATCCAGTCC	
54	 CACCGAGATGCGATTAGTGTACTCT	
55	 AAACAGAGTACACTAATCGCATCTC	
56	 CACCGTTTAATGTTTGGTAACTAAA	
57	 AAACTTTAGTTACCAAACATTAAAC	
58	 CTGGATTATCACAAAAAAGAAAAGCTCCTACAG	
59	 CTGTAGGAGCTTTTCTTTTTTGTGATAATCCAG	
60	 ACGACCTAGAGTTCATGTATACTCGCATC	
61	 GATGCGAGTATACATGAACTCTAGGTCGT	
62	 CTCGCATCTACCCTTCAGCTACCAAACATTAAATG	
63	 CATTTAATGTTTGGTAGCTGAAGGGTAGATGCGAG	
64	 GACCTAGAGTACACGTATACGGCGCCTCAGCGGCATCA	
65	 AAGGGTAGATGCGAGTATACTCAGAAGAACTCGTCAAGAAGGCGATAGAAGG	
66	 GAACTTGGGACTGGATTATCAC	
67	 CTATCACAGTCACATTCAGGCTTTC	
68	
CTGACATGGAAATGCATCGGGTATACCGTTCGTATAATGTATGCTATACGAAGT
TATAGAACCAGCTGTGGAATGTGTG	
69	
ATGCCACACCTTTGCTTGTATACCGTTCGTATAGCATACATTATACGAAGTTATG
GTTATCGCTATCGATTCACACAAAAAACCAAC	
70	 GATAGTTCTCCAGCCACTCCTG	
71	 GTTGCTGACTAATTGAGATGCATGC	
72	 TCACATGGAGGAATTCAATGCCACAC	
73	 AGCTCTCGAATTCAAAGGAGGTACCATGTCCAGAAATGACAAAGAACC	
74	 ACCTCGAGGTAGATATCGCGGTACCTTAGTGTACTCTAGGTCGTTTGATTT	
75	 CCTTCTTGACGAGTTCTTCTGAGAATTCG	
76	 GCTTACACGTAGCTTGCACACATAG	
77	 CTCGACACACCCGCCAGCGGCCGCTGCCAAGCTTCCGAGCTCTCGAATTC	
78	 CTTGGGACACATCTCTGGGACTGCATGCAGTACAGGACTACCTG	
79	 CAGGTAGTCCTGTACTGCATGCAGTCCCAGAGATGTGTCCCAAG	
80	 ACAACTTCTAGAAACCTCGAGGTAGATATCGCGGTACC	
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Chapter 3: Strategies employed for the generation of a TopBP1 
knockout in the DT40 model system 
 
The recent years have witnessed an increase in the amount of information on the 
role of TopBP1 within different aspects of the cell cycle of eukaryotic cells. The use of 
RNA depletion approaches in human cell lines and also various in vitro systems have 
expanded our knowledge about this protein. Between the two, however, there seems to 
be a gap. The available tools in molecular biology have imposed constraints in the 
breadth and depth of experiments on human or other cell lines and also some of the 
interesting data obtained from in vitro studies has not yet been examined in vivo. The 
lack of a defined system, amenable to genetic manipulation, has thus left a lot of 
questions about the role of TopBP1 within the DDR largely unanswered. This chapter 
describes the different approaches followed towards the creation of a novel TopBP1 
knockout system in the DT40 model system. Such a system would enable the functional 
analysis of TopBP1 by reverse genetics and would serve to bridge the aforementioned 
gap in the TopBP1 field.  
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3.1: Strategy 1; creation of the TopBP1flox/flox/+/OvaCMVTopBP1/+/+ DT40 cell line and 
initial attempts to create the knock out 
 
The central aim of this current piece of research was to delete the entire TopBP1 
gene, located on the reverse strand of chromosome II of DT40 cells (chr2:43,231,685-
43,253,592 21, UCSC Genome Browser), so as to create a TopBP1-/-/- model system. 
The reason why I decided to target the entire locus rather than a portion of it as is 
usually the preferred method, was that although a partial deletion would in most 
probability disrupt the transcription of the gene of interest, it does not eliminate the 
possibility of an alternatively spliced fragment, perhaps non-detectable by the antibody 
against the protein on a western blot, still being expressed. The chicken TopBP1 locus 
consists of 27 exons and is predicted to produce a protein of 1512 amino acids in length. 
Briefly, the targeting strategy employed for the generation of a TopBP1-/-/- cell line 
involved the use of  “recombineering” and homologous integration to complete creation 
of DT40 cells in which all endogenous TopBP1 alleles would be deleted and one 
“transgenic” allele introduced at an ectopic locus, the Ovalbumin (Ova) locus also 
located on chromosome II. The transgenic allele was a wild-type copy of the TopBP1 
cDNA flanked by lox sites, thus easily excisable by Cre recombinase. Because of the 
essential nature of the TopBP1 protein, the only requirement in this targeting strategy 
was that the introduction of the wild-type cDNA should precede the deletion of the third 
endogenous TopBP1 allele, as shown in Figure 3.1. DT40 cells are trisomic for 
chromosome II, but this did not pose any problem, except for the fact that an additional 
round of gene targeting had to be performed. The resulting TopBP1-/-/-
/OvaWTTopBP1cDNA/+/+ could be used for the introduction of transgenic mutant versions of 
TopBP1, resistant to the action of Cre recombinase, and the mutant phenotype revealed 
following loss of the wild-type copy. 
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Figure 3.5: Diagrammatic representation of the TopBP1 knockout strategy. A) The TopBP1 and Ova 
loci on the trisomic chromosome II of wild-type cells. B) Deletion of one TopBP1 allele to create 
TopBP1-/+/+. C) Deletion of the second TopBP1 allele to create TopBP1-/-/+. D) Integration of a wild-type 
copy of the TopBP1 cDNA under the control of a constitutive promoter and flanked by lox sites in the 
Ova locus to create TopBP1-/-/+/OvaWTTopBP1cDNA/+/+. E) Deletion of the third TopBP1 allele to create 
TopBP1-/-/-/OvaWTTopBP1cDNA/+/+. F) Integration of any mutant of interest of the TopBP1 transgene into the 
second Ova allele. The mutant transgene is also under the control of a constitutive promoter but is not 
flanked by lox sites and also contains a different selection marker. G) Induction of Cre recombinase to 
flox the wild-type transgene and reveal the phenotype of the mutant transgene of the TopBP1 protein. 
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 3.1.1 Deletion of two TopBP1 alleles to create the TopBP1flox/flox/+ cell line 
 
3.1.1.1 Replacement of two TopBP1 genomic alleles with selection markers 
to create the TopBP1puro/his/+ cell line. 
The method of gene targeting employed herein is based on the use of 
homologous recombination to delete the genomic fragment of interest with base-pair 
precision. This involves the assembly of homology arms that flank the region to be 
deleted within a targeting vector, which will be electroporated as a linearized DNA 
molecule to cells in culture. To enable successfully transfected cells to be identified, a 
selection cassette containing an antibiotic resistance marker under the expression of a 
viral promoter is cloned between the two homology arms. In essence, a successfully 
targeted clone of the cell population will have the gene of interest being replaced by the 
selectable marker cassette and will confer resistance to this particular antibiotic. To 
allow for recycling of selectable markers in future studies, such selection cassettes are 
flanked by lox sites so they can easily be removed by expression of the Cre 
recombinase. Overall, this so-called recombineering technique allows the introduction 
of targeting vectors that act as homologous substrates for the HR machinery of the cell 
to create genetic changes. 
The first step of our gene targeting strategy was the deletion of two out of the 
three TopBP1 alleles of DT40 cells. Construction of the appropriate gene-targeting 
vectors was performed using the method and vectors described by Iiizumi et al (2006) 
(and shared by the Hochegger laboratory) and the Multisite Gateway Cloning system 
from Invitrogen (see Materials and Methods). In particular, two sets of targeting 
constructs were created with homology arms flanking the gene of interest (designated as 
LA for left arm and RA for right arm), only differing in the selectable marker they 
contained. The selection cassettes were flanked by direct repeats of lox recombination 
sites making them amenable to Cre-mediated excision. 
For generating these two targeting constructs (Figure 3.2 A), a 5’ homology arm 
(4kb) and a 3’ homology arm (2,003kb), flanking exons 1 to 27 of TopBP1, were 
selected. The sequence information was retrieved from the UCSC gallus gallus 
database. Different sets of primers (one pair for each arm) flanked by the att sites 
(sequence of att sites taken from Iiizumi et al (2006) were designed. The 5’ homology 
arm (LA) was PCR amplified using primers P1 and P2 and the 3’ homology arm (RA) 
was PCR amplified using primers P3 and P4.  The LA and RA PCR products were then 
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gel purified and inserted into the pDONR P4-P1R and pDONR P2R-P3 donor vectors 
using BP recombination reaction of the Gateway technology (Materials and Methods). 
The resulting LA and RA entry clones were confirmed by diagnostic enzyme digestion 
and Sanger sequencing. Subsequently, the LR recombination reaction was performed 
whereby the LA entry clone, RA entry clone, puromycin (or histidinol) entry clone and 
the pDEST DTA-MLS were all recombined together to produce the final gene targeting 
vector (Iiizumi, Nomura et al. 2006). In fact, two versions of the LA & RA-containing 
construct were obtained that contained different markers (Puromycin or Histidinol) for 
selection in DT40 cells. The final constructs were confirmed by PCR amplification of 
the arms, diagnostic restriction enzyme digestion and Sanger sequencing. For the sake 
of simplicity these constructs will be referred to as LARAPuro and LARAHis. 
To generate a TopBP1puro/+/+ cell line, the LARAPuro targeting vector was 
linearised by PmeI digestion (which linearizes the plasmid, cutting outside of the cloned 
sequences) and transfected by electroporation (Materials and Methods) into wild-type 
DT40 cells, kindly provided by the Hochegger laboratory. Out of 5 independent 
transfections, 62 puromycin (puro) resistant clones were obtained and of these only one 
was confirmed to be positive from Southern blot analysis with probe A, yielding 1.6% 
targeting efficiency. In more detail, genomic DNA was digested with NcoI restriction 
enzyme. In the wild-type locus probe A hybridizes to a 4.8kb fragment whereas in a 
successfully targeted locus the next NcoI restriction site is 10.5kb away (Figure 3B C). 
This positive clone was expanded and appropriately frozen down in aliquots as the 
TopBP1puro/+/+ cell line. 
The TopBP1puro/+/+ clone was freshly woken up from liquid nitrogen stock and 
transfected with PmeI-linearised LARAHis targeting vector that contained the same 
combination of arms as LARAPuro (Figure 3.2 A). As a lower efficiency of successful 
targeting was expected, this time 10 rounds of transfections were performed and 150 
histidinol (his) resistant clones screened by Southern blot analysis. Indeed, with two 
clones confirmed as positive, the targeting efficiency was at 1.3%. NcoI digestion of 
genomic DNA of successfully targeted clones creates a 3.7kb DNA fragment that is 
being recognized by probe A in addition to the already targeted and intact alleles 
(Figure 3.2 D E). The two positive clones were expanded and appropriately frozen 
down in aliquots as TopBP1puro/his/+ clone1 and TopBP1puro/his/+ clone2. Furthermore, to 
re-confirm the genotype of these positive clones, fresh genomic DNA was prepared and 
digested with NcoI as before or SacI enzymes. The probe A-hybridised fragments on the 
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blot were of the expected sizes as before (Figure 3F left panel). With SacI digestion of 
the wild-type locus a band of 5.9kb was expected whereas the puro and his targeted 
alleles were expected to give bands of 6.8kb and 8.5kb, respectively. The Southern blot 
results for SacI digests confirm the expected sizes (Figure 3F right panel). 
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Figure 3.2: Targeted deletion of two TopBP1 alleles and generation of the TopBP1puro/+/+ and 
TopBP1puro/his/+ cell lines. A) Schematic representation of the endogenous wild-type TopBP1 locus, 
LARAPuro and LARAHis targeting vectors and successfully targeted allele. B) Southern blot analysis of 
wild type (WT) control (lane 2) and potential TopBP1Puro/+/+ clones (10.5kb) digested with NcoI. C) 
Targeting efficiency of the transfections performed to obtain the TopBP1puro/+/+ cell line. D) Southern blot 
analysis of wild type (WT) control (lane 2) and potential TopBP1Puro/his/+ clones digested with NcoI 
(3.7kb). E) Targeting efficiency of the transfections performed to obtain the TopBP1puro/his/+ cell line. F) 
Southern blot analysis of wild type (WT) control (lane 2) and TopBP1puro/+/+ and TopBP1puro/his/+ clone 1 
and clone 2. NcoI-digested genomic DNA on the left panel and SacI-digested genomic DNA on the right 
panel. In all B, D, F digested genomic DNA was hybridized with the 3’ external probe (red bar) shown in 
A. 
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3.1.1.2 Stable integration of Cre recombinase and removal of the selection 
cassettes from TopBP1puro/his/+ cell line to create TopBP1flox/flox/+ 
The next step of this strategy was to stably integrate the Cre recombinase 
enzyme in the genome to allow for excision of the selection marker cassettes or of any 
other lox-containing sequences valuable to future studies. To achieve this, the 
expression plasmid pANMerCreMer-hygro (provided from the Hochegger laboratory) 
encoding a tamoxifen-regulated chimeric Cre enzyme was linearised by AhdI digestion 
and introduced into the TopBP1puro/his/+ clone 1 in a non-targeted way; i.e. randomly 
within the genome. The MerCreMer version of the Cre recombinase protein is inactive 
due to its retention in the endoplasmic reticulum in the absence of oestrogen derivatives 
(Zhang, Riesterer et al. 1996).  
Transfected single clones were selected in the presence of hygromycin B and 
resistant clones were screened for inducible-Cre expression. Initially, Western blot 
analysis was used but due to the non-specific binding of the antibody (abcam #40011, 
data not shown), an alternative approach was applied: TopBP1puro/his/+ cells were grown 
in 2µM 4-hydroxytamoxifen (4-HT) overnight to induce nuclear localization of the Cre 
enzyme. The selection cassettes integrated within the TopBP1 loci of this cell line are 
flanked by direct repeats of lox recombination sites, easily excisable by induction of Cre 
recombinase. Cells were then serially diluted and plated on 96-well plates to isolate 
single colonies. To test for the success of the recombination reaction and the resulting 
deletion of the selection cassette, equal amount of 4-HT-treated clones were transferred 
to normal as well as puromycin- or histidinol-supplemented growth media and left to 
grow. Loss of the puro and his selection markers was expected to result in loss of 
viability when cells were grown in the presence of puromycin and histidinol, 
respectively. The untreated control culture served to assess the sensitivity of these cell 
lines to 4-HT but also as a healthy, untreated stock for future freezing down.  
All clones screened had successfully floxed out the selection cassettes (Figure 
3.3 A). To more directly confirm for successful integration of the Cre recombinase in 
the genome, two sets of primers were designed along the length of the pANMerCreMer-
hygro expression vector and genomic DNA of TopBP1flox/flox/+ clones 1-3 alongside the 
parental TopBP1puro/his/+ were subjected to PCR amplification.  
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Figure 3.3: Stable non-targeted integration of the Cre recombinase and floxing of the selection 
markers from the TopBP1puro/his/+ to create TopBP1flox/flox/+ cell line. A) Following stable non-targeted 
integration of the pANMerCreMer-hygro vector into the TopBP1puro/his/+ cell line, single isolated clones 
were tested for inducible Cre expression. 10µl of the single clones cultures were transferred to 6-wells 
containing normal media, 0.5µg/ml supplemented media or 1mg/ml histidinol suplemeted media. The top 
panel shows the parental cell line growing in all three conditions. The panels below show clones that have 
successfully induced Cre and have floxed the puro and his selection cassettes from the TopBP1 locus 
hence have become sensitive to puromycin and histidinol. B) PCR amplification across the 
pANMerCreMer-hygro vector from genomic DNA of the parental cell line (negative control) alongside 
three of the clones that have successfully integrated the Cre expression vector acccroding to A. C) 
Growth curves of wild type (TopBP1+/+/+), TopBP1puro/his/+ and TopBP1flox/flox/+ clones 1, 2, 3. The error 
bars represent the standard deviation of the mean for three independent experiments. D) Diagrammatic 
representation of the wild-type, puro-targeted and his-targeted TopBP1 alleles showing the floxing of the 
selection cassettes and the expected sizes following SacI or NcoI digestion of genomic DNA. E) Southern 
blot analysis of TopBP1+/+/+, TopBP1puro/+/+, TopBP1puro/his/+ and TopBP1flox/flox/+ clones 1, 2, 3 following 
SacI or NcoI digestion of genomic DNA. In the left panel (SacI), diagnostic bands representing the puro 
(6.8kb) and his (8.5kb)-targeted TopBP1 alleles as well as the puro-floxed (5kb) and his-floxed (5kb) 
TopBP1 alleles are indicated. In the right panel (NcoI), diagnostic bands representing the puro (10.5kb) 
and his (3.7kb)-targeted TopBP1 alleles as well as the puro-floxed (8.7kb) and his-floxed (8.7kb) TopBP1 
alleles are indicated. Digested genomic DNA was hybridized with the 3’ external probe (red bar) shown 
in D. 
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PCR products were run on agarose gel and results confirmed a single amplification band 
of the expected 1kb, as both primer sets amplified similar sized bands (Figure 3.3 B). 
To chose which one of the TopBP1flox/flox/+ clones 1-3 grows more similarly to the 
parental TopBP1puro/his/+ cell line so that any potentially slow-growing clones would not 
be used for the subsequent steps the knockout strategy, a proliferation assay was 
performed to assess the proliferation rate of these clones. As shown in Figure 3.3 C 
they all proliferated with similar kinetics. Furthermore, to convincingly confirm the 
removal of the selection markers from the targeted TopBP1 alleles, TopBP1flox/flox/+ 
clones 1-3 were freshly woken-up, their DNA purified and digested with either SacI or 
NcoI enzymes as before.  Successful removal of the puro and his cassettes (1.8kb- and 
3.5kb-long, respectively) in SacI-digested samples was expected to shift the 6.8kb and 
8.5kb bands down to 5kb and 5kb, respectively. Removal of the puro and his cassettes 
in NcoI-digested samples was expected to shift the 10.5kb and 3.7kb bands to 8.7kb and 
8.7kb, respectively. The rest of the expected sizes have been explained previously 
(Figure 3.3 B). Southern blot analysis with probe A did indeed confirm the expected 
results so the TopBP1flox/flox/+ clones 1-3 were all expanded and frozen in aliquots for 
storage in liquid nitrogen. TopBP1flox/flox/+ clone 1 only was used for subsequent 
experiments. 
 
 3.1.1.3 Stable integration of an ectopic transgenic copy of TopBP1 to create 
TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ 
The next step of the knockout strategy was to introduce a wild-type copy of the 
TopBP1 cDNA flanked by LoxM sites in the ovalbumin locus of chromosome II 
(Chromosome 2: 67,948,051-67,955,623 reverse strand, ENSGALT00000037195.1). 
The ovalbumin locus is repressed in the chicken B cells as this is a gene only expressed 
in oviduct cells in response to oestrogen (Buerstedde and Takeda 1991). Choosing a 
silent locus for the ectopic expression of the rescue construct is important for two 
reasons. Firstly, to avoid disrupting a housekeeping gene and secondly, to prevent 
potential effects on the expression of the transgenic allele by a local regulation of 
transcriptional activity. To generate a TopBP1flox/flox/+ / OvaCMVTopBP1/+/+ cell line, a 
targeting construct OVACMV-IRES had been designed by previous members of the 
Carr laboratory. To confirm the sequence of the construct before proceeding to the 
experiment, Sanger sequencing was performed. OVACMV-IRES contained the wild-
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type cDNA of the TopBP1 protein under the control of the human cytomegalovirus 
(CMV) promoter (Figure 3.4 A).  
The CMV promoter has been extensively used for the ectopic overexpression of 
transgenes and the substitution of endogenous genes in DT40 systems (Fukagawa, 
Mikami et al. 2001, Zimmermann, Ahrens et al. 2002, Johnston, Joglekar et al. 2010). 
Furthermore, transcription of the TopBP1 transgene in our OVACMV-IRES targeting 
construct was coupled to transcription of the downstream neomycin selectable marker 
through the IRES (Internal Ribosome Entry Site), a sequence able to recruit the 
ribosome to the mRNA thus allowing cap-independent translation of the second gene. 
The IRES technology has also been exploited for the co-expression of genes in DT40 
cells (Szuts, Simpson et al. 2006, Arakawa, Kudo et al. 2008).  The entire CMV-
TopBP1-IRES-Neo was flanked by direct repeats of LoxM recombination sites and at 
the extreme ends were the left and right ovalbumin homology arms, as shown in Figure 
3.4 A.  
The targeting vector was linearized by PvuI digestion and transfected into the 
TopBP1flox/flox/+ cell line. 24h post-transfection, transfectants were microscopically 
observed and looked healthy. They were then selected with the standard concentration 
of 2mg G418 per ml of culture but no colonies were obtained in  12 transfections 
attempted. To try and assess if this was due to a potentially toxic concentration of the 
antibiotic, 16 transfections were performed and they were selected pairwise in variable 
concentrations of G418 (0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75 and 2mg/ml) but still no 
colonies were observed. What is more, to eliminate the possibility of the cells being 
resistant to transfection, a wild-type cell line was also manipulated the same way but no 
colonies were obtained with OVACMV-IRES construct. As a positive control in the 
experiment, a plasmid containing a neomycin resistance gene under the control of the 
SV40 promoter successfully produced G418-resistant colonies at 2mg/ml G418 
containing media. As an extra control, TopBP1flox/flox/+ cells transfected with OVACMV-
IRES and manipulated the same way but plated in G418 (-) media grew to confluence. 
From these experiments it was concluded that the IRES sequence did not work in our 
system and in the context of the CMV promoter. Thus a new strategy was devised for 
creating a TopBP1flox/flox/+ cell line ectopically overexpressing wild-type TopBP1.  
The new strategy was based on having the TopBP1 transgene and the selection 
marker being independently transcribed from different promoters. A linear DNA 
fragment containing the CMV promoter, a poly A tail, the SV40 promoter, neomycin 
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gene and another polyA tail was synthesized from Genscript using the EcoRV cloning 
site of the pUC57 vector. To ensure that the expression system being developed would 
be functional, the nucleotide sequences of the aforementioned genetic elements were 
copied from widely used mammalian expression vectors. More specifically, the CMV 
promoter and the first polyA tail sequences were copied from the pCDNA3.1 vector 
(V790-20, Addgene) whereas the SV40-neomycin-polyA fragment was copied from 
pCI vector (E1841, Addgene). Unique cloning sites were created within the sequences 
of the different elements to allow for subcloning of the ovalbumin left arm (OVALA) at 
NheI/SalI, the ovalbumin right arm (OVARA) at AscI/XhoI and TopBP1 cDNA at 
NotI/XmaI. The pairs of primers used for these three cloning steps were P5/P6, P7/P8 
and P9/P10, respectively. Each cloning step was monitored by diagnostic digestion and 
after the final cloning step Sanger sequencing successfully confirmed the newly made 
OvaCMV expression vector (Figure 3.4 A).  
OVACMV was linearized by XhoI digestion and transfected to the 
TopBP1flox/flox/+ cell line. 4 independent transfections were performed and over 100 
G418-resistant clones obtained at a selection of 2mg/ml G418. This confirmed that it 
was indeed the IRES sequence that was impairing the viability of the cells transfected 
with the OVACMV-IRES construct used before and allowed our gene knock out 
strategy to proceed. Of the 124 clones selected, 34 were initially screened by Southern 
blot analysis, as the Ova locus is well known for its high rate of integration. Genomic 
DNA from these 34 clones was purified and digested with SphI restriction enzyme for 
Southern blot analysis. A probe was also designed specific for the analysis of the Ova 
locus (probe B). SphI digestion of the wild-type Ova locus was expected to generate a 
12.2kb band on the Southern blot after hybridization with probe B, which is indeed the 
case. Successful integration of the OVACMV expression vector was expected to 
produce a 7.6kb band. It is worth-mentioning that the extra band just above the 8kb 
denoted by an asterisk is a result of a polymorphism in one of the three Ova alleles.  
 Out of the 34 samples tested, 14 seem to have been successfully targeted 
according to Figure 3.4 B. To re-confirm this, fresh DNA samples from some positive 
(clones 1, 2, 30) and some negative (clones 20, 21) clones were digested with BamHI 
and analysed by Southern blot. The wild-type locus came up at the expected size of 
18.4kb and the successful targeting events were visualized at the expected size of 
10.7kb. The results obtained from the BamHI blot thus reconfirmed the ones obtained 
from the SphI blot. In addition, the polymorphism in one of the Ova alleles was not 
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generating any additional unexpected BamHI site so no extra band was obtained here 
(Figure 3.4 C). Finally, to have an idea of the efficiency of our rescue expression 
system, Western blot analysis was performed using total cell extracts of Southern-
positive (left panel) and Southern-negative (right panel) clones, alongside the parental 
cell line serving as a control for the TopBP1 protein levels produced from the single 
remaining endogenous TopBP1 allele. Surprisingly enough, no differences (in terms of 
protein expression levels) could be observed between the parental cell line or the clones 
negative for Ova targeting and the clones constitutively expressing the additional 
transgenic TopBP1 allele from the Ova locus (Figure 3.4 D). To ensure that the 
transgene has been integrated intact with no mutations, PCR amplifications of slightly 
overlapping ~0.6kb-1kb fragments specifically from the integrated OVACMV fragment 
were performed and sent for Sanger sequencing. The specificity of the PCR reactions 
within the TopBP1 cDNA region was achieved by designing primers that would not be 
able to anneal within the endogenous TopBP1 locus (i.e. an oligo perfectly annealing on 
the TopBP1 transgene was comprised of the end of exon (n) and the start of exon (n+1) 
at the endogenous locus). Sanger sequencing of 4 independent clones confirmed that no 
mutations were incorporated at the Ova targeted locus (data not shown). These were 
expanded and frozen down in liquid nitrogen as TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ clones 
1, 2, 3 and 4. 
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Figure 3.4: Stable integration at the Ova locus of the rescue wild-type TopBP1 transgene under the 
control of the CMV constitutive promoter.  A) Schematic representation of (from top to bottom) the 
ovalbumin (Ova) locus, the homology arms used, the targeting vectors attempted and the OVA locus 
successfully targeted with vector OVACMV. B) Southern blot analysis of TopBP1flox/flox/+ parental cell 
line (control) and potential TopBP1flox/flox/+ / ovaCMVTopBP1/+/+ clones following digestion of genomic DNA 
with SphI. Top panel depicts clones 1 to 17 and bottom panel clones 18 to 35. The diagnostic bands 
correspond to 12.2kb for an intact allele and 7.7kb for a successfully targeted allele. The asterisk 
corresponds to one of the three Ova alleles containing a polymorphism and producing an SphI diagnostic 
band of ~8.5kb. C) Clones denoted by red boxes in A were re-analysed by Southern blot analysis 
following digestion with SphI or BamHI. The diagnostic bands for SphI are same as in B, whereas for 
BamHI the wild-type diagnostic band is 18.4kb and the targeted band is 10.7kb. Digested genomic DNA 
was hybridized with the 3’ external probe (purple bar) shown in A. D) Western blot analysis of indicated 
clones with an anti-TopBP1 (~180kDa) polyclonal antibody. Beta-tubulin was used as the loading 
control. 
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3.1.1.4 Attempting to knock out the third TopBP1 allele with LARAHis 
targeting construct 
To indirectly but perhaps more effectively investigate the functionality of the 
ectopic expression, I decided to attempt knocking out the remaining third allele from the 
endogenous TopBP1 locus. To do so the LARAHis vector was linearized and 
transfected as explained before. As deletion of the third allele could perhaps be a rare 
event and also to account for clonal variation, all four clones confirmed by sequencing 
in the previous step (clones 1, 2, 3 and 4) were used and a total of 32 knockout 
transfections performed. It is worth mentioning that since background activity of 
MerCreMer can lead to undesired excision of the TopBP1 cDNA rescue construct from 
the ovalbumin locus during prolonged culture, we selected for cells retaining the 
transgene by culturing in media containing G418 prior to attempting the knockout 
transfection. Selection gave rise to 776 histidinol-resistant clones, which were 
subsequently screened for loss of the endogenous TopBP1 locus. Screening all by 
Southern blot analysis would be quite time-consuming and expensive so a different 
method was followed. In fact, I took advantage of the floxable nature of the ectopic 
transgene and reasoned that a transfectant that would have successfully deleted the third 
endogenous copy of TopBP1, would display loss of viability following treatment with 
4-HT. So equal amounts of all 776 cultures were transferred into fresh media with or 
without containing 4-HT and left to grow. Of the 776 clones, 126 were scored as 4-HT-
sensitive (Figure 3.5 B) and these were frozen down and also subjected to Southern blot 
analysis. SacI digestion of wild-type DNA and probing with the TopBP1 locus-specific 
probe A hybridized to a diagnostic 5.9kb band. The TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ 
parental control generates one band at 5.9kb for the remaining intact allele and two 
overlapping bands at 5kb for the deleted/floxed alleles. Successful replacement of the 
intact allele with the LARAHis targeting vector was expected to shift the wild-type 
band to 8.5kb (Figure 3.5 A). However, as is evident from the representative Southern 
blot shown in Figure 3.6 C, the clones obtained were either genotypically the same as 
the parental cell line for the TopBP1 locus or they had one of the already targeted alleles 
being retargeted and the wild-type copy still remaining intact (Figure 3.5 A, C). In fact, 
60.3% of the 4-HT-sensitive clones apparently remained TopBP1flox/flox/+ 
/OvaCMVTopBP1/+/+ and 39.7% became TopBP1flox/his/+/ OvaCMVTopBP1/+/+ (Figure 3.5 D). 
Therefore, using the same targeting vector promotes a retargeting event mediated by the 
same homology arms. This retargeting event is more favorable than the deletion of the 
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third intact copy perhaps due to the much smaller size of the intervening sequence. The 
false positive result obtained from the 4-HT experiment is perhaps associated to an 
inherent sensitivity to this drug, even at low doses, for some of the clones. 
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Figure 3.5: Attempt to knockout the third TopBP1 allele in TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ using the 
LARAHis targeting vector. A) Schematic representation of the wild-type TopBP1 allele, LARAHis 
targeting vector and the successfully targeted locus. Inside the box at the bottom is a representation of the 
already targeted TopBP1 alleles from the previous steps. B) Screening for clones that have deleted all of 
the TopBP1 alleles and hence should lose viability following induction of Cre recombinase. On the left 
panel is an example of a clone losing viability after 4-HT treatment (bottom) compared to the parental cell 
line (top). The right panel represents a table summarising the results obtained from this screening 
experiment. C) Southern blot analysis of the 4-HT-sensitive clones obtained in B. After SacI digestion of 
genomic DNA, a diagnostic band of 5.9kb represents the wild-type allele, a band of 5kb represents each 
of the floxed alleles and a band of 8kb represents a re-targeting event. Digested genomic DNA was 
hybridized with the 3’ external probe (red bar) shown in A. This blot is a representative figure and D) 
summarises all the results obtained from the Southern blots performed.  
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3.1.1.5 Attempting to knock out the third TopBP1 allele with LARA2His 
targeting construct 
To try and avoid the re-targeting event I changed the homology arms with arms 
homologous to internal regions of the TopBP1 locus (now present only in the third 
copy). Using the Gateway recombination technology and donor vectors from Iiizumi et 
al (2006) again I attempted to assemble the LA2RA2His targeting construct (Figure 3.6 
A). Numerous failures to PCR amplify the LA2, even trying different primer pairs, 
prompted us to assemble the LARA2His targeting construct instead, where the LA was 
exactly the same as the one used before (Figure 3.6 A). To do so the LA was amplified 
with primers P1 and P2 as before whereas primers P11 and P12 were used to amplify 
the RA2 from genomic DNA of the TopBP1flox/flox/+ cell line. The resulting LARA2His 
plasmid was checked by PCR amplification of the subcloned arms, diagnostic enzyme 
digestion and Sanger sequencing.  
Once verified, LARA2His was linearized by PmeI digestion and transfected into 
the TopBP1flox/his/+ /OvaCMVTopBP1/+/+ cell line. Transfectants were selected in the 
presence of histidinol and then were screened by the method of Cre induction as before. 
Of the 400 histidinol-resistant clones obtained from 22 transfections and screened for 
sensitivity to 4-HT, 341 were scored as resistant and 59 as sensitive (Figure 3.6 B). The 
clones displaying loss of viability following Cre induction were analysed for loss of the 
third endogenous TopBP1 copy by Southern blot following BglII genomic DNA 
digestion. Probe A hybridized to a 7.5kb band whereas the already targeted alleles ran at 
6kb. Deletion of the third copy and its replacement by the His cassette between the 
regions comprising the homology arms was expected to generate a 13.2kb diagnostic 
band following hybridization. However, an unexpected band at 9.5kb was observed that 
based on the relative intensities seemed to be a re-targeting of one of the already deleted 
copies. In fact, 22% of the clones screened were untargeted hence displaying same 
Southern blot profile as their parental counterparts, whereas the remaining 78% 
contained this band of unexpected size (Figure 3.6 C, D).  
One possibility was that a novel BglII site was generated by some acquired 
mutation/polymorphism following the integration of the targeting vector. One way to 
avoid this potential novel site and screen for positive clones was to digest DNA with an 
alternative restriction enzyme. Unfortunately, all enzymes to the 3’ region of the probe 
that could be used were also cutting within the area of the RA2 thus making the 
distinction between TopBP1flox/flox/+ and TopBP1flox/flox/his impossible. 
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Figure 3.6: Attempt to knockout the third TopBP1 allele in TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ using the 
LARA2His targeting vector. A) Schematic representation of the wild-type TopBP1 allele, LARA2His 
targeting vector and the successfully targeted locus. Inside the box at the bottom is a representation of the 
already targeted TopBP1 alleles from the previous steps. B) Screening for clones that have deleted all of 
the TopBP1 alleles and hence should lose viability following induction of Cre recombinase. The table 
summarises the results obtained from this screening experiment. C) Southern blot analysis of the 4-HT-
sensitive clones obtained in B. After BglII digestion of genomic DNA, a diagnostic band of 7.5kb 
represents the wild-type allele, a band of 6kb represents each of the floxed alleles and a band of 9.5kb 
represents the product of erroneous recombination (see text for details). Digested genomic DNA was 
hybridized with the 3’ external probe (red bar) shown in A. This blot is a representative figure and D) 
summarises all the results obtained from the Southern blots performed. The asterisk represents the 
erroneous recombination event. 
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This was not considered a major problem as we reasoned that it is quite 
impossible for such a high percentage of clones to have all acquired the very same 
mutation/polymorphism and thus sought an alternative explanation.  
Closer observation of the possible ways for a 9.5kb band to be generated 
revealed a potential erroneous recombination event (although a different scenario cannot 
be excluded). As depicted in Figure 3.7 A, the homology for this erroneous 
recombination event was mediated by the portion (shown in orange) of the LARAHis 
targeting vector surrounding the lox site that has remained in the second locus of 
TopBP1 and that is homologous to the LARA2His targeting vector. This scenario 
requires resection of the linearized targeting vector beyond the RA2 region and thus 
implies that the product of the erroneous recombination would contain the RA instead 
of the RA2. So, in short, what this erroneous recombination event yields is a retargeted 
TopBP1 allele (the one targeted with the His vector and floxed out) but instead of the 
presence of the RA2, the RA remains. 
 A second erroneous recombination event that could help explain why cells die 
following Cre induction would be at the region of the LA. In particular, it is possible 
that a recombination reaction between the LA on the targeting vector and the intact 
TopBP1 allele rendered the protein produced from this allele partly- or non-functional 
with an impaired N-terminus. Alternatively, an inherent sensitivity to 4-HT can help 
explain the observed phenotypes as mentioned earlier. Finally, to prove this erroneous 
recombination event hypothesis a different probe, 5’ to the LA was designed that would 
help distinguish the erroneous recombination product on the basis of size. Primers P13 
and P14 were used to amplify the probe from wild-type DT40 genomic DNA. As for the 
Southern blot strategy, EcoRV digestion of genomic DNA of wild-type cells would 
yield a band of 9.8kb whereas the erroneous recombination product would be 
distinguished (21kb) from the already targeted alleles (17.5kb) (Figure 3.7 B). EcoRI 
was also serving the same purpose leading to a diagnostic band of 10.5kb for wild-type, 
11kb for intact targeted allele and 7.5kb for the product of the erroneous recombination. 
Unfortunately, the probe designed gave a lot of background non-specific binding to 
DT40 DNA, and although sample digestion was efficient for both enzymes, 
hybridization of the membrane could not deduce conclusive results (data not shown). 
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Figure 3.7: Erroneous recombination upon attempt to knockout the third TopBP1 allele in 
TopBP1flox/flox/+ /OvaCMVTopBP1/+/+ using the LARA2His targeting vector. A) The predicted erroneous 
recombination involves two steps. In the first step, the LARA2His targeting vector recombines with the 
LA region of the intact TopBP1 allele. In the second step, the LARA2His targeting vector erroneously 
recombines with the TopBP1 allele that has been already targeted with the LARAHis construct and the 
marker has been floxed. The homology is provided by the backbone sequences between the homology 
arms and the lox sites that have remained in the deleted allele but are also present in the LARA2His 
targeting vector. B) Schematic representation of the three TopBP1 alleles following erroneous 
recombination. It is predicted that clones that displayed the 9.5kb unexpected band in figure 3.7 would be 
composed of a partly-functional full-length TopBP1 allele, an allele produced from the erroneous 
recombination event and the allele that was deleted with LARApuro and which remains intact during the 
erroneous recombination reaction.  
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Summary for chapter 3 
 In this chapter, I described the use of homology-directed repair to achieve 
complete deletion of two alleles of the TopBP1 gene in DT40 cells. Next, I described 
the stable non-targeted integration of the MerCreMer enzyme under the control of a 
tamoxifen-inducible promoter, as a useful tool for future use of my model system. Then 
I went on to describe the removal of the selection cassettes from the targeted TopBP1 
alleles by induction of MerCreMer as well as the subsequent integration of the wild-
type cDNA of TopBP1 under the control of the CMV promoter at the Ova locus. 
Having confirmed the stable insertion of the rescue construct within the Ova locus, it 
was attempted to knockout the third endogenous allele of TopBP1. Two gene targeting 
constructs were tried and more than 1200 clones screened for loss of viability after 
treatment with 4-HT but no positive clone was obtained following Southern blot 
analysis. This prompted me to investigate whether the protein levels produced from the 
ectopic rescue construct were sufficient to sustain the viability of cells in the absence of 
the endogenous TopBP1. Also, the inability to obtain the knockout cell line despite the 
miscellaneous and intense approaches was informative and intriguing per se.   
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4.1: Creation of a stably integrated overexpression system for the production of 
increased amounts of the ectopic TopBP1 transgene and subsequent novel attempts 
to create the knock out 
  
The inability to obtain the knock out after screening more than a thousand clones 
raised the question of whether the levels being produced from the ectopic TopBP1 copy 
at the Ova locus were enough to allow cells to let go of their final endogenous TopBP1 
allele. As discussed in the previous chapter, the cells harbouring the transgene at the 
Ova locus did not produce any apparent increase in the total amount of TopBP1 protein 
as judged by Western blot analysis of whole cell extracts using a polyclonal antibody 
raised against a C-terminal peptide of TopBP1. But since the ectopic transgene did not 
harbour any tag I was unable to specifically visualise the protein levels being produced 
from the Ova locus. Stable integration of more than one TopBP1 transgenes under the 
control of the CMV promoter was the first method I employed to increase the levels of 
the protein. This time the transgene was also fused to a tag to enable separation of the 
TopBP1 protein pools, endogenous versus ectopic. The second method I embarked on 
involved a novel characterisation of different promoter regions driving expression of the 
TopBP1 transgene from various loci in order to identify the best way of achieving 
maximal expression of the rescue construct and thus increase the probability of 
successfully achieving deletion of the remaining endogenous copy. These two methods 
together with novel ways of attempting the knockout are the focus of this subchapter.  
 
 
4.1.1: Stable non-targeted transfection of the transgene under the control of CMV 
promoter to increase protein levels 
 The quickest way of achieving our goal of increasing the protein levels of 
TopBP1 was to stably integrate the TopBP1 transgene randomly within the genome as a 
way of optimising overexpression and achieving sufficient complementation. 
Theoretically, the lack of homology arms and the high levels of energy used for 
electroporation allow the integration of more than one copy of the targeting vector in 
some, if not all, of the clones.  To achieve non-targeted integration the OvaCMV 
expression vector described earlier was used to subclone the TopBP1 cDNA at 
NotI/XmaI as before. For the reason explained in the introduction an array of three 
FLAG epitopes was introduced at the C-terminal end of the cDNA replacing the stop 
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codon. Subcloning of the FLAG-tags was achieved using annealed oligomers containing 
the octapeptides and ligation of the resulting linear molecule as an XmaI/PmeI fragment. 
The construct assembled called “CMVnon-targeted” contained no homology arms so by 
using relatively high electroporation energies that cause DNA breaks stable non-
targeted integration into the genome could be achieved. Unlike for targeted integration, 
here it was not necessary to linearise the targeting construct.  
The circular plasmid was transfected into the TopBP1flox/flox/+ cell line and the 
G418-resistant clones obtained were screened by Western blot analysis with an anti-
FLAG antibody. Almost 50% of the clones have successfully integrated the construct 
and it is interesting to note that some clones display higher expression levels than 
others, presumably due to more copies having integrated into the genome or different 
sites of integration affecting expression (Figure 4.1 A). All of the positive clones were 
expanded and frozen down as TopBP1flox/flox/+ /OvaCMVTopBP1FLAGnon-targeted/+/+. The only 
caveat with this system of non-targeted integration of the transgene was that induction 
of Cre by 4-HT treatment would not flox these randomly integrated copies of the 
TopBP1 cDNA. Treating cells with the standard concentration of 2µM did not catalyse 
the deletion of the expression fragment flanked by the lox sites, as is evident from the 
persisting protein signal on the Western blot membrane. Doubling the concentration of 
4–HT used did not make any difference whereas higher concentrations of 4-HT tested 
were toxic to the cells   (Figure 4.1 B).  
Despite this imperfection of the “CMVnon-targeted system, I decided to attempt 
the knockout targeting transfection to answer the question of whether more copies of the 
constitutively expressed and CMV-driven TopBP1 cDNA would allow deletion of the 
endogenous locus. To avoid the issues of retargeting and erroneous recombination 
observed with the LARAHis and LARA2His targeting constructs, I had in the meantime 
designed a new TopBP1 knockout vector containing arms homologous to internal 
regions within the gene and in respect to the LA and RA regions used before. It is worth 
mentioning that to be absolutely certain that the nucleotide sequence of the third intact 
copy does not differ from the consensus sequence on the genome database, I decided to 
design primers along the length of the new arm regions and PCR amplify them from the 
TopBP1flox/flox/+ cell line. The ~0.7kb amplified fragments were gel extracted and 
sequenced and analysis of the sequencing data revealed no mismatches to the consensus 
sequence on the database. The new arm regions chosen, LAiRAi (I for internal) were 
therefore suitable for targeting of the third TopBP1 copy. In addition to the construction 
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of internal arms, I also decided to use a different backbone vector (i.e. not the pDONOR 
vectors used before) so that the vector sequences present in the already targeted alleles 
would bear no homology to this newly assembled deletion construct. Finally, to avoid 
any erroneous inter-allelic recombination event lox sites were not included flanking the 
selection cassette. 
To assemble the LAiRAiPuro construct, the neomycin gene within OvaCMV was 
replaced with a gene conferring resistance to puromycin using the flanking 
EcoRI/BamHI single cutters. The primers used were P15 and P16 and the substrate in 
the PCR reaction was a puromycin-containing expression vector kindly provided by the 
Hochegger laboratory. The resulting SV40-puro-pA fragment was excised by cutting 
with EcoRV/XbaI and subcloned into pBluescript SK+. Subsequently the LAi and RAi 
were amplified from genomic DNA with primers P17/P18 and P19/P20 and subcloned 
at SalI and NotI, respectively.  The resulting LAiRAiPuro (Figure 4.1 C) was confirmed 
by diagnostic restriction enzyme digestion and Sanger sequencing.  
Two of the TopBP1flox/flox/+ / OvaCMVTopBP1FLAGnon-targeted/+/+ clones displaying high 
levels of expression of the transgene were transfected with AhdI-linearised LAiRAiPuro 
and selected in puromycin. This time the 4-HT screening method could not be used as 
explained earlier so all clones were subjected to genotyping by PCR (P40/P41). The 
primers used for the genotyping anneal to sequences in exon 19 and intron 22 
respectively which serves two purposes; Firstly, amplification of the ectopic TopBP1 
transgene is impossible since the cDNA does not contain introns and secondly, it allows 
screening for knockout cells by negative selection, which means that no amplified band 
should be observed in a clone that has all endogenous TopBP1 alleles deleted. None of 
the 250 clones tested had successfully deleted the TopBP1 locus as is evident from 
representative results in Figure 4.1 C. A LAiRAiPuro successfully targeted clone 
should not produce an amplified product in the PCR reaction. Finally, representative 
results from Southern blot analysis of some of these clones confirmed that no 
successfully targeted clones were obtained. Following BglII digestion of wild-type cells 
the intact TopBP1 allele was represented by a diagnostic band of 7.5kb whereas the 
floxed alleles were both represented by overlapping bands at 6kb. A successfully 
targeted clone was expected to generate a diagnostic band of 9.2kb corresponding to the 
replacement of the third intact TopBP1 allele by the LAiRAiPuro targeting vector. As 
shown from the representative results in Figure 4.1 D, the obtained clones showed the 
exact same pattern as the parental cell line and have not lost the final endogenous allele 
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of TopBP1. At least no retargeting was observed with the use of the LAiRAiPuro 
targeting vector. 
Overall, in this experiment we have managed to create the TopBP1flox/flox/+ / 
OvaCMVTopBP1FLAGnon-targeted/+/+ cell line, visualise the protein produced from the 
exogenous construct and attempt the deletion of TopBP1 with a newly made targeting 
construct specific for the third intact allele. The failure to target the endogenous wild-
type copy prompted us to consider the possibility of the CMV promoter element not 
producing sufficient levels of the rescue TopBP1, not even when present in more than 
one copies within the genome. I thus sought novel ways of further increasing expression 
the exogenous protein expression.  
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Figure 4.1: Creation of the TopBP1flox/flox/+ /CMVTopBP1FLAGnon-targeted cell line and attempt to knockout 
the third endogenous copy with the LAiRAiPuro targeting vector.  A) (top panel) Schematic 
representation of the “CMV non-targeted” targeting vector for stable non-targeted integration of the 
TopBP1 transgene under the control of the constitutive CMV promoter. (bottom panel) Western blot 
analysis of clones transfected with the “CMV non-targeted” vector alongside the wild-type and parental 
cell lines in order to screen for the ones that display expression of the transgene. Cell lysates were blotted 
with an anti-FLAG antibody to control for transgenic TopBP1 expression. Blotting for beta-tubulin 
served as a loading control. B) Western blot analysis of lysates of the indicated cell lines following 4-HT 
treatment to screen for floxing of the ectopic non-targeted copy (copies) of the FLAG-tagged TopBP1 
transgene. Cells were treated with 0, 2 or 4µM 4-HT for 24h and then serially diluted to isolate single 
colonies. C) Diagrammatic representation of the wild-type TopBP1 locus, LAiRAiPuro targeting vector 
and successfully targeted locus of TopBP1flox/flox/+ /OvaCMVTopBP1FLAGnon-targeted/+/+ cells. D) PCR genotyping 
of wild-type DT40 and TopBP1flox/flox/+ /OvaCMVTopBP1FLAGnon-targeted/+/+ parental control alongside 
puromycin-resistant clones obtained from transfection of the parental control with the LAiRAiPuro 
targeting vector shown in C. Successfully targeted clones would be negative for the 2.3kb amplified band, 
E) Southern blot analysis of BglII-digested DNA of wild-type DT40 and TopBP1flox/flox/+ / 
OvaCMVTopBP1FLAGnon-targeted/+/+ cells alongside puromycin-resistant clones obtained from transfection of the 
parental control with the LAiRAiPuro targeting vector shown in C. Diagnostic bands represent the intact 
(7.5kb) and floxed TopBP1 alleles (6kb and 6kb). Digested genomic DNA was hybridized with the 3’ 
external probe (red bar) shown in C. 
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4.1.2: A comparison of viral promoter elements integrated at active or silent loci to 
enhance exogenous protein expression in the DT40 model system 
The adequate choice of the promoter element and the characterization of the 
protein expression level is of significant importance towards the development of a 
suitable model system, tailored to meet the needs of the researcher and serve the 
purpose of the biological question. To our knowledge, no characterisation of promoter 
elements has been performed in the DT40 model system. In an effort to identify an 
expression system suitable for optimal exogenous protein expression in DT40 cells, I 
decided to compare the already used CMV promoter with two other promoter elements, 
CAG (CMV early enhancer and chicken beta actin) and CBA (chicken beta actin), in 
their ability to drive expression of the TopBP1 transgene. The reason I chose these 
particular ubiquitous promoters was that they are generally described as being among 
the stronger constitutive promoters available in molecular biology (Powell, Rivera-Soto 
et al. 2015). Our work so far has indicated that the levels produced from the CMV 
element do not confer any overall increase in the total amount of TopBP1 produced 
inside the cells. Thus attempting the design of novel constructs that would increase the 
protein levels of our protein would possibly be of significant importance for sustaining 
viability of the TopBP1 knockout.  
To avoid the high variation in transgene expression resulting from uncontrolled 
copy number and chromosomal position effects when using non-targeted integration, I 
targeted the CAG, CBA and CMV expression systems in the same chromosomal 
position, the Ova locus, of the TopBP1flox/flox/+ cell line thus creating three isogenic 
clones constitutively overexpressing the TopBP1 transgene. This has enabled the direct 
comparison of constructs from within the same genomic context and allowed a 
systematic and quantitative assessment of the strengths of the promoters. 
 Furthermore, since Ova is a silent gene in the chicken B cells (Buerstedde and 
Takeda 1991), I wanted to investigate whether the local chromatin environment would 
have an effect on the levels of expression. Thus exogenous protein production from the 
Ova locus was compared to that of a transcriptionally active locus. The following 
paragraphs describe the creation of a stably integrated overexpression system (SIOS). 
SIOS is an easy to use and versatile system for constitutive, reversible exogenous 
protein production that provides a range of potential expression levels. This is a useful 
experimental tool for future DT40 experiments. 
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 The three constructs assembled for the creation of the three expression systems 
at the Ova locus are shown in Figure 4.2 A. The design of the OvaCMV construct was 
explained in paragraph 3.1.1.3. To assemble the OvaCBA and OvaCAG constructs we 
purchased two expression vectors, pSF-CBA (OG262) and pSF-CAG (OG505). I then 
sequentially subcloned the TopBP1 cDNA at the KpnI site, the SV40-neomycin-pA-
loxM3-OvaRA fragment at the PacI site and the OvaLA-loxP at PvuI.  Successfully 
cloned molecules were screened by diagnostic enzyme digestion after each cloning step 
and finally verified by Sanger sequencing. The primers used for these three steps were 
P21-P26. Additionally, the TopBP1 transgene was fused to three FLAG epitopes 
included as an overhang in the reverse primer.  
The OvaCMV targeting vector was linearized with XhoI as before whereas 
ApaLI was used to linearise OvaCBA and OvaCAG prior to electroporation into the 
TopBP1flox/flox/+ cell line. Cells that successfully formed single colonies following 
selection in 2mg/ml G418 were subjected to Western blot analysis with an anti-FLAG 
antibody to visualize ectopic TopBP1-3XFLAG. The three targeting experiments and 
subsequent analysis were performed in parallel to eliminate variations in the 
experimental conditions. As shown in Figure 4.2 B most of the clones obtained were 
positive for the expression of the FLAG-tagged TopBP1 but to distinguish the clones 
that have targeted the construct specifically at the Ova locus, Southern blot analysis of 
SphI-digested genomic DNA was performed. Hybridisation with probe B revealed the 
overexpression clones positive for the Ova locus, evident from the 7.6kb band 
corresponding to a successfully targeted Ova allele (Figure 4.2 D, E, positives shown in 
red boxes).  
Two clones of each of TopBP1flox/flox/+/Ova CMVTopBP1/+/+, TopBP1flox/flox/+/Ova 
CBATopBP1/+/+ and TopBP1flox/flox/+/Ova CAGTopBP1/+/+ were subjected to PCR amplification 
of ~0.7kb partly overlapping fragments and Sanger sequencing across the length of the 
transgene to ensure no mutations have been incorporated following integration. 
Interestingly, having the transgene fused to a protein tag allowed the characterization of 
the relative efficiencies of the three distinct promoters among the three isogenic 
counterparts. As depicted in Figure 4.2 C, the CAG promoter displayed the highest 
strength in relation to TopBP1 expression. The average relative expression of the two 
CAG clones was 7.5AU, of the four CBA clones 2.8AU and of the two CMV clones 
1.3AU. Hence the CAG promoter element showed more than 2.6-fold higher relative 
expression of the transgene than the CBA and 5.8-fold than the CMV.  
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Probing with the anti-TopBP1 antibody raised against a C-terminal peptide of 
the protein (Appendix 1) enabled a qualitative assessment of the three systems based on 
the fold-increase of the total protein levels over the amount of endogenous TopBP1 in 
the parental cell line. When compared to exogenous TopBP1, the CMV construct 
contributes less than 1-fold) of the total pool of TopBP1 protein inside the cells, 
whereas CBA and CAG contribute to 3- and 6-fold than the endogenous allele (Figure 
4.2 F, G). Thus, a single copy of the CBA promoter increases the TopBP1 levels to 
approximately the levels normally found in wild-type cells (where there are three copies 
of the endogenous gene) while the CAG promoter provides approximately twice the 
amount of TopBP1 than that found in wild-type cells. 
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Figure 4.2: Relative promoter activities of TopBP1 transgenic constructs stably integrated at Ova. 
A) Schematic representation of TopBP1 expression constructs under the control of different promoters for 
stable integration into the Ova locus of DT40 cells. B) Western blot analysis of cell lysates from cells 
transfected with the expression constructs shown in A. Immunoblotting with an anti-FLAG antibody 
controls for the expression of the ectopic TopBP1-3xFLAG. Cell lysates of wild-type and parental cells 
were used as a negative control. The levels of beta-tubulin were used as a loading control. C, D) Clones 
showing expression of the TopBP1 transgene in B were subjected to Southern blot analysis following 
SphI digestion of genomic DNA. The diagnostic bands corresponding to the wild-type allele (12.2kb) and 
the successfully targeted allele (7.6kb) are indicated. The asterisk corresponds to one of the three Ova 
alleles containing a polymorphism that generates an SphI restriction site. Digested genomic DNA was 
hybridized with the 3’ external probe (purple bar) shown in A. E) Western blot analysis of cell lysates of 
cells overexpressing the TopBP1 transgene under the control of the three constitutive promoters shown in 
A. Immunoblotting with an anti-TopBP1 antibody controls for the visualisation of the increase of 
TopBP1 protein levels over the levels produced from the endogenous promoter. Beta-tubulin serves as the 
loading control. F) Quantification of the blot in E. 
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Ova is a silent gene in the chicken B cells, which may affect the expression 
levels due to the local chromatin environment. To examine if this was the case we 
compared TopBP1 protein production from the CAG promoter integrated at the Ova 
locus to the levels of TopBP1 when expressed from the same promoter construct 
integrtated at a transcriptionally active locus.  To achieve this, the TopBP1 transgene 
construct under the control of the CAG promoter was recreated with different homology 
arms. I chose to target a region downstream of the endogenous TopBP1 locus on 
chromosome II (42,781,752-42,789,165), a region between the 3’end of the TopBP1 
locus and the 5’ start of the CDV3 protein-coding gene.  
To assemble the “euchromatinCAG” (euCAG) construct shown in Figure 4.3 A, 
the TopBP1 cDNA was first subcloned at the KpnI site of pSF-CAG (OG505), as 
before. In the meantime, the euchromatin LA was PCR amplified from genomic DNA 
and subcloned in the OvaCMV using NheI/SalI sites and replacing in this way the 
existing OvaLA (P27 and P28). Following the same logic the euchromatin RA was 
amplified and subcloned in OvaCMV using AscI/XhoI sites and replacing in this way 
the existing OvaRA (P29 and P30).  These cloning steps were confirmed by diagnostic 
enzyme digestion and Sanger sequencing. Subsequently, the SV40-neomycin-pA-loxM-
euchromatinRA and the euchromatinLA-loxP fragments were PCR amplified from the 
aforementioned constructs and subcloned sequentially at the PacI and PvuI sites of pSF-
CAG, respectively (P31 and P32 & P33 and P26). The final euCAG construct was 
verified by diagnostic enzyme digestion and Sanger sequencing. 
 The resulting construct was linearized by ApaLI digestion and transfected into 
the TopBP1flox/flox/+ cell line. To be able to directly compare the relative efficiency of the 
CAG promoter element between the Ova locus and the euchromatic locus downstream 
of the endogenous TopBP1 gene of the TopBP1flox/flox/+ cell line, the OvaCAG targeting 
vector was transfected in parallel to the euCAG targeting vector (Figure 4.3 B). Single 
clones were isolated following selection with G418 and were checked for expression of 
the transgene by Western blot analysis and immunoblotting with an anti-FLAG 
antibody. The majority of the Ova-targeted (Figure 4.3 C) and the euchromatic region-
targeted (Figure 4.3 D) cells were positive for TopBP1-3xFLAG expression. But to test 
which of those had the transgenes integrated at the loci of interest, Southern blot 
analysis was performed. 6 out of the FLAG-positive clones had specifically targeted 
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Figure 4.3: Relative strength of the CAG promoter driving expression of the TopBP1 transgene 
when stably integrated at the Ova locus versus a euchromatic locus. A) Schematic representation of 
the targeting constructs used to stably integrate the CAG-TopBP1 transgene at the Ova locus and B) A 
euchromatic locus nearby the endogenous TopBP1 gene (right panel). C) Western blot analysis of cell 
lysates from cells transfected with the expression construct shown in A. Immunoblotting with an anti-
FLAG antibody controls for the expression of the Ova TopBP1-3xFLAG. Cell lysates of wild-type and 
parental cells were used as a negative control. The levels of beta-tubulin were used as a loading control. 
D) Western blot analysis of cell lysates from cells transfected with the expression construct shown in B. 
Immunoblotting with an anti-FLAG antibody controls for the expression of the euchromatin TopBP1-
3xFLAG. Cell lysates of wild-type and parental cells were used as a negative control. The levels of beta-
tubulin were used as a loading control. Clones positive according to WB in C and D were subjected to 
Southern blot analysis in E) and F). In E the diagnostic bands following BamHI digestion of genomic 
DNA correspond to the wild-type allele (18.4kb) and the successfully targeted allele (10.7kb). Digested 
genomic DNA was hybridized with the 3’ external probe (purple bar) shown in A. In F the diagnostic 
bands following NdeI digestion of genomic DNA correspond to the wild-type allele (9.8kb) and the 
successfully targeted allele (6kb). The band at the top of the membrane results from a polymorphism (see 
text). Digested genomic DNA was hybridized with the 5’ external probe (red bar) shown in B. G) 
Western blot analysis Ova-CAGTopBP1 and euchromatin-CAGTopBP1 lysates of cells positive 
according to E and F. Immunoblotting with an anti-TopBP1 antibody controls for the visualisation of the 
increase of TopBP1 protein levels over the levels produced from the endogenous promoter. Beta-tubulin 
serves as the loading control. 
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the Ova locus and 3 out of the 17 had successfully targeted the euchromatic locus. The 
expected sizes for the successfully targeted Ova locus has been explained already. For 
the euchromatic locus, NdeI digestion of genomic DNA and hybridization to probe A 
was expected to generate a 9.8kb band for wild-type cells and a 6kb band for clones that 
have successfully integrated the euCAG construct (Figure 4.3 E, F). The extra band 
above the 10kb is more likely a polymorphism within one of the three alleles on 
chromosome II as it was present in all the cell lines (Figure 4.3 F). To estimate the 
potential differences in expression between the two loci, total protein was prepared from 
five OvaCAG and three euCAG integrants, subject to Western blotting and probed with 
α-TopBP1. Some variation (up to three fold) was observed within the five OvaCAG 
clones and also within the three euCAG clones. In total, the data indicate that there is no 
major difference when comparing OvaCAG and euCAG, suggesting that the Ova locus 
in an appropriate site for integrating exogenous genes for expression. The main 
advantage of the Ova locus is its integration rate (Figure 4.3 G). 
Furthermore, the CMV, CAG and CBA overexpression systems were 
characterised in terms of their stability to be used as reliable tools in future experiments.  
In fact, the behavior of these cell lines was followed for 8 days in culture to ensure that 
ectopically expressed TopBP1 did not reduce over time and that overexpression of the 
transgene was not toxic to the cells. The continued culturing of these cell lines did not 
affect the promoters’ activity, as judged by Western blot analysis and immunoblotting 
against TopBP1 (Figure 4.4 A). I followed the cell cycle profiles by Flow Cytometry to 
establish of the overexpression of TopBP1 was influencing the progression of the cell 
cycle. No changes were observed over the course of the eight days (Figure 4.4 B). In 
addition, when compared to the parental strain, no growth defect was associated with 
overexpression of the TopBP1 cDNA when cell numbers were followed over a 120 hour 
period (Figure 4.4 C). Finally, induction of Cre recombinase by 4-HT treatment for 24h 
and subsequent serial dilution to isolate single clones confirmed that the ectopic 
transgenes could successfully be floxed (Figure 4.4 D). 
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Figure 4.4: Stability of the SIOS system. A) The indicated cell lines were cultured for a period of seven 
days and samples were kept for Western blot analysis at the specified times. Immunoblotting with an anti-
TopBP1 antibody controls for the expression of TopBP1. Cell lysates of wild-type and parental cells were 
used as a negative control. The levels of beta-tubulin were used as a loading control. B) Flow cytometry 
analysis of samples fixed and stained with propidium iodide. C) Growth curves for the indicated cell 
cultures. D) The indicated TopBP1 overexpressing cell lines were tested for their ability to flox the 
ectopic transgene following treatment with 4-HT (2µM) for 24h. The treated pools of cells were serially 
diluted and single clones were subsequently expanded and analysed by Western blotting. Immunoblotting 
with an anti-FLAG antibody controls for the expression of the TopBP1-3xFLAG transgene. Lysates of 
cells not containing any transgene or were used as a negative control. The levels of beta-tubulin were 
used as a loading control. The clones used in this experiment are CAG 2, CBA 4 and CMV 2 presented in 
figure 4.2. 
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4.1.2.1 Attempting to knock out the third TopBP1 allele with novel methods 
 Having optimised the ectopic expression of the rescue transgene, the next step 
was to attempt knocking out the third intact copy of TopBP1 in the TopBP1flox/flox/+/Ova 
CAGTopBP1/+/+ cell line (clones 1 and 2). To achieve this goal several strategies have been 
employed.  
Firstly, a new knock out TopBP1 targeting construct, LARAbsr (Figure 4.5 A), was 
assembled that contained the arms used for targeting the first two alleles, LA and RA, 
but a new selection marker cassette conferring resistance to blasticidin (bsr). This would 
prevent an erroneous recombination event promoted by the vector sequences between 
the arms and would help answer whether the optimised ectopic over-expression can help 
avoid re-targeting the already deleted TopBP1 alleles. To assemble the LARAbsr 
construct, the pBSK+ containing the SV40-puro-pA fragment (described in 3.2.1) was 
digested with EcoRI/BamHI to replace the puromycin gene with bsr. Primers P34/P35 
were used to amplify bsr. Subsequently the LA was amplified with primers P36/P37 
and subcloned at SalI and the RA was amplified with primers P38/P39 and subcloned at 
NotI. Diagnostic enzyme digestion and Sanger sequencing confirmed the final sequence 
composition of the LARAbsr targeting vector. The vector was linearised by AhdI 
digestion and transfected into the TopBP1flox/flox/+/Ova CAGTopBP1/+/+ clones 1 and 2. The 
150 clones that conferred resistance to blasticidin were genotyped by PCR (P40/P41). A 
positive clone should show no band after PCR as the region where the primers anneal 
would have been deleted. None of the clones screened had lost this region of PCR 
amplification meaning that none has deleted the locus (Figure 4.5 B). To visualize how 
the targeting construct has recombined with the TopBP1 alleles, 10 of the clones 
screened by PCR were also subjected to Southern blot analysis following SacI 
digestion. This revealed that all of the clones had re-targeted one of the two deleted 
alleles (Figure 4.5 C) and from this it was concluded that using the LA and RA arms 
makes re-targeting a quite frequent event. 
Secondly, it was decided that using the internal arms LAi and RAi was the optimal 
strategy for achieving the knockout and thus the previously described LAiRAiPuro 
construct was employed here as well. Additionally, the LAiRAibsr construct was 
assembled which only differed in having the bsr gene in the place of puro at the 
EcoRI/BamHI site (Figure 4.5 D). The reason behind this was that by testing two 
different drugs I could eliminate the possibility of failing to obtain the knockout due to a 
potential low-level toxicity of one of the drugs to the cells. Both plasmids were 
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linearised by AhdI digestion and transfected into the TopBP1flox/flox/+/Ova CAGTopBP1/+/+ 
clones 1 and 2. The 90 clones that conferred resistance to blasticidin or puromycin were 
genotyped by PCR (P40/P41). Again all clones were negative for the deletion of the 
endogenous locus (Figure 4.5 E) and also negative when analysed by Southern blot. 
The only difference was that the use of internal arms eliminated the retargeting event 
and all clones analysed had exactly the same hybridisation pattern as the parental cells 
(Figure 4.5 F).  
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Figure 4.5: Attempt to knockout the third TopBP1 allele in TopBP1flox/flox/+ /Ova CAGTopBP1 using the 
LARAbsr targeting vector. A) Diagrammatic representation of the wild-type TopBP1 locus and 
LARAbsr targeting vector. B) PCR genotyping of wild-type DT40 and TopBP1flox/flox/+ /Ova +/+/CAGTopBP1 
parental control alongside bleomycin-resistant clones obtained from transfection of the parental control 
with the LARAbsr targeting vector shown in A. Successfully targeted clones would be negative for the 
2.3kb amplified band. C) Southern blot analysis of SacI-digested DNA of wild-type DT40 and 
TopBP1flox/flox/+ /Ova +/+/CAGTopBP1 cells alongside bleomycin-resistant clones obtained from transfection of 
the parental control with the LARAbsr targeting vector. Diagnostic bands represent the intact (5.9kb) and 
floxed TopBP1 alleles (5kb and 5kb). Digested genomic DNA was hybridized with the 3’ external probe 
(red bar) shown in C. D) Diagrammatic representation of the LAiRAibsr and LAiRAiPuro targeting 
vectors. E) PCR genotyping of wild-type DT40 and TopBP1flox/flox/+ /Ova +/+/CAGTopBP1 parental control 
alongside bleomycin or puromycin-resistant clones obtained from transfection of the parental control with 
the targeting vector shown in D. Successfully targeted clones would be negative for the 2.3kb amplified 
band. F) Southern blot analysis of SacI-digested DNA of wild-type DT40 and TopBP1flox/flox/+ /Ova 
+/+/CAGTopBP1 cells alongside bleomycin-resistant clones obtained from transfection of the parental control 
with the LARAbsr targeting vector. Diagnostic bands represent the intact (5.9kb) and floxed TopBP1 
alleles (5kb and 5kb). Digested genomic DNA was hybridized with the 3’ external probe (red bar) shown 
in C. 
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The third strategy devised was the creation of a cell line where the TopBP1 
transgene under the control of the strong CAG promoter was stably integrated into the 
genome in a non-targeted manner. This is similar to what was described in 3.2.1 section, 
although the much stronger CAG promoter was used here and also the transgene was 
not fused to an oligopeptide tag. To assemble the “CAG non-targeted untagged” 
construct (Figure 4.6 A), the TopBP1 cDNA was first subcloned at the KpnI site of the 
original pSF-CAG (OG505) expression vector using primers P42/P43. Then the SV40-
neomycin-pA-loxM fragment was subcloned at the PacI site (P44/P45) and a loxP site 
inserted at PvuI using annealed oligonucleotides (P46/P47). The resulting expression 
vector was confirmed by diagnostic digestion and Sanger sequencing. The “CAG non-
targeted untagged” construct was then linearised by ApaLI digestion and transfected 
into the TopBP1flox/flox/+ cell line using high voltage. More than 30 G418 resistant clones 
were obtained and 8 of them were checked by Western blot analysis using the anti-
TopBP1 antibody. All but one of the clones were successfully showing overexpression 
of the TopBP1 protein (Figure 4.6 B). Two of these TopBP1flox/flox/+ CAG non-targeted 
clones were subsequently transfected with the LAiRAiPuro construct for attempting 
once again to delete the endogenous copy of TopBP1. All of the 184 puromycin-
resistant single clones obtained were genotyped by PCR amplification using the same 
primers as before. None was identified as a knockout clone (Figure 4.6 C). 
Finally, the CRISPR (clustered regularly interspaced short palindromic repeats) and 
CRISPR-associated (Cas) 9 genome editing technology was employed to attempt the 
TopBP1 knockout. The CRISPR-Cas9 system makes use of the mechanism of adaptive 
immunity present in some bacteria and archaea that enable these microorganisms to 
raise a response and eliminate invading genetic material. In short, these organisms have 
the ability to chop invading DNA into small fragments which they then integrate into 
their CRISPR loci as short repeats. These loci are transcribed producing transcripts, 
which are processed into CRISPR RNA molecules. These RNA oligos can then target 
cellular endonucleases to invading DNA molecules by means of sequence 
complementarity.  Thus microbes have memory recording of their infections which 
allows them to defend themselves against pathogens (Jinek, Chylinski et al. 2012).  And 
although the biology of microbes’ immunity has been known for many years, it wasn’t 
until 2012 that scientists including Feng Zhang and Jeniffer Doudna reported that a 
simplified version of CRISPR could be used for genome editing in mammalian and 
other cells (Lander 2016).  
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Here two constructs were assembled to specifically target the Cas9 enzyme to the 
LAi and RAi regions only present in the third intact TopBP1 copy. The vector used for 
co-expression of the guide RNA and the Cas9 enzyme was pSpCas9(BB)-2A-Puro 
(PX459), initially described in Ran et al 2013 and available from addgene (Ran, Hsu et 
al. 2013). One guide RNA (gRNA) specific for the LAi was synthesised by annealing 
primers P48/P49 and one gRNA specific for the RAi was synthesised by annealing 
primers P50/P51 and subcloning at the BbsI site of PX459 (Figure 4.6 D, E). As the 
gRNAs were too small, bacterial clones could not be checked by diagnostic restriction 
digest and thus were confirmed by Sanger sequencing.  The resulting PX459-gRNALAi 
and PX459-gRNARAi expression constructs were co-transfected with the LAiRAibsr 
targeting construct. The thinking behind this experiment was the Cas9 enzyme would 
create DSBs within the genomic regions of the homology arms thus creating the need 
for repair. Having no other TopBP1 alleles containing such regions so as to repair the 
damage cells would in theory use the repair template provided by LAiRAibsr. It is worth 
mentioning that in order to render the LAiRAibsr targeting vector (i.e. the repair 
template) resistant to cleavage by Cas9, one base within the ~20bp sequence 
corresponding to the gRNA specific for the LAi was mutated (in a way so as to silently 
mutate the codon) by site-directed mutagenesis. The same was done for the RAi region. 
The transfection of the CRISPR constructs was attempted in both the 
TopBP1flox/flox/+/Ova CAGTopBP1/+/+ clones 1 and 2 and the TopBP1flox/flox/+ CAG non-
targeted clones. In total, 214 blasticidin-resistant clones were obtained which were all 
subjected to genotyping by PCR. None of the clones displayed loss of the TopBP1 allele 
as is evident from the amplification of the 2.3kb band across exon 19 and intron 22 
(Figure 4.6 F).  
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Figure 4.6: Attempt to knockout the third TopBP1 allele in the newly created TopBP1flox/flox/+/ 
CAGTopBP1 untagged non-targeted cell line using the LAiRAiPuro gene targeting vector alone or 
aided by the use of CRISPR gene editing technology. A) Schematic representation of the targeting 
construct used for stable non-targeted integration of the CAG-TopBP1 transgene in the genome of 
TopBP1flox/flox/+cells. B) Western blot analysis of cell lysates from cells transfected with the expression 
construct shown in A. Immunoblotting with an anti-TopBP1 antibody controls for the expression of the 
exogenous over the endogenous TopBP1 protein. Cell lysates of parental cells were used as a control. The 
levels of beta-tubulin were used as a loading control. C) PCR genotyping of wild-type DT40 and 
TopBP1flox/flox/+ parental control alongside puromycin-resistant clones obtained from transfection of 
TopBP1flox/flox/+/CAGTopBP1untagged non-targeted cells with the LAiRAiPuro targeting vector. 
Successfully targeted clones would be negative for the 2.3kb amplified band. D) Schematic representation 
of the CRISPR strategy used with gRNAs designed to recognise sequences within the LAi and RAi 
regions. E) Map of the PX459 CRISPR vector used to subclone the gRNAs at BbsI site.  The resulting 
constructs were co-transfected with the LAiRAibsr targeting construct in both the TopBP1flox/flox/+/Ova 
CAGTopBP1/+/+ and the TopBP1flox/flox/+ CAG non-targeted cell lines. F) PCR genotyping of wild-type DT40 
and parental controls alongside bleomycin-resistant clones obtained from transfection of the parental cell 
lines as explained in E. Successfully targeted clones would be negative for the 2.3kb amplified band.  
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Summary for chapter 4 
 To increase the TopBP1 protein levels and thus increase the probability of 
achieving the knock out of the third TopBP1 allele, I first attempted integrating more 
copies of the CMV-TopBP1 transgene within the genome but this proved fruitless in 
terms of achieving the knockout and also the presence of many copies rendered the 
floxing of the integrated transgenes impossible. The next set of experiments I performed 
involved a characterisation of the relative efficiencies of different constitutive promoter 
elements (CMV, CBA, CAG) in an isogenic background. With this characterisation I 
achieved the design of a stably integrated overexpression system (SIOS) that provides a 
range of potential expression levels of the TopBP1 transgene. SIOS is also a stable 
system amenable to recombinase-mediated cassette exchange thus rendering it an easy 
to use versatile system for various experimental purposes in the field of DT40.  Finally, 
I went on to show that various attempts to obtain the knockout cell line –including using 
several gene targeting constructs, targeted or non-targeted integrations of the rescue 
construct and CRISPR technology- were unsuccessful, despite the optimised exogenous 
expression of TopBP1. Overall the development of the TopBP1-/-/+MerCreMer cell line 
and the SIOS were valuable tools for the subsequent work described in this thesis. Also, 
the inability to obtain the knockout cell line despite the miscellaneous and intense 
approaches was informative and intriguing per se.   
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Preface 
 
In order to study the function of a gene and its protein product in an 
experimental system, it is important to eliminate the function of this gene and study the 
resulting phenotype. Depletion studies of the TopBP1 mRNA using siRNA or shRNA 
have produced most of the knowledge we now have about the role of the mammalian 
homologue in the initiation of DNA replication and the signalling and activation of 
DNA structure-dependent checkpoints. Despite being very informative, adapting RNAi 
techniques to silence gene expression in vivo in mammalian systems also has its 
disadvantages. Firstly, it does not take into account the existence of potential splice 
variants of the mRNA of interest, which might be resistant to the RNAi molecule 
introduced into the system. Secondly, such techniques are transient in nature thus only 
useful for short-term studies, which also poses the risk of the phenotype being lost due 
to the inherent instability of the RNAi molecule. Additional disadvantages of transient 
siRNA studies are the potential off-target effects and incomplete knockdown efficiency. 
So although RNAi techniques are useful for a short-term evaluation of gene expression, 
they can never replace knockout models. Knockout models can be powerfully used to 
create even an entire organism in which a specific gene has been deleted or deactivated 
in all its body cells. At a cellular level, gene knockouts allow the study of the specific 
phenotypes generated from loss of function of a gene, in an otherwise normal cell. 
Although being both labor and time consuming, the application of reverse genetics 
allows manipulation of the protein of interest at its source, hence the generation of 
stable experimental systems useful for allele-specific expression, complete loss of 
function, partial loss of function, mutational and complementation studies. 
 
 
 
Chapter 5: Novel characterization of the avian TopBP1 mRNA and 
generation of a TopBP1 knockout DT40 model system 
 
The failure of achieving a complete knockout of TopBP1 in DT40 cells was 
interesting on its own right. Given that the tools that have been developed so far, 
including the gene knockout strategy and the SIOS system, were tailored to meet the 
needs of the experimental system and its purposes, I wondered whether the TopBP1 
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transgene expressed from the Ova locus, which corresponded to the cDNA sequence of 
TopBP1 available from the Genome Browser, was incorrect. In all genome browser 
databases, the gallus gallus TopBP1 protein sequence is classified as “predicted”, a 
term used for entries without evidence at protein, transcript, or homology levels. A 
potential “mistake” in the protein sequence of TopBP1, as this is available on the 
genome database, could render the ectopic protein being produced from the OvaCAG 
overexpression system a partly or non-functional one. This would explain why the final 
TopBP1 allele of TopBP1flox/flox/+/OvaCAGTopBP1/+/+ cells could not be deleted. 
Alternatively, it is possible that cells that had successfully deleted their intact TopBP1 
copy failed to sustain viability due to some essential function missing from the 
ectopically expressed TopBP1 transgene. In either case, the ectopic transgene was 
unable to provide all the functions of TopBP1 required for survival of DT40 cells. To 
investigate this hypothesis I embarked on two experiments. I first created a cell line 
where the human homologue of TopBP1 was overexpressed from the Ova locus and 
attempted to knockout the remaining endogenous copy. Given that the human TopBP1 
cDNA has been extensively used in the literature it was less likely that it would be 
incorrect and indeed it allowed the deletion of the endogenous TopBP1 allele. The next 
experiment involved the isolation and characterisation of the gallus gallus TopBP1 
mRNA sequence and successfully identified a fragment missing from the sequence 
available on the genome database. The newly identified TopBP1 sequence described 
herein allowed the creation of the DT40 TopBP1 knockout model system, 
TopBP1flox/flox/puro/OvaCAGnewTopBP1/+/+. 
 
 
5.1.1: Creation of the DT40 TopBP1 knockout model system by ectopic 
overexpression of the human TopBP1 cDNA 
 In an attempt to identify parts of the primary sequence of the avian TopBP1 that 
could be incorrect I performed multiple sequence alignments with the sequences of 
other mammalian species (Appendix 2) or indeed other organisms (data not shown). 
Alignment of the chicken and human TopBP1 protein sequences showed that they 
shared 68% identity (calculated using the ClustalW protein alignment software from 
alignment presented in Appendix 2). Close observation of the aligned sequences did not 
reveal any extended discrepancy except for an array of ~14amino acids (aa 519-533) 
that was absent from gallus gallus, partly absent from mus musculus, gorilla gorilla and 
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Pan troglodytes (chimpanzee) but present in Homo sapiens. One observation that was 
striking, however, was that the predicted chicken TopBP1 sequence initiated with an 
arginine (R) rather than a methionine (M) residue, which is the consensus start codon of 
an mRNA transcript translated by a ribosome in eukaryotes.  
 As a first way of getting an indication of whether the annotated chicken TopBP1 
cDNA was incorrect, the human homologue of TopBP1 (hTopBP1) was stably 
integrated in the Ova locus of TopBP1flox/flox/+ cells under the control of the CAG 
promoter and subsequently the knockout of the final endogenous allele attempted. To 
create the new targeting vector, the OvaCAG construct described in Chapter 4 was 
modified to replace the annotated chicken TopBP1 cDNA with the human homologue. 
As no suitable restriction sites were available, the hTopBP1 cDNA (kindly provided by 
the Pearl lab) was subcloned at the KpnI site of the original pSF-CAG (OG505) 
expression vector with primers P73/P74. The SV40-neomycin-pA-loxM3-OvaRA 
fragment was then subcloned at the PacI site and the OvaLA-loxM3 at PvuI, as 
described before. The resulting OvaCAGhTopBP1 vector (Figure 5.1 A) was linearized 
by AhdI digestion prior to electroporation into the TopBP1flox/flox/+ cell line. Ten of the 
clones that successfully formed single colonies following selection in 2mg/ml G418 
were subjected to Southern blot analysis of BamHI-digested genomic DNA. 
Hybridisation with probe B showed that 8 out of the 10 clones examined had 
successfully integrated the OvaCAGhTopBP1 into the Ova locus, as evident from the 
10.7kb targeted band (Figure 5.1 B). Two of these clones were frozen down in liquid 
nitrogen as TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ clones 1 and 2 and only clone 1 was used 
for future experiments. Western blot analysis of TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ clones 
1 alongside the TopBP1flox/flox/+ parental cell line confirmed the overexpression of the 
human transgene (Figure 5.1 C). 
 To attempt knocking out the third endogenous copy of TopBP1, LAiRAiPuro 
targeting vector was linearised by AhdI digestion and transfected into 
TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ clone 1. Transfectants were serially diluted and 
selected as described before. In total, 41 puromycin-resistant clones were obtained and 
subjected to genotyping by PCR with primers P40/P41 (Figure 5.1 D). One of the 
clones tested did not produce the 2.3kb band corresponding to amplification of the 
TopBP1 locus between exon 19 and intron 22 and which was present in the 
TopBP1flox/flox/+ and TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ controls. This was indicative of 
successful deletion of the remaining TopBP1 allele (Figure 5.1 E). To conclusively 
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confirm this result, Southern blot analysis of BglI or BglI/ClaI-digested genomic DNA 
of the indicated cell lines was performed. Following BglI digestion and hybridisation 
with probe A, the intact TopBP1 allele was represented by a diagnostic band of 5.7kb, 
which was expected to move to 6.2kb upon successful targeting. Additionally, 
BglI/ClaI-digestion and hybridisation with probe A generated a 5.7kb band 
corresponding to the wild-type TopBP1 allele. This was expected to move to 5.3kb upon 
successful deletion of the remaining allele. Indeed, the Southern results confirmed the 
PCR result and the TopBP1flox/flox/puro/OvaCAGhTopBP1/+/+ cell line was appropriately 
frozen down (Figure 5.1 D, F, left panel). To my knowledge, this is the first time that a 
conditional knockout cell line of the TopBP1 gene has been created. 
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Figure 5.1: Complete knockout of TopBP1 by overexpression of the human TopBP1 cDNA. A) 
Schematic representation of the targeting constructs used to stably integrate the CAGhumanTopBP1 
transgene at the Ova locus. B) Southern blot analysis of potential TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ clones 
alongside the TopBP1flox/flox/+ parental control. The diagnostic bands following BamHI digestion of 
genomic DNA correspond to the wild-type allele (18.4kb) and the successfully targeted allele (10.7kb). 
Digested genomic DNA was hybridized with the 3’ external probe (purple bar) shown in A. C) Western 
blot analysis of cell lysate from one TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ clone positive according to B. 
Immunoblotting with an anti-TopBP1 antibody controls for the expression of total TopBP1. Cell lysates 
of the parental cells were used as a negative control. The levels of beta-tubulin were used as a loading 
control. D) Diagrammatic representation of the wild-type TopBP1 locus, LAiRAiPuro targeting vector and 
successfully targeted locus of TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ cells. E) PCR genotyping of potential 
TopBP1flox/flox/puro/OvaCAGhTopBP1/+/+ clones obtained from transfection of the 
TopBP1flox/flox/+/OvaCAGhTopBP1/+/+ with the LAiRAiPuro targeting vector shown in D alongside wild-type 
and parental controls. Successfully targeted clones would be negative for the 2.3kb amplified band. F) 
Southern blot analysis of BglI or BglI/ClaI-digested DNA of the TopBP1flox/flox/puro/OvaCAGhTopBP1/+/+ clone 
identified in E alongside the indicated controls. Digested genomic DNA was hybridized with the 3’ 
external probe (red bar) shown in D. 
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5.1.2: Novel characterisation of the DT40 TopBP1 mRNA and identification of a 
novel TopBP1 protein domain 
 The successful generation of a DT40 system genetically deficient of the TopBP1 
locus by overexpression of the human cDNA suggested that my hypothesis was right. 
That indeed the inability to create the knockout so far (after having established an 
optimal ectopic expression system and an efficient knockout strategy) was most likely 
due to some error or missing sequence in the annotated chicken TopBP1 cDNA. Using 
the exact same overexpression system (i.e. CAG SIOS) and only replacing the 
annotated chicken cDNA with the human one was enough to allow the creation of the 
TopBP1flox/flox/puro/OvaCAGhTopBP1/+/+ conditional knockout.  
 The challenge now was to identify the region(s) of the chicken TopBP1 primary 
sequence that was missing or incorrect on the genome browser. To do so, it was 
necessary to isolate the TopBP1 RNA and identify its sequence, which would prove 
useful both for the creation of the final TopBP1 conditional knockout (i.e. by 
overexpressing the correct chicken protein rather than the human homologue) as well as 
for the characterisation of the avian TopBP1 protein in general. The experiments 
performed towards achieving this goal are the focus of the following paragraphs.  
 In order to obtain the sequence of the TopBP1 cDNA, Rapid Amplification of 
cDNA Ends (RACE) was used. This is a method that allows the amplification of the 5’ 
or 3’ends of a cDNA molecule of interest and its only requirement is that 23-28 
nucleotides of sequence information are known in order to design gene-specific primers 
(GSPs) for the RACE reaction. I decided to use the SMARTer RACE 5’/3’ kit 
(Clontech), which eliminates the need for adaptor ligation and allows the use of first-
strand cDNA directly in RACE PCR. The other advantage of this technology is that it is 
optimised for using either polyA+ or total RNA as a starting material and it also allows 
the construction of even long cDNAs.  
As mentioned already it was thought bizarre that the TopBP1 protein sequence 
available on the database contained an arginine as the start codon. In addition to that, 
the first eight amino acids of TopBP1 were conserved across all the species examined 
but not in gallus gallus (Figure 5.2 A). So in order to characterise the 5’ end of the 
avian TopBP1, total RNA was extracted from wild-type DT40 cells using the TRIzol 
method (described in methods and materials). To first assess total RNA template 
quality, which is a key determinant of successful RACE, the purified RNA was 
visualised on a denaturing formaldehyde agarose gel under UV light. Total eukaryotic 
 147 
RNA of high quality is expected to give a theoretical 28S:18S ratio of approximately 
2:1. As shown in Figure 5.2 C, the purified RNA was of good quality and so RACE 
analysis could be performed.  
The purified total RNA was used for first strand cDNA synthesis according to 
the manufacturers’ instructions and samples were kept at -20°C. For 5’ RACE, seven 
“reverse” GSPs (F1-F7, Figure 5.2 B) were designed that would anneal in a 3’ to 5’ 
direction thus allow to obtain sequence information towards the start of the TopBP1 
cDNA. There were two reasons why I decided to use more than one GSPs: First, since 
the GSPs were designed according to the database cDNA sequence of TopBP1, it was 
possible that any discrepancies with the RACE amplified TopBP1 cDNA would 
preclude annealing to the template. Second, some GSPs could be suboptimal for 
successful amplification due to their base composition or secondary structure, despite 
careful design. So 5’ RACE reactions with GSPs F1-F7 were performed according to 
the manufacturers’ instructions. The products obtained from the 5’RACE reaction of 
each GSP alongside a positive control of mouse heart total RNA were visualised by gel 
electrophoresis and ethidium bromide staining (Figure 5.2 D). Subsequently, the RACE 
fragments were characterised to make sure that the desired products have been 
amplified. This involved gel extracting the ethidium bromide-stained bands in Figure 
5.2 D and subcloning them in the pRACE vector by In-Fusion cloning (vector provided 
with the Clontech kit). To obtain the maximum amount of sequence information, 15 
different independent clones for each 5’ RACE product were characterised by Sanger 
sequencing using primers suggested by the manufacturer. Analysis of the sequencing 
data of RACE products revealed some interesting information.  
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Figure 5.2: 5’ RACE of TopBP1 cDNA. A) Alignment of the first 50 amino acids of TopBP1 across 
different species using the ClastalW alignment software. B) Schematic representation of the GSPs used 
for the 5’ RACE reaction. C) Gel electrophoresis of a formaldehyde gel stained with ethidium bromide 
and visualized under UV light to assess the integrity of the total RNA purified from wild-type DT40 cells. 
D) 5’ RACE products visualized by gel electrophoresis and ethidium bromide staining. The sample in 
lane 1 corresponding to mouse total heart RNA served as the positive control.  
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 Identification of a new splicing pattern at the 5’ region of the DT40 TopBP1 mRNA 
 Figure 5.3 A, shows a linear map of the intron/exon pattern of the 5’ end of 
TopBP1 as well as the start of the TopBP1 ORF (ORFannotated), as these are available 
from the genome browser. The start codon for translation of TopBP1 according to the 
database genome data is located within the first exon (Figure 5.3 A top panel, red 
asterisk). Therefore the region upstream of the annotated initiation methionine 
represents the annotated 5’ untranslated region (annotated 5’ UTR). The 5’ UTR of an 
mRNA molecule is the region that precedes the start codon and is important for 
translation of the mRNA to protein by the ribosome. Flanking exon 1 are the first and 
second introns.  
Analysis of the RACE sequencing data showed that ~74% of the sequenced 
clones were missing a fragment of 128 bp (or 128 + 3 bp in some clones) within exon 1 
(termed “new intron” in Figure 5.3 A). It is likely that this fragment corresponds to an 
intronic region as it is flanked by GT/AG, a sequence considered to be the splicing 
signal for the spliceosome at the intron/exon boundary. Thus, the current analysis 
defines a region within the exon 1 of the TopBP1 locus that is intronic, thus splitting 
this first exon into two exons separated by this 128 bp (or 128 + 3 bp) identified intron. 
It should be noted that the 3’ junction of this new intron was the same for all 70% of the 
clones and contained a consensus AG splice acceptor site. In contrast, the 5’ end varied 
by 3bp. In other words, most of these clones contained a “new” intron 128 bp-long and 
a smaller subset had an extra codon at the 5’ junction as part of this “new” intron, thus 
making their intron longer by 3bp. In both cases however, the 5’ side of the newly 
identified intron contained a GT splice donor site (Figure 5.3 B).  
The new exon identified upstream of this aforementioned new intron contained a 
new open reading frame, termed ORFshort, which overlapped with the C-terminal end of 
the database intron 1. The fact that this region was present in the RACE product (thus in 
the cDNA copy of the TopBP1 mRNA) suggests that it part of the new exon in my 
RACE data. This data thus propose a different intron/exon junction between the 
annotated intron 1 and the annotated exon 1 but because of limited sequencing 
information it was unable for the splicing boundaries to be defined (Figure 5.3 B). 
Interestingly, about ~10% of the ~74% clones containing ORFshort, were missing 
the oligonucleotide “GTTAAAGG” immediately upstream of the annotated methionine 
(hence called ORFshort processed), suggesting alternative processing within this region of a 
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population of TopBP1 RNA molecules. Thus, overall, ~64% of all RACE clones 
sequenced contained ORFshort and ~10% contained ORFshortprocessed (Figure 5.3 B). 
Furthermore, ~24% of the sequenced clones contained the entire sequence 
corresponding to the database exon 1 (ORFlong). This might be indicative of alternative 
splicing of a subset of TopBP1 transcripts at this particular region (Figure 5.3 B).  
Two clones (~2%) contained sequences ORFshort’ and ORFshort’’, which 
resembled sequence ORFshort but were shorter (ORFshort’) or slightly different in 
sequence (ORFshort``). These were most likely a result of incorrect RACE 
amplification (as they occurred at a very low frequency) but were nonetheless included 
in the subsequent analysis (Figure 5.3 B). 
Figure 5.3 C summarises the most abundant N-terminally extended ORFs 
identified in the present study (ORFshort, ORFlong and ORFshortprocessed), aligned to the 
consensus TopBP1 ORF from the database (ORFannotated) and Figure 5.3 F shows 
representative Chromas data for these ORFs. The differential splicing pattern described 
in the previous paragraphs concerning the region upstream of the annotated start codon 
of the TopBP1 transcript suggested that there could be a functional sequence element 
contained within the newly identified ORFs that was required for complete functionality 
of the TopBP1 protein. Therefore the results described so far do not propose the 
existence of a novel TopBP1 sequence absent from the genomic data available for the 
TopBP1 locus but rather propose a different splicing pattern at the 5’ end. The different 
arrangements of the splicing events at the 5’ region of the genomic TopBP1 locus is 
shown in Figure 5.3 D.  
To graphically define the 3’ start site of the RACE data across all sequenced 
clones, I counted how many transcripts start at each respective base within the 5’ region 
of the TopBP1 genomic locus. The graph depicted in Figure 5.3 E shows that the 
majority of the RACE data read through the newly identified ATG (represented by 
nucleotides 14-16).  
 Finally, analysis of the sequencing data revealed that despite the confusion at the 
5’ end of the TopBP1 mRNA, the region downstream of the R and proceeding 
consensus M entirely aligned to the known primary sequence and no mismatches were 
identified. In fact, our sequencing data confirm the consensus amino acid sequence of 
TopBP1 (and the intron/exon boundaries therein at the nucleotide level) from amino 
acid 1 to amino acid 908 (data not shown). 
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Figure 5.3: Analysis of 5’ RACE data and identification of a new splicing pattern of the 5’ region of 
the TopBP1 RNA. A) Schematic representation of the consensus TopBP1 genomic region at the start of 
the TopBP1 locus (top panel). The bottom panel represents the reconstructed intron/exon map based on 
the RACE data. B) Newly identified ORFs upstream of the annotated ATG. ORFshort was the most 
abundant among the 5’ RACE data, followed by ORFlong and ORFshortprocessed. Colour coding; cyan denotes 
exons, grey denotes introns and green denotes protein sequence. C) Amino acid sequence alignment of 
the consensus 5’ TopBP1 sequence (ORFannotated) and the extended versions of the TopBP1 protein 
(ORFshort, ORFlong and ORFshortprocessed) identified in the present study. D) Diagrammatic representation of 
the splicing events in the 5’ region of the TopBP1 gene locus identified in the present study. E) Graphic 
representation of the RACE sequencing start site. Base 1 is defined as the 3’-most nucleotide identified 
from the sequenced RACE clones. Newly identified ATG is represented by nucleotide positions 14-16. F) 
Chromas data of the sequenced RACE-identified ORFs. 
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5.1.3: Creation of the DT40 TopBP1 knockout model system by ectopic 
overexpression of the 5’RACE-identified TopBP1 protein sequence  
The newly identified 5’ sequences were assembled on the rest of the TopBP1 
cDNA sequence and new OvaCAG overexpression vectors were constructed. The 
resulting ovalbumin targeting constructs OvaCAGnewTopBP1_ORFshort, 
OvaCAGnewTopBP1_ORFlong, OvaCAGnewTopBP1_ORFshortprocessed, 
OvaCAGnewTopBP1_ORFshort’and OvaCAGnewTopBP1_ORFshort”, (Figure 5.4 B) 
were confirmed by Sanger sequencing.  
The constructs were linearized by ApaLI digestion prior to electroporation into 
the TopBP1flox/flox/+ cell line. For each construct, ten of the clones that successfully 
formed single colonies following selection in 2mg/ml G418 were subjected to PCR 
analysis with primers P75/P76 to identify the ones that have specifically targeted the 
Ova locus. P75 annealed within the selection cassette whereas P76 annealed to a 
chromosomal region outside the OvaRA thus a successfully Ova targeted clone would 
produce a PCR product of ~3kb in length (Figure 5.4 B). Gel electrophoresis of the 
PCR products identified the targeted clones (Figure 5.4 C). To confirm this result, two 
PCR positive clones corresponding to each construct was subjected to Southern blot 
analysis of BamHI-digested genomic DNA. Hybridisation with probe B showed that all 
of the clones examined had successfully integrated the corresponding 
OvaCAGnewTopBP1 construct into the Ova locus, as evident from the 10.7kb targeted 
band (Figure 5.4 D). All the clones were frozen down in liquid nitrogen for long-term 
storage. 
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Figure 5.4: Stable integration of the 5’ RACE-identified TopBP1 cDNAs in the ovalbumin locus of 
TopBP1flox/flox/+ cells. A) Diagrammatic representation of the cloning strategy devised for the assembly of 
the new cDNA targeting constructs. B) Schematic representation of the targeting constructs used to stably 
integrate the newly assembled CAGnewTopBP1 constructs at the Ova locus. C) PCR screening of clones 
that have successfully targeted the Ova locus. D) Southern blot analysis of potential TopBP1flox/flox/+ Ova 
CAGnewTopBP1/+/+ clones alongside the TopBP1flox/flox/+ parental control. The diagnostic bands following 
BamHI digestion of genomic DNA correspond to the wild-type allele (18.4kb) and the successfully 
targeted allele (10.7kb). Digested genomic DNA was hybridized with the 3’ external probe (purple bar) 
shown in B.  
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To knock out the third endogenous copy of TopBP1, LAiRAiPuro targeting 
vector was linearised by AhdI digestion and transfected into the respective 
TopBP1flox/flox/+/OvaCAGnewTopBP1/+/+ cell line (Figure 5.5 A). Transfectants were serially 
diluted and selected as described before. In total, 437 puromycin-resistant clones were 
obtained and subjected to genotyping by PCR with primers P40/P41. It should be noted 
that 137 potential TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort/+/+, 35 potential 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFlong/+/+, 141 potential 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort’/+/+, 124 potential 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort”/+/+ clones and 83 potential 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshortprocessed/+/+ clones were screened by PCR. Six of 
the clones tested did not produce the 2.3kb band corresponding to amplification of the 
TopBP1 locus between exon 19 and intron 22 and which was present in the TopBP1-/-/+ 
and TopBP1flox/flox/+/OvaCAGnewTopBP1/+/+ parental controls. This was indicative of 
successful deletion of the remaining TopBP1 allele (Figure 5.5 B). In parallel, OvaCAG 
(i.e. the construct harbouring the annotated TopBP1 cDNA) was transfected into the 
same cells and all of the 95 clones obtained were negative, which served as a control 
(data not shown). To conclusively confirm this result, Southern blot analysis of BglI or 
BglI/ClaI-digested genomic DNA of the PCR-positive cell lines was performed. 
Following BglI digestion and hybridisation with probe A, the intact TopBP1 allele was 
represented by a diagnostic band of 5.7kb, which was expected to move up to 6.2kb 
upon successful targeting. Additionally, BglI/ClaI-digestion and hybridisation with 
probe A generated a 5.7kb band corresponding to the wild-type TopBP1 allele. This was 
expected to move down to 5.3kb upon successful deletion of the remaining allele. The 
Southern blot results confirmed that two of the six PCR-positive clones (clones 4 and 5) 
have successfully knocked out the remaining TopBP1 chromosomal locus (Figure 5.5 
C). These contained “ORFshort” or  “ORFshortprocessed” TopBP1 cDNA integrated at the 
Ova locus. Unsuccessful PCR reaction due to the lack of sufficient genomic DNA in the 
sample could explain the false positive result obtained for the other four clones (clones 
1-3 and 6). Finally, TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort/+/+ as well as 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshortprocessed/+/+ knockout clones were appropriately 
frozen down in liquid nitrogen. Finally, it is worth pointing out that the small number of 
clones obtained from transfection of the LAiRAiPuro targeting vector  
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Figure 5.5: Complete knockout of TopBP1 by overexpression of the 5’ RACE-identified avian 
protein sequences. A) Diagrammatic representation of the wild-type TopBP1 locus, LAiRAiPuro 
targeting vector and successfully targeted locus of TopBP1-/-/+/OvaCAGnewTopBP1/+/+ cells. B) PCR 
genotyping of potential TopBP1-/-/-/OVACAGnewTopBP1/+/+ clones obtained from transfection of the TopBP1-/-
/+/OVACAGnewTopBP1/+/+ with the LAiRAiPuro targeting vector shown in A alongside wild-type and parental 
controls. Successfully targeted clones would be negative for the 2.3kb amplified band. C) Southern blot 
analysis of BglI or BglI/ClaI-digested DNA of the six TopBP1-/-/-/OVACAGnewTopBP1/+/+ clones identified in 
E alongside the indicated controls. Digested genomic DNA was hybridized with the 3’ external probe (red 
bar) shown in A. D) Western blot analysis of TopBP1flox/flox/+/OvaORFshort/+/+ and 
TopBP1flox/flox/+/OvaORFshortprocessed/+/+ knockout. clones Immunoblotting with an anti-TopBP1 antibody 
controls for the expression of total TopBP1. Cell lysates of TopBP1+/+/+, TopBP1flox/flox/+ and 
TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort/+/+ & TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshortprocessed/+/+ parental 
cells were used as a negative control. The levels of GADPH were used as a loading control. 
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into the TopBP1flox/flox/+OVACAGnewTopBP1ORFlong/+/+ cell line prevents me from drawing a 
conclusion concerning the ability of this sequence (sequence ORFlong, Figure 5.3 B) in 
providing the same function(s) required to achieve the knock out. Future experiments 
are required to assess the function of ORFlong by screening more cells for the knockout 
targeting. 
 Western blot analysis of the knockout clones alongside their parental controls 
reveals that only TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshortprocessed/+/+ cells show an 
overexpression pattern when immunoblotting with an anti-TopBP1 antibody. In 
contrast, TopBP1flox/flox/puro/OvaCAGnewTopBP1ORFshort/+/+ cells show no TopBP1 
corresponding band on the immunoblot (Figure 5.5 D). This is presumably due to the 
fact that ORFshort is out of frame with the annotated TopBP1. Closer look to Figure 5.3 
B reveals that if translation starts at the novel methionine of ORFshort then this creates a 
stop codon at the start of the annotated TopBP1. This raises the possibility of the newly 
identified domain upstream of the annotated TopBP1 (ORFshort herein) being capable of 
providing the essential function required for DT40 viability on its own (without the rest 
of the TopBP1 protein sequence). Although the present data are a good indication 
towards this scenario, future work is required to prove it.   
Overall, the 5’ RACE results described herein and the new TopBP1 cDNA 
assembled provided the necessary function(s) of the protein required for achieving 
deletion of the endogenous TopBP1 gene and sustaining viability of DT40 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 159 
Summary of Chapter 5 
 This chapter describes the experiments performed to investigate the hypothesis 
of the consensus TopBP1 cDNA missing some function(s) necessary for allowing the 
knock out of the intact TopBP1 allele of TopBP1flox/flox/+ cells. An initial good indication 
in support of this hypothesis came from achieving the complete knock out of TopBP1 
by overexpressing the human cDNA using the SIOS system described before. The next 
challenge was to examine the primary sequence of the TopBP1 mRNA present in wild-
type DT40 cells.  This involved the isolation and characterisation of the 5’ end of the 
TopBP1 cDNA using 5’ RACE. Analysis of RACE sequencing results revealed 
different intron/exon boundaries and subsequently a different splicing pattern of the 
TopBP1 mRNA compared to the consensus. Additionally, an array of ~43 amino acid 
lying upstream of the annotated translational start site was identified in the majority of 
the sequenced RACE clones. Stable integration of this newly identified sequence of 
TopBP1 at the Ova locus using the SIOS system allowed the generation of the complete 
knock out of TopBP1. Thus the avian TopBP1 mRNA identified herein contained the 
necessary function(s) to sustain viability of DT40 cells in the absence of the endogenous 
protein. 
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Chapter 6 
 
 
 
 
A novel knock in gene targeting 
system based on the gene dosage-
dependent functions of TopBP1 
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Preface 
Like most of the key proteins involved in the checkpoint signaling, TopBP1 was 
initially identified and has been extensively studied in S. pombe and S. cerevisiae yeast 
model organisms, where it is known as Rad4/Cut5 and Dpb11, respectively. Depletion 
studies have also been used extensively to unravel the functions of TopBP1 in 
mammalian cells. However, the lack of readily available tools, including genetically 
defined mutant cell lines, has rendered the characterisation of TopBP1 in higher 
eukaryotes more challenging. In addition to gene knockout, gene knock inmodel 
systems  
 
Chapter 6: TopBP1 functions are gene dosage-dependent  
 
To unravel the functions of TopBP1 in cell proliferation, survival, DNA 
damage-dependent checkpoint activation and damage repair, it is important to create 
separation of function mutants using genetically defined model systems. In addition to 
the TopBP1 knockout model systems created (see Chapter 5), I wanted to generate a 
knock in system as well. The advantage of such a system is that it allows the study of a 
gene at its source by incorporating point mutations of interest at the endogenous locus. 
Thus, it is more physiologically relevant and together with the knockout system 
represent powerful tools for a structure-function analysis of the TopBP1 protein in 
DT40.  
Theoretically, one could use the TopBP1 locus to knock in a point mutation(s) 
of interest to all three TopBP1 (+/+/+) alleles on chromosome II thus replacing the 
entire wild-type TopBP1 protein population by the mutant and studying the resulting 
phenotypes. Alternatively, one of the three endogenous alleles are knocked out (-/+/+) 
and the remaining is (are) used to knock in the point mutation(s) of interest. 
Interestingly, such a system can be used for recapitulating both homozygous and 
heterozygous mutants. A third scenario would be to delete two of the three TopBP1 
alleles and use the third one as the knock in platform. Combining any of the +/+/+,        
-/+/+ or -/-/+ system with the SIOS system developed in Chapter 4, also allows the 
study of lethal knock in point mutations. 
To create this in vivo TopBP1 gene knock in platform, an isogenic set of stable 
cell lines from the chicken B cell line DT40 was established by targeted deletion of the 
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TopBP1 alleles. This chapter describes the generation of the +/+/+, -/+/+ and -/-/+ novel 
knock in platforms as well as the study of the kinetics of the events induced by 
progressive loss of function of TopBP1. Thus, it provides a basic characterisation of the 
knock in platforms per se, prior to the integration of any point mutations. 
 
6.1.1: Successive deletion of the TopBP1 alleles in an isogenic set of stable cell lines 
results in successively decreasing levels of the TopBP1 protein 
 In chapter 3 I described the generation of the TopBP1-/+/+ and TopBP1-/-/+ from a 
TopBP1+/+/+ wild-type DT40 parental strain. For these cell lines to only differ in their 
respective TopBP1 status and be otherwise isogenic, pANMerCreMer was transfected in 
TopBP1+/+/+ wild-type cells as well, in the same way as described before. The newly 
generated DT40 cell lines were expanded and appropriately frozen down in liquid 
nitrogen as TopBP1+/+/+ (isogenic), TopBP1flox/+/+  (isogenic) and TopBP1flox/flox/+ 
(isogenic), but for the shake of simplicity will be referred to as TopBP1+/+/+, TopBP1-
/+/+ and TopBP1-/-/+ (or simply +/+/+, -/+/+ and -/-/+ in figures).  All work described in 
the following paragraphs makes use of these three isogenic cell lines. A schematic 
representation of the three flavors of TopBP1 alleles is shown in Figure 6.1 A.  
 Having established a stable and isogenic cell-based system with varying copies 
of the TopBP1 gene, I wanted to investigate the effect, if any, of TopBP1 gene dosage 
on the TopBP1 protein levels.  Whole cell lysates were prepared from the three cell 
lines and analysed by Western blot with an anti-TopBP1 antibody raised against a C-
terminal peptide of the protein (Appendix 1). Immunoblot analysis indicated that the 
successive deletion of the TopBP1 alleles led to a concomitant decrease in the TopBP1 
levels inside the cells. In fact, TopBP1-/+/+ expressed ~67% and TopBP1-/-/+ expressed 
~37% of the levels found in the parental wild-type cells (Figure 6.1 B, C). Hence cells 
did not compensate for the loss of each TopBP1 copy by increasing transcription from 
the remaining loci, as judged by the total TopBP1 protein levels in the three cell lines. 
This struck my attention and I decided to use these three isogenic cell lines as a novel 
system to study the effects of reducing TopBP1 levels on various aspects of cellular 
biology. Figure 6.1 D shows a diagrammatic representation of this novel TopBP1 
system in the DT40 model organism, which is the focus of the work described in the 
following pages. 
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Figure 6.1: Deletion of the TopBP1 alleles leads to a step-wise decrease in the TopBP1 protein 
levels. A) Schematic representation of the wild-type and deleted TopBP1 alleles on chromosome II of 
DT40. The TopBP1+/+/+ cell line possesses three wild-type copies, the TopBP1-/+/+ possesses two wild-
type and one replaced by the puro cassette which has been floxed and TopBP1-/-/+ possesses one wild-
type, one puro-floxed and one his-floxed. B) Western blot analysis of cell lysates of the indicated 
genotypes. Immunolotting with an anti-TopBP1 antibody controls for the visualisation of the decrease of 
TopBP1 protein levels with the successive deletion of the TopBP1 gene copies. Beta-tubulin serves as the 
loading control. C) Relative expression of the TopBP1 protein based on a quantification of the 
immunoblot in B. The levels found in the mutants are normalised to the levels found in wild-type cells. 
Also, the bar chart represents the average of the 1x and 2x panels that represent the total amount of 
protein loaded on each well. Error bar represent the standard deviation from the mean. D) A schematic 
representation of the three stable cell lines producing different levels of the TopBP1 protein from the 
TopBP1 locus on chromosome II.  
 
 
0	 20	 40	 60	 80	 100	
	+++	
	-++	
	--+	
Rela(ve	TopBP1	expression	
to
pb
p1
	g
en
ot
yp
e	
1x	 2x	
+/
+/
+	
-/
+/
+	
-/
-/
+	
-/
+/
+	
-/
-/
+	
α-TopBP1	
α-tubulin	
170	
50	
+/
+/
+	
kDa	
Total	protein	loaded	
Targeted		
Locus	
with	His	
Targeted		
Locus	
with	puro 
ClaI	
BglI	
5.7kb	
BglI	WT	topbp1	
BglI	
2.4kb	
2.6kb	
BglI	ClaI	
A	 B	
C	
D	
100%	 67%	 37%	
topbp1  
+/+/+
topbp1 
 -/+/+
Intact	chromosome	II	
chromosome	II	
with	deleted	topbp1	locus	
TopBP1	protein	
 
topbp1 
-/-/+
Ch
r I
I
Ch
r I
I
Ch
r I
I
topbp1	locus	
 164 
6.1.2: Successive deletion of the TopBP1 alleles leads to altered replication 
properties 
 Being an essential protein for the initiation of replication, the first question I 
sought to address with the three-strain TopBP1-dosage system was whether the 
reduction of the TopBP1 levels impacted on the proliferative ability of cells. Although 
TopBP1-/-/+ were viable, they multiplied more slowly than TopBP1+/+/+ cells during 
exponential phase growth, whereas the TopBP1-/+/+ cell line showed an intermediate rate 
of proliferation (Figure 6.2 A). This defect becomes more obvious if the proliferation 
rate is used to deduce the doubling time, the period of time required for the cell number 
of the respective strains in culture to double. Although it takes 8.2h for TopBP1+/+/+ 
cells to double, TopBP1-/+/+ double in 8.9h and TopBP1-/-/+ in 10.8h. Thus to complete a 
full cell cycle TopBP1-/+/+ cells need 0.7h and TopBP1-/-/+ cells need 2.6h more than 
TopBP1+/+/+ (Figure 6.2 B). This proliferation defect is also associated with an 
accumulation of more dead cells in the mutant cultures compared to the parental control, 
as determined by trypan blue exclusion and optical microscopy. Interestingly, dead cells 
in the TopBP1-/+/+ and TopBP1-/-/+ cultures started to appear after the first day of seeding 
and gradually expanded as cells were kept in tissue culture for 72h (Figure 6.2 C). 
What is also worth noticing is that the differences observed in the growth rate and 
viability are bigger between the TopBP1-/-/+ and TopBP1-/+/+ than between the TopBP1-
/+/+ and the TopBP1+/+/+, perhaps suggesting that the contribution of the deleted alleles 
to the observed phenotypes are not proportional.  
As another way to assess their proliferation properties, the three cell lines were 
plated on semi-solid media and assessed for their ability to form colonies. The allele-
dependent reduction in the levels of the TopBP1 protein impaired the clonogenic ability 
of mutant cells. In fact, although 80% of the TopBP1+/+/+ cells seeded managed to form 
colonies in methylcellulose-containing growth media, 69% of TopBP1-/+/+ and 42% of 
TopBP1-/-/+ did (Figure 6.2 D). Finally, to determine the relative proportions of G1, S 
and G2/M phase cells and whether loss of TopBP1 alleles affected the progression 
through the cell cycle, the three cell lines were subjected to Fluorescence-activated cell 
sorting (FACS) using the nucleic acid stain propidium iodide (PI). Wild-type 
TopBP1+/+/+ cells contained 41%, 13% and 31% of G1, S and G2 phase cells, 
respectively. Interestingly, successive deletion of the TopBP1 alleles led to a modest 
increase in the proportion of cells in S at the expense of G1 and G2/M as determined by 
DNA content (Figure 6.2 E). Thus the overall slower multiplication of TopBP1-/+/+ and 
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to a greater extent slower multiplication of TopBP1-/+/+ is due to a combination of slight 
alterations in cell cycle phases distribution and spontaneous cell death.  
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Figure 6.2: Proliferation properties of TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells. A) Growth 
curves for the indicated cell cultures. B) Doubling time of the indicated cell lines calculated from the data 
in A. C) Accumulation of dead cells with time as determined by trypan blue staining and optical 
microscopy. D) Clonogenic ability of indicated cells grown in semi-solid media. Equal number of cells 
was seeded on day 1 and left to grow before colonies were visible and counted at the bottom of the plates. 
E) Flow cytometry analysis of asynchronous cultures fixed and stained with propidium iodide. All error 
bars show the standard deviation of the mean for three independent experiments. 
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6.1.3: Successive deletion of the TopBP1 alleles renders cells more sensitive to 
killing with DNA damaging agents 
 To investigate the function of TopBP1 gene-dosage on the sensitivity to DNA 
damaging agents, viability and survival assays were performed with a battery of 
genotoxic agents including UV, MMS, IR and HU. Such agents exert different effects 
on the DNA; UV causes structural alterations which distort base pairing, MMS is an 
alkylating agent causing DNA damage by stalling replication forks, IR directly causes 
DSBs and HU is a potent inhibitor of the ribonucleotide reductase holoenzyme thus 
leading to depletion of the dNTPs pools and replication stress. Firstly, the viability of 
TopBP1-/+/+ and TopBP1-/-/+ cells compared to their TopBP1+/+/+ counterparts following 
treatment with the aforementioned damaging agents was measured using alamarBlue®.  
Successive reduction of the TopBP1 gene dosage was correlated with a stepwise 
increasing sensitivity to all the genotoxic agents tested (Figure 6.3 A). More 
specifically, mutant strains seem to tolerate concentrations of HU up to 50µM 
comparable to wild-type cells but at increasing concentrations of HU the sensitivity of 
the mutants becomes apparent. It is worth noticing that the drop in the viability of the 
TopBP1-/-/+ cells at 100µM HU is quite abrupt compared to TopBP1-/+/+ cells whereas 
the drop in the viability of the latter compared to TopBP1+/+/+ is quantitatively less 
severe. A similar pattern is observed following treatment of the three cell lines with 
ionizing radiation (IR) and ultraviolet light (UV), with TopBP1-/-/+ cells exhibiting a 
more increased sensitivity to killing than TopBP1-/+/+ cells, compared to the 
TopBP1+/+/+. For viability following MMS treatment, the big error bars make it hard to 
get a clear picture of the precise pattern of the graphs but what is clear from the data is 
that the cell lines expressing less TopBP1 are significantly more sensitive than the 
TopBP1+/+/+. Notably, in these assays sensitivity was measured using alamarBlue®, 
which assesses the ability of a cell population to metabolise resazurin but not its 
proliferative capacity. To measure cell survival and quantify the ability of individual 
cells to expand and form a viable population, colony formation assays were employed 
using semi-solid media. The data obtained from these survival experiments confirmed 
the data of the viability assays. As for the sensitivity to MMS, it is now more clear that 
deletion of one TopBP1 allele renders DT40 cells sensitive to killing by MMS 
compared to TopBP1+/+/+ but deletion of two out of the three alleles exacerbates this 
phenotype (Figure 6.3 A). Thus TopBP1 gene dosage is correlated with the ability of 
DT40 cells to survive genotoxic stress. 
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Figure 6.3: Successive deletion of TopBP1 alleles leads to successively increased sensitivity to 
damage caused by HU, IR, MMS and UV. A) Cell viability was measured after continuous 48h-
treatment with increasing doses of HU, after 1h-treatment with MMS followed by 48h recovery time and 
after increasing doses of IR or UV followed by 48h recovery time. B) This method was compared to 
colony survival assays whereby cells were plated singularly in HU-containing semi-solid media or in 
drug-free semi-solid media following the indicated dosed of IR or UV or following 1h-treatment with the 
increasing doses of MMS. After 7-10 days from plating, white colonies were counted at the bottom of the 
plates. All error bars show the standard deviation of the mean for three independent experiments. 
 
0.1	
1	
10	
100	
0	 0.0005	 0.001	 0.0015	 0.002	 0.0025	
Su
rv
iv
al
	(%
)	
MMS	(%)	
0.1	
1	
10	
100	
0	 2	 4	 6	
Su
rv
iv
al
	(%
)	
IR	(Gy)	
10	
100	
0	 2	 4	 6	
Vi
ab
ili
ty
	(%
)		
IR	(Gy)	
1	
10	
100	
0	 2	 4	 6	
Vi
ab
ili
ty
	(%
)	
UV	(J/m2)	
10	
100	
0	 0.0015	 0.0025	 0.003	
Vi
ab
ili
ty
	(%
)	
MMS	(%)	
B	
A	
1	
10	
100	
0	 2	 4	 6	
Su
rv
iv
al
	(%
)	
UV	(J/m2)	
1	
10	
100	
0	 50	 100	
Vi
ab
ili
ty
	(%
)	
HU	(µM)	
1	
10	
100	
0	 40	 80	 160	
Su
rv
iv
al
	(%
)	
HU	(µM)	
+/+/+	 -/+/+	 -/-/+	
 169 
6.1.4: Successive deletion of the TopBP1 alleles leads to defects in checkpoint 
signalling and activation 
 To try and understand the increasing sensitivity of DT40 cells as they become 
progressively deficient of their TopBP1 alleles, the TopBP1+/+/+, TopBP1-/+/+ and 
TopBP1-/-/+ isogenic cell lines were examined for their respective ability to activate the 
DNA structure-dependent checkpoints. HU was used to investigate the response of 
DT40 cells to replication stress and subsequent activation of the replication and S-M 
checkpoints. Additionally, I sought to gain insight into the kinetics of activation of the 
G2-M checkpoint following treatment with IR of this three-cell system. Previous 
evidence has shown that the G2/M and S/M checkpoints triggered by DNA damage or 
replication arrest in DT40 cells are both dependent on Chk1 (Zachos et al 2003 and 
Zachos et al 2005). Chk1 phosphorylation of S345 (pS345 Chk1) has also been 
described as a bona fide read-out of checkpoint activation in response to both DNA 
damage and replication arrest in DT40 cells (Wang et al 2009). To determine whether 
pS345 Chk1 could indeed be used as a marker of checkpoint activation in our system 
and with the available antibodies, wild-type DT40 cells were treated with 2mM HU for 
two hours and whole cell lysates were prepared at 1h and 2h time points for Western 
blot analysis. In parallel, wild-type DT40 cells were treated with 5Gy of IR and lysed 1h 
post-irradiation for Western blot analysis. As shown in Figure 6.4 A and B, Chk1 
kinase was indeed phosphorylated after both HU-induced replication stress and IR-
induced DNA damage. Consistent with Wang et al (2006), IR induced a more modest 
increase in pS345 Chk1.  
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Figure 6.4: Phosphorylation of S345 Chk1 as a marker of checkpoint activation following 
replication stress or DNA damage. A) Whole cell lysates of wild-type DT40 cells were prepared after 
1h and 2h of continuous HU treatment (2mM) and run on SDS-PAGE gel. B) Whole cell lysates of wild-
type DT40 cells were prepared 1h after irradiation with 5Gy of IR and run on SDS-PAGE gel. In both A 
and B western blots were analysed using anti-S345 phospho-specific Chk1 antibody and an antibody 
against total Chk1, while GADPH served as the loading control. Experiments in A and B have been 
performed in parallel and only presented separately.  
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6.1.4.1: Response of TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells to 
replication stress caused by hydroxyurea 
To assess the kinetics of checkpoint activation in response to replication stress, 
TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells were grown in the continuous presence 
of 2mM HU for 6h and samples for Western blot and FACS analyses were kept at 0, 1, 
2, 4 and 6h post addition of the drug. As shown in Figure 6.5 A, B, treatment of wild-
type DT40 cells with HU led to activation of Chk1, evident from both increased pS345 
and altered electrophoretic mobility. Additionally, an increase in the total TopBP1 
levels and phosphorylation of S139 on γH2AX were observed. However, cells deleted 
for one or two of the TopBP1 alleles showed an impaired checkpoint response 
compared to TopBP1+/+/+ cells. In fact, although TopBP1+/+/+ cells presented an 
increase in the levels of the TopBP1 protein as early as 1h (1.6-fold) post addition of 
HU and reaching a maximum at 2h (2.5-fold), TopBP1-/+/+ and TopBP1-/-/+ cells only 
slightly increased (~1.5-fold) TopBP1 above the basal levels at 1h. Interestingly, mutant 
cells were also impaired in their ability to phosphorylate S345 Chk1, with TopBP1+/+/+ 
cells presenting a 23-fold increase over the untreated sample and TopBP1-/+/+ & 
TopBP1-/-/+ cells only below 5- and 4-fold, respectively. Phosphorylation of γH2AX 
S139 reached a maximum level at 2h for all three strains but it was more robust in 
TopBP1+/+/+ (27-fold) than in cells deleted of their TopBP1 alleles (12- and 18-fold, 
respectively).  
Furthermore, cell cycle analysis by flow cytometry revealed that despite the 
defects of TopBP1-/+/+ & TopBP1-/-/+ cells in the strength and kinetics of checkpoint 
activation in response to HU, they were able to arrest the cell cycle by 6h similarly to 
their wild-type counterparts, albeit with slower kinetics. As shown in Figure 6.5 C, 
untreated control cultures contained cells distributed across all phases of the cell cycle. 
However, after treatment with 1mM HU for 2h, cells started accumulating in G1/early S 
and by 6h most cells were in the G1/S as judged by PI staining with a corresponding 
reduction in the proportion of cells in S and G2/M. What is more, TopBP1-/-/+ and, to a 
lesser extent, TopBP1-/+/+ cells contained more sub-G1 cells compared to TopBP1+/+/+.  
Taken together, data show that HU activates Chk1 in wild-type DT40 cells and 
leads to increased TopBP1 levels and increased pS345 Chk1 and pS139 γH2AX. Gene 
dosage reduction of TopBP1 impairs the response to replication stress and although 
most cells successfully arrest at G1/S, they do so in an altered way and with slower 
kinetics than TopBP1+/+/+ DT40 and also at the expense of some cell death. The 
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impairment of the checkpoint response is thus proportional to TopBP1 gene dosage as 
well as to the extent of replication stress, with higher concentrations of HU exacerbating 
the observed phenotypes. 
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Figure 6.5: Gene dosage-dependent defect of checkpoint activation in response to continuous 
replication stress. The indicated strains were treated with 2mM HU and samples were kept at the 
specified times for analysis by Western blotting and FACS. A) Whole cell lysates of the indicated DT40 
cell types were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies 
against total TopBP1, phospho-specific S345 Chk1 antibody, total Chk1 and phospho-specific S139 
γH2AX, while GADPH served as the loading control. B) Quantification of the blot in A, using the ImageJ 
software. C) Flow cytometry analysis of samples fixed and stained with propidium iodide. A 
representative blot of three independent and consistent experiments is presented in this figure. 
Note that equivalent results have been obtained from repeat experiments. 
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6.1.4.2: Response of TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells during 
recovery from replication stress caused by hydroxyurea 
To investigate whether TopBP1 gene dosage is also important for the recovery 
from replication stress, TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells were arrested in 
G1/S by treatment with 1mM HU for 12h and then were washed clear of the drug and 
followed through a period of 6h recovery time. Western blot analysis (Figure 6.6 A, B) 
showed that an increase in the levels of TopBP1 and pS345 Chk1 following HU block 
and release were dependent on TopBP1 gene dosage. In fact, by the end of the 12h 
arrest in HU TopBP1+/+/+ cells increased TopBP1 protein levels more than 2-fold 
compared to the basal (untreated) levels whereas TopBP1-/+/+ showed a 1.5-fold increase 
and TopBP1-/-/+ cells no increase at all. During the recovery period, TopBP1 levels 
started to steadily decline for TopBP1+/+/+ cells before reaching the basal level at 6h 
post-release. On the contrary, the mutant cell lines displayed an increasing amount of 
TopBP1. More specifically, TopBP1-/+/+ cells further increased their TopBP1 levels to 
1.7- and 1.8-fold at 1h and 2h post-release respectively, before returning to near normal 
levels (0.9-fold) by 4h. Similarly, TopBP1-/-/+ cells reached a 1.4-fold increase at 2h 
post-release and by 4h they presented TopBP1 protein below basal levels (0.7-fold), 
which further decreased (0.3-fold) by 6h.  
Furthermore, phosphorylation of the replication checkpoint effector kinase Chk1 
was also impaired in a gene dosage-dependent manner. The HU block resulted in a 8-
fold increase of the pS345 Chk1 pool in TopBP1+/+/+ cells and this phosphorylation 
persisted 4h post-release before starting to decline. Consistent with the phenotypes 
observed in the experiment in Figure 6.6, TopBP1-/+/+ and TopBP1-/-/+ cells were 
impaired in their ability to phosphorylate Chk1 on S345 to the extent of TopBP1+/+/+ 
cells, following 12h incubation with HU. More specifically, only a 3.2- and 2.7-fold 
increase in the pS345 Chk1 population was observed in TopBP1-/+/+ and TopBP1-/-/+ 
mutants respectively by the end of the arrest. Contrary to TopBP1+/+/+ DT40, pS345 
Chk1 was not maintained elevated in the mutants. Both TopBP1-/+/+ and TopBP1-/-/+ 
cells reduced their pool of phosphorylated Chk1 in a stepwise manner before returning 
to the levels of undamaged cells by 6h post-release. This is markedly different from 
what was observed in TopBP1+/+/+ cells, which displayed increased pS345 Chk1 even 
6h post-release (4.1-fold over untreated), indicative of persisting checkpoint activation.  
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Additionally, TopBP1-/-/+ cells were characterized by an increased 
phosphorylation of S139 γH2AX by the end of the HU block (8.1-fold over untreated) 
compared to TopBP1+/+/+ (5.1-fold) and TopBP1-/+/+ (6.5-fold). At later time points, 
TopBP1+/+/+ cells decreased pS139 before phosphorylation starting returning to basal 
levels (2.8, 4.2, 4 and 2.5-fold over untreated at 1, 2, 4 and 6h post-release, 
respectively). TopBP1-/+/+ cells followed a similar trend like wild-type cells (3.5, 6.8, 
3.2 and 3.3-fold, respectively) but in marked contrast, TopBP1-/-/+ cells presented higher 
levels of pS139 across all time points compared to the other cell lines (5.3, 7.7, 4.5 and 
4.3-fold, respectively)  (Figure 6.6 A, B). 
Cell cycle analysis by flow cytometry revealed that the three cell lines block at 
the G1-S in response to HU in a gene dosage-dependent manner, with TopBP1-/-/+ 
blocking less efficiently. The resumption of the cell cycle following release from the 
HU was found to be TopBP1 gene dosage-dependent. In particular, a subset of TopBP1-
/-/+ -and to a lesser extent TopBP1-/+/+- cells displayed 2N DNA content at 2 and 4h post 
HU release, when in fact TopBP1+/+/+ cells have all synchronously moved to the next 
G2 phase. And by 6h, TopBP1-/+/+ and to a greater extent TopBP1-/-/+ cultures had more 
cells in the G1 phase compared to the TopBP1+/+/+ wild-type control (Figure 6.6 C).  
 Taken together, the observed data suggest that successive deletion of the 
TopBP1 alleles results in not only an impaired checkpoint response to replication stress 
but also in an impaired recovery from replication stress. Compared to TopBP1+/+/+ 
DT40 cells, this recovery period in TopBP1-/+/+ and TopBP1-/-/+ cells is characterized by 
a defect in increasing the expression of the TopBP1 itself, a severe impairment in 
phosphorylating the effector kinase Chk1 on S345 and a premature restoration of this 
phosphorylation to basal levels, which is accompanied by a faster resumption of the cell 
cycle. At the same time, increased phosphorylation of S139 γH2AX was observed in a 
gene dosage-dependent manner. 
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Figure 6.6: Gene dosage-dependent recovery from replication stress. The indicated strains were 
treated with 1mM HU for 12h before being transferred into normal media. Samples were kept at the 
specified times for analysis by Western blotting and FACS. A) Whole cell lysates of the indicated DT40 
cell types were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies 
against total TopBP1, phospho-specific S345 Chk1 antibody, total Chk1 and phospho-specific S139 
γH2AX, while GADPH served as the loading control. B) Quantification of the blot in A, using the ImageJ 
software. C) Flow cytometry analysis of samples fixed and stained with propidium iodide. A 
representative blot of three independent and consistent experiments is presented in this figure. 
Note that equivalent results have been obtained from repeat experiments. 
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6.1.4.3: Response of TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells to DNA 
damage caused by ionizing radiation. 
 To determine whether TopBP1 gene-dosage is important for DNA 
damage-induced G2/M arrest, TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells were 
exposed to 10Gy of IR and Western blot analysis was used to assess the activation of 
the G2/M checkpoint. Irradiation of the TopBP1+/+/+cells led to progressively increasing 
levels of the TopBP1 protein reaching a 2.7-fold compared to untreated at 4h post-IR. 
At later time points the TopBP1 levels of TopBP1+/+/+ cells returned nearly to the 
untreated levels (1.3- and 1.2-fold at 6h and 8h, respectively). In striking contrast 
TopBP1-/+/+ cells completely failed to increase the levels of TopBP1 following 
irradiation and at time points beyond 2h post-IR TopBP1 dropped to levels below what 
is found in the untreated. Now the TopBP1-/-/+ cells showed an inability to increase the 
levels of TopBP1 to the extent of TopBP1+/+/+ but they presented a slight 1.4-fold 
increase at 4h post-IR. At later time points however they exhibited very low levels of 
the protein (0.4- and 0.3-fold at 6h and 8h, respectively). Similarly to TopBP1, the 
extent and kinetics of Chk1 phosphorylation at S345 displayed a different pattern in the 
mutant cells compared to the wild-type. In particular, TopBP1+/+/+ displayed a 1.9-fold 
increase of pS345 Chk1 over untreated at 1h post-IR, which remained relatively stable 
until 8h post-IR (2.5-fold). The mutant cell lines, however, showed a TopBP1 gene 
dosage-dependent increase of pS345 Chk1. Throughout the 8h timecourse, TopBP1-/+/+ 
cells displayed more than 3-fold increase in the levels of pS345 indicating that a higher 
percentage of their Chk1 pool was phosphorylated on S345 compared to TopBP1+/+/+. 
Even more pronounced was the 6.4-fold increase over untreated of pS345 Chk1 in the 
TopBP1-/-/+ cells 1h post-IR, which gradually increased reaching a 10.2-fold increase at 
8h. Examination of pS139 γH2AX revealed that TopBP1-/-/+ cells showed a consistently 
decreased ability of phosphorylating this residue compared to TopBP1+/+/+ across all the 
time points examined (Figure 6.7 A, B). 
At the same time the effect of IR on cell cycle progression was determined by 
flow cytometry. Wild-type DT40 cells lack functional p53 (Takao et al, 1999) and 6-8h 
after irradiation accumulated predominantly in G2/M. In comparison, TopBP1-/+/+ and 
to a greater extent TopBP1-/-/+ cells exhibited a slower accumulation in G2/M, indicative 
of a TopBP1 gene dosage-dependent checkpoint defect. In fact, 8h after irradiation 
TopBP1-/-/+ cultures still contained a significant amount of S phase cells (Figure 6.7 C). 
 178 
 To further confirm that the G2/M defect of the mutant cell types is attributable 
to gene dosage reduction, TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells were 
incubated in medium containing nocodazole for 12h with or without prior irradiation 
(10Gy). The percentage of mitotic cells was then determined by DAPI staining of the 
nucleus. As shown in Figure 6.7 D, successive deletion of the TopBP1 alleles leads to a 
successive defect in G2/M arrest following the nocodazole block. In fact, 88% of the 
TopBP1+/+/+ cells successfully arrested in mitosis by the end of the nocodazole block, 
but only 82.5% of TopBP1-/+/+ and 73.5% of TopBP1-/-/+ managed to do so. 
Additionally, irradiation completely prevented nocodazole-treated TopBP1+/+/+ cells 
from accumulating in mitosis (11.5%), indicating a successful arrest in the G2 phase. In 
contrast, 17% of TopBP1-/+/+ and 28% of TopBP1-/-/+ cells entered mitosis regardless of 
prior irradiation. 
 Taken together the above data suggest that TopBP1 is required in a gene dosage-
dependent manner for proper functioning of the G2/M checkpoint in DT40 cells. 
Successive deletion of the TopBP1 alleles results to a progressively defective DNA 
damage response characterized by an inability to increase TopBP1 protein levels, an 
abnormally elevated phosphorylation of Chk1 on S345 and γH2AX on S139 and a 
defect in arresting the cell cycle at the G2 phase following IR or combined IR and 
nocodazole trap.  
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Figure 6.7: Gene dosage-dependent defect of checkpoint activation in response to IR. The indicated 
strains were irradiated with 10Gy of IR before being transferred into normal media. Samples were kept at 
the specified times for analysis by Western blotting and FACS. A) Whole cell lysates of the indicated 
DT40 cell types were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies 
against total TopBP1, phospho-specific S345 Chk1 antibody, total Chk1 and phospho-specific S139 
γH2AX, while GADPH served as the loading control. B) Quantification of the blot in A, using the ImageJ 
software. C) Flow cytometry analysis of samples fixed and stained with propidium iodide. D) Mitotic 
indices of the indicated cells incubated with nocodazole for 12h with or without prior irradiation (10Gy). 
A minimum of 200 nuclei was counted for each mitotic index measurement. Error bars indicate the 
standard deviation of the mean for two independent experiments. A representative blot of three 
independent and consistent experiments is presented in this figure. Note that equivalent results have been 
obtained from repeat experiments. 
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6.1.4.4: Milder defects of TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells to 
lower doses of replication stress or DNA damage 
 To investigate whether the TopBP1 gene dosage-dependent defects of the 
checkpoint response were correlated with the extent of genotoxic stress, cells were 
treated with lower doses of HU and IR and checkpoint activation assessed by Western 
blot analysis and FACS.  
Blocking TopBP1+/+/+ cells in early S phase with 0.25mM HU for 12h resulted 
in a 1.8-fold increase of the TopBP1 levels compared to the untreated sample. The 
protein levels further increased to 2.6-fold at 1h post-release from HU before returning 
to the basal levels at subsequent time points. TopBP1-/+/+ cells showed a similar pattern 
reaching 1.7- and 2-fold increase of TopBP1 at 12h block and 1h post-release 
respectively before returning to basal levels of TopBP1 protein. In contrast, TopBP1-/-/+ 
cells reached the peak of TopBP1 protein levels at the end of the HU block (1.9-fold 
over untreated) but failed to sustain it and returned back to basal earlier than the other 
two cell types cells. Compared to the HU block-release experiment described in Figure 
6.7 where a concentration of HU used was 4-fold higher (1mM instead of 0.25mM used 
here), it is observed that TopBP1-/-/+ cells have a milder defect in boosting TopBP1 
protein levels when exposed to a milder HU block. In fact, when treated with 1mM HU 
TopBP1-/-/+ cells only increased TopBP1 protein levels to 1.1-fold above untreated, 
whereas with 0.25mM they can achieve a 1.9-fold increase above untreated.  
Furthermore, phosphorylation of S345 Chk1 of TopBP1+/+/+ cells was markedly 
increased to 8.1-fold by the end of the HU block, whereas TopBP1-/+/+ and TopBP1-/-/+ 
cells displayed a TopBP1 gene dosage-dependent reduced ability (4.3- and 3.2-fold, 
respectively) of catalysing this modification compared to wild-type. Following release 
into normal media, pS345 Chk1 started to gradually reduce for all cell types. By 8h 
post-release however, TopBP1+/+/+ cells still possessed pS345 at 1.7-fold over untreated 
but for the mutants a gene dosage-dependent premature return to basal levels was 
observed. When comparing the 1mM versus 0.25mM HU-block release experiments it 
is noticed that there is a comparable gene dosage-dependent defect in sustaining 
checkpoint activation (as judged by pS345 Chk1) compared to TopBP1+/+/+. 
Additionally, all three cell types displayed phosphorylation of γH2AX after treatment 
with HU for 12h. Interestingly, TopBP1-/-/+ cells displayed higher amounts of S139 
γH2AX phosphorylation than TopBP1+/+/+ and TopBP1-/+/+ both by the end of the HU 
block and at 1h post-release release period (Figure 6.8 A, B). This was consistent with 
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the observed phosphorylation pattern of S139 γH2AX across the three cell types 
following a 12h HU block (1mM) and 1h release from this harsh block, described in 
Figure 6.6. At later time points, however, the milder damage seems to have alleviated 
the observed phenotypes of the mutants (Figure 6.8 A, B).  
 Flow cytometry analysis showed that similarly to the stronger HU block, the 
majority of cells successfully arrested their cell cycles at early S phase and at 2h and 4h 
post-release they were synchronously going through S and G2 phases, respectively. 
Interestingly, at 6h post-release where cells have progressed through a next round of the 
cell cycle, TopBP1-/-/+ cultures contained more G1 cells compared to TopBP1+/+/+ and 
TopBP1-/+/+. So although the milder HU treatment seems to have diluted out the 
phenotype of the TopBP1-/+/+ cells, TopBP1-/-/+ cells were still presented with a 
phenotype defective compared to the wild-type cells (Figure 6.8 C).  
 To determine whether TopBP1 gene-dosage is important for DNA damage-
induced G2/M arrest after treatment with low IR doses, TopBP1+/+/+, TopBP1-/+/+ and 
TopBP1-/-/+ cells were exposed to 5Gy of IR and Western blot analysis was used to 
assess the activation of the G2/M checkpoint. 1h post-IR, wild-type DT40 showed 3-
fold increase of their total TopBP1 protein levels, which returned to near normal levels 
at later time points. In marked contrast, the mutant cell lines were unable to increase 
TopBP1 levels, in a similar manner as observed after irradiation with 10Gy of IR. 
Additionally, the IR dose used was too mild to induce pS345 Chk1 above the basal 
levels in TopBP1+/+/+ cells, whereas 1h post-IR TopBP1-/+/+ and TopBP1-/-/+ cells 
displayed 1.6- and 1.8-fold increase of pS345 phosphorylation, respectively, compared 
to the untreated samples. This increased phosphorylation persisted until later time 
points. This is comparable to what was observed when the three cell types were 
irradiated with 10Gy of IR where the mutant cells exhibited higher levels of pS345 
Chk1 than wild-type and TopBP1-/-/+ cells displayed the highest among all. It is worth 
noticing however, that although the pattern of pS345 Chk1 induction is comparable 
between the 10Gy versus 4Gy irradiation experiments, the lower dose of IR causes a 
more modest phosphorylation of S345. Finally, 5Gy of IR were sufficient to increase 
pS139 γH2AX 12.2-fold above untreated in TopBP1+/+/+ cells 1h post-IR. In contrast, 
TopBP1-/+/+ and TopBP1-/-/+ cells showed a 3.2- and 1.8-fold increase over the basal 
levels. What is more, the levels of pS139 γH2AX followed a decreasing pattern between 
1h and 6h post-IR for both TopBP1+/+/+ and TopBP1-/+/+ cells and at 8h they showed a 
slight increase again. TopBP1-/-/+ cells however, increased pS139 γH2AX to 3.8-fold at 
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2h after irradiation, higher than the other cell types. At later time points their levels of 
pS139 decreased again to levels below wild-type (Figure 6.8 D, E). Therefore, the 
milder irradiation resulted in a limited amount pS139 γH2AX in cells harboring less 
TopBP1, which is comparable to what observed in Figure 6.7 where a harsher IR 
treatment was used. 
 In parallel flow cytometry was used to assess the effect of this lower dose of IR 
on the progression of the cell cycle of the respective cell types. In marked contrast to the 
higher IR experiment described earlier, here the mutant cell lines displayed similar cell 
cycle progression to wild-type. So by 6h TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ cells 
had all successfully blocked at the G2 phase of the cell cycle (Figure 6.8 F). 
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Figure 6.8: Gene dosage-dependent checkpoint defects at lower doses of replication stress or DNA 
damage. (left panel) The indicated strains were treated with 0.25mM HU for 12h before being transferred 
into normal media. (right panel) The indicated strains were irradiated with 5Gy of IR before being 
transferred into normal media. Samples were kept at the specified times for analysis by Western blotting 
and FACS. A) D) Whole cell lysates of the indicated DT40 cell types were prepared and run on SDS-
PAGE gel. Western blots were analysed using antibodies against total TopBP1, phospho-specific S345 
Chk1 antibody, total Chk1 and phospho-specific S139 γH2AX, while GADPH served as the loading 
control. B) E) Quantification of the blot in A and D, using the ImageJ software. C) F) Flow cytometry 
analysis of samples fixed and stained with propidium iodide. A representative blot of three independent 
and consistent experiments is presented in this figure. Note that equivalent results have been obtained 
from repeat experiments. 
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6.2: Creation of a novel system to study the effects of TopBP1 destruction in 
the human h-TERT RPE-1 cell line 
To gain insight into the dosage function of TopBP1 in mammalian cells, I used 
the small molecule-assisted shutoff (SMASh) technology (Chung, Jacobs et al. 2015) 
combined with the mini-AID degron (Nishimura and Kanemaki 2014) to create a 
human cell line amenable to manipulation of the TopBP1 protein levels. This involved 
tagging both TopBP1 alleles of the human h-TERT RPE-1 cell line with an array of the 
SMASh and min-AID destabilizing degrons that can be conditionally (and 
independently) activated to target the tagged protein for degradation. The combined use 
of two degrons provides a powerful means to effectively degrade the protein of interest 
in a minimally disruptive, inducible and reversible way. The TopBP1mAIDSMASh 
model developed herein provides a novel system to study the effects of TopBP1 protein 
dosage on checkpoint signaling and activation, much like the TopBP1 gene dosage 
system developed in DT40. Additionally, the TopBP1mAIDSMASh system provides a 
time window between TopBP1 protein destruction where the phenotypes arising from 
TopBP1 absence on checkpoint functioning or indeed other cellular processes can be 
assessed.  
 
6.2.1: Generation of the TopBP1+/mAID-S rosa26+/osTIR1myc and TopBP1mAID-S/mAID-S 
rosa26 +/osTIR1myc RPE cell lines 
  A CRISPR/Cas-based tagging method was used to tag the endogenous TopBP1 
gene with the miniAID/SMASh array of degrons in the RPE cell line. Although these 
two degrons both enable the destruction of the tagged protein, they work in completely 
different ways and have different requirements. The SMASh tag system is composed of 
the Hepatitis C virus (HCV) protease NS3 followed by the degron tag. Fusion of the 
SMASh tag to the target protein occurs via an HCV NS3 protease-recognition site. 
After protein folding, the SMASh tag is removed from the protein by its internal 
protease activity and is also degraded owing to its internal degron activity. Addition, 
however, of a protease inhibitor called asunaprevir (ASV) blocks the auto-cleavage step 
of the SMASh tag leading to degradation of the synthesized copies of the tagged protein 
(Chung, Jacobs et al. 2015). The miniAID degron on the other hand, requires the 
introduction of a second component inside the cells at a safe harbor locus, like the 
rosa26 locus used herein (Friedrich and Soriano 1991, Irion, Luche et al. 2007). This 
component is the auxin-responsive F box protein, TIR1, which forms a functional 
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SCFTIR1 (Skp1–Cullin–F-box) ubiquitin ligase with the endogenous components in 
human cells. The TIR1 used here is derived from Oryza sativa (OsTIR1), because 
previous evidence suggests that it works better than its homolog in A. thaliana at higher 
temperatures (Nishimura, Fukagawa et al. 2009). So in the presence of auxin, a protein 
tagged with miniAID is polyubiquitinated and targeted for ubiquitin-mediated 
proteosomal degradation. To render this a conditional rather than a constitutive event, 
the OsTIR1 transgene was placed under the control of tetracyclin responsive TRE 
promoter (TRE-OsTIR1) such that transcription is reversibly turned on or off in the 
presence of the antibiotic tetracyclin or its derivative doxycycline (Dox) (Gossen, 
Freundlieb et al. 1995). Overall, SMASh tag-mediated degradation of a miniAID-
SMASh-tagged TopBP1 would require addition of ASV, whereas mini-AID-mediated 
degradation would require addition of auxin and Dox in the culture. Treatment of cells 
with all three drugs -ASV, auxin and Dox- would activate both degrons, presumably 
leading to a more robust degradation of the TopBP1 protein, compared to ach system 
alone. A schematic representation of the two degron systems is depicted in Figure 6.9 
A, B. 
 As shown in Figure 6.9 C, the targeting strategy devised for the generation of 
the cell lines of interest involved C-terminally tagging the endogenous TopBP1 gene 
with the miniAID-SMASh array. A first targeting step would yield TopBP1+/mAID-S 
heterozygous cells and a second targeting step would yield TopBP1mAID-S/mAID-S 
homozygous. Alternatively, owing to the previously reported efficiency of the CRISPR-
Cas9 system, heterozygous and homozygous cells could be obtained from a single 
targeting step (and indeed that was the case eventually). The generation of these cells 
lines would resemble the DT40 gene dosage system described earlier in the sense that 
the protein product of each TopBP1 allele could be selectively degraded. To fulfill the 
second requirement of the miniAID system, a myc-tagged OsTIR1 transgene was 
integrated at the safe harbour rosa26 locus under the control of a TRE promoter. This 
targeting strategy was used to generate TopBP1+/mAID-S rosa26+/osTIR1myc and 
TopBP1mAID-S/mAID-S rosa26 +/osTIR1myc RPE cell lines.  
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Figure 6.9: Schematics of the SMASh and miniAID systems and targeting strategy. A) Translation of 
a SMASh-tagged protein results to intramolecular cleavage by the NS3 protease, releasing the protein in 
its native form whereas the NS3 protease and degron are degraded by the cell (bottom panel). Addition of 
asunaprevir (ASV) however, inhibits NS3 and consequently the degron promotes proteasomal 
degradation of the tagged protein (top panel) (Adapted from Chung et al 2015). B) Expressed OsTIR1 
forms a functional SCFOsTIR1 E3 ubiquitin ligase complex with the endogenous components of the 
pathway in human cells. In the presence of auxin, a miniAID-tagged protein is degraded via 
polyubiquitylation mediated proteosomal degradation. C) To generate an RPE cell line where both of the 
TopBP1 alleles would be tagged with the combined miniAID-SMASh system, a miniAID-SMASh fusion 
would first be integrated using CRISPR at the C-terminal end of TopBP1 removing the stop codon. To 
also satisfy the requirement of the miniAID system, an OsTIR1 transgene would be integrated under the 
control of an inducible promoter at the rosa26 safe harbour locus using CRISPR. 
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 To C-terminally tag the TopBP1 alleles with the miniAID-SMASh degron tag 
array, a homology directed repair (HDR) template was co-transfected with the Cas9-
expressing vector pX459, where the single-guide RNA (sgRNA) has been subcloned. 
More specifically, to assemble the HDR template (Figure 6.10 A top panel), a left 
homology arm (LHA) -corresponding to 500bp upstream of the stop codon of the 
genomic TopBP1 locus- followed by a BstZI7I restriction site and a right homology arm 
(RHA) –corresponding to 500bp downstream of the stop codon- were synthesized in 
pBluescript SK+ as an XhoI/SpeI fragment. In parallel, three sgRNAs were selected 
using the Benchling software and the algorithm therein, capable of locating potential 
protospacer adjacent motif (PAM) and target sequences and ranking the associated 
sgRNAs based on their predicted on-target and off-target activity. In this case, 
sequences amenable to recognition and cleavage by the Streptococcus pyogenes (SP) 
Cas9 (SpCas9) with a PAM of NGG were selected. Each sgRNA was assembled by 
annealing a forward and a reverse primer and a total of three sgRNAs were made that all 
were specific for regions ~100bp around the stop codon of the endogenous TopBP1 
gene (primers used P52-57). The ends of the sgRNA oligonucleotides contained the 
appropriate sequences as described by Ran et al 2013 to enable their subcloning at the 
BbsI site of pX459 vector.  
Additionally, PCR mutagenesis was performed to render the HDR template 
resistant to cleavage by the Cas9 enzyme with primers P58-63. This involved silently 
mutating two juxtaposed codons within the Cas9 target site/PAM site on the HDR 
template so as to avoid both the cleavage of the HDR prior to integration as well as the 
continuous cleavage of the genomic site following successful targeting. Overall, three 
versions of the pX459 vector, each with a different TopBP1-specific sgRNA and three 
versions of the HDR template (TopBP1taggingHDR 1-3), each silently mutated in a 
manner specific for each sgRNA were designed. The final cloning step for the design of 
the HDR 1-3 templates involved the subcloning of a miniAID-SMASh-T2A-Neomycin 
fragment, kindly provided by the Hochegger laboratory. This fragment was PCR 
amplified with primers P64 & P65 and subcloned at the unique BstZI7I restriction site 
of HDRs 1-3. Sanger sequencing analysis confirmed all the DNA molecules created.  
 To integrate the miniAID-SMASh double degron tag at the C-terminus of the 
endogenous TopBP1 gene, each HDR template was co-transfected with its appropriate 
sgRNA-expressing Cas9 pX459 vector into wild-type h-TERT RPE-1 cells using the 
Neon transfection system (see Methods and Materials). To control for the efficiency of 
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the transfection, an EGFP tagged H2B-expressing vector was transfected in parallel. 
24h post-transfection, control cells were examined by fluorescence microscopy for the 
EGFP signal and this confirmed successful transformation. Media was refreshed and 
cells left to recover for another 24h before being serially diluted and selected in the 
presence of 1mg/ml G418 in 96-well plates. Three weeks later single colonies started 
appearing and these were expanded in duplicates; one of the samples was kept for future 
freezing down and the other sample was used for genomic DNA extraction and PCR 
analysis. Successful tagging of the TopBP1 locus would increase the 125bp PCR 
product obtained with primers P66 & P67 to 2200bp as shown in Figure 6.10 A.  
Of the 18 clones screened by PCR, 6 contained both the wild-type and targeted 
amplification products hence were classified as heterozygous, whereas 12 contained 
only the targeted product and were classified as homozygous (Figure 6.10 B). Two 
heterozygous and three homozygous clones were confirmed by Sanger sequencing, 
appropriately frozen down in liquid nitrogen and also subjected to Western blot analysis 
of whole cell extracts. Wild-type TopBP1 protein has a predicted size of 170.7kDa 
whereas a tagged TopBP1 is expected to be 181.3kDa owing to the presence of the 
miniAID tag attached to its C-terminus (SMASh tag is auto cleaved) (Figure 6.10 C).  
Western blot analysis enabled the size-dependent separation of the tagged versus 
untagged TopBP1 protein populations and confirmed the creation of the TopBP1+/mAID-S 
(which is heterozygous hence expresses both the 170.7 and 181.3kDa TopBP1 
populations) and TopBP1mAID-S/mAID-S (which is homozygous and only expresses the 
181.3kDa tagged TopBP1) RPE cell lines (Figure 6.10 D). 
  To complete the design of the TopBP1 degradation system, a myc-tagged 
OsTIR1 transgene under the control of the TRE promoter was integrated at the rosa26 
locus of both TopBP1+/mAID-S and TopBP1mAID-S/mAID-S cells, using CRISPR technology 
(Figure 6.10 E). Similarly as before, a pX459 vector expressing a rosa26 locus-specific 
sgRNA was co-transfected with a targeting HDR vector harbouring arms homologous to 
sequences of the rosa26 locus (LHA and RHA). Successful integration of the HDR 
vector would result in the replacement of the rosa26 locus with a transgene containing 
OsTIR1-myc under the control of TRE promoter. In addition, to enable selection of the 
successfully transfected cells, the ectopic transgene also contained a Sh ble gene under 
the control of the SV40 promoter. Both the sgRNA-expressing Cas9 vector and the 
rosa26 HDR were kindly provided by the Hochegger laboratory. Transfectants were 
thus selected in the presence of 500µg/ml zeocin and once expanded, they were 
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subjected to Western blot analysis to check for the expression of OsTIR1-myc. In fact, 
parental cell lines alongside 21 bleomycin-resistant clones were treated with 1µg/ml 
Dox for 24h and whole cell extracts run on SDS PAGE gel.  
Parental cell lines were negative for the expression of OsTIR1-myc whereas 19 
out of the 21 clones showed expression of OsTIR1-myc showing successful integration 
of the transgene (Figure 6.10 F). However, to distinguish between a correct targeting of 
the rosa26 locus and an erroneous targeting of the HDR somewhere else inside the 
genome, 4 of the TopBP1+/mAID-S and 7 of the TopBP1mAID-S/ mAID-S that showed 
OsTIR1-myc expression in Figure 6.11 F were subjected to PCR analysis. The forward 
primer of the reaction annealed within the SV40 promoter in the HDR whereas the 
reverse primer was specific to a region of the rosa26 locus located 3’ to the RHA region 
(Figure 6.10 E bottom diagram (purple arrows)). In all of the clones tested, the 
transgene had indeed integrated at the rosa26 locus as is evident from the 2.3kb band 
amplified from the genomic DNA of the clones but not that of the parental cell lines 
(Figure 6.10 G). This series of targeting events has successfully generated the 
TopBP1+/mAID-S rosa26+/osTIR1myc and TopBP1mAID-S/mAID-S rosa26 +/osTIR1myc RPE cell 
lines. 
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Figure 6.10: Construction of a conditional miniAID-SMASh TopBP1 system in human RPE cells.  
A) Schematic of the degron targeting construct, comprising the miniAID and SMASh sequences coupled 
to the neomycin marker via the T2A sequence and all flanked by 500bp arms homologous to the regions 
of the TopBP1 gene immediately upstream and downstream the stop codon. Unsuccessful targeting would 
leave the TopBP1 allele intact whereas gene targeting would result in replacement of the stop codon with 
the targeting construct. PCR with the primers shown (purple arrows) could be used to distinguish 
successfully targeted clones as well as heterozygously- from homozygously-tagged based on the size of 
the PCR product (125bp VS 2200bp). T2A is a small “self-cleaving” peptide that was initially identified 
in the foot-and-mouth disease virus (FMDV) (Ryan, King et al. 1991). Subsequent studies have 
demonstrated that ribosomes skip the synthesis of the glycyl-prolyl peptide bond at the C-terminus of a 
2A peptide, leading to the cleavage between a 2A peptide and its immediate downstream peptide 
(Donnelly, Luke et al. 2001). In molecular biology, T2A has proved a useful tool for the fusion of genes 
whose expressions are driven by a single promoter (Kim, Lee et al. 2011). B) G418-resistant were 
genotyped by PCR (as explained in A) for determining clones that had successfully performed gene 
targeting. Wild-type cells generating a 125bp PCR product -indicative of an untagged TopBP1 C-
terminus- served as the negative control. C) Expected sizes of untagged versus tagged TopBP1 protein as 
calculated with the ExPasy tool. D) Whole cell lysates of clones classified as heterozygous or 
homozygous in B were prepared and run on SDS-PAGE gel. Western blots were analysed using antibody 
against total TopBP1 while beta-tubulin served as the loading control. The tagged and untagged TopBP1 
protein populations can be separated on the basis of size on an SDS gel; top band corresponding to the 
tagged and bottom band to the untagged on the anti-TopBP1 immunoblot. E) Schematic representation of 
the rosa26 locus, OsTIR1 containing targeting vector and successfully targeted rosa26 locus. The purple 
arrows indicate the primers used for PCR analysis in G. F) Whole cell lysates of clones obtained from 
transfection of the OsTIR1 construct in TopBP1+/mAID-S and TopBP1mAID-S/mAID-S cells (obtained from B 
and D) were prepared and run on SDS-PAGE gel. Western blots were analysed using antibody against the 
myc-tagged OsTIR1 while GADPH served as the loading control. To activate transcription of the 
transgene cells were pre-treated with 1µg/ml doxycycline 24h prior to harvesting. G) PCR analysis of the 
indicated clones classified as positive for the OsTIR1 integration in F to show that the transgene has 
indeed integrated at the rosa26 locus. Primers are depicted in E (purple arrows).  
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6.2.2: Activation of the miniAID-SMASh system leads to TopBP1 degradation and 
inability to incorporate EdU and DNA damage. 
  I next tested the efficacy of the miniAID-SMASh combined system as well of 
each system on its own in suppressing the protein levels of TopBP1 present inside the 
cells. TopBP1+/+ (wild-type), TopBP1+/mAID-Srosa26+/osTIR1myc and TopBP1mAID-S/mAID-S 
rosa26+/osTIR1myc cells were exposed to ASV (3µΜ) alone, IAA (500µΜ) alone or a 
combination of both drugs in order to activate the SMASh or miniAID or both, 
respectively. It should also be noted that activation of the miniAID required pre-
treatment of cells with Dox (1µg/ml) for a period of 2h prior to the addition of IAA 
(N.B. Dox was not washed off). This was necessary in order to activate expression of 
the ectopic OsTIR1 transgene required for the degrading mechanism of the miniAID 
system. Following exposure to the respective drugs, cells were followed for a period of 
6h and whole cell extracts were analysed by Western blotting at 0, 1, 2, 4 and 6h time 
points (Figure 6.11 A). Exposure of wild-type cells to any of the drugs’ combinations 
did not have an effect on the levels of the TopBP1 protein and also no OsTIR1-myc 
expression was observed, which served as a control in the experiment.  
Activation of only the SMASh tag by exposure to ASV and subsequent 
stabilisation of the degron tag on TopBP1 did not result to any obvious degradation of 
the TopBP1 protein in the tagged cell lines. The miniAID system, on the other hand, 
when activated by exposure to Dox and 2h later addition of IAA, was found to be more 
efficient in promoting the degradation of TopBP1 within the time period of 6h studied. 
Interestingly, making use of both the miniAID and SMASh tag systems led to a similar 
depletion of TopBP1 within 6h after addition of ASV and IAA. A drawback of this 
miniAID-SMASh system is that, in the absence of any drugs, the levels of TopBP1 
protein in the tagged cell lines are decreased compared to wild-type RPE cells. In fact, 
tagging of one of the TopBP1 alleles with miniAID-SMASh causes a reduction of the 
TopBP1 levels of untreated cells whereas tagging of both alleles leads to a further 
reduction by default. 
To summarize my results so far, the miniAID system is more potent than the 
SMASh system in promoting degradation of the tagged protein. Additionally, tagging of 
one or both of the endogenous TopBP1 alleles with the miniAID-SMASh degron results 
to a slight reduction of the protein levels by default. Nonetheless, this double degron 
system can be activated to drastically reduce the levels of the tagged TopBP1 protein 
beyond the extent of the default situation.  
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 Having established that the combined miniAID-SMASh degron leads to the 
depletion of the protein of interest, I then wanted to investigate the kinetics of this 
depletion since the 6h period examined so far was not sufficient to completely eliminate 
TopBP1 from the cells. FACS analysis was used this time to follow cells for a period of 
24h following activation of the miniAID, SMASh or both systems. This was considered 
a more informative experiment than performing Western blot analysis, as disappearance 
of the TopBP1 band from the Western blot would not necessarily mean that TopBP1 is 
entirely depleted. Instead, factors like sensitivity of the antibody or exposure time could 
result to a false interpretation of the effect of degron activation on the levels of the 
protein. On the other hand, maximum activation of the miniAID-SMASh system and 
subsequent depletion of TopBP1 would prevent cells in culture from actively replicating 
their genomes as TopBP1 is essential for the initiation step of DNA replication.   Pulse 
labelling cells with EdU, therefore, would allow the identification of the time point 
following addition of the drugs, that TopBP1 depletion would have reached low enough 
levels to render cells non-replicating hence unable to incorporate EdU. 
TopBP1+/+ (wild-type), TopBP1+/mAID-Srosa26+/osTIR1myc and TopBP1mAID-S/mAID-S 
rosa26+/osTIR1myc cells were exposed to ASV (3µΜ) alone, IAA (500µΜ) alone or a 
combination of both. Activation of the miniAID required pre-treatment of cells with 
Dox (1µg/ml) for a period of 2h prior to addition of IAA, as before. FACS data 
presented in Figure 6.11 B show that depletion of the TopBP1 protein expressed from 
one or two of the TopBP1 alleles leads to a proportional reduction of EdU positive cells, 
compared to TopBP1+/+ (wild-type) cells. What is more, activation of the miniAID 
degron results in a more potent reduction of EdU positive cells compared to SMASh 
degron activation at 24h post drug addition. Activation of both degrons leads to an 
inability of TopBP1mAID-S/mAID-S rosa26+/osTIR1myc cells to incorporate EdU, whereas 
TopBP1+/mAID-Srosa26+/osTIR1myc cells show a partial inability and TopBP1+/+ no defect at 
all. Overall, combined activation of miniAID and SMASh for 24h is sufficient for cells 
to stop actively replicating their DNA, without causing cell death, within the time frame 
studied. However, the effect of both degrons is similar to the effect of miniAID degron 
activation alone with respect to EdU incorporation.   
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Figure 6.11: Kinetics of TopBP1 destruction following activation of the miniAID-SMASh system. 
A) Detection of TopBP1 and OsTIR1 using anti-TopBP1 and anti-myc antibodies of whole cell extracts 
of the indicated cell lines run on an SDS-PAGE gel. Cells were treated with either ASV (3µM) alone to 
activate the SMASh tag or Dox (1 µg/ml for 2h) and IAA (500 µM) to activate the miniAID tag or a 
combination of all to make use of the degrading ability of the combined miniAID-SMASh system. Cells 
were followed for a period of 6h and samples were collected at 0 (untreated), 1, 2, 4 and 6h post drug 
addition. Note that Dox was added 2h prior to the 0h time point and was not washed off. Beta-tubulin 
served as the loading control. B) Cell cycle distribution of the indicated cell lines at 0, 6, 12 and 24h post 
addition of ASV (3µM) alone or Dox (1 µg/ml fro 2h) and IAA (500 µM) or a combination of all, as 
measured by EdU incorporation and DNA content Flow cytometry analysis.  
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Having established that 24h of miniAID-SMASh activation is sufficient to 
prevent cells from replicating due to TopBP1 depletion, I then wanted to test what effect 
this depletion has on the checkpoint proficiency of the respective cell lines. To do so, 
TopBP1+/+ (wild-type), TopBP1+/mAID-Srosa26+/osTIR1myc and TopBP1mAID-S/mAID-S 
rosa26+/osTIR1myc cells were exposed to ASV (3µΜ) and IAA (500µΜ) for a period of 
36h. Activation of the miniAID required pre-treatment of cells with Dox (1µg/ml) for a 
period of 2h prior to addition of IAA, as before. About 2h before the final harvesting 
samples of each cell line were also exposed to HU (0.25mM) or IR (2Gy). At 6, 12, 24 
and 36h post-drug addition samples were collected for Western blot analysis. As a 
negative control in this experiment cell lysates of untreated cells at 0 and 36h were also 
collected.  
As depicted in Figure 6.12, exposure of wild-type cells to ASV and IAA had no 
effect on the levels of total TopBP1 inside the cells. On the other hand, TopBP1+/mAID-
Srosa26+/osTIR1myc cells showed a reduction in TopBP1 12h after activation of the 
degrons, which became more potent at 24 and 36h post-degron activation. This suggests 
that the default (i.e. degrons not activated by drug addition) depletion of the miniAID-
SMASh tagged protein reduced TopBP1 to levels that produce an unwanted phenotype. 
Furthermore, 6h following activation of the degron system TopBP1 was no longer 
detectable by the anti-TopBP1 antibody. By 36h, phosphorylation of S139 γH2AX was 
observed even in otherwise undamaged cells, suggesting that depletion of TopBP1 per 
se caused DNA damage.  
The extent of this phosphorylation in TopBP1mAID-S/mAID-S rosa26+/osTIR1myc 
undamaged cells is comparable to samples treated with HU or IR.  Interestingly, if we 
compare the three panels of blots from the three respective cell lines we observe that the 
extent of depletion of TopBP1 is proportional to the amount of γH2AX phosphorylation 
observed, with wild-type cells presenting hardly any, TopBP1+/mAID-Srosa26+/osTIR1myc 
cells presenting some and, strikingly, TopBP1mAID-S/mAID-S rosa26+/osTIR1myc cells 
showing increased phosphorylation of γH2AX following TopBP1 depletion. It also 
worth-mentioning that treatments of 0.25mM HU for 2h and 4Gy of IR were sufficient 
to make TopBP1mAID-S/mAID-S rosa26+/osTIR1myc cells that have been depleted of TopBP1 
detach from the culture plate, something that was not observed in the TopBP1+/+ (wild-
type) and TopBP1+/mAID-Srosa26+/osTIR1myc cells.  
To sum up, activation of the miniAID-SMASh double degron efficiently 
depleted homozygously tagged cells of their TopBP1 protein pool leading to an inability 
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to actively replicate as well as to accumulation of DNA damage evident from increased 
S139 phosphorylation on γH2AX. 
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Figure 6.12: Depletion of TopBP1 in human cell leads to DNA damage. The indicated cell lines were 
pre-treated with Dox (1 µg/ml for 2h) before the addition of ASV (3µM) and IAA (500µM). Whole cell 
extracts were collected at 0, 6, 12, 24 and 36h post addition of the drugs and run on an SDS-PAGE gel. 
Untreated samples were also collected at the start (0h) and end (36h) of the experiment serving as a 
negative control. In addition, 2h prior to harvesting both untreated and ASV/IAA treated cells were either 
exposed to HU (0.25mM for 2h) or IR (4Gy) to activate the checkpoints. Antibodies were used to 
visualise TopBP1, Os-TIR1myc, pS139 γH2AX whereas GADPH served as the loading control.  
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Summary for chapter 6 
This work describes the establishment of a TOPBP1 knock in gene targeting 
system, useful for the generation of mutant cell lines of interest in the DT40 model 
organism. In fact, depending on the researchers needs, all three, two or one of the 
endogenous TOPBP1 alleles can be mutated in TopBP1+/+/+, TopBP1-/+/+ or TopBP1-/-/+ 
cell lines, respectively, leading to the replacement of the total wild-type TopBP1 protein 
inside the cell by the mutant. The use of this system, however, requires the 
characterization of the events induced by the deletion of the alleles per se (in TopBP1-
/+/+ and TopBP1-/-/+ systems) before proceeding to the characterization of the mutants. In 
the same way, using the wild-type system to knock in all three TopBP1 alleles requires 
characterization of the TopBP1+/+/+ system prior to integration of the mutations of 
interest.  Here I showed that successive deletion of the avian TopBP1 alleles leads to a 
progressive reduction of the TopBP1 protein levels. Interestingly, this reduction is 
accompanied by progressively decreasing cellular proliferation and clonogenic ability, 
increasing sensitivity to DNA damaging agents, altered cell cycle profile as well as mild 
defects in the checkpoint response following replication stress or DNA damage. Such 
defects are associated with the extent of genotoxic stress imposed on the cells, with 
milder HU or IR treatments yielding milder defects in the observed phenotypes and 
harsher treatments exacerbating those defects.  
Finally, to deplete TopBP1 in human cells in an allele-specific manner, I tagged 
one or both of the TOPBP1 alleles of RPE cells with the miniAID-SMASh degron. 
Tagging of the TopBP1 alleles with miniAID-SMASh leads to a reduction of the 
TopBP1 levels by default. This suggests that there is an inherent instability to the 
miniAID-SMASh system, mediated either by a default activation of miniAID due to 
leaky expression of the OsTIR1 transgene or by an incomplete NS3-mediated auto 
cleavage of the SMASh degron off TopBP1 or indeed by a combination both. 
Alternatively, tagging of the TopBP1 protein per se may have an effect on the stability 
of the protein. Nonetheless, activation of the degron tags by drug addition in cells that 
are heterozygous leads to depletion of the TopBP1 population produced from the tagged 
allele whereas applying this technology in homozygously tagged cells allowed the 
complete or near-complete depletion of the entire TopBP1 pool inside the cells. Such 
complete depletion of TopBP1 led to a progressive elimination of S phase cells from the 
culture and persisting damage on the chromatin (even in the absence of genotoxic stress, 
as judged by pS139 γH2AX).  
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The two systems described herein allowed a characterization of the effects of 
TopBP1 gene dosage as well as TopBP1 protein elimination on the checkpoint 
proficiency of DT40 and RPE cells, respectively. More importantly, they represent 
useful tools for future structure-function studies of TopBP1 in DT40 and human cell 
lines.  
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Preface 
In addition to gene knockouts, reverse genetics can be used for knock in studies. 
Apart from eliminating a gene and observing the phenotypes generated from loss of 
function of the protein product, it is often useful to specifically mutate the gene and 
investigate the structure and biological activity of the mutant protein. Generating 
separation of function mutants allows the identification of specific roles of our favourite 
protein within distinct cellular pathways and provides us with a powerful tool to 
understand the underlying molecular mechanisms in a genetically defined system in 
vivo.  
 
7: In vivo characterization of  
the avian TopBP1 ATR activation domain and its function 
TopBP1 performs vital roles for the correct functioning of the checkpoint in 
response to replication stress and DNA damage. Firstly, by acting as a molecular 
scaffold, TopBP1 bridges between the DNA damage sensors and the checkpoint 
mediators, which present the effector kinases to ATR/ATM. It thus performs an 
important skeletal function for the propagation of the checkpoint signalling. 
Additionally, TopBP1 harbours the ATR Activation Domain (AAD), which in higher 
eukaryotes is necessary for ATR activation. Replacing Xenopus TopBP1 with 
recombinant TopBP1 mutated within the AAD (W1138) completely abolished ATR 
activation in aphidicolin-treated egg extracts (Kumagai et al 2006). TopBP1 AAD was 
also described to be essential for early embryonic development in mice as mutation of 
the AAD arrested development at the blastocyst stage (Zhou et al 2013). Furthermore, 
TopBP1 has been described as having a functional role in a pathway that connects ATM 
to ATR at sites of DSBs. In fact, ATM-catalysed phosphorylation of Xenopus TopBP1 
S1131 was shown to be necessary for activation of ATR-ATRIP in response to DSBs 
but not replication stress (Yoo et al 2007). This favours a model whereby 
phosphorylation of this residue by ATM may mediate a handover from ATM to ATR 
activation at DSBs by increasing the ability of TopBP1 to stimulate the kinase activity 
of ATR via the AAD.  
The multifaceted nature of TopBP1 render it an integral part of the DDR, 
required both for the generation and sustaining of the checkpoint signal in response to 
DNA lesions but also for the correct transmission of the signal across the checkpoint 
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cascade. Interestingly, these functions of TopBP1 are conserved from yeasts to humans 
but the precise molecular mechanisms have evolved. So although the yeast 
TopBP1Rad4/Dpb11 AAD is dispensable for ATR activation, the architecture of ATR 
activation in higher eukaryotes is thought to be largely dependent on TopBP1 AAD. In 
order to investigate the function of the TopBP1 AAD in vivo, a knock-in gene-targeting 
approach was designed to introduce point mutations of interest into the intact TopBP1 
genomic locus of TopBP1-/-/+ DT40 cells. The use of the gallus gallus-derived DT40 
cells would hopefully help us avoid the issue of embryonic lethality of the AAD 
mutants and hence allow a proper in vivo characterisation of the resulting phenotypes. 
The work presented here investigates the function of the DT40 TopBP1 AAD and in 
particular of residues S1132 and W1139 using a knock-in gene targeting strategy, based 
on the gene dosage knock in platform described in the previous chapter. 
 
7.1.1: Generation of AAD mutant DT40 cells 
The characterisation of the TopBP1+/+/+, TopBP1-/+/+ and TopBP1-/-/+ gene 
dosage systems (Chapter 6) allows their use as knock in gene targeting systems for the 
study of TopBP1. Here this system was used to knock in point mutations of interest 
within the intact TopBP1 locus of TopBP1-/-/+ cells. In this way, the population of the 
TopBP1 protein inside the cells would be replaced by a mutant population of interest (in 
a single gene targeting step). The advantage of mutating the endogenous TopBP1 allele 
is that the gene will still be expressed under the control of the endogenous promoter and 
subjected to physiological cell cycle regulation or mRNA splicing. Such a system would 
enable the analysis of TopBP1 mutants under physiological conditions in vivo and 
would help avoid potential undesirable effects often associated with overexpressing the 
cDNA from a viral promoter. 
 The knock-in targeting strategy devised herein makes use of homologous 
recombination to integrate point mutations within the genomic locus of interest. Briefly, 
a selection marker cassette flanked by lox sites and long homology arms (where the 
mutation is incorporated) are synthesized in a plasmid. The arm regions are chosen in 
such a way so as to integrate the marker cassette within an intronic region and without 
affecting the amino acid frame downstream following successful integration. PCR 
analysis and Restriction Fragment Length Polymorphism (RFLP) are used to screen for 
transfected clones that have both integrated the marker cassette at the locus of interest 
and have incorporated the mutation. Having characterized the TopBP1-/-/+ cell line in 
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terms of its replication properties, response to replication stress and DNA damage 
compared to its wild-type counterpart, I decided to use it as the parental cell line for the 
generation of the TopBP1 mutants. This would offer the advantage of having to perform 
only one targeting step to create a cell line where all the wild-type TopBP1 population 
would have been replaced by the mutant. It is also worth noticing that the TopBP1-/-/+ 
cell line used herein contains the MerCreMer enzyme stably integrated into the genome 
(described in chapter 3). 
The first biological question addressed concerned the physiological function of 
the gallus gallus TopBP1 AAD in checkpoint signaling. The TopBP1 AAD in chickens 
spans exons 19 and 20, with the core indispensable residue W1139 as well as the ATM-
targeted residue S1132 both encoded within exon 20 (Figure 7.1 A). To change serine 
1132 to alanine (S1132A), T3394 was mutated to G3394 and to change tryptophan 1139 
to arginine (W1139R), T3415 was mutated to C3415 in the remaining intact TopBP1 
allele of TopBP1-/-/+ cells. In parallel, I wanted to create cell lines that would be silently 
mutated for the exact same residues, which would serve as a control for future 
experiments. Thus C3396 was mutated to A3396 (S1132S) and G3417 was mutated to 
A3417 (W1139W). Overall, four knock-in targeting constructs were assembled, namely 
AAD-SAki and its control AAD-SSki as well as AAD-WRki and its control AAD-
WWki (Figure 7.1 B). The cloning strategy involved two cloning steps. First, a 2kb left 
homology arm and a 2kb right homology arm separated by a BstZI71 restriction site 
were synthesized as a NotI/XhoI fragment in pUC57 vector. The sequence of the arms 
was retrieved from the genome browser so it was the wild-type sequence of TopBP1. 
The unique BstZI71 cutting site was used to subclone the lox-SV40-puromycin-polyA-
lox fragment, which was amplified from the previously described LAiRAiPuro construct 
with primers P68/P69. For the second cloning step I made use of two unique restriction 
sites that flanked the Exon20 region of interest. In fact, this region was flanked by 
EcoRV and SpeI restriction sites that did not cut anywhere else in the insert or the 
pUC57 backbone. Thus, EcoRV/SpeI-flanked gene block fragments that were 
homologous to wild-type TopBP1 but contained the mutation of interest (SA, SS, WR, 
WW) were synthesized from IDT and subcloned in the targeting vector. The resulting 
knock-in targeting constructs, AAD-Saki (S1132A), AADSSki (S1132S), AAD-WRki 
(W1139R) and AAD-WWki  (W1139W) were verified by Sanger sequencing. 
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Figure 7.1: Knock-in targeting strategy for AAD mutants. A) Structure alignment of TopBP1 AAD 
obtained using the ClustalW sequence alignment software. Alignment of the AAD sequences from 
different species is shown, with the AAD domain being enclosed in the black box. The sequence encoded 
by exon 19 is highlighted by the blue line and that encoded by exon 20 by the yellow line. B) Schematic 
representation of the AAD genomic locus, the knock-in targeting constructs used and the TopBP1 locus 
successfully targeted with the respective vectors. Coloured crosses represent the novel restriction sites 
generated after gene targeting to allow RFLP analysis of the obtained clones.  
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Knock-in targeting vectors were linearized by AhdI digestion and electroporated 
into TopBP1-/-/+ cells. Transformants were selected in the presence of puromycin and 5-
7 days later puromycin-resistant clones were expanded and screened by PCR analysis 
for successful knock-in targeting. More specifically, the screening strategy was a two-
step process. First, PCR with primers P70 and P71 was performed to screen for cells 
that had successfully integrated the knock-in construct within intron 21 of the intact 
TopBP1 locus of TopBP1-/-/+ cells. P70 annealed to a genomic region 5’ with respect to 
the left homology arm and P71 annealed within the selection marker cassette (Figure7.2 
A). In this way the PCR product would be specific to the locus of interest avoiding the 
selection of false positive clones that have erroneously integrated the targeting 
construct. Of the 35 potential TopBP1-/-/+SS and of the 45 potential TopBP1-/-/+SA clones 
screened, 9 and 7 were classified as positive according to PCR analysis, respectively. 
Additionally, of the 28 potential TopBP1-/-/+WW and of the 55 potential TopBP1-/-/+WR 
clones screened, 4 and 10 were classified as positive according to PCR analysis, 
respectively (data not shown). 
Next, the method of RFLP was employed whereby incorporation of the mutation 
would create a novel restriction site allowing in this way identification of successfully 
targeted clones.  More specifically, successful targeting of the AAD-SAki construct and 
incorporation of the S1132A mutation would generate a novel NaeI site, whereas 
successful targeting of the AAD-WRki construct and incorporation of the W1139R 
mutation would generate a novel NciI site. Clones successfully targeted with the control 
constructs, AADSSki (S1132S) and AAD-WWki  (W1139W), would not contain such 
restriction sites. Therefore in the second step of the screening strategy, the PCR product 
of clones classified as positive from step 1 was digested with the appropriate restriction 
enzyme to identify those clones that have incorporated the mutation of interest. As 
shown in Figure 7.2 B, all TopBP1-/-/+SS and TopBP1-/-/+WW control clones did not 
present fragment size variation before and after digestion, as expected (compare top and 
bottom of the gel). In contrast, 3 of the 7 potential TopBP1-/-/+SA clones presented bands 
corresponding to NaeI-digested DNA fragments suggesting successful incorporation of 
the S1132A mutation. Additionally, 7 of the 10 potential TopBP1-/-/+WR clones presented 
bands corresponding to NciI-digested DNA fragments suggesting successful 
incorporation of the W1139R mutation. All clones classified as positive by the second 
step of the screening strategy were confirmed by Sanger sequencing and appropriately 
frozen down in liquid nitrogen. 
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Finally, to remove the selection marker cassette from intron 21, the stably 
integrated Cre recombinase was induced by treatment of cells with 2µM 4-HT. 24h 
later, treated cells were serially diluted and 5-7 days later single colonies were expanded 
and tested for their sensitivity to puromycin. All of the single clones isolated have lost 
resistance to puromycin suggesting successful removal of the selection cassette from the 
TopBP1 locus (Figure 7.2 C). This was also confirmed by PCR analysis with primers 
P70 and P72 (data not shown).  
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Figure 7.2: Generation of AAD mutant DT40 cells. A) Schematic representation of the AAD locus of 
TopBP1-/-/+SS, TopBP1-/-/+SA, TopBP1-/-/+WW and TopBP1-/-/+WR cell lines following successful knock-in 
targeting. On the right four panels show the sequencing data of the genomic DNA from the 
aforementioned cell lines, confirming the mutation of TCC to GCC (S1132A) and of TGG to CGG 
(W1139R) as well as the corresponding silent mutations in the control cell lines  (see text for details). 
B) RFLP analysis of puromycin resistant clones obtained following transfection of the knock-in targeting 
constructs into the TopBP1-/-/+ cell line. PCR was performed with primers P70 and P71 shown in A and 
the PCR products were digested with NaeI (SA) or NciI (WR) to confirm successful integration of the 
point mutations. C) Positive clones obtained from B were incubated with 2µM 4-HT for 24h and serially 
diluted to obtain single clones that have successfully floxed the selection cassette and have become 
puromycin sensitive again. The parental cell lines served as the control on the experiment. 
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7.1.2: Inactivation of TopBP1 S1132 leads to a defective checkpoint response to 
replication stress caused by hydroxyurea 
 To gain insight into a potential functional role of the TopBP1 S1132 residue 
during replication stress, colony formation assays in HU were initially performed for 
TopBP1+/+/+, TopBP1-/-/+SS and TopBP1-/-/+SA cell lines. The data obtained from 
continuous exposure to HU using semi-solid media suggested that TopBP1-/-/+SA cells 
are more sensitive to replication stress caused by HU than their TopBP1-/-/+SS control 
counterparts. More specifically, the mutant strains seemed to tolerate concentrations of 
HU up to 20µM but their sensitivity became apparent at higher concentrations (40-
80µM). The data showed that the S1132 residue of TopBP1 is important for the ability 
of DT40 cells to survive HU-caused genotoxic stress (Figure 7.3 A). 
 To further explore this increased HU sensitivity, TopBP1-/-/+SA cells were 
examined for their ability to activate the G1-S and S-M as well as the G2-M DNA 
damage checkpoints when treated with HU. To do so, TopBP1+/+/+, TopBP1-/-/+SS and 
TopBP1-/-/+SA cells were grown in the continuous presence of 1mM HU for 6h and 
samples for Western blot, FACS and microscopic analyses were taken at 0, 1, 2, 4 and 
6h post addition of the drug. As shown in Figure 7.3 B, treatment of wild-type cells 
with 1mM HU led to a slight increase in the levels of TopBP1 at 6h after addition of 
HU. Additionally, HU addition led to phosphorylation of pS345 Chk1 after 1h to levels 
22.9-fold over the untreated. This phosphorylation was maintained at similar levels until 
2h and during the last two hours of the time course it further increased to 24.6- and 27-
fold. Phosphorylation of S139 γH2AX increased to 23.9-fold 1h post HU addition and 
reached a maximum of 38.6-fold over untreated at 2h whereas at later time points it 
reduced to 19.1- and 22.4-fold. The control strain TopBP1-/-/+SS displayed an altered 
response similar to the response of TopBP1-/-/+ compared to wild-type, as explained in 
Chapter 6. In fact, TopBP1-/-/+SS displayed a reduced ability of phosphorylating Chk1 
with pS345 reaching levels of 13.8-, 16.3-, 23.4- and 21.6-fold over untreated at 1, 2, 4 
and 6h, respectively. Phosphorylation of γH2AX was also impaired as TopBP1-/-/+SS 
cells failed to display the initial increase of pS139 observed in the wild-type cells. In 
fact, TopBP1-/-/+SS increased pS139 to only 17.7- and 12-fold over untreated 1h and 2h 
post HU addition, respectively. Checkpoint activation of TopBP1-/-/+SS persisted until 6h 
as indicative of Chk1 phosphorylation but the extent of pS345 was reduced compared to 
wild-type cells. Interestingly, the TopBP1-/-/+SA mutant presented an even more defective 
checkpoint response than its TopBP1-/-/+SS counterpart control. Mutation of the S1132 
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residue of TopBP1 interfered with the ability of DT40 cells to both phosphorylate S345 
Chk1 and S139 γH2AX. TopBP1-/-/+SA cells phosphorylated S345 with the same kinetics 
as the control cells and following the same pattern but the extent of pS345 Chk1 was 
consistently reduced. In fact, they presented a 12.3- and 14.3-fold increase at 1 and 2h 
of HU exposure and reached a maximum of 17.6-fold after 4h (versus 23.4-fold 
observed in the control cells) before a slight drop to 17.1-fold at the end of the time 
course. Furthermore, consistent with a defective checkpoint response, TopBP1-/-/+SA 
mutants showed only an 8.2- and 9.5-fold increase over untreated of pS139 γH2AX 
when exposed to 1mM HU for 1 and 2h, respectively. Phosphorylation of γH2AX 
remained at low levels at 4h and reached a maximum value at 6h post HU addition (7.4- 
and 10.4 fold over untreated, respectively). As for the levels of the TopBP1, the mutant 
cells were able to increase protein levels over the untreated in a manner very much like 
the wild-type cells so in that sense they were not defective, which comes in contrast to 
their TopBP1-/-/+SS counterparts. However, it is worth noticing that the levels of the 
TopBP1 protein pool inside the mutant cells are by default reduced compared to 
TopBP1-/-/+SS. In fact, quantification of the TopBP1 levels over background showed that 
TopBP1-/-/+SA mutants contain only 56% of the TopBP1 protein levels found in TopBP1-
/-/+SS, raising the question of whether the S1132A mutation influences the stability of the 
protein. 
 To assess whether treatment of the mutant cells with HU interfered with cellular 
integrity, samples from the 6h time course were fixed on glass slides, stained with DAPI 
and analyzed by microscopy. This experiment showed that HU treatment led to a 
progressive accumulation of fragmented nuclei –a hallmark of apoptosis- in the cultures 
of the mutant cells. In fact, 4h in HU were enough to kill 6.5% of the mutant cells when 
only 3.5% of TopBP1-/-/+SS contained fragmented nuclei. By 6h the extent of fragmented 
nuclei further increased to 4.5% and 8% for the TopBP1-/-/+SS and TopBP1-/-/+SA, 
respectively (Figure 7.3 C).  
 Cell cycle analysis by flow cytometry (Figure 7.3 D) revealed that despite the 
slight defects of the S132A mutants in the strength and kinetics of checkpoint activation 
in response to HU, they were able to arrest the cell cycle by 6h similarly to the wild-
type and control counterparts. Importantly, to ensure that the phenotypes observed were 
not specific to a single TopBP1-/-/+SA mutant clone, four different isolates were analysed 
by FACS and two different isolates by Western blot. 
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Figure 7.3: Checkpoint activation defect of S1132A TopBP1 mutant in response to continuous 
replication stress. A) Colony survival assay of the indicated cell types plated singularly in HU-
containing semi-solid media at the indicated concentrations. Error bars represent the standard deviation of 
the mean for three independent experiments. B, C, D) The indicated strains were treated with 1mM HU 
and samples were kept at the specified times for analysis by Western blotting, FACS and DAPI staining. 
B) Whole cell lysates of the indicated DT40 cell types were prepared and run on SDS-PAGE gel. Western 
blots were analysed using antibodies against total TopBP1, phosphor-specific S345 Chk1 antibody, total 
Chk1 and phosphor-specific S139 γH2AX, while GADPH served as the loading control. Charts at the 
bottom represent quantification of the Western blots using the ImageJ software. Experiments have been 
repeated at least twice and representative figures are shown. C) Cells were fixed on microscopy slides and 
stained with DAPI to analyse nuclear morphology. 200 cells were scored in total and error bars represent 
the standard deviation of the mean for at least two independent experiments. D) Flow cytometry analysis 
of samples fixed with propidium iodide. A representative blot of three independent and consistent 
experiments is presented in this figure. Note that equivalent results have been obtained from repeat 
experiments. 
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To investigate whether the observed checkpoint response defects of the TopBP1-
/-/+SA mutants were correlated with the extent of genotoxic stress, cells were treated with 
lower doses of HU and checkpoint activation assessed in the same way as before. 
Treating asynchronously growing TopBP1-/-/+SA cells with 0.25mM HU resulted to 
increased TopBP1 protein levels 2h post drug addition for both the wild-type and the 
TopBP1-/-/+SS controls (1.4-fold over untreated for both). At later time points TopBP1 
levels returned to basal levels for wild-type cells whereas TopBP1-/-/+SS further increased 
TopBP1 to 1.6-fold over untreated at 4h and this increase was sustained until 6h. 
TopBP1-/-/+SA mutants, however, failed to increase their TopBP1 levels. Furthermore, 
although TopBP1+/+/+ and TopBP1-/-/+SS presented a significant increase in the extent of 
S345 Chk1 phosphorylation as early as 1h post addition of HU (8.2- and 6.9-fold, 
respectively), TopBP1-/-/+SA mutants failed to do so. At later time points, wild-type cells 
sustained pS345 Chk1 at constant levels of around 5-fold over untreated. Similarly, 
TopBP1-/-/+SS maintained the S345 phosphorylated pool of Chk1 but the extent of 
phosphorylation was lower than wild-type at 2 and 4h (~4-fold over untreated) and 
slightly higher at 6h (5.6-fold).   Interestingly, 2h post drug addition mutant cells 
displayed pS345 Chk1 of levels comparable to the control cell lines, but during later 
time points they sustained pS345 at lower but steady levels. Additionally, 
phosphorylation of S139 γH2AX followed the same pattern as in Figure 7.3. More 
specifically, although the lower HU concentration used here ameliorated the defects of 
the TopBP1-/-/+SS controls, TopBP1-/-/+SA mutants still displayed a markedly reduced 
ability to phosphorylate S139 γH2AX (Figure 7.4 A). 
 Microscopic analysis of DAPI-stained time course samples revealed that the 
milder HU treatment helped reduce the number of dead cells in the cultures of TopBP1-/-
/+SA mutants to 3.5% at 6h (when TopBP1-/-/+SS controls had 1% of their cells displaying 
an apoptotic phenotype) (Figure 7.4 B). Furthermore, cell cycle analysis by flow 
cytometry revealed that despite the defects of TopBP1-/-/+SA mutant cells in the strength 
and kinetics of checkpoint activation in response to 0.25mM HU, they were able to 
arrest the cell cycle by 6h similarly to their TopBP1-/-/+SS counterparts, albeit with 
slower kinetics (Figure 7.4C).  
Taken together, the above data suggest that the TopBP1 S1132 residue is 
required for proper functioning of the replication stress checkpoint. Mutation of this 
phosphorylatable serine to a non-phosphorylatable alanine results to a defective 
checkpoint response characterized by an inability to increase TopBP1 protein levels and 
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abnormally reduced phosphorylation of Chk1 on S345 and γH2AX on S139. And 
although mutant cells successfully arrested at G1/S, they did so with slightly slower 
kinetics and at the expense of some cell death, as evident from DAPI staining of the 
nucleus.  Milder replication stress by using lower concentrations of HU did not 
ameliorate the defects of the mutant cells in checkpoint activation, although it did 
improve the response of TopBP1-/-/+SS controls as has been already described in Chapter 
6. 
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Figure 7.4: Milder checkpoint activation defect of S1132A TopBP1 mutant in response to lower 
HU-caused replication stress. A, B, C) The indicated strains were treated with 0.25mM HU and samples 
were kept at the specified times for analysis by Western blotting, FACS and DAPI staining. A) Whole 
cell lysates of the indicated DT40 cell types were prepared and run on SDS-PAGE gel. Western blots 
were analysed using antibodies against total TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 
and phosphor-specific S139 γH2AX, while GADPH served as the loading control. Charts at the bottom 
represent quantification of the Western blots using the ImageJ software. Experiments have been repeated 
at least twice and representative figures are shown. B) Cells were fixed on microscopy slides and stained 
with DAPI to analyse nuclear morphology. 200 cells were scored in total and error bars represent the 
standard deviation of the mean for at least two independent experiments. C) Flow cytometry analysis of 
samples fixed with propidium iodide. A representative blot of three independent and consistent 
experiments is presented in this figure. Note that equivalent results have been obtained from repeat 
experiments. 
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7.1.3: Inactivation of TopBP1 S1132 leads to a defective recovery from replication 
stress caused by hydroxyurea 
 To examine whether the S1132 residue of TopBP1 is also important for the 
recovery from replication stress, TopBP1+/+/+, TopBP1-/-/+SS and TopBP1-/-/+SA cells were 
arrested in G1/S by treatment with 0.25mM HU for 12h and then were washed clear of 
the drug and followed through a period of 6h recovery time. Western blot analysis 
(Figure 7.5 A, B) revealed that phosphorylation of S345 Chk1 and S139 γH2AX after 
exposure to HU as well as during release from the block was slightly impaired in a 
TopBP1 S1132-dependent manner. The 12h HU block resulted in a 9.2-fold increase of 
the pS345 Chk1 pool in TopBP1+/+/+ cells and this phosphorylation persisted at elevated 
levels during the 6h recovery time. Consistent with the phenotypes observed in Figures 
7.3 and 7.4, TopBP1-/-/+SA cells were impaired in their ability to phosphorylate Chk1 on 
S345 to the extent of the TopBP1-/-/+SS controls after 12h incubation with HU. Only a 
5.3- and 4.7-fold increase in the pS345 Chk1 population was observed for the two 
TopBP1-/-/+SA independent clones tested when in fact TopBP1-/-/+SS controls displayed a 
7.4-fold increase. From this analysis it is also observed that the mutant cells failed to 
maintain elevated levels of pS345 during the recovery period and so pS345 returned to 
near-basal levels. This is different from what was observed in wild-type cells, which 
displayed increased pS345 Chk1 even 6h post-release (6.8-fold over untreated versus 
0.7- and 1.8-fold for the mutant clones), indicative of persisting checkpoint activation. 
Furthermore, TopBP1-/-/+SS cells were characterized by an increase in the population of 
phosphorylated γH2AX by the end of the HU block (22.9-fold over untreated), 
compared to TopBP1+/+/+ (21-fold) and TopBP1-/-/+SA (13.3- and 11.7-fold for the two 
clones). During the release period, TopBP1+/+/+ cells retained increased pS139 for two 
hours, before phosphorylation started to decline (18.6-, 17.3-, 5.7- and 4.2-fold at 1, 2, 4 
and 6h post-release, respectively). TopBP1-/-/+SS control followed a similar trend like 
wild-type albeit with altered kinetics. In contrast, TopBP1-/-/+SA clones displayed a 
severe inability of increasing pS139 γH2AX. By the end of the HU block they managed 
to reach a 13.3- and 11.7-fold increase over the untreated levels but this quickly 
returned to basal levels at 4h post release. 
 At the same time analysis of the cell cycle profile by flow cytometry revealed 
that all the three cell types successfully halted the cell cycle in response to the HU  
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Figure 7.5: S1132 TopBP1-dependent recovery from replication stress. A, B, C) The indicated strains 
were treated with 0.25mM HU for 12h, washed clear of the drug and samples were kept at the specified 
times for analysis by Western blotting and FACS. A) Whole cell lysates of the indicated DT40 cell types 
were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies against total 
TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 and phosphor-specific S139 γH2AX, while 
GADPH served as the loading control. B) Quantification of the Western blots in A using the ImageJ 
software. Experiments have been repeated at least twice and representative figures are shown. C) Flow 
cytometry analysis of samples fixed with propidium iodide. 
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treatment, suggesting that the slightly altered checkpoint response observed by Western 
blot analysis did not affect the cell cycle kinetics (Figure 7.5 C).  
 
7.1.4: Inactivation of TopBP1 S1132 leads to a defective response to DNA damage 
caused by ionizing radiation and induces cell death. 
 To determine whether mutation of TopBP1 S1132 confers sensitivity to killing 
by IR, TopBP1+/+/+, TopBP1-/-/+SS and TopBP1-/-/+SA cells were exposed to 1 or 2Gy of 
IR and then plated onto semi-solid media to examine their colony forming ability, hence 
their replicative and survival potential following DNA damage. As shown, in Figure 
7.6 A, the TopBP1-/-/+SA mutants displayed significantly reduced survival compared to 
TopBP1+/+/+ and TopBP1-/-/+SS controls, which was exacerbated with increasing doses of 
radiation. It should be noted that the mutant cells did not survive higher doses of IR 
tested (4, 6 and 8Gy) despite the fact that 10-fold more cells were plated compared to 
wild-type.   
 To further explore a potential role of TopBP1 S1132 in damage-induced G2/M 
arrest, TopBP1+/+/+, TopBP1-/-/+SS and TopBP1-/-/+SA cells were exposed to 6Gy of IR and 
followed through a period of 6h recovery time. Analysis of whole cell extracts by 
Western blot at 0, 2, 4, 6 and 8h post-IR revealed a defective checkpoint activation 
response compared to control cell types. In fact, mutant cells were characterized by an 
inability to phosphorylate S345 Chk1 to the levels observed for their TopBP1-/-/+SS 
counterparts. So although TopBP1-/-/+SS showed 3.8-, 2-, 1.5- and 1.4-fold increase over 
untreated at 2, 4, 6 and 8h post-IR, respectively, TopBP1-/-/+SA showed only 2.4-, 1.2-, 
0.8- and 1-fold increase at the same time points. Thus there was a consistently decreased 
ability of phosphorylating the effector kinase following DNA damage. Phosphorylation 
of γH2AX on S139 was also found to be dependent on TopBP1 S1132 as TopBP1-/-/+SA 
mutants displayed an inability to boost pS139 1h post IR to the extent of the TopBP1-/-
/+SS controls (3.3/4.7- versus 9.1-fold over untreated). This reduced phosphorylation of 
γH2AX was consistent across all the time points tested suggesting an inherent defect in 
checkpoint activation of DT40 cells expressing only TopBP1 S1132A (Figure 7.6 B).  
 Interestingly, DAPI staining of the nuclei revealed that 6Gy of ionizing radiation 
sensitized TopBP1-/-/+SA mutants, as evident from the altered morphology of the nuclear 
chromatin. In fact, the number of fragmented nuclei in the TopBP1-/-/+SA cultures was 
almost two-fold higher at 4, 6 and 8h post-IR (9, 13.5 and 18.5%) compared to TopBP1-
/-/+SS controls (4.5, 6.5 and 9%) (Figure 7.6 C).  
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 Examination of the cell cycle phase distribution revealed that the TopBP1-/-/+SA 
mutants progressed towards a damage induced G2/M arrest with altered kinetics 
compared to both the wild-type and the TopBP1-/-/+SS controls. In fact, 8h following 
irradiation TopBP1+/+/+ and the TopBP1-/-/+SS displayed a 4N DNA content indicative of 
a successful G2/M arrest. In contrast, although the majority of TopBP1-/-/+SA cells had 
reached a G2/M arrest, a subset still presented a DNA content corresponding to S phase 
(Figure 7.6 D). 
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Figure 7.6: S1132 TopBP1-dependent checkpoint activation in response to IR. A) Colony survival 
assay of the indicated cell types plated singularly in semi-solid media following exposure to the indicated 
doses of IR. Error bars represent the standard deviation of the mean for three independent experiments. B, 
C, D) The indicated strains were irradiated with 6Gy of IR and samples were kept at the specified times 
for analysis by Western blotting, FACS and DAPI staining. B) Whole cell lysates of the indicated DT40 
cell types were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies 
against total TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 and phosphor-specific S139 
γH2AX, while GADPH served as the loading control. Charts at the bottom represent quantification of the 
Western blots using the ImageJ software. Experiments have been repeated at least twice and 
representative figures are shown. C) Cells were fixed on microscopy slides and stained with DAPI to 
analyse nuclear morphology. 200 cells were scored in total and error bars represent the standard deviation 
of the mean for at least two independent experiments. D) Flow cytometry analysis of samples fixed with 
propidium iodide. A representative blot of three independent and consistent experiments is presented in 
this figure. Note that equivalent results have been obtained from repeat experiments. 
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7.1.5: Inactivation of TopBP1 S1132 leads to a milder defect in checkpoint 
activation in response to DNA damage caused by low doses of ionizing radiation 
and does not induce cell death. 
 To examine whether lower doses of ionizing radiation could alleviate the 
phenotypes of the S1132A mutants, TopBP1+/+/+, TopBP1-/-/+SS and TopBP1-/-/+SA cells 
were exposed to 3Gy of IR and followed through a period of 6h recovery time as before. 
Western blot analysis revealed a similar response as in Figure 7.6 B, with TopBP1-/-/+SA 
mutants being characterized by a reduced ability to phosphorylate the Chk1 effector 
kinase on S345 as well the γH2AX marker on S139 compared to the TopBP1-/-/+SS 
controls. In fact, 2h post-irradiation TopBP1-/-/+SS presented 3.1-fold increase of pS345 
Chk1 and 25.7-fold increase of pS139 γH2AX over untreated. In contrast, the two 
independent TopBP1-/-/+SA mutant clones tested presented 1.6-/1.9-fold increase of 
pS345 Chk1 and 12.1-/15-fold increase of pS139 γH2AX over untreated at the same 
time point. This reduced ability of the mutant cell type to catalyze the Chk1 and γH2AX 
phosphorylation events was consistent across the entire 6h recovery period investigated 
(Figure 7.7 A, B). 
 Interestingly, microscopic analyses of DAPI-stained nuclei revealed that the low 
dose of IR used herein was insufficient to induce nuclear fragmentation in the TopBP1-/-
/+SA cultures. So only 2.5% and 2% of the TopBP1-/-/+SS and TopBP1-/-/+SA cells appeared 
to contain fragmented nuclei 8h post-IR. This suggests that although TopBP1 S1132A 
leads to a defective checkpoint response after both high (6Gy) and low (3Gy) doses of 
IR, it is the extent of the damage that will dictate the outcome in terms of cellular 
viability (Figure 7.7 C). 
 Cell cycle progression towards an IR-caused G2/M arrest was found to be 
slower for the TopBP1-/-/+SA cells than for the controls, as in Figure 7.6 D. At 8h 
following irradiation TopBP1+/+/+ and the TopBP1-/-/+SS displayed 4N DNA content 
whereas a subset of TopBP1-/-/+SA cells still presented a DNA content corresponding to S 
phase (Figure 7.7 D). 
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Figure 7.7: S1132 TopBP1-dependent checkpoint activation in response to low IR doses. A, B, C) 
The indicated strains were irradiated with 3Gy of IR and samples were kept at the specified times for 
analysis by Western blotting, FACS and DAPI staining. A) Whole cell lysates of the indicated DT40 cell 
types were prepared and run on SDS-PAGE gel. Western blots were analysed using antibodies against 
total TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 and phosphor-specific S139 γH2AX, 
while GADPH served as the loading control. B) Quantification of the Western blots in A using the 
ImageJ software. Experiments have been repeated at least twice and representative figures are shown. C) 
Cells were fixed on microscopy slides and stained with DAPI to analyse nuclear morphology. 200 cells 
were scored in total and error bars represent the standard deviation of the mean for at least two 
independent experiments. D) Flow cytometry analysis of samples fixed with propidium iodide. 
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7.1.6: The W1139 core AAD residue of TopBP1 is required for ATR pathway 
activation in response to replication stress caused by hydroxyurea. 
 To investigate the function of the W1139 core indispensable aromatic residue of 
the TopBP1 AAD in ATR pathway activation following replication stress, TopBP1+/+/+, 
TopBP1-/-/+WW and TopBP1-/-/+WR cells were plated onto HU-containing semi-solid 
media at the indicated concentrations. Mutation of the W1139 residue to R was 
correlated with a markedly increased sensitivity to killing by HU even at concentrations 
as low as 20 and 40µM that do not affect the survival of the control cell lines. This 
suggested that the TopBP1 W1139 residue is critical for sustaining cell survival during 
continuous exposure to HU (Figure 7.8 A).  
 To more precisely understand the function of TopBP1 W1139 in the replication 
stress checkpoint response, TopBP1+/+/+, TopBP1-/-/+WW and TopBP1-/-/+WR cells were 
grown in the continuous presence of 0.2mM HU for 6h and samples for Western blot, 
FACS and microscopy were kept at 0, 1, 2, 4 and 6h post addition of the drug. It is 
worth mentioning that higher concentrations of HU induced cell death within one cell 
cycle and the 0.2mM used herein was the optimal concentration that could both yield 
checkpoint activation in the control cell lines and not entirely kill the mutant cells 
within the time window studied. Interestingly, the mutant cells presented an inability of 
increasing the levels the total TopBP1. Instead the total TopBP1 protein levels were 
attenuated.  
Immunostaining for phosphorylated Chk1 (pS345 Chk1) to detect substrates 
downstream of ATR activation showed an increase of pS345 Chk1 in TopBP1+/+/+ 
(between 4.6- and 6.2-fold over untreated) and to a lesser extent TopBP1-/-/+WW 
(between 3.2- and 3.4-fold over untreated) controls across the entire period of 6h post 
HU addition. In marked contrast, TopBP1-/-/+WR mutants displayed a marginal increase 
of pS345 Chk1 only reaching 1.9- and 1.5-fold over untreated at 1h and 2h post HU 
addition, respectively. At later time points the pool of pS345 Chk1 in TopBP1-/-/+WR 
cells returned to levels below what is found in the untreated situation which contrasts 
with the increased and sustainable phosphorylation of the effector kinase observed in 
the control cell types. Notably, the mutant cells also seem to contain less of total Chk1 
protein and their Chk1 pool is characterized by an altered electrophoretic mobility 
compared to the control cell lines (α-Chk1 immunostaining). Interestingly, mutant cells 
also presented a defective pattern of S139 γH2AX phosphorylation. More specifically, 
TopBP1-/-/+WR presented higher levels of pS139 (5.4-fold over untreated) compared to 
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their TopBP1-/-/+WW counterparts (3.4-fold over untreated) after 1h in the presence of 
HU. This hyper phosphorylation returned to abnormally low levels at later time points 
when in fact control cell types maintained pS139 at high levels (Figure 7.8 B). Finally, 
it should be noted that another independent TopBP1-/-/+WR clone was subjected to the 
same experiment and the same phenotypes were observed.  
 What is more, continuous exposure to 0.2mM HU affected the integrity of the 
TopBP1-/-/+WR cells. DAPI staining of fixed samples across the same time points 
revealed a progressive accumulation of cells with fragmented nuclei in the TopBP1-/-
/+WR cultures. As early as 2h after drug addition 4.5% of the mutant cells displayed 
fragmented nuclei, which increased to 19.5% and 29% at 4 and 6h, respectively. 
Prolonged exposure to HU for 14h resulted to 69% of the TopBP1-/-/+WR cells presenting 
fragmented nuclei, a hallmark of apoptosis. This apoptotic phenotype was severe 
compared to the 6, 6.5 and 9% of fragmented nuclei observed in the TopBP1-/-/+WW 
controls at 4, 6 and 14h, respectively (Figure 7.8 C). 
 Analysis of the cell cycle by flow cytometry revealed a sub-G1 accumulation of 
a subset of the mutant cells at 4h post HU addition. Notably, by 6h the majority of the 
cells displayed a sub-G1 phenotype. All of the four independent TopBP1-/-/+WR clones 
tested displayed a similar cell cycle profile following HU treatment (Figure 7.8 D). 
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Figure 7.8: W1139 TopBP1-dependent replication checkpoint activation in response to HU. A) 
Colony survival assay of the indicated cell types plated singularly in HU-containing semi-solid media at 
the indicated concentrations. Error bars represent the standard deviation of the mean for three independent 
experiments. B, C, D) The indicated strains were treated with 0.2mM HU and samples were kept at the 
specified times for analysis by Western blotting, FACS and DAPI staining. B) Whole cell lysates of the 
indicated DT40 cell types were prepared and run on SDS-PAGE gel. Western blots were analysed using 
antibodies against total TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 and phosphor-
specific S139 γH2AX, while GADPH served as the loading control. Charts at the bottom represent 
quantification of the Western blots using the ImageJ software. Experiments have been repeated three 
times and representative data is shown. C) Cells were fixed on microscopy slides and stained with DAPI 
to analyse nuclear morphology. 200 cells were scored in total and error bars represent the standard 
deviation of the mean for at least two independent experiments. D) Flow cytometry analysis of samples 
fixed with propidium iodide. A representative blot of three independent and consistent experiments is 
presented in this figure. Note that equivalent results have been obtained from repeat experiments. 
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7.1.7: The W1139 core AAD residue of TopBP1 is required for ATR pathway 
activation and cell fate during recovery from replication stress caused by 
hydroxyurea. 
 To assess the function of the W1139 residue of TopBP1 during recovery from 
replication stress, TopBP1+/+/+, TopBP1-/-/+WW and TopBP1-/-/+WR cells were arrested in 
G1/S by treatment with 0.125mM HU for 15h and then were washed clear of the drug 
and followed through a period of 6h recovery time. The longer HU block (15h herein 
compared to 12h block used in previous experiments) was applied due to the longer 
doubling time of the TopBP1-/-/+WR cells (~14.2h) compared to their TopBP1-/-/+WW 
counterparts (~11h). Western blot analysis at the indicated time points revealed a down 
regulation of the TopBP1 protein levels in TopBP1-/-/+WR, which contrasts the increased 
TopBP1 levels observed in the TopBP1+/+/+ and TopBP1-/-/+WW controls.  
Furthermore, phosphorylation of the effector kinase Chk1 on S345 was 
attenuated in TopBP1-/-/+WR cells (pS345 Chk1 immunoblot). This attenuation of pS345 
was coupled with a concomitant down regulation of the total Chk1 protein levels (Chk1 
immunoblot) observed at the end of the HU block as well as post release. The 
percentage of pS345 Chk1 relatively to total Chk1, however, was higher in the mutant 
cells. In fact, the TopBP1-/-/+WW controls showed 8.2-fold increase of pS345 Chk1 over 
untreated by the end of the arrest, which was not too different from what was observed 
in the TopBP1-/-/+WR clones (10.6- and 7.3-fold). During the release from the HU block, 
however, the total Chk1 protein was reduced in the mutant cells that the percentage of 
Chk1 being phosphorylated on S345 increased to 28.6/12.6-, 18.6/30.1-, 52/47.9- and 
26/8.1-fold for the TopBP1-/-/+WW♯1 and TopBP1-/-/+WW♯2 mutant clones, respectively, at 
1, 2, 4 and 6h post release. In marked contrast, pS345 Chk1 in TopBP1-/-/+WR controls 
progressively returned to near basal levels during the recovery period. Another 
interesting observation is that the autophosphorylation of Chk1 picked up by the 
antibody against total Chk1 at the end of the HU block is not observed in the mutant 
cells. Finally, phosphorylation of pS139 γH2AX was defective in cells containing a 
mutated AAD.  Both of the TopBP1-/-/+WR clones were unable to catalyse this 
phosphorylation event to the extent of the TopBP1-/-/+WW controls across all the time 
points examined (Figure 7.9 A, B). 
 The attenuation of the Chk1 protein levels observed in the above experiment as 
well as the observation that continuous exposure to 0.125mM HU for 15h leads to a 
substantial increase in nuclear fragmentation (Figure 7.8 C), prompted me to examine in 
 228 
yet another way whether replication stress caused by HU induces apoptosis in DT40 
cells mutated for the TopBP1 AAD core residue. Figure 7.9 C shows agarose gel 
electrophoresis analysis at the indicated time points of TopBP1+/+/+, TopBP1-/-/+WW and 
TopBP1-/-/+WR blocked in 0.125mM HU and released. This experiment demonstrated the 
ladder pattern of DNA fragmentation in the cultures of the mutant cells. Overall, 
abolishment of TopBP1 W1139 leads to apoptosis following replication stress as 
evident from both inactivation of Chk1 and internucleosomal DNA fragmentation. 
 Finally, cell cycle analysis of the respective samples confirmed that the lower 
HU block applied here was sufficient to arrest the cells at G1/S, albeit less efficiently in 
the mutants. Interestingly, the TopBP1-/-/+WR were unable to recover from the HU block 
and gradually accumulated at the sub-G1 phase (Figure 7.9 D). 
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Figure 7.9: W1139 TopBP1-dependent cell fate decision during recovery from replication stress. A, 
B, C) The indicated strains were treated with 0.125mM HU for 15h, washed clear of the drug and samples 
were kept at the specified times for analysis by Western blotting, FACS and genomic DNA. A) Whole 
cell lysates of the indicated DT40 cell types were prepared and run on SDS-PAGE gel. Western blots 
were analysed using antibodies against total TopBP1, phosphor-specific S345 Chk1 antibody, total Chk1 
and phosphor-specific S139 γH2AX, while GADPH served as the loading control. B) Quantification of 
the Western blots in A using the ImageJ software. Experiments have been repeated at least twice and 
representative figures are shown. C) Internucleosomal DNA fragmentation in cells treated with 0.125mM 
HU for 15h and released in drug-free media. Genomic DNA was extracted and electrophoresed with 
ethidium bromide staining. In control cells there is lack of DNA fragmentation whereas mutants present a 
“ladder” of internucleosomal DNA fragments at ~200bp intervals (black arrows). Molecular weight 
standards are shown on the left. D) Flow cytometry analysis of samples fixed with propidium iodide. A 
representative blot of three independent and consistent experiments is presented in this figure. Note that 
equivalent results have been obtained from repeat experiments. 
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7.1.8: Inactivation of TopBP1 W1139 leads to a mild defect in checkpoint 
activation in response to DNA damage caused by low doses of ionizing radiation  
 To investigate whether mutation of W1139 within TopBP1 AAD confers 
sensitivity to IR, TopBP1+/+/+, TopBP1-/-/+WW and TopBP1-/-/+WR cells were plated onto 
semi-solid media immediately after being exposed to the indicated doses of IR. 
Quantitative assessment of the colony forming abilities of the respective cell lines 
revealed an inherent sensitivity of TopBP1-/-/+WR cells to killing my IR. This suggested 
that the W1139 residue of TopBP1 might also be required for checkpoint activation in 
response to DNA damage (Figure 7.10 A). 
 To mechanistically understand the role of W1139 in the DNA damage response, 
TopBP1+/+/+, TopBP1-/-/+WW and TopBP1-/-/+WR cell lines were irradiated with 3Gy and 
followed through a period of 8h. It should be noted that higher doses of IR were not 
tolerated by the mutant cells. Western blot analysis showed that TopBP1-/-/+WR mutants 
were unable to phosphorylate S345 Chk1 to the extent of the TopBP1-/-/+WW controls. So 
although TopBP1-/-/+WW showed 6.8-fold increase of pS345 Chk1 2h post IR, the two 
mutant clones showed an attenuated response at 1.5- and 2.7-fold, respectively. This 
reduced ability of phosphorylating S345 was also observed at later time points. Contrary 
to the response observed following HU treatment, here there was no inactivation of the 
Chk1 protein as judged by immunostaining with an antibody against total Chk1.  What 
is more, phosphorylation of pS139 γH2AX was severely impaired in the TopBP1-/-/+WR 
mutant clones as they hardly managed to increase pS139 above the basal levels when in 
fact the TopBP1-/-/+WW controls reached a 12.4-fold increase over untreated as early as 
2h following irradiation (Figure 7.10 B).  
 DAPI staining of fixed cells and assessment of nuclear morphology showed that 
TopBP1-/-/+WR mutants were slightly sensitive to IR. In fact, 6h post IR 10.5% of the 
cells in the TopBP1-/-/+WR cultures presented fragmented nuclei and this rose to 20.5% 
by 8h. In contrast, only 4% of the TopBP1-/-/+WW controls presented the same nuclear 
morphology at 8h (Figure 7.10 C). 
 Cell cycle analysis of the same time points following irradiation with 3Gy 
revealed that despite their slower cell cycle, TopBP1-/-/+WR mutants reached the G2/M 
block with slightly faster kinetics than the TopBP1+/+/+ and TopBP1-/-/+WW controls. 
(Figure 7.10 D). 
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Figure 7.10: W1139 TopBP1 mutants are not sensitive to IR but still possess a defective checkpoint 
response. A) Colony survival assay of the indicated cell types plated singularly in semi-solid media 
following exposure to the indicated doses of IR. Error bars represent the standard deviation of the mean 
for three independent experiments. B, C, D) The indicated strains were irradiated with 3Gy of IR and 
samples were kept at the specified times for analysis by Western blotting, FACS and DAPI staining. B) 
Whole cell lysates of the indicated DT40 cell types were prepared and run on SDS-PAGE gel. Western 
blots were analysed using antibodies against total TopBP1, phosphor-specific S345 Chk1 antibody, total 
Chk1 and phosphor-specific S139 γH2AX, while GADPH served as the loading control. Charts at the 
bottom represent quantification of the Western blots using the ImageJ software. Experiments have been 
repeated three times and representative data is shown. C) Cells were fixed on microscopy slides and 
stained with DAPI to analyse nuclear morphology. 200 cells were scored in total and error bars represent 
the standard deviation of the mean for at least two independent experiments. D) Flow cytometry analysis 
of samples fixed with propidium iodide. A representative blot of three independent and consistent 
experiments is presented in this figure. Note that equivalent results have been obtained from repeat 
experiments. 
-/-/+WW		+/+/+		 -/-/+WR	#1	
0	
2	
4	
6	
Ev
en
ts
	
PI	
Ti
m
e	
po
st
	IR
(h
)	
-/-/+WR	#3	-/-/+WR	#4	
8	
-/-/+WR	#2	
B	
C	
D	
1	 2	 4	
α-TopBP1	
Time		
post	IR(h)	
6	
-/-/+WW		+/+/+		 -/-/+WR	#1	
0	 1	 2	 4	 6	0	 1	 2	 4	 6	0	
-/-/+WR	#2	
1	 2	 4	 6	0	
α-GADPH	
α-pS345	Chk1	
α-Chk1	
α-pS139	γH2AX	
Time	post	IR	(h)	
+/
+/
+	
-/
-/
+W
W
	
-/
-/
+W
R	
0	 8	
0.1	
1	
10	
100	
0	 2	 4	 6	 8	
Fr
ag
m
en
te
d	
nu
cl
ei
	(%
)	
Time	post	IR	(h)	
	+/+/+	 	-/-/+	WW	 	-/-/+	WR	
0	
1	
2	
3	
0	 2	 4	 6	 8	In
cr
ea
se
	o
ve
r	u
nt
re
at
ed
(A
U
)	
Time	post	IR	(h)	
TopBP1	
0	
5	
10	
0	 2	 4	 6	 8	In
cr
ea
se
	o
ve
r	u
nt
re
at
ed
(A
U
)	
	
Time	post	IR	(h)	
	
pS345	Chk1/Chk1	
0	
5	
10	
15	
0	 2	 4	 6	 8	In
cr
ea
se
	o
ve
r	u
nt
re
at
ed
(A
U
)	
Time	post	IR	(h)	
	
γΗ2ΑΧ	
	+/+/+	 	-/-/+	WW	 	-/-/+	WR	 	-/-/+	WR	
A	
1	
10	
100	
0	 1	 2	
Su
rv
iv
al
	(%
)	
	
Gy	
	+/+/+	 	-/-/+WW	 	-/-/+WR	
 233 
Summary of Chapter 7 
 
This chapter describes the use of a novel TopBP1 knock in gene targeting 
system to study the function of the TOPBP1 AAD in DT40.  This involved the 
generation of the TopBP1-/-/+SA and TopBP1-/-/+WR mutant cell lines and their respective 
controls, TopBP1-/-/+SS and TopBP1-/-/+WW. Creation of these mutant cell lines allowed 
the investigation of the function of the TopBP1 AAD in vertebrates, which proved to be 
impossible in the published mice system as inactivation of the AAD led to early 
embryonic lethality (Zhou et al, 2013). The current analysis revealed a role of the 
S1132 residue of TopBP1 in checkpoint activation following replication stress and 
DNA damage. Mutation of this residue to a non-phosphorylatable alanine led to defects 
in phosphorylation of the effector kinase Chk1 on S345 as well as defects in S139 
γH2AX phosphorylation. Such defects were accompanied by nuclear fragmentation of a 
small percentage of the mutant cells in the TopBP1-/-/+SA cultures but did not affect 
genotoxic stress-dependent cell cycle arrest after HU or IR. On the contrary, 
abolishment of the core TopBP1 residue W1139 led to severe phenotypes in response to 
HU, including defective checkpoint signaling, Chk1 inactivation and nuclear 
fragmentation. TopBP1 W1139 is thus required for activation of the ATR-Chk1 
pathway. Defective checkpoint signaling was also observed following irradiation of the 
TopBP1-/-/+WW cells but this did not affect cell fate. The work described herein provides 
novel in vivo evidence of the functions of the TopBP1AAD residues S1132 and W1139 
in checkpoint activation and signaling in vertebrates.  
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Chapter 8 
 
 
 
 
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 235 
8: Discussion 
 The work presented in this thesis describes the development of genetically 
defined systems that enable the study of the TopBP1 protein and its functions in the 
DT40 cells. In the following paragraphs I will briefly summarise the results presented in 
the preceding chapters and discuss their relevance to the literature. 
 
Unsuccessful attempts to knock out TopBP1 in DT40 and establishment of SIOS 
 The aim of this project (Chapters 3 and 4) was to delete the three alleles of the 
TopBP1 gene in DT40 cells, while sustaining cell viability by stably integrating a 
TopBP1 cDNA transgene under the control of a constitutive promoter at the Ova locus. 
With the use of homology-mediated genetic engineering I have achieved the deletion of 
two of the three TopBP1 alleles (~23kb) located on chromosome II of DT40 cells and 
their respective replacement with selection marker cassettes. These cell lines were 
designated TopBP1puro/+/+ and TopBP1puro/his/+. Next, MerCreMer was stably integrated 
in the genome of these two cell lines in a non-targeted manner. Induction of MerCreMer 
nuclear localisation by treatment with 4-HT led to the generation of TopBP1flox/+/+ and 
TopBP1flox/flox/+ cell lines. Before attempting knocking out the third allele of TopBP1, 
the chicken TopBP1 cDNA under the control of the CMV promoter was stably 
integrated within the Ova locus. Subsequent attempts to complete deletion of the 
endogenous TopBP1 copies with LARAHis and LARA2His were unsuccessful (more 
than a thousand cells have been screened in total). The use of the same homology arms 
present in LARAHis probed retargeting of the already targeted alleles. The use of 
LARA2His, on the other hand, revealed a potential erroneous recombination event. 
Finally, the other major caveat of this initial strategy was the insufficient levels of 
TopBP1 being produced from the OvaCMV expression construct, thus perhaps not 
creating the favourable environment for cells to delete their final endogenous TopBP1 
copy. 
To specifically visualise the TopBP1 protein produced from the ectopic 
transgene and also stably integrate more copies of it within the genome (or at potentially 
more favourable loci), a 3xFLAG-tagged version of TopBP1 was subcloned in the 
OvaCMV construct and integrated within the genome of TopBP1flox/flox/+ cells in a non-
targeted manner. Additionally, a new gene-targeting construct (LAiRAiPuro) 
specifically tailored to help avoid retargeting was assembled. Attempts to knock out the 
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third TopBP1 allele, however, were again unsuccessful. Overall, this work has 
established an efficient gene knock out strategy that was successfully used for the 
deletion of the two alleles of TopBP1. Additionally, it was shown that the use of the 
CMV promoter was inadequate for the purposes of our biological system. The next 
challenge was to optimise the levels of TopBP1 protein being produced from the ectopic 
rescue transgene. This involved a novel characterisation of different promoter regions 
driving expression of the TopBP1 cDNA from the Ova (a locus not expressed in DT40 
cells) versus a transcriptionally active locus (designated “euchromatic”). 
 Exogenously expressing a protein of interest has proved to be a valuable tool 
during the study of diverse biological processes. A limiting factor for the development 
of artificial genetic systems is the availability of suitable promoter elements. Many 
constitutive promoters are used during the study of either loss of function (i.e. shRNA) 
or gain of function (i.e. cDNA expression) systems as well as systems designed to 
replace a gene of interest with a mutated copy upon deletion of the endogenous copies 
or to produce recombinant proteins. However, there are few examples of systematic 
comparative studies of the expression levels of commonly used promoter elements in 
specific cell types. Because different experiments have distinct requirements for the 
level of transgene expression, and because there is limited information available on the 
efficiency of different promoter systems, the choice of appropriate promoter is often 
ambiguous: choices are often based on technical convenience or the assumption that, 
since a particular promoter worked in one cell line, it will work similarly in another. 
A characterization of promoter strengths has been performed by Qin et al 2010 
who tested a group of six commonly used mammalian constitutive promoters for their 
ability to drive expression of a GFP reporter in as a panel of eight mammalian cell 
types. They observed that expression from the CMV promoter was the most variable, 
being strong in some cell types but approximately 7–8 fold lower in others.  (Qin, 
Zhang et al. 2010). This finding was consistent with the observation from many other 
groups that the CMV promoter becomes silenced in some cells. A second important 
finding by Qin et al. (2010) was that the EF1A and CAG promoters were similarly 
highly expressed, but were more reliable across all the cell lines tested, varying by less 
than a factor of two (Teschendorf, Warrington et al. 2002, Brooks, Harkins et al. 2004, 
Meilinger, Fellinger et al. 2009, Qin, Zhang et al. 2010).  
 To our knowledge, no charaterisation of promoter elements has been performed 
in the DT40 model system. To identify an expression system suitable for optimal 
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exogenous protein expression in DT40 cells, the already used CMV (cytomegalovirus) 
promoter was compared to the CAG (CMV early enhancer and chicken beta actin) and 
CBA (chicken beta actin) promoter elements, in their respective ability to drive 
expression of the TopBP1 transgene in DT40. The reason I chose these particular 
ubiquitous promoters was that they are generally described as being among the stronger 
constitutive promoters available in molecular biology (Powell, Rivera-Soto et al. 2015). 
Additionally, the CBA promoter has been successfully used for the overexpression of an 
ATR transgene integrated within the OVA locus and the subsequent disruption of the 
endogenous ATR locus of DT40 cells (Eykelenboom, Harte et al. 2013). 
 I demonstrate that CMV is a relatively weak promoter in DT40, producing 
approximately the same quantity of an exogenous TopBP1 reporter protein as is 
produced from a single copy of the native TopBP1 gene. CBA shows several fold higher 
activity while CAG showed the highest level of activity in my assay, resulting in 
approximately 7-8 fold more protein than a single endogenous TopBP1 allele. I di 
observe variation between individual clones for a specific promoter construct but this 
did not exceed three fold. Importantly, the level of protein produced from each of the 
three promoters was not altered following growth for 8 days. This data suggests that 
integration of these promoters in DT40 does not result in silencing over this timeframe 
and thus these are suitable tools for protein expression studies.  
 The Ova locus is commonly used for protein expression in DT40 cells because it 
is transcriptionally silent in tis cell line and it shows a high targeting efficiency 
compared to multiple other loci studied (Buerstedde and Takeda 1991) however, it was 
not clear if the silent nature of the locus would affect the efficiency of the integrated 
promoters. Here I compared the levels of TopBP1 produced from a CAG-driven 
transgene at the Ova locus (OvaCAG) with the same transgene and promoter integrated 
at a euchromatic site (eCAG). Although I did observe that individual clones showed 
variation within each of the two loci (not exceeding three fold), I did not see any major 
difference between the OvaCAG and eCAG clones. From this I conclude that the Ova 
locus is an appropriate choice for integration.  
Taken together, this work has established the creation of SIOS, a system useful 
for the overexpression of the TopBP1 transgene or any protein of interest. Being a stable 
and versatile system, SIOS can indeed prove useful for various experimental purposes 
in the field of DT40, including protein production for biochemical studies and 
generation of knock out cell lines of genes of interest. SIOS is also amenable to 
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recombinase-mediated cassette exchange, which allows the integration of any transgene 
in a one-step reaction. This makes SIOS a rapid tool to examine cellular phenotypes of 
site-specific vertebrate mutants of a gene of interest and examine, in detail, the 
biological and biochemical outcomes with efficiencies equivalent to yeast genetics. 
 Despite the establishment of SIOS, however, subsequent attempts to create the 
TopBP1 knockout using targeted or non-targeted integration of the OvaCAG expression 
construct as well as CRISPR technology were unsuccessful. 
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Characterisation of the TopBP1 mRNA and assembly of a new TopBP1 cDNA capable 
of sustaining viability of TopBP1 knock out  DT40 cells. 
 The inability to obtain the TopBP1 knockout in DT40 cells raised the question of 
whether the amino acid sequence of the TopBP1 protein available from the Genome 
Browser was erroneous or incomplete. The protein sequence of avian TopBP1 on the 
genome browser (XP_015137236.1) is classified as “uncharacterised” and “predicted by 
automated computational analysis”, which suggests there has not been an in vivo 
characterisation of the gallus gallus TopBP1 protein or its RNA, at least not published. 
Instead, the sequence was generated by a prediction program, Gnomon. The main 
problem with computational annotation is that it relies on sequence similarities of 
ORFs, with putatively functional short ORFs (of less than 80 amino acids) being 
assigned lower quantitative conservation scores than protein-coding long ORFs. And 
because the human genome contains millions of small ORFs, cut-offs for 50-100bp-
long ORFs are used by annotation programs, discarding in this way any small ORFs for 
which no experimental evidence exists (Couso and Patraquim 2017). 
 Protein sequence-alignment analysis of the avian TopBP1 with the TopBP1 
homologues of other species did not reveal any obvious misalignment that could help 
identify if the “predicted” primary sequence on the database was incomplete or 
incorrect. The fact, however, that the consensus gallus gallus TopBP1 protein sequence 
started with an arginine instead of a methionine combined with the misalignment of the 
first ten amino acids with those of the TopBP1 homologues, led me to hypothesise that 
perhaps the 5’end of the protein was incorrect or incomplete in some way. Before 
embarking on characterising the TopBP1 mRNA, I decided to use the human cDNA 
transgene as the rescue construct in my knock out system. Overexpression of the human 
TopBP1 cDNA using the OvaCAG SIOS system allowed deletion of the final copy of 
TopBP1flox/flox/+/OVACAGhTopBP1/+/+ cells, thus strengthening my hypothesis that the 
primary sequence of the available chicken cDNA was not providing the function(s) 
required to maintain viability of DT40 cells.  
 To precisely address my hypothesis, however, I isolated the total RNA of wild-
type DT40 cells and performed 5’ RACE with primers specific to the TopBP1 cDNA. 
Analysis of the sequencing data of the 5’ RACE products revealed some interesting 
observations concerning the primary sequence and splicing pattern of the TopBP1 
mRNA in DT40 cells. First and foremost, it was reassuring that the sequencing data 
confirmed the nucleotide and amino acid sequence of the first 908 amino acids of the 
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TopBP1 protein, with amino acid 1 being defined as the database annotated M (ATG). 
Interestingly, however, the region upstream of the consensus M, as this was identified 
by the 5’ RACE, presented some interesting features. Firstly, the 5’ RACE analysis 
defined a region within the database exon 1 of the TopBP1 locus as an intron. A smaller 
subset of the sequenced RACE products contained the entire region annotated as exon 1 
on the genome database, suggesting that the region upstream of the consensus start site 
is subjected to alternative splicing or some other processing activity that results to the 
production of two versions of TopBP1 mRNAs; one with a shorter and one with a 
longer 5’ end. Furthermore, a small region encompassing the end of the database intron 
1 was sequenced in all the 5’ RACE products, suggesting a different intron/exon 
boundary between the first intron and the downstream exon than the consensus. 
Unfortunately, limited sequence information precluded the identification of this 
boundary. Finally, the current analysis identified a new open reading frame (ORF) 
within this 5’ end sequence, which -according to the database- spans across the end of 
intron 1 and the first 90bp (or 87bp) of exon 1. This ORFshort was present in ~74% while 
a smaller subset of those (~10%) containing the ORFshortprocessed, which was identical to 
ORFshort but lacked “GTTAAAGG” upstream of the annotated M. In addition, ~24% of 
the RACE products contained a longer ORF (ORFlong), which corresponds to the ORshort 
region but also contains all downstream sequences until the annotated ATG. Finally, an 
ORFshort’ being composed of the first 20 aa of the ORFshort and an ORFshort’’ resembling 
ORFshort’ were identified in two of the sequenced clones.  
 Assembly of these newly identified ORFs at the 5’ end of the consensus cDNA 
and the OvaCAG SIOS, stable integration within the Ova locus and subsequent attempt 
to knock out the last endogenous copy of TopBP1 showed that the ORFshort and 
ORFshortprocessed sequences provided the function(s) necessary for the viability of DT40 
cell devoid of endogenous TopBP1. Insufficient number of clones obtained from 
TopBP1flox/flox/+/OVACAGnewTopBP1ORFlong/+/+ knockout targeting does not allow us to draw 
conclusions about the functionality of the ORFlong. 
 Closer examination of this newly identified domain reveals that it is a sequence 
rich in arginine residues, the most positive among the 20 amino acids. In fact, this 
peptide is 23.9% R-rich, 15.2% G-rich, 15.2% V-rich and 13% A-rich (Figure 8.1 A). 
A very similar amino acid composition is also observed in the region upstream of the 
ATG of the human homologue. Structure prediction of this sequence using the Phyre2 
software reveals a primarily alpha-helical secondary structure with small intervening 
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disordered sequences (Figure 8.1 B). One possibility is that this ORF provides a 
missing function(s) to the TopBP1 protein itself or alternatively complements a function 
that was partially missing from the 5’ end of the protein. Indeed, one of the most 
common functions of arginine-rich cationic peptides is the stabilisation of 
macromolecular structures through the establishment of appropriate interactions (e.g. 
salt bridges and hydrogen bonds) (Chandana and Venkatesh 2016). Glycine-arginine-
rich (GAR) domains are also frequent targets for arginine methylation, a modification 
that occurs frequently on nucleic acid binding proteins containing a GAR motif 
(Boisvert, Chenard et al. 2005). In fact, GAR domains are particularly common in 
proteins involved in RNA processing and trafficking (Godin and Varani 2007) therefore 
it could be related to the known role of TopBP1 as a transcriptional regulator. 
Interestingly, Mre11 contains a C-terminal GAR domain subjected to methylation.  This 
methylation regulates the exonuclease activity of Mre11 as well as its association with 
sites of DNA damage, thus playing a significant role in the outcome of the checkpoint 
response (Boisvert, Dery et al. 2005, Boisvert, Hendzel et al. 2005). 
The other possibility is that this newly identified ORF is important for post-
transcriptional control of the TopBP1 RNA.  This region may adopt some secondary 
structure(s) that ultimately dictates the function and fate of the TopBP1 RNA. Using the 
RNAstructure Web Server available from the Mathews lab, several potential structures 
that this region can adopt have been computed (Appendix 3). Interestingly, this region 
contains several arrays of guanine bases separated by one or more bases, with potential 
to form G-quadruplex structures (putative quadruplex sequence, PQS). In fact, 
bioinformatic analysis has revealed that RNA PQSs are highly enriched within the 5’ 
UTR of human genes compared to the entire transcriptome (Huppert, Bugaut et al. 
2008). Increasing evidence also suggests the PQSs are involved in the regulation of 
translation (Bugaut and Balasubramanian 2012).  
Another interesting feature of this domain within ORFshortprocessed is that its 
methionine is not in frame with the consensus methionine of TopBP1 such that 
translation seems to terminate at the start of the annotated TopBP1 transcript. Given that 
Western blot analysis with an anti-TopBP1 antibody shows no transgene 
overexpression, it is probable that the reading frame of the protein has been changed. 
Thus it seems that there is some kind of translation initiation regulation within this 
region, given that 64% of the RACE clones contained ORFshort and 10% contained 
ORFshortprocessed.  
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One mechanism for the regulation of translation as well as gene expression 
involves a combination of tRNA abundance with codon usage bias. In general, codons 
recognized by abundant tRNAs are more efficiently translated (Stoecklin and 
Diederichs 2014). Thus a potentially lower abundance of tRNA anti-R in DT40 cells 
combined with the enrichment of R residues within the new ORF region could serve as 
a way of controlling the rate of ribosome scanning or indeed its association with the 
TopBP1 RNA. Besides, it is known that tissue-specific expression of tRNA species is a 
general mechanism of regulating translation in vertebrates (Dittmar, Goodenbour et al. 
2006).  
What is more, there is evidence that codons other than AUG can be used for 
translation initiation. In fact, more than 21 alternative translation initiation codons 
(TICs) have been described in mammalian cells (Touriol, Bornes et al. 2003, Tikole and 
Sankararamakrishnan 2006). Therefore the newly identified ORF is not necessarily 
initiating at the ATG as it has been described so far. An interesting alternative is reading 
this ORF in a +1 frame (relatively to the one presented) and in this way a different ORF 
is created starting from a valine V (GUC) residue (Figure 8.1 C). This region indeed 
resembles an efficient consensus GTG(AG)CCGTCG (Kozak consensus is 
[GCC(AG)CCAUGG] (Kozak 1987)). This frame also creates two stop codons within 
the region corresponding to “new exon”, which can again serve a functional role for the 
ribosome to stall/pause or fall off during scanning of the 5’ end. Overall, it is possible 
that a combination of all the aforementioned mechanisms control the fate of the TopBP1 
RNA. This is not something unheard of; translation of the different isoforms of the 
eIF4G (eukaryotic initiation factor 4G) results from a combination of multiple 
promoters, alternative splicing events and the use of an upstream non-canonical 
initiation codon (Coldwell, Sack et al. 2012). 
But the most important finding strongly supported by the data herein, is that the 
newly identified ORF provides the function necessary to sustain viability of DT40 cells 
in the absence of the endogenous TopBP1 protein. 
Taken together, I have created two TopBP1 knockout model systems useful for 
the study of both the human and the avian TopBP1 proteins. I have also identified the 
bona fide mRNA sequence of the gallus gallus TopBP1 required to sustain viability of 
DT40 cells, where all endogenous TopBP1 alleles have been knocked out. This work 
opens up exciting possibilities concerning the functional importance of this upstream 
region of the TopBP1 mRNA in DT40 cells. Identifying the potential role of this region 
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in functionality of the TopBP1 protein itself, post-transcriptional control of the TopBP1 
RNA, or indeed both would be necessary for a complete characterisation of the avian 
TopBP1. 
 
 
Figure 8.1: Characteristics of the novel 5’region of the TopBP1 RNA. A) Sequence and amino acid 
composition as calculated using the ExPasy ProtParam software. B) Secondary structure as predicted 
from the Phyre2 software. C) Translation of the newly identified upstream RNA sequence of TopBP1 in 
two different frames. Frame 0 uses AUG as the translation initiation codon whereas Frame +1 uses a 
GUC downstream, which resembles more a Kozak consensus. 
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A novel knock in gene targeting system based on the gene dosage-dependent functions 
of TopBP1 
To generate a knock in system for the study of TopBP1, an isogenic set of stable 
cell lines from the chicken B cell line DT40 was established by targeted deletion of the 
TopBP1 alleles. Depending on the researchers needs, all three, two or one of the 
endogenous TOPBP1 alleles can be mutated in TopBP1+/+/+, TopBP1-/+/+ or TopBP1-/-/+ 
cell lines, respectively, leading to the replacement of the total wild-type TopBP1 protein 
inside the cell by the mutant. Analysis of this system revealed that successive deletion 
of the avian TopBP1 alleles led to a progressive reduction of the TopBP1 protein levels. 
This novel DT40 model system allowed the study of the kinetics of the events induced 
by progressive loss of function of TopBP1 in terms of checkpoint activation.  
The very first intriguing observation that led to pursuing all work described in 
chapter 6 was the progressive reduction of TopBP1 protein levels with successive 
deletion of the TopBP1 alleles. This suggested that there was no gene dosage 
compensation from the intact allele(s) for the loss of protein caused by TopBP1 
deletion.  
Progressive gene dosage-dependent reduction of the TopBP1 levels leads to a 
progressively decreasing proliferation rate as well as decreased clonogenic potential of 
DT40. As explained in the introduction, Dpb11TopBP1 –together with Sld2RecQL4 and 
Sld3Treslin/Ticrr– is one of the limiting factors for replication initiation. Overexpression of 
these factors in budding yeast is sufficient to convert late- into early-firing origins 
(Mantiero, Mackenzie et al. 2011). Conversely, low levels of these factors result to low 
levels of replication initiation (Zegerman 2015). Using a novel genetic system with 
varying TopBP1 levels, I provide in vivo evidence that the availability of TopBP1 
determines the rate of replication in DT40 cells. 
More importantly, gene dosage-dependent reduction of TopBP1 causes 
increasing sensitivity to killing by multiple DNA damaging agents. To investigate 
whether this sensitivity translates into genomic instability, TopBP1+/+/+, TopBP1-/+/+ and 
TopBP1-/-/+ cells were examined for their respective checkpoint responses following 
replication stress or DNA damage. Analysis showed that both the replication and the 
DNA damage checkpoint pathways are TopBP1 dosage- sensitive.  
TopBP1 gene dosage reduction was associated with a partial defect in S345 
Chk1 phosphorylation and presumably activation in response to replication stress as 
well as recovery from replication stress. There was also a partial defect in S139 γH2AX 
 245 
phosphorylation at early stages of replicative stress. In contrast, prolonged replication 
stress resulted to increased pS139 γH2AX, indicative of persisting unrepaired damage. 
Additionally, reduction of the TopBP1 levels rendered some cells unable to recover 
from replication stress. These results show that TopBP1 is required for proper 
functioning of the ATR-Chk1 pathway in a gene dosage-dependent way. We speculate 
that the reduction in the protein levels of TopBP1 is associated with both a reduced 
activation of ATR (thus impairment of the auto-amplification loop) and a limited 
scaffolding function for assembly of the checkpoint apparatus, opening the gate to 
genetic instability. Therefore an intact ATR-Chk1 pathway is dependent on an optimal 
threshold of TopBP1 availability. Taken together these results suggest that activation of 
Chk1 in the context of prolonged replication stress is essential for suppression of DNA 
damage and this depends on TopBP1 gene dosage. But why the majority of cells still 
manage to successfully arrest the cell cycle? This is probably due to compensation by 
the Chk2 kinase, which is known to enforce the S-M checkpoint in Chk1 knockout 
DT40 cells (Zachos, Rainey et al. 2003).  
Gene dosage reduction of TopBP1 resulted to decreased pS139 γH2AX 
following IR, indicative of defective ATM/ATR signaling. Interestingly, 
phosphorylation of H2AX is thought to be dispensable for activation of ATM substrates 
but necessary for recruitment of DNA repair factors (Fernandez-Capetillo, Chen et al. 
2002). Furthermore, TopBP1 gene dosage reduction caused abnormally increased levels 
of pS345 Chk1 following IR. We speculate that this is due to a repair defect resulting 
from limited TopBP1. In other words, reduced TopBP1 causes impaired ATM/ATR 
signaling and subsequently a defective assembly of damage repair machinery or 
defective repair per se. Besides, TopBP1 is known to be directly involved in repair via 
its association with the SLX4 repair scaffold as well as via its role in Rad51 loading 
(Gritenaite, Princz et al. 2014, Moudry, Watanabe et al. 2016). As a result, it is possible 
that when the available TopBP1 pool is limited, repair intermediates persist longer and 
lead to increased phosphorylation of the effector kinase. 
A subset of TopBP1-/-/+ cells was also unable to traverse from G1/S towards the 
G2 arrest following high doses of irradiation. This is possibly a result of unrepaired 
DNA damage preventing the S-M transition. Furthermore, the nocodazole-trap 
experiment showed that cells with reduced TopBP1 were unable both to properly hold 
the mitotic block in response to nocodazole treatment and to efficiently arrest at G2 
when they have been previously irradiated.  
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Finally, depletion of TopBP1 using the miniAID-SMASh degron in RPE cells 
resulted in a complete inability to incorporate EdU, which is reminiscent of the essential 
function of TopBP1 during the initiation of DNA replication. Furthermore, TopBP1 
depletion resulted to pS139 γH2AX accumulation, in otherwise untreated cells, 
pinpointing again to the role of TopBP1 in genome stability. 
Taken together, TopBP1 gene dosage is required for transmission of checkpoint 
signals through the ATR/ATM stress response kinases. The present study therefore 
complements the long-standing model that it is the threshold of TopBP1 that determines 
checkpoint signalling.  The levels of TopBP1 are commonly disrupted in human 
cancers. These results might explain why genetic changes that alter TopBP1 levels are 
positively selected for during tumour evolution, since it fuels genomic instability thus 
tumour progression.  
The establishment of this isogenic set of DT40 stable cell lines with varying 
copies of the TopBP1 alleles defines a novel gene knock in platform for a structure-
function analysis of Topbp1. Future work could also more precisely define the TopBP1 
dosage-dependent checkpoint defects at the molecular level. 
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Characterisation of the TopBP1 AAD using a knock-in point mutation strategy. 
 Central to the role of the TopBP1 protein within the DDR is its ability to act as a 
molecular scaffold for the assembly of the checkpoint apparatus as well as its ability to 
directly activate the stress response kinases ATM and ATR. Using a knock-in gene 
targeting strategy for the integration of TopBP1 point mutants within the intact allele of 
TopBP1-/-/+ cells, we have uncovered potential in vivo functions of the TopBP1 AAD 
both in the generation and transmission of the checkpoint signal as well as in the 
crosstalk between ATM and ATR activation routes. Our data corroborate previous 
studies, propose new possible explanations for the observed phenotypes and allow the 
study of TopBP1 mutants that have resulted to embryonic lethality in our mouse 
models, thus rendering the study of cellular phenotypes impossible (Zhou, Liu et al. 
2013). 
 The S1132 residue within the AAD of TopBP1 has been described to have an 
essential role for the activation of ATR at DSBs but not stalled forks. In fact, ATM-
catalysed phosphorylation of S1132 was shown to be necessary for activation of ATR in 
Xenopus egg extracts exposed to DNA damage (Yoo, Kumagai et al. 2007). This 
observation, however, was different to what Hashimoto et al (2006) has reported. To 
investigate this in vivo, I mutated S1132 at the chromosomal locus of TopBP1-/-/+ cells, 
thus replacing the entire wild-type TopBP1 population with a TopBP1 S1132A mutant.  
The results described in Chapter 7 propose a functional role of the TopBP1 
S1132 during replication stress and DNA damage, albeit with different outcomes with 
respect to cell fate. S1132A mutant cells were less effective in phosphorylating S345 
Chk1 and S139 γH2AX than the parental control cells. And this was observed both 
during continuous replicative stress and recovery as well as post-IR at all doses tested. It 
should be reminded, however, that the observed defects were more severe when cells 
were irradiated compared to HU-caused replication stress. Such observations help us 
speculate on the function of TopBP1 S1132. Although abolishment of TopBP1 S1132 
leads to a slight impairment of checkpoint signaling following replication stress, this is 
not enough to impair successful cell cycle arrest. This is presumably because the 
abolishment of the ATM-Chk1 arm plays a comparatively minor role to the major ATR-
Chk1 replication stress response mechanism. Therefore, the replication stress response 
mainly functions in a TopBP1 S1132-independent way to relay the checkpoint signal to 
the Chk1 effector kinase. And the presumably defective ATM-dependent and TopBP1 
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S1132-dependent phosphorylation of Chk1 is not sufficient to affect cell cycle arrest 
and cell fate.  
In contrast, TopBP1 S1132 appears to play a more significant role during the 
DNA damage response, with mutant cells presenting low levels of nuclear 
fragmentation and defective cell cycle progression in addition to the signaling defects 
described earlier. We speculate that although the major IR response pathway ATM-
Chk1(/Chk2) is functional, there is a TopBP1 S1132-dependent mechanism that is also 
important for successful G2 arrest and cell fate. One possibility is that ATR activation is 
required for the repair of a subset of IR-induced breaks (or indeed for cells traversing 
G1/S at the time of irradiation) and this activation depends on ATM-catalysed 
phosphorylation of TopBP1 S1132. Abolishment of this residue precludes its 
phosphorylation by ATM, impairs its interaction with ATR and thus overall prevents 
relaying of the signal from ATM to ATR. The other possibility which is more appealing 
but perhaps more speculative is that TopBP1 S1132 is required for activation of the 
ATM kinase itself. 
Taken together, we propose that activation of Chk1 in response to replication 
stress partly requires TopBP1 S1132 but failure to do so does not impact on cell fate. 
On the other hand, activation of Chk1 following DNA damage is to a greater extent 
dependent on TopBP1 S1132 and abolishment of this mechanism sensitises a subset of 
cells to apoptosis before they reach the G2 arrest. Future work is required to gain insight 
into the underling molecular mechanisms of the observed phenotypes. 
 Examination of the W1139 core residue of the TopBP1 AAD reveals an 
essential function during replication stress but not DNA damage, consistent with 
previous observations. First of all, the fact that W1139R cells have a longer cell cycle 
compared to their parental counterparts (15h versus 11.5h) suggests that this residue of 
the AAD is important, although not essential, during unperturbed growth. We speculate 
that this is related to the housekeeping function of ATR in the stabilisation of stalled 
forks even in undamaged cells. More importantly, our results provide in vivo evidence 
for an essential function of TopBP1 W1139 in checkpoint activation and cell fate 
following replication stress, which cannot be substituted for by other potential AAD 
domains in my assay and under the conditions tested. Abolishment of W1139 is 
sufficient to abolish phosphorylation of the effector kinase Chk1 on S345 in response to 
HU. Additionally, the altered mobility shift of the Chk1 protein itself in W1139R cells 
is presumably indicative of an inability to phosphorylate Chk1 on residues other than 
 249 
S345 as well. Another possible explanation is that Chk1 becomes inactivated, as cells 
become apoptotic. In fact it has been documented that apoptosis is characterised by 
degradation of Claspin and subsequent inactivation of the Chk1 effector (Semple, Smits 
et al. 2007). This Chk1 phenotype correlates with the observation that prolonged 
exposure to replication stress –even at extremely low levels- renders W1139R cells 
unable to recover and induces nuclear fragmentation, a hallmark of apoptotic cell death. 
This apoptotic phenotype observed in the mutants is accompanied by an increased 
phosphorylation of pS345, presumably a result of severe damage remaining unrepaired. 
 Despite the severely impaired phosphorylation of S345 Chk1 (and S139 
γH2AX) observed in W1139R cells that have been previously irradiated, cell fate is not 
affected. In fact, W1139R cells can successfully halt their cell cycle in response to IR, 
with very limited nuclear fragmentation observed. This suggests, that the ATM-
Chk1(/Chk2) pathway functions –at least to a large extent- in a TopBP1 W1139-
independent manner during the DNA damage checkpoint response. 
 Taken together, this data suggests that there are two mechanisms of checkpoint 
activation in this context. One mechanism operates during DNA damage and relays the 
signal to downstream effectors leading to successful cell cycle arrest. This is 
presumably an ATM-mediated pathway, which results to low levels of pS345 Chk1 and 
is not dependent on TopBP1 W1139, hence on activation of ATR. The other mechanism 
is the well-established mechanism of ATR activation by TopBP1, which is thought to 
provide a way of signal auto-amplification and full activation of the ATR pathway. This 
mechanism is W1139-dependent.  
The fact that W1139R mutants completely fail to respond to replication stress 
and immediately become apoptotic suggests that during replication stress both of the 
aforementioned mechanisms do not operate. I speculate that this is due to the impaired 
activation of ATR by the mutant TopBP1 (W1139R) during HU leading to increased 
levels of ssDNA being generated. Consequently, coating of the extensive tracts of 
ssDNA with RPA leads to RPA exhaustion and replication catastrophy. In support of 
this hypothesis, the phenotypes observed after HU treatment of the W1139R mutants, in 
particular the accumulation of fragmented nuclei with sub-G1 content, resemble the 
phenotypes observed after loss of ATR kinase activity in human cell lines (Toledo et al 
2013).  
Another possibility is that the phenotypes may be due to TopBP1 W1139-
dependent ATR activation being required for activation of ATM at broken forks. This 
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reveals a possible crosstalk route between the two kinases. So similarly to how TopBP1 
S1132 is required for activation of ATR after DNA damage, it is possible that W1139 is 
required for activation of ATM during replication stress. In support of this idea, Chk1 is 
not essential in DT40 cells and in the absence of Chk1 compensatory mechanisms take 
over to elicit a checkpoint response (Zachos et al 2003). Here, we observe both an 
inability to phosphorylate Chk1 (which is dependent on TopBP1 W1139) and a 
complete absence of some compensatory mechanism that would act to at least prevent 
apoptosis. 
Another interesting observation from the data presented herein is that no other 
protein factor seems to compensate for the mutated TopBP1 AAD domain following 
HU treatment.  The recently characterised ATR activator ETAA1 would be an ideal 
candidate to rescue the apoptotic phenotype of W1139R cells through its ability to bind 
RPA and propagate ATR activation along stretches of ssDNA independently of the 9-1-
1 complex (Bass et al 2016). But this is not the case in the system presented herein. This 
could be due to the AAD function of ETAA1 being in some way dependent on the AAD 
function of TopBP1, in DT40 at least. Alternatively, the W1139R mutation of TopBP1 
might lock the protein on the lesion precluding the physical access to other AAD-
containing proteins like ETAA1. In other words, the W1139R TopBP1 gets localised to 
the lesion as would the wild-type protein but no activation of ATR above the basal 
levels occurs.  
Future work is necessary to gain insight into the mechanism of operation of the 
W1138 core AAD residue. For now, our data suggest that the ATR pathway determines 
cell fate in response to replication stress and this is dependent on TopBP1 W1138, in a 
way that is reminiscent of ATR deletion (Brown and Baltimore 2000, de Klein, 
Muijtjens et al. 2000). Therefore the TopBP1 W1139 residue performs a function that 
becomes essential during replication stress and possibly involves both an ability to 
activate the ATR kinase and the ability to signal to ATM. 
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Epilogue 
 The current work made use of novel genetically defined model systems to study 
the avian TopBP1 protein and its functions (Figure 8.2). Future use of these systems 
and the information obtained from this thesis will help gain insight into the 
characteristics of TopBP1 at the protein and RNA levels as well as its various roles of 
TopBP1 in the DNA Damage Response. 
 
Figure 8.2: Summary of the work and approaches carried out in the current thesis. 
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There is still a lot to learn. The puzzle is far from being complete. The innate complexity 
of biological systems requires persistent research and faith towards a unifying 
understanding of living matter. 
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APPENDIX 1 
Generation of a polyclonal anti-TopBP1 antibody 
To study the function of the avian TopBP1, an antibody against a C-terminal peptide of 
the gallus gallus protein was raised in rabbits by Eurogentec. This corresponded to 
55kDa. To first test the specificity of the antibody, I performed some Western blot (as 
shown in A) analysis using recombinant fragments (or the corresponding bacterial 
lysates) of either terminus of the protein as well as a full length clone to quickly test 
whether the serum could specifically recognize the peptide used to immunize the 
rabbits. Once specificity was confirmed, this peptide was recombinantly expressed in 
bacteria (as shown in B) and used to purify the TopBP1 antibody from the rabbit serum 
as explained in the Material and Methods section. The gel in C shows the heavy and 
light chains stained with Coomassie blue following elution of the antibody from the 
column. All work in this thesis makes use of this antibody. 
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APPENDIX 2 
 
TopBP1 protein sequence alignment in different organisms as generated by the 
ClustalW sequence alignment software 
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APPENDIX 3 
Predicted secondary structures of the new 5’ end of the gallus gallus TopBP1 RNA 
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